CN1741741A - 用于治疗狼疮肾炎的组合物和方法 - Google Patents
用于治疗狼疮肾炎的组合物和方法 Download PDFInfo
- Publication number
- CN1741741A CN1741741A CNA2003801090876A CN200380109087A CN1741741A CN 1741741 A CN1741741 A CN 1741741A CN A2003801090876 A CNA2003801090876 A CN A2003801090876A CN 200380109087 A CN200380109087 A CN 200380109087A CN 1741741 A CN1741741 A CN 1741741A
- Authority
- CN
- China
- Prior art keywords
- leu
- bflp0169
- polypeptide
- ser
- ala
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Rehabilitation Therapy (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
本发明提供新的分离的BFLP0169多核苷酸和由该BFLP0169多核苷酸编码的多肽。也提供特异性免疫结合BFLP0169多肽或BFLP0169多肽、多核苷酸或抗体的任何衍生物(包括融合衍生物)、变体、突变体或片段的抗体。另外本发明提供利用BFLP0169多肽、多核苷酸和抗体检测和治疗大量病理状态的方法,及其它用途。
Description
发明领域
总的说来,本发明涉及核酸和多肽,更具体地,涉及编码用于检测和治疗狼疮肾炎,以及鉴定用于治疗狼疮肾炎的治疗剂的多肽的核酸和多肽。
发明背景
狼疮肾炎是″经典的″自身免疫性疾病的实例,其中患者的免疫系统攻击其自身的器官。已经估计45-75%的狼疮患者总会患某些形式或其它的肾脏损伤。从需要极少介入的轻微病例直至重要器官,例如肺、肾脏、心脏和脑发生显著损伤并最终可能致命的病例,狼疮的严重程度有很大的不同。狼疮主要是女性疾病,女性与男性比率约是9∶1。在北美,估计每500个年龄在20至40岁的女性中就有一个1个受到影响。
针对狼疮的治疗还是未知的。治疗一般旨在控制症状以希望使疾病的症状缓解。最近,已经证明抗生素雷帕霉素在该疾病的鼠模型中对于治疗狼疮肾炎有效。
发明概述
本发明部分地是基于名称为BFLP0169基因的发现,其在患有狼疮肾炎的小鼠肾脏组织中表达增加;然而,该基因的表达水平不随雷帕霉素治疗而显著降低。这个表达图谱表明,当施用这个抗生素以改善狼疮肾炎的症状时,BFLP0169基因的产物与雷帕霉素相互作用。当缺乏雷帕霉素时,该基因产物是游离的,以造成患病状态,并且其影响可能包括活化为导致该患病状态所需要的基因。当存在雷帕霉素时,BFLP0169基因产物是失活的并且使患病状态减弱。因此,BFLP0169蛋白质可用作鉴定在治疗狼疮肾炎症状中类似雷帕霉素的有用的试剂的靶。
在一个方面,本发明提供包括编码BF40169基因产物的核苷酸序列的分离核酸分子。在优选的实施方案中,该核苷酸序列包括SEQ IDNO:1的序列,或其片段、同系物、类似物或衍生物。该核酸可包括例如,编码与包括SEQ ID NO:2的氨基酸序列的多肽至少70%、例如80%、85%、90%、95%、98%,甚至99%或以上相同的多肽的核酸序列。该核酸可以是例如,基因组DNA片段或cDNA分子。
本发明也包括包含一种或多种在此所描述的核酸的载体,和包含所述载体或核酸的细胞。
本发明也针对用包括如上所述的任何核酸分子的载体转化的宿主细胞。
在另一个方面,本发明包括包含BFLP0169核酸和药物学上可接受的载体或稀释剂的药物组合物。
在进一步的方面,本发明包括基本上纯化的BFLP0169多肽,例如任何由BFLP0169核酸编码的BFLP0169多肽,及其片段、同系物、类似物和衍生物。本发明也包括包含BFLP0169多肽和药物学上可接受的载体或稀释剂的药物组合物。
在更进一步的方面,本发明提供特异结合BFLP0169多肽的抗体。该抗体可以是例如,单克隆或多克隆抗体,及其片段、同系物、类似物和衍生物。本发明也包括包含BFLP0169抗体和药物学上可接受的载体或稀释剂的药物组合物。本发明也针对结合由如上所述任何核酸分子编码的多肽上的表位的分离抗体。
本发明也包括试剂盒,其在一个或多个容器中包括BFLP0169核酸、BFLP0169多肽和/或BFLP0169多肽的抗体的一种或多种化合物。优选该试剂盒配备有使用说明书。如果需要,试剂盒中的化合物与药物学上可接受的载体一起提供。
本发明进一步通过提供包含BFLP0169核酸,例如包括BFLP0169核酸的载体的细胞,并且在足够表达由该核酸编码的BFLP0169多肽的条件下培养细胞,而提供用于生产BFLP0169多肽的方法。然后从该细胞回收表达的BFLP0169多肽。优选地,该细胞产生极少或者几乎不产生内源的BFLP0169多肽。该细胞可以是例如,原核细胞或真核细胞。
本发明也涉及通过将样品与特异结合该多肽或核酸的化合物接触,通过检测复合物形成而鉴定样品中的BFLP0169多肽或核酸的方法。
本发明进一步提供通过将BFLP0169多肽与化合物接触,并且确定BFLP0169多肽活性是否改变而鉴定调节BFLP0169多肽活性的化合物的方法。
本发明还涉及通过将BFLP0169多肽与化合物接触,并且确定该化合物是否改变BFLP0169多肽的活性、结合BFLP0169多肽、或结合编码BFLP0169多肽的核酸分子而鉴定的调节BFLP0169多肽活性的化合物。
另一个方面,本发明提供确定受试个体中存在或易患BFLP0169相关病症的方法。本方法包括提供来自受试个体的样品并且测量受试个体样品中BFLP0169多肽的量。然后将受试个体中BFLP0169多肽的量与对照样品中BFLP0169多肽的量相比。受试个体蛋白质样品中BFLP0169多肽量相对于对照蛋白质样品中BFLP0169多肽量的变化,表明受试个体具有组织增殖相关的状况。优选从相配的个体,即相似年龄、性别、或其它一般条件,但不被怀疑具有组织增殖相关状况的个体取对照样品。备选地,对照样品可取自当受试个体不被怀疑具有组织增殖相关病症的时候的受试个体。在一些实施方案中,利用BFLP0169抗体检测BFLP0169。
在另一个方面,本发明提供确定受试个体中存在或易患BFLP0169相关病症的方法。该方法包括提供来自受试个体的核酸样品,例如RNA或DNA或两者,并且测量受试个体核酸样品中BFLP0169核酸的量。然后将受试个体核酸样品中BFLP0169核酸样品的量与对照样品中BFLP0169核酸的量相比。样品中BFLP0169核酸量相对于对照样品中BFLP0169量的变化,表明该受试个体具有组织增殖相关的病症。
在更进一步的方面,本发明提供治疗或预防或延迟BFLP0169相关病症的方法。该方法包括对需要此种治疗或预防或延迟的受试个体施用足以治疗、预防或延迟受试个体中组织增殖相关病症的量的BFLP0169核酸、BFLP0169多肽、或BFLP0169抗体。这种病症的实例包括风湿性关节炎和多发性硬化。
除非另外限定,否则在此所使用的所有技术和科学术语具有如本发明所属领域的普通技术人员通常所认为的相同意义。尽管与在此所描述的相似或等效的方法和物质可用于本发明的实施或测试,适当的方法和物质描述如下。 在此提及的所有出版物、专利申请、专利,以及其他参考文献全部引入作为参考。在出现分岐时,以本说明书的定义为准。此外,材料、方法和实施例只是说明性的而不是限制性的。
本发明的其他特性和优势可从下列的详细描述和权利要求中明显体现出来。
附图简述
图1是显示在雷帕霉素治疗前、治疗期间和治疗后,在NZB×NZWF1的肾脏以及在不同的对照小鼠株和条件下,人BFLP0169基因的小鼠直向同源物中基因表达相对水平的直方图。
发明详述
在此公开的BFLP0169核酸序列是根据与来自非患病小鼠肾脏中该基因表达相比,狼疮肾炎模型小鼠肾脏中该基因表达的变化而鉴定的。更特别地,该基因在幼仔小鼠和不显示狼疮肾炎症状的小鼠中以相对低的水平表达。在患有狼疮肾炎的小鼠中基因表达升高,而在已经用雷帕霉素或抗-B7抗体成功处理的小鼠中是较低的。当肾脏功能正常而观察到表达水平恢复正常,表明升高的水平与疾病进展相关和并可诊断疾病的进展。阻断这些基因的功能可以抑制或延迟疾病进展。表达水平也可用于评估和比较不同治疗介入的有效性。
因此,BFLP0169核酸序列对于检测受试个体中狼疮肾炎的存在是有用的。相对于对照样品中的水平,BFLP0169转录本或多肽的水平升高表明在受试个体中存在狼疮肾炎。BFLP0169核酸序列也可用来监测治疗狼疮肾炎的有效性:相对于患病治疗水平,BFLP0169基因表达的减少表明该治疗是有效的。
另外BFLP0169序列可用来鉴定在受试个体中用于治疗或预防狼疮肾炎的治疗剂。例如,可使BFLP0169多肽与测试剂接触。BFLP0169多肽与测试剂的结合显示该测试剂调节BFLP0169活性。可进一步测试BFLP0169结合剂,确定它是否在测试生物体(例如,NZB×NZW小鼠)中促进或抑制狼疮症状。狼疮症状的抑制显示该试剂具有治疗或预防狼疮肾炎、或与狼疮肾炎相关的症状的用途。在此公开其它的用途。
表1显示了一种包括人BFLP0169核酸在内的5987个核苷酸的序列(SEQ ID NO:1)。确定该人序列为鼠基因的人直向同源物,所述鼠基因在患有狼疮肾炎样症状的NZB×NZW小鼠中其表达增加。
该序列的第1-5259位核苷酸如表1所示,其编码如表2所示序列的1753个氨基酸的多肽(SEQ ID NO:2)。
表1
ATGATCAGAAAGAGCAAAATTACCTCTGTTCTCTCATTTTGCAGGAGCAGTAGAGAACTGTGGACTATTCTGCTTGGA
AGGTCAGCTCTGAGAGAGCTGAGTCAGATTGAGGCAGAACTGAATAAACATTGGCGGCGATTGTTAGAGGGGCTTTCT
TACTACAAACCTCCCAGTCCAAGTTCAGCTGAAAAAGTGAAAGCTAATAAAGATGTAGCTTCACCATTGAAGGAACTG
GGTTTAAGAATCAGCAAGTTTTTGGGTCTTGATGAAGAACAGAGTGTGCAGTTACTCCAGTGTTACCTGCAAGAGGAC
TACAGGGGTACTCGGGACTCAGTAAAGACAGTACTGCAAGATGAGAGGCAGAGCCAGGCCTTAATCCTGAAGATTGCA
GATTATTATTATGAAGAAAGAACCTGTATTCTTCGTTGTGTCTTACACCTTCTCACTTACTTCCAAGATGAAAGACAC
CCCTATAGGGTTGAATATGCAGACTGTGTTGATAAATTGGAGAAGGAACTAGTTTCAAAATACAGACAGCAGTTCGAA
GAGCTTTATAAAACTGAAGCACCAACTTGGGAGACACATGGAAATCTCATGACAGAGCGCCAAGTGTCTCGCTGGTTT
GTTCAGTGCCTTCGGGAACAGTCCATGCTGCTAGAAATTATTTTCCTTTATTATGCATACTTTGAGATGGCACCCAGT
GACTTACTTGTATTAACCAAGATGTTTAAAGAGCAAGGATTTGGTAGTAGGCAGACCAATAGGCACCTGGTGGATGAG
ACTATGGATCCTTTTGTAGATCGGATTGGCTACTTCAGTGCCCTCATCCTGGTGGAGGGCATGGATATCGAGTCCTTG
CATAAGTGTGCTTTGGATGACAGAAGAGAACTGCATCAGTTTGCGCAGGATGGGCTTATTTGTCAGGATATGGACTGT
TTAATGTTGACCTTTGGGGACATTCCACATCATGCCCCAGTGCTTTTGGCCTGGGCTCTCCTCCGTCACACTCTGAAC
CCAGAAGAGACAAGCAGTGTGGTCCGGAAGATAGGTGGCACAGCCATCCAGCTGAATGTGTTTCAGTACTTGACCCGA
TTGCTCCAGTCCCTTGCCAGTGGGGGAAATGATTGCACCACCAGCACTGCATGCATGTGTGTCTATGGACTGCTCTCT
TTCGTTCTGACCTCGTTGGAGCTGCACACCCTGGGCAATCAGCAGGATATAATTGATACAGCATGTGAAGTATTGGCC
GACCCTTCTCTTCCGGAACTGTTCTGGGGAACAGAGCCAACTTCTGGCCTTGGGATCATTCTGGACAGTGTGTGTGGA
ATGTTTCCCCACCTTCTCTCCCCACTCCTGCAACTGCTCCGAGCCCTGGTATCAGGGAAGTCCACAGCCAAAAAGGTG
TATAGCTTCTTGGATAAGATGTCTTTCTACAATGAACTTTATAAACACAAGCCTCATGATGTGATCTCCCATGAAGAT
GGAACTCTTTGGCGGAGACAAACACCCAAACTCCTTTATCCCCTTGGGGGTCAAACCAACCTTCGCATACCTCAAGGC
ACTGTGGGCCAAGTAATGTTGGATGATAGGGCATACCTGGTACGCTGGGAATACTCCTATAGCAGCTGGACCCTCTTT
ACCTGCGAGATTGAAATGTTGCTTCATGTTGTTTCAACTGCAGATGTGATTCAGCACTGCCAGCGAGTCAAACCCATC
ATTGATCTCGTCCATAAGGTCATCAGTACAGACCTGTCGATAGCAGACTGTCTCCTGCCCATCACATCTCGCATCTAC
ATGCTGCTGCAGCGGTTAACGACAGTGATCTCCCCACCTGTGGATGTCATTGCTTCTTGTGTCAACTGCTTAACTGTT
TTGGCTGCCCGCAATCCAGCAAAGGTCTGGACTGATCTTCGTCACACAGGTTTTTTACCATTTGTGGCCCATCCTGTC
TCCAGCCTGAGTCAGATGATTAGTGCGGAAGGGATGAATGCTGGAGGGTACGGAAACCTCTTGATGAACAGTGAACAG
CCTCAGGGCGAGTATGGGGTTACTATTGCCTTTCTGCGCTTGATCACCACCCTTGTCAAGGGGCAACTTGGTAGTACC
CAGAGCCAAGGACTTGTACCCTGTGTAATGTTTGTGCTGAAGGAGATGCTTCCCAGCTACCATAAGTGGCGCTACAAC
TCTCATGGAGTGAGGGAACAGATTGGTTGCCTGATCTTGGAGCTGATTCATGCGATACTGAACCTGTGCCACGAGACA
GACCTGCACAGCAGTCATACTCCCAGCCTGCAGTTTCTCTGCATCTGCAGCCTGGCATACACAGAAGCAGGACAGACA
GTTATCAATATCATGGGCATTGGCGTGGACACCATTGACATGGTGATGGCTGCTCAGCCTCGAAGTGATGGGGCAGAG
GGCCAGGGGCAGGGCCAGCTGCTGATCAAGACAGTGAAACTGGCATTCTCCGTCACCAACAATGTTATTCGGCTGAAA
CCTCCTTCTAATGTGGTGTCCCCCCTGGAACAGGCTCTCTCACAACATGGTGCTCATGGAAACAACCTCATTGCTGTT
CTAGCCAAATACATCTACCACAAACATGACCCTGCTTTGCCACGTCTTGCCATTCAGCTGCTGAAACGTCTGGCCACG
GTGGCCCCAATGTCAGTGTATGCTTGTCTGGGCAATGATGCGGCTGCCATTCGTGATGCCTTCCTGACCCGATTGCAG
AGCAAAATTGAGGACATGCGCATCAAAGTCATGATTCTAGAGTTCCTCACTGTTGCAGTAGAGACCCAGCCAGGCCTC
ATCGAACTGTTTCTGAACCTGGAAGTTAAGGATGGCAGTGATGGCTCAAAGGAATTCAGCCTTGGGATGTGGAGCTGT
CTCCATGCAGTGCTGGAGCTGATTGATTCCCAACAGCAAGATCGATACTGGTGCCCACCCCTGCTGCATCGTGCCGCC
ATTGCCTTTTTGCATGCTCTGTGGCAGGATCGGAGGGACAGTGCCATGCTGGTCCTCCGAACCAAACCCAAGTTTTGG
GAAAATTTAACCAGTCCGCTGTTTGGAACCCTTTCTCCTCCCTCTGAAACATCAGAGCCCAGCATCCTGGAAACCTGT
GCCCTAATCATGAAGATAATTTGCTTGGAGATATACTATGTAGTAAAGGGTTCATTAGACCAGTCATTAAAGGATACA
CTGAAGAAATTTTCCATCGAGAAACGCTTTGCCTACTGGTCAGGGTATGTCAAGTGATTGGCAGTTCACGTGGCCGAA
ACAGAAGGCAGCAGCTGCACCTCCTTGTTAGAGTACCAGATGCTGGTGTCCGCCTGGAGGATGCTTCTCATCATTGCC
ACCACTCATGCAGATATAATGCACCTGACTGACTCTGTGGTGCGTCGCCAGCTCTTTCTTGACGTGCTTGATGGAACC
AAAGCATTACTCCTAGTTCCAGCCTCAGTGAACTGCCTTCGCCTTGGCTCCATGAAGTGCACTCTGCTGCTTATCCTC
CTCCGGCAGTGGAAGAGAGAGTTAGGTTCTGTGGATGAAATCCTTGGACCCTTGACGGAGATCCTGGAGGGAGTGCTG
CAGGCCGACCAGCAACTCATGGAGAAGACCAAGGCCAAGGTGTTCTCAGCATTCATCACAGTGTTGCAAATGAAGGAG
ATGAAAGTAAGTGACATCCCCCAGTACTCCCAGCTGGTGCTGAATGTCTGTGAGACCCTCCAAGAGGAAGTGATTGCA
CTCTTCGACCAGACCCGCCACAGTCTGGCATTAGGCAGTGCCACAGAGGACAAGGACAGCATGGAGACTGACGACTGT
TCTCGGTCCCGGCACAGGGACCAGCGTGATGGGGTGTGTGTCCTGGGCCTGCACCTGGCCAAGGAGCTGTGTGAGGTA
GACGAGGATGGTGACTCCTGGCTGCAGGTAACCCGCAGGCTCCCCATCCTACCCACCCTCCTCACCACTCTAGAGGTG
AGCCTTCGCATGAAGCAGAACCTGCATTTCACTGAGGCCACATTGCATCTGCTCCTCACCCTGGCTCGCACTCAGCAG
GGAGCCACAGCAGTGGCTGGAGGTGGCATCACCCAGAGCATTTGTTTGCCCCTTCTGAGTGTGTACCAGCTGAGCACC
AACGGCACAGCACAGACACCTAGTGCCTCTCGGAAGTCCCTGGATGCCCCCTCTTGGCCAGGAGTCTACCGCCTGTCC
ATGTCCCTGATGGAGCAGCTGCTCAAAACTCTGCGCTACAACTTCCTGCCTGAGGCCCTGGACTTCGTGGGTGTCCAC
CAGGAGCGGACCTTACAGTGCCTCAACGCAGTGAGGACAGTGCAGAGTCTGGCCTGCCTGGAGGAGGCGGACCACACC
GTGGGTTTTATTCTGCAGCTCTCTAACTTCATGAAGGAGTGGCACTTCCACCTGCCTCAGCTCATGCGTGATATCCAG
GTCAACCTGGGTTACTTGTGCCAGGCATGTACCTCTCTCCTGCACAGTCGAAAGATGCTGCAGCATTACTTACAGAAC
AAAAATGGGGATGGCCTCCCCTCAGCTGTTGCCCAGCGAGTCCAGAGGCCACCGTCTGCTGCTTCTGCTGCCCCCTCC
TCCTCAAAGCAGCCCGCTGCTGACACAGAGGCATCAGAGCAGCAGGCCTTGCACACAGTCCAGTATGGCCTTCTCAAG
ATCCTCAGCAAGACGCTGGCAGCCCTGCGCCACTTCACCCCAGATGTCTGCCAGATTCTGCTGGATCAGTCCCTGGAC
CTTGCTGAATACAACTTCCTGTTTGCCCTGAGCTTTACCACTCCCACCTTTGACTCCGAAGTGGCCCCCTCCTTCGGG
ACCCTTCTGGCCACAGTGAATGTGGCCCTCAACATGCTTGGAGAGCTGGACAAGAAAAAGGAGCCCCTCACCCAGGCA
GTGGGGCTCAGCACACAGGCAGAAGGGACCAGGACGTTAAAGTCCCTCCTGATGTTTACCATGGAAAACTGCTTCTAC
CTGCTCATCTCTCAGGCGATGCGGTACCTTAGGGACCCGGCTGTGCACCCCCGGGACAAACAGCGGATGAAGCAGGAG
CTCAGCTCTGAGTTGAGCACGCTGCTGTCCAGCCTCTCGCGCTACTTCCGCCGGGGAGCCCCCAGCTCCCCTGCCACT
GGTGTCCTCCCCTCGCCGCAGGGCAAGTCCACCTCTCTCTCCAAAGCCAGCCCTGAGAGTCAGGAGCCTCTGATCCAG
TTGGTGCAGGCGTTTGTCCGGCATATGCAAAGATAGGGCAGTGCTGTTCTGCCCACCTACCCCTCTCCACCAGCCTAC
ACTGCACCCTGGCTGGCAGGGGTGCTGCTGGCTGCTAGGGCCTATACAATGGAGGGCACCTCCTGTCACCCCCCTCCC
GGAGTAGCCACGACTCCAGCCACCACCCACTGACGTTATTTTTATACTAGATGAAGAGGTCAACAGCAGGCATGGGGA
GCCGAGTCTTCTGTGCTCAGGTCCTCACGCTGCAGACGCCCCCTAGAGGAACTTTCCTTCCTTTCCAGCATTCCCCAC
AGCACTGCCGGCCAGGGGAGAGGCGGCAGCCCAGCAGAGGGCTCTATGCACGGGTTTCAAACCTGTTTTCCACACTCT
GTCTTTGCAGTTTTGGTAATTCTGTGGTCTATTTATACAGATATTAAAATCTTGTTTATAGACAGCTGTGTGATGTTT
AACTTCAAAGCCCAGGGATGACAACGTGGCTCTCAGAACCTAGAAAACTCCCCTGGCCAGGCGCCTGGGAGTGGGGCT
GCAGCCTCGGGGGAAGGCAGGTACTGATGGATGGCTAGTTCACCAGCATCTCCTCATTCCTGTCCTTGGGCTGAGGGT
TTGGCTGGGTGGGCGCTGTCAGATATTCCCTTCCTTGGCCTGCGCTGGTCCTGTCCTTGACCCTGCTTTCATTGGCCC
AGTGGGCTGAGCTCATCCCTGGGTGAGCCTTTCTTGAAGCTCTGTGCCTTCCTATTTAT(SEQ ID NO:1)
表2
MIRKSKITSVLSFCRSSRELWTILLGRSALRELSQIEAELNKHWRRLLEGLSYYKPPSPSSAEKVKANKDVASPLKEL
GLRISKFLGLDEEQSVQLLQCYLQEDYRGTRDSVKTVLQDERQSQALILKIADYYYEERTCILRCVLHLLTYFQDERH
PYRVEYADCVDKLEKELVSKYRQQFEELYKTEAPTWETHGNLMTERQVSRWFVQCLREQSMLLEIIFLYYAYFEMAPS
DLLVLTKMFKEQGFGSRQTNRHLVDETMDPFVDRIGYFSALILVEGMDIESLHKCALDDRRELHQFAQDGLICQDMDC
LMLTFGDIPHHAPVLLAWALLRHTLNPEETSSVVRKIGGTAIQLNVFQYLTRLLQSLASGGNDCTTSTACMCVYGLLS
FVLTSLELHTLGNQQDIIDTACEVLADPSLPELFWGTEPTSGLGIILDSVCGMFPHLLSPLLQLLRALVSGKSTAKKV
YSFLDKMSFYNELYKHKPHDVISHEDGTLWRRQTPKLLYPLGGQTNLRIPQGTVGQVMLDDRAYLVRWEYSYSSWTLF
TCEIEMLLHVVSTADVIQHCQRVKPIIDLVHKVISTDLSIADCLLPITSRIYMLLQRLTTVISPPVDVIASCVNCLTV
LAARNPAKVWTDLRHTGFLPFVAHPVSSLSQMISAEGMNAGGYGNLLMNSEQPQGEYGVTIAFLRLITTLVKGQLGST
QSQGLVPCVMFVLKEMLPSYHKWRYNSHGVREQIGCLILELIHAILNLCHETDLHSSHTPSLQFLCICSLAYTEAGQT
VINIMGIGVDTIDMVMAAQPRSDGAEGQGQGQLLIKTVKLAFSVTNNVIRLKPPSNVVSPLEQALSQHGAHGNNLIAV
LAKYIYHKHDPALPRLAIQLLKRLATVAPMSVYACLGNDAAAIRDAFLTRLQSKIEDMRIKVMILEFLTVAVETQPGL
IELFLNLEVKDGSDGSKEFSLGMWSCLHAVLELIDSQQQDRYWCPPLLHRAAIAFLHALWQDRRDSAMLVLRTKPKFW
ENLTSPLFGTLSPPSETSEPSILETCALIMKIICLEIYYVVKGSLDQSLKDTLKKFSIEKRFAYWSGYVKSLAVHVAE
TEGSSCTSLLEYQMLVSAWRMLLIIATTHADIMHLTDSVVRRQLFLDVLDGTKALLLVPASVNCLRLGSMKCTLLLIL
LRQWKRELGSVDEILGPLTEILEGVLQADQQLMEKTKAKVFSAFITVLQMKEMKVSDIPQYSQLVLNVCETLQEEVIA
LFDQTRHSLALGSATEDKDSMETDDCSRSRHRDQRDGVCVLGLHLAKELCEVDEDGDSWLQVTRRLPILPTLLTTLEV
SLRMKQNLHFTEATLHLLLTLARTQQGATAVAGAGITQSICLPLLSVYQLSTNGTAQTPSASRKSLDAPSWPGVYRLS
MSLMEQLLKTLRYNFLPEALDFVGVHQERTLQCLNAVRTVQSLACLEEADHTVGFILQLSNFMKEWHFHLPQLMRDIQ
VNLGYLCQACTSLLHSRKMLQHYLQNKNGDGLPSAVAQRVQRPPSAASAAPSSSKQPAADTEASEQQALHTVQYGLLK
ILSKTLAALRHFTPDVCQILLDQSLDLAEYNFLFALSFTTPTFDSEVAPSFGTLLATVNVALNMLGELDKKKEPLTQA
VGLSTQAEGTRTLKSLLMFTMENCFYLLISQAMRYLRDPAVHPRDKQRMKQELSSELSTLLSSLSRYFRRGAPSSPAT
GVLPSPQGKSTSLSKASPESQEPLIQLVQAFVRHMQR(SEQ ID NO:2)
本发明的BFLP0169样核酸和多肽(包括表1中所示的序列)在此称为″BFLP0169″核酸和多肽。
根据本发明的BFLP0169核酸和编码的多肽可用于多种应用和范围中。
如表3中所描述的BLAST结果所示,BFLP0169显示与其它蛋白质的同源性。KIAA0169,IMAGE:3461492,和3598686,以及cDNA:FLJ21639是在基因组DNA中发现的由部分阅读框(表达序列标记(ESTs))编码的所有蛋白质。因为BFLP0169与这些蛋白质具有同源性,它也是由全部的开放阅读框或更大开放阅读框的一部分(EST)编码的。
表3:BFLP0169的Blast结果 | |||||
基因目录/鉴定号 | 蛋白质/生物体 | 长度(aa) | 同一性(%) | 阳性(%) | 预期值 |
gi|1136397|dbj|D79991.1| | KIAA0169蛋白质的智人mRNA,部分cds | 1745 | 1635/1739(94%) | 1635/1739(94%) | 0.0 |
gi|2204611|ref|XP_052725.6|(XM 052725) | 与KIAA0169蛋白质相似[智人] | 1767 | 1635/1743(93%) | 1635/1743(93%) | 0.0 |
gi|23618434|ref|XP_130085.2|(XM 130085) | 与KIAA0169蛋白质相似[智人] | 1111 | 949/1111(85%) | 982/1111(87%) | 0.0 |
gi|13529308|gb|AAH05407.1|AAH05407(BC005407) | 未知(IMAGE:3461492的蛋白质)[智人] | 853 | 740/801(92%) | 740/801(92%) | 0.0 |
gi|19343754|gb|AAH25526.1|(BC025526) | 与KIAA0169蛋白质相似[鼠肌] | 525 | 411/522(78%) | 422/522(80%) | 0.0 |
表4显示上述表3中所示蛋白质与BFLP0169(SEQ ID NO:2)的ClustalW序列对比。
表4.SEQ ID NO:2的ClustalW分析
1) SEQ ID NO:2
2) gi|1136397|dbj|D79991.1|(SEQ ID NO:21)
3) gi|22046118|ref|XP_052725.6|(XM_052725)(SEQ ID NO:22)
4) gi|23618434|ref|XP_130085.2|(XM_130085)(SEQ ID NO:23)
5) gi|13529308|gb|AAH05407.1|AAH05407(BC005407)(SEQ ID NO:24)
6) gi|19343754|gb|AAH25526.1|(BC025526)(SEQ ID NO:25)
10 20 30 40 50 60
....|....|....|....|....|....|....|....|....|....|....|....|
SEQ ID NO:2 ----------MIRKSKITSVLSFCRSSRELWTILLGRSALRELSQIEAELNKHWRALLEG 50
gi|1136398|dbj| ------------------AGGPCVRSSRELWTILLGRSALRELSQIEAELNKHWRRLLEG 42
gi|22046118|ref MASGGGVRASGRAKMAAAAGGPCVRSSRELWTILLGRSALRELSQIEAELNKHWRRLLEG 60
gi|23618434|ref ------------------------------------------------------------ 1
gi|13529308|gb| ------------------------------------------------------------ 1
gi|19343754|gb| ------------------------------------------------------------ 1
70 80 90 100 110 120
....|....|....|....|....|....|....|....|....|....|....|....|
SEQ ID NO:2 LSYYKPPSPSSAEKVKANKDVASPLKELGLRISKFLGLDEEQSVQLLQCYLQEDYRGTRD 110
gi|1136398|dbj| LSYYKPPSPSSAEKVKANKDVASPLKELGLRISKFLGLDEEQSVQLLQCYLQEDYRGTRD 102
gi|22046118|ref LSYYKPPSPSSAEKVKANKDVASPLKELGLRISKFLGLDEEQSVQLLQCYLQEDYRGTRD 120
gi|23618434|ref ------------------------------------------------------------ 1
gi|13529308|gb| ------------------------------------------------------------ 1
gi|19343754|gb| ------------------------------------------------------------ 1
130 140 150 160 170 180
....|....|....|....|....|....|....|....|....|....|....|....|
SEQ ID NO:2 SVKTVLQDERQSQALILKIADYYYEERTCILRCVLHLLTYFQDERHPYRVEYADCVDKLE 170
gi|1136398|dbj| SVKTVLQDERQSQALILKIADYYYEERTCILRCVLHLLTYFQDERHPYRVEYADCVDKLE 162
gi|22046118|ref SVKTVLQDERQSQALILKIADYYYEERTCILRCVLHLLTYFQDERHPYRVEYADCVDKLE 180
gi|23618434|ref ------------------------------------------------------------ 1
gi|13529308|gb| ------------------------------------------------------------ 1
gi|19343754|gb| ------------------------------------------------------------ 1
190 200 210 220 230 240
....|....|....|....|....|....|....|....|...|....|....|....|
SEQ ID NO:2 KELVSKYRQQFEELYKTEAPTWETHGNLMTERQVSRWFVQCLREQSMLLEIIFLYYAYFE 230
gi|1136398|dbj| KELVSKYRQQFEELYKTEAPTWETBGNLMTERQVSRWFVQCLREQSMLLEIIFLYYAYFE 222
gi|22046118|ref KELVSKYRQQFEELYKTEAPTWETHGNLMTERQVSRWFVQCLREQSMLLEIIFLYYAYFE 240
gi|23618434|ref ------------------------------------------------------------ 1gi|13529308|gb| ------------------------------------------------------------ 1
gi|19343754|gb| ------------------------------------------------------------ 1
250 260 270 280 290 300
....|....|....|....|...|....|....|....|....|....|....|....|
SEQ ID NO:2 MAPSDLLVLTKMFKEQGFGSRQTNRHLVDETMDPFVDRIGYFSALILVEGMDIESLHKCA 290
gi|1136398|dbj| MAPSDLLVLTKMFKEQGFGSRQTNRHLVDETMDPFVDRIGYFSALILVEGMDIESLHKCA 282
gi|22046118|ref MAPSDLLVLTKMFKEQGFGSRQTNRHLVDETMDPFVDRIGYFSALILVEGMDIESLHKCA 300
gi|23618434|ref ------------------------------------------------------------ 1
gi|13529308|gb| ------------------------------------------------------------ 1
gi|19343754|gb| ------------------------------------------------------------ 1
310 320 330 340 350 360
....|....|....|....|....|....|....|....|....|....|....|....|
SEQ ID NO:2 LDDRRELHQFAQDGLICQDMDCLMLTFGDIPHHAPVLLAWALLRHTLNPEETSSVVRKIG 350
gi|1136398|dbj| LDDRRELHQFAQDGLICQDMDCLMLTFGDIPHHAPVLLAWALLRHTLNPEETSSVVRKIG 342
gi|22046118|ref LDDRRELHQFAQDGLICQDMDCLMLTFGDIPHHAPVLLAWALLRHTLNPEETSSVVRKIG 360
gi|23618434|ref ------------------------------------------------------------ 1
gi|13529308|gb| ------------------------------------------------------------ 1
gi|19343754|gb| ------------------------------------------------------------ 1
370 380 390 400 410 420
....|....|....|....|....|....|....|....|....|....|....|....|
SEQ ID NO:2 GTAIQLNVFQYLTRLLQSLASGGNDCTTSTACMCVYGLLSFVLTSLELHTLGNQQDIIDT 410
gi|1136398|dbj| GTAIQLNVFQYLTRLLQSLASGGNDCTTSTACMCVYGLLSFVLTSLELHTLGNQQDIIDT 402
gi|22046118|ref GTAIQLNVFQYLTRLLQSLASGGNDCTTSTACMCVYGLLSFVLTSLELHTLGNQQDIIDT 420
gi|23618434|re ------------------------------------------------------------ 1
gi|13529308|gb| ------------------------------------------------------------ 1
gi|19343754|gb| ------------------------------------------------------------ 1
430 440 450 460 470 480
....|....|....|....|....|....|....|....|....|....|....|....|
SEQ ID NO:2 ACEVLADPSLPELFWGTEPTSGLGIILDSVCGMFPHLLSPLLQLLRALVSGKSTAKKVYS 470
gi|1136398|dbj| ACEVLADPSLPELFWGTEPTSGLGIILDSVCGMFPHLLSPLLQLLRALVSGKSTAKKVYS 462
gi|22046118|ref ACEVIADPSLPELFWGTEPTSGLGIILDSVCGMFPHLLSPLLQLLRALVSGKSTAKKVYS 480
gi|23618434|ref ------------------------------------------------------------ 1
gi|13529308|gb| ------------------------------------------------------------ 1
gi|19343754|gb| ------------------------------------------------------------ 1
490 500 510 520 530 540
....|....|....|....|....|....|....|....|....|....|....|....|
SEQ ID NO:2 ELDKMSFYNELYKHKPHDVISHEDGTLWRRQTPKLLYPLGGQTNLRIPQGTVGQVMLDDR 530
gi|1136398|dbj| FLDKMSFYNELYKHKPHDVISHEDGTLWRRQTPKLLYPLGGQTNLRIPQGTVGQVMLDDR 522
gi|22046118|ref FLDKMSFYNELYKHKPHDVISHEDGTLWRRQTPKLLYPLGGQTNLRIPQGTVGQVMLDDR 540
gi|23618434|ref ------------------------------------------------------------ 1
gi|13529308|gb| ------------------------------------------------------------ 1
gi|19343754|gb| ------------------------------------------------------------ 1
550 560 570 580 590 600
....|....|....|....|....|....|....|....|....|....|....|....|
SEQ ID NO:2 AYLVRWEYSYSSWTLFTCEIEMLLHVVSTADVIQHCQRVKPIIDLVHKVISTDLSIADCL 590
gi|1136398|dbj| AYLVRWEYSYSSWTLFTCEIEMLLHVVSTADVIQHCQRVKPIIDLVHKVISTDLSIADCL 582
gi|22046118|ref AYLVRWEYSYSSWTLFTCEIEMLLHVVSTADVIQHCQRVKPIIDLVHKVISTDLSIADCL 600
gi|23618434|ref ------------------------------------------------------------ 1
gi|13529308|gb| ------------------------------------------------------------ 1
gi|19343754|gb| ------------------------------------------------------------ 1
610 620 630 640 650 660
....|....|....|....|....|....|....|....|....|....|....|....|
SEQ ID NO:2 LPITSRIYMLLQRLTTVISPPVDVIASCVNCLTVLAARNPAKVWTDLRHTGFLPFVAHPV 650
gi|1136398|dbj| LPITSRIYMLLQRLTTVISPPVDVIASCVNCLTVLAARNPAKVWTDLRHTGFLPFVAHPV 642
gi|22046118|ref LPITSRIYMLLQRLTTVISPPVDVIASCVNCLTVLAARNPAKVWTDLRHTGFLPFVAHPV 660
gi|23618434|ref ------------------------------------------------------------ 1
gi|13529308|gb| ------------------------------------------------------------ 1
gi|19343754|gb| ------------------------------------------------------------ 1
SEQ ID NO:2的第1-14位残基在此称为SEQ ID NO:20。包括第1-6位氨基酸的SEQ ID NO:21的片段在此称为SEQ ID NO:26。
BFLP0169核酸
本发明的核酸包括编码BFLP0169多肽或蛋白质的核酸。如在此所使用的,术语多肽和蛋白质是可互换的。
在一些实施方案中,BFLP0169核酸编码成熟的BFLP0169多肽。如在此所使用的,在此所描述的″成熟″形式的多肽或蛋白质涉及天然存在的多肽或前体形式或原蛋白的产物。作为非限制性的实例,天然存在的多肽、前体或原蛋白包括由相应基因编码的全长基因产物。备选地,可定义为由在此所描述的开放阅读框编码的多肽、前体或原蛋白。再作为非限制性的实例,出现产物″成熟″形式,作为一个或多个天然存在的进行步骤的结果,可能在细胞内发生,并出现基因产物。这种导致″成熟″形式的多肽或蛋白质的进行步骤的实例包括由开放阅读框的起始密码子编码的N-末端甲硫氨酸残基的切割,或信号肽或前导序列的蛋白水解切割。如此从具有残基1至N,其中第1位残基是N-末端甲硫氨酸的前体多肽或蛋白质产生的成熟形式将在除去N-末端甲硫氨酸后保留有残基2至N。备选地,从具有残基1至N,其中从残基1至残基M的N-末端信号序列被切割的前体多肽或蛋白质产生的成熟形式,将保留有从残基M+1至残基N的残基。进一步的如在此所使用的,″成熟″形式的多肽或蛋白质可能由于除了蛋白水解切割事件的翻译后修饰的步骤而产生。作为非限制性的实例,这种附加过程包括,糖基化、豆蔻酰化或磷酸化。通常,成熟多肽或蛋白质可能只由这些过程中的一个,或其任意组合而产生。
本发明包括SEQ ID NO:1的突变体或变体核酸、或其片段,其任何碱基可从SEQ ID NO:1所示的相应碱基进行变化,同时其仍然编码至少保持其BFLP0169-样活性和生理功能(即,调节血管生成、神经元发育)中的一个的蛋白质。本发明进一步包括与SEQ ID NO:1的核酸序列,包括其片段、衍生物、类似物和同系物互补的序列。另外本发明包括其结构包括化学修饰的核酸或核酸片段、或其互补物。
本发明的方面涉及编码BFLP0169蛋白质或其生物学活性部分的分离核酸分子。也包括足以用作杂交探针,以鉴定编码BFLP0169的核酸,以及用作聚合酶链式反应(PCR)的引物片段来用于扩增或突变BFLP0169核酸分子的核酸片段。如在此所使用的,术语″核酸分子″意在包括DNA分子(例如,cDNA或基因组DNA)、RNA分子(例如,mRNA)、利用核苷酸类似物产生的DNA或RNA的类似物、及其衍生物、片段和同系物。核酸分子可以是单链或双链,但优选是双链DNA。
″探针″是指长度可变的核酸序列,根据用途优选在至少大约10个核苷酸(nt)、100nt、或多至大约例如6,000nt之间。探针用于检测相同的、相似的、或互补的核酸序列。更长长度的探针通常获自天然或重组来源,是高度特异的,并且比低聚物杂交更慢。探针可以是单-或双链的,并且设计成在PCR、基于膜的杂交技术、或ELISA类似技术中具有特异性。
″分离的″核酸分子是与存在于核酸天然来源中的其它核酸分子相分离的核酸分子。分离核酸分子的实例包括但不限于,包含于载体中的重组DNA分子、保持在异源宿主细胞中的重组DNA分子、部分或基本上纯化的核酸分子、以及合成的DNA或RNA分子。优选地,″分离的″核酸是与在该核酸所衍生的生物体的基因组DNA中该核酸的侧翼序列(即,位于核酸的5′和3′末端的序列)分离开来。例如,在不同的实施方案中,分离的BFLP0169核酸分子可包含小于大约50kb、25kb、5kb、4kb、3kb、2kb、1kb、0.5kb或0.1kb的核苷酸序列,所述的核苷酸序列在该核酸衍生的细胞的基因组DNA中天然侧接该核酸分子。此外,″分离的″核酸分子,例如cDNA分子,当通过重组技术产生时,可以是基本上从其它细胞物质或培养基分离出来的,或当通过化学合成时,可以是基本上从化合物前体或其它化合物分离出来的。
本发明的核酸分子,例如具有SEQ ID NO:1或其互补核苷酸序列的核酸分子可利用标准的分子生物学技术和在此提供的序列信息加以分离。利用SEQ ID NO:1的所有或部分的核酸序列作为杂交探针,可利用标准的杂交和克隆技术(例如,如Sambrook等人,编辑,MOLECMLAR CLONING:A LABORATORY MANUAL 2nd Ed.,Cold Spring Harbor Laboratory Press,Cold Spring Harbor,NY,1989;和Ausubel等人,编辑,CURRENT PROTOCOLS INMOLECMLAR BIOLOGY,John Wiley & SonS,纽约,NY,1993.)分离BFLP0169核酸序列。
可利用cDNA、mRNA或备选地,基因组DNA作为模板,以及适当的寡核苷酸引物,根据标准的PCR扩增技术扩增本发明的核酸。可将如此扩增的核酸克隆到适当的载体中并且通过DNA序列分析鉴定。此外,可通过标准的合成技术,例如,利用自动化DNA合成仪制备相应于BFLP0169核苷酸序列的寡核苷酸。
如在此所使用的,术语″寡核苷酸″是指一系列连接的核苷酸残基,该寡核苷酸具有足够的核苷酸碱基数目来用于PCR反应。短的寡核苷酸序列可能是基于或从基因组或cDNA序列设计的,用来在特定的细胞或组织中扩增、证实、或显示相同、相似或互补DNA或RNA的存在。寡核苷酸包括具有长度为大约10nt、50nt、或100nt,优选长度为大约15nt至30nt的核酸序列部分。在一个实施方案中,包括长度小于100nt的核酸分子的寡核苷酸将进一步包括SEQ ID NO:1或其互补序列的至少6个连续的核苷酸。寡核苷酸可以化学合成并且可用作探针。
在另一个实施方案中,本发明的分离核酸分子包括SEQ ID NO:1所示的核苷酸序列或该核苷酸序列部分的互补序列的核酸分子。与SEQ ID NO:1所示的核苷酸序列互补的核酸分子是足够与SEQ ID NO:1所示的核苷酸序列互补的核酸分子,其可与SEQ NO:1所示的核苷酸序列以氢键作用而很少或没有错配,由此形成稳定的双螺旋。
如在此所使用的,术语″互补的″是指核酸分子的核苷酸单元之间的Watson-Crick或Hoogsteen碱基配对,而术语″结合″是指2个多肽或化合物或相关的多肽或化合物或其组合之间的物理或化学相互作用。结合包括离子的、非离子的、Van der Waals、疏水性相互作用等。物理的相互作用可以是直接或间接的。间接的相互作用可以是指通过或由于另一个多肽或化合物的影响。直接结合是指不通过、或由于另一个多肽或化合物的影响,没有其它实质性的化学中间体而发生的相互作用。
此外,本发明的核酸分子可以只包括SEQ ID NO:1的部分核酸序列,例如可用作探针或引物的片段、或编码BFLP0169的生物活性部分的片段。在此提供的片段定义为至少6个(连续的)核酸或至少4个(连续的)氨基酸的序列,分别就核酸来说其长度足够容许特异的杂交,或对于氨基酸来说其长度足够用于特异的表位识别,并且至多一些部分小于全长序列。片段可以来源于任何连续的所选择的核酸或氨基酸序列部分。衍生物是由天然化合物直接或通过修饰或部分取代而形成的核酸序列或氨基酸序列。类似物是结构与天然化合物相似,然而并非相同,就某些组分或侧链而论有差异的核酸序列或氨基酸序列。类似物可以是合成的或来自不同的演化起源,并且可能与野生型相比具有相似或相反的代谢活动。
如下所述如果衍生物或类似物包含修饰的核酸或氨基酸,衍生物和类似物可以是全长或不是全长。本发明核酸或蛋白质的衍生物或类似物包括但不限于,包括基本上与本发明核酸或蛋白质同源的区域的分子,在不同的实施方案中,相同大小的核酸或氨基酸序列的同一性为至少大约70%、80%、85%、90%、95%、98%、甚至99%(优选同一性为80-99%),或当通过本领域已知的计算机同源性程序与排列的序列进行序列对比时,或其编码的核酸能够与编码上述蛋白质的序列的互补序列在严谨、中等严谨、或低严谨条件下杂交。例证性的程序是利用设置缺省值、使用Smith和Waterman算法的Gap程序(Wisconsin Sequence Analysis Package,Version 8 for UNIX,Genetics Computer Group,University Research Park,Madison,WI)。
″同源的核酸序列″或″同源的氨基酸序列″或其变体,是指通过如上所讨论的核苷酸水平或氨基酸水平的同源性而表征的序列。同源的核苷酸序列编码BFLP0169多肽同工型的编码序列。同工型可作为例如RNA的选择性拼接的结果而在相同生物体的不同组织中表达。 备选地,同工型可通过不同的基因编码。在本发明中,同源的核苷酸序列包括编码除了人之外的种属BFLP0169多肽的核苷酸序列,包括但不限于哺乳动物,并且因而可包括例如小鼠、大鼠、兔、狗、猫、牛、马和其他生物体。同源的核苷酸序列也包括但不限于,在此阐明的核苷酸序列的天然存在的等位变体和突变体。然而同源的核苷酸序列不包括编码人BFLP0169蛋白质的核苷酸序列。同源的核酸序列包括编码SEQ ID NO:2中的保守氨基酸取代(见下文)的核酸序列,以及具有BFLP0169活性的多肽。BFLP0169蛋白质的生物活性描述如下。同源的氨基酸序列不编码人BFLP0169多肽的氨基酸序列。
从人BFLP0169基因的克隆确定的核苷酸序列可设计并产生用于鉴定和/或克隆其它细胞类型,例如来自其它组织中的BFLP0169同系物,以及来自其它哺乳动物的BFLP0169同系物的探针和引物。探针/引物一般包括基本上纯化的寡核苷酸。寡核苷酸一般包括在严谨条件下与至少大约12、25、50、100、150、200、250、300、350或400个或更多以上的SEQ ID NO:1的连续有义链核苷酸序列;或SEQ ID NO:1的反义链核苷酸序列;或SEQID NO:1的天然存在的突变体杂交的核苷酸序列区域。
基于人BFLP0169核苷酸序列的探针可用于检测编码相同或同源蛋白质的转录本或基因组序列。在不同的实施方案中,探针进一步包括附着到其上的标记基团,例如标记基团可以是放射性同位素、荧光化合物、酶或酶辅助因子。这种探针可用作,例如通过测量来自受试个体的细胞样品中编码BFLP0169的核酸的水平,例如检测BFLP0169mRNA水平或确定基因组BFLP0169基因是否已经突变或缺失,而用于鉴定错误表达BFLP0169蛋白质的细胞或组织的诊断测试试剂盒的部分。
″具有BFLP0169的生物活性部分的多肽″是指通过特定的生物分析测量,有或没有剂量依赖性地显示出与本发明的多肽,包括成熟形式活性相似、而并非必须相同的活性的多肽。可通过分离编码具有BFLP0169生物活性(BFLP0169蛋白质的生物活性描述如下)的多肽的SEQ ID NO:1的部分,表达BFLP0169蛋白质的编码部分(例如,通过体外重组表达)以及评估BFLP0169的编码部分的活性来制备编码″BFLP0169生物活性部分″的核酸片段。
本发明也提供BFLP0169核酸序列的多态型,以及检测BFLP0169序列中多态型序列的方法。多态型包括相应于与BFLP0169相关的外显子和/或内含子的基因组序列。
可在DNA、RNA、或蛋白质水平,利用本领域公知的多种技术检测携带本发明多态型等位基因的个体。本方法通常使用预先表征的多态性。也就是说,已经确定了存在于位点的多态型的基因型位置和性质。这些信息的有效利用容许设计特异鉴定已知多态型的成组探针。
用于诊断的基因组DNA可获自机体的任何有核细胞,例如存在于外周血、尿、唾液、口腔样品、外科手术样本,和尸检样本中的有核细胞。可直接使用DNA或在突变分析前通过使用PCR或其它的体外扩增方法,例如连接酶链式反应(LCR)、链易位扩增(SDA)、自给的序列复制(3SR)而体外酶促扩增DNA。
在特异的DNA序列中检测多态性可伴随有多种方法,包括但不限于,基于等位基因特异的限制性核酸内切酶切割的限制性片段长度多态性检测、与等位基因特异的寡核苷酸探针,包括固定寡核苷酸或寡核苷酸的阵列杂交、等位基因特异的PCR、错配修复检测(MRD)、MutS蛋白质的结合、变性梯度凝胶电泳(DGGE)、单链构象多态性检测、RNA酶切割错配碱基对、异源双链DNA的化学或酶促切割、基于等位基因特异引物延伸的方法、遗传位分析(GBA)、寡核苷酸连接分析(OLA)、等位基因特异的连接链式反应(LCR)、缺口-LCR、利用本领域公知标准方法的放射性和/或荧光DNA测序,以及肽核酸(PNA)分析。
BFLP0169变体
本发明进一步包括由于遗传密码的简并性而不同于SEQ ID NO:1所示核苷酸序列的核酸分子。这些核酸因此编码与由SEQ ID NO:1所示核苷酸序列编码的,例如SEQ ID NO:2的多肽相同的BFLP01 69蛋白质。 在另一个实施方案中,本发明的分离核酸分子具有编码SEQID NO:2所示氨基酸序列的蛋白质的核苷酸序列。
除SEQ ID NO:1所示的人BFLP0169核苷酸序列之外,本领域的技术人员可认识到导致BFLP0169氨基酸序列变化的DNA序列多态性可能存在于群体内(例如人类群体)。BFLP0169基因中的这种遗传多态性可能由于天然的等位变体而存在于群体内的个体中。如在此所使用的,术语″基因″和″重组基因″是指包括编码BFLP0169蛋白质,优选哺乳动物BFLP0169蛋白质的开放阅读框的核酸分子。这种天然的等位变体一般可能导致BFLP0169基因核苷酸序列的1-5%的变化。由天然等位变体产生的、并且不改变BFLP0169功能活性的BFLP0169中,任何和所有的这种核苷酸变体和所得到的氨基酸多态性都在本发明的范围内。
此外,来自其它种属的编码BFLP0169蛋白质的核酸分子,和具有不同于SEQ ID NO:1的人序列的核苷酸序列也在本发明的范围内。可根据其与在此公开的人BFLP0169核酸的同源性,利用人cDNAs或其部分作为杂交探针,根据标准的杂交技术在严谨杂交条件下,分离相应于本发明BFLP0169 cDNAs的天然等位变体和同系物的核酸分子。例如,可根据其与人的膜结合BFLP0169的同源性分离可溶的人BFLP0169 cDNA。同样地,可根据其与可溶的人BFLP0169的同源性分离膜-结合的人BFLP0169 cDNA。
因此,在另一个实施方案中,本发明的分离核酸分子长度是至少6个核苷酸,并且在严谨条件下与包括SEQ ID NO:1的核苷酸序列的核酸分子杂交。 在另一个实施方案中,该核酸长度是至少10、25、50、100、250、500或750个核苷酸。在另一个实施方案中,本发明的分离核酸分子与编码区域杂交。如在此所使用的,术语″在严谨条件下杂交″是用来描述用于在该条件下彼此至少60%同源的核苷酸序列一般保持相互杂交的杂交和洗涤条件。
可通过以全部或部分的特定人序列作为探针,利用本领域用于核酸杂交和克隆的公知方法进行低的、中等或高严谨杂交来获得同系物(即,编码来源于除了人外种属的BFLP0169蛋白质的核酸)或其它相关序列(例如平行同源物)。因此,本发明也包括能够在降低的严谨条件,更优选严谨条件,以及最优选高度严谨条件下与在此所描述的多核苷酸杂交的多核苷酸。严谨条件的实例如下列表格所示:高严谨条件是至少如例如条件A-F一样严谨的条件;严谨条件是至少如例如条件G-L一样严谨的条件;以及较低的严谨条件是至少如例如条件M-R一样严谨的条件。
表4.严谨条件
严谨条件 | 多核苷酸杂合物 | 杂合物长度(bp)1 | 杂交温度和缓冲液H | 洗涤温度和缓冲液H |
A | DNA:DNA | ≥50 | 65℃;1×SSC-或42℃;1×SSC,50%甲酰胺 | 65℃;0.3×SSC |
B | DNA:DNA | <50 | TB *;1×SSC | TB *;1×SSC67℃;0.3×SSC |
C | DNA:RNA | ≥50 | 67℃;1×SSC-或45℃;1×SSC,50%甲酰胺 | |
D | DNA:RNA | <50 | TD *;1×SSC | TD *;1×SSC70℃;0.3×SSC |
E | RNA:RNA | ≥50 | 70℃;1×SSC-或50℃;1×SSC,50%甲酰胺 | |
F | RNA:RNA | <50 | TF *;1×SSC | Tf *;1×SSC65℃;1×SSC |
G | DNA:DNA | ≥50 | 65℃;4×SSC-或42℃;4×SSC,50%甲酰胺 | |
H | DNA:DNA | <50 | TH *;4×SSC | TH *;4×SSC67℃;1×SSC |
I | DNA:RNA | ≥50 | 67℃;4×SSC-或45℃;4×SSC,50%甲酰胺 | |
J | DNA:RNA | <50 | TJ *;4×SSC | TJ *;4×SSC67℃;1×SSC |
K | RNA:RNA | ≥50 | 70℃;4×SSC-或50℃;4×SSC,50%甲酰胺 | |
L | RNA:RNA | <50 | TL *;2×SSC | TL *;2×SSC50℃;2×SSC |
M | DNA:DNA | >50 | 50℃;4×SSC-或40℃;6×SSC,50%甲酰胺 | |
N | DNA:DNA | <50 | TN *;6×SSC | TN *;6×SSC55℃;2×SSC |
O | DNA:RNA | >50 | 55℃;4×SSC-或42℃;6×SSC,50%甲酰胺 | |
P | DNA:RNA | <50 | TP *;6×SSC | TP *;6×SSC60℃;2×SSC |
Q | RNA:RNA | >50 | 60℃;4×SSC-或45℃;6×SSC,50%甲酰胺 | |
R | RNA:RNA | <50 | TR *;4×SSC | TR *;4×SSC |
1:杂合物的长度是预期用于杂交多核苷酸的杂交区域的长度。当使多核苷酸与未知序列的靶多核苷酸杂交时,假定杂合物长度是杂交多核苷酸的长度。当使用已知序列的多核苷酸进行杂交时,可通过排列多核苷酸的序列并且鉴定该区域或最佳序列互补的区域来确定杂合物的长度。
H:在杂交和洗涤缓冲液中SSPE(1×SSPE是0.15M NaCl,10mMNaH2PO4,和1.25mM EDTA,pH7.4)可替换为SSC(1×SSC是0.15MNaCl,和15mM柠檬酸钠);完成杂交后洗涤15分钟。
TB *-TR *:预期长度小于50个碱基对的杂合物的杂交温度应低于杂合物的解链温度(Tm)5-10℃,其中根据下列方程式确定Tm。对于长度小于18个碱基对的杂合物,Tm(℃)=2(A+T碱基#)+4(G+C碱基#)。对于长度在18和49个碱基之间的杂合物,Tm(℃)=81.5+16.6(log10Na+)+0.41(%G+C)-(600/N),其中N是杂合物中碱基的数目,而Na+是杂交缓冲液中钠离子的浓度(1×SSC的Na+=0.165M)。
优选地,每个这种杂交多核苷酸的长度为其杂交的本发明多核苷酸长度的至少25%(更优选至少50%,以及最优选至少75%),并且当通过排列使重叠部分和同一性最大化,同时使序列缺口最小化来比较杂交多核苷酸的序列而确定序列同一性时,和与其杂交的本发明多核苷酸具有至少60%的序列同一性(更优选至少75%同一性;最优选至少90%或95%同一性)。
严谨杂交条件的非限制性实例是在包含6×SSC,50mM Tris-HCl(pH7.5),1mM EDTA,0.02% PVP,0.02% Ficoll,0.02% BSA,和500mg/ml变性的鲑鱼精DNA高盐缓冲液中于65℃杂交。杂交后于50℃在0.2×SSC,0.01%BSA中进行一次或多次洗涤。在严谨条件下与SEQ ID NO:1的序列杂交的本发明的分离核酸分子相应于天然存在的核酸分子。如在此所使用的,″天然存在的核酸分子″是指具有天然存在的核苷酸序列(例如,编码天然的蛋白质)的RNA或DNA分子。
在第二个实施方案中,提供可与包括SEQ ID NO:1的核苷酸序列、或其片段、类似物或衍生物的核酸分子在中等严谨条件下杂交的核酸序列。中等严谨杂交条件的非限制性实例是在6×SSC、5×Denhardt′s溶液、0.5% SDS和100mg/ml变性鲑鱼精DNA中于55℃杂交,然后于37℃在1×SSC,0.1%SDS中进行一次或多次洗涤。
在第三个实施方案中,提供可与包括SEQ ID NO:1的核苷酸序列、或其片段、类似物或衍生物的核酸分子在低严谨条件下杂交的核酸。低严谨杂交条件的非限制性实例是在35%甲酰胺,5×SSC,50mMTris-HCl(pH7.5),5mM EDTA,0.02% PVP,0.02% Ficoll,0.2%BSA,100mg/ml变性鲑鱼精DNA,10%(wt/vol)硫酸葡聚糖中于40℃杂交,然后于50℃在2×SSC,25 Mm Tris-HCl(pH7.4),5mM EDTA,和0.1% SDS中进行一次或多次洗涤。
保守突变
除可能存在于人群中的BFLP0169序列的天然等位变体外,熟练技术人员将进一步认识到可通过突变SEQ ID NO:1的核苷酸序列而导入变化,由此导致改变编码的BFLP0169蛋白质的氨基酸序列,而不改变BFLP0169蛋白质的功能性能力。例如,可在SEQ ID NO:1的序列中产生导致在″非必需的″氨基酸残基的氨基酸取代的核苷酸取代。″非必需的″氨基酸残基是可从BFLP0169的野生型序列改变而不改变其生物活性的残基,同时″必需的″氨基酸残基是为生物活性所需要的。 例如,改变在本发明的BFLP0169蛋白质中保守的氨基酸残基很可能导致丧失BFLP0169蛋白质活性。
本发明的另一个方面涉及编码包含活性非必需的氨基酸残基发生变化的BFLP0169蛋白质的核酸分子。这种BFLP0169蛋白质与SEQ IDNO:2有氨基酸序列的差异,然而保留生物活性。在一个实施方案中,分离的核酸分子包括编码蛋白质的核苷酸序列,其中该蛋白质包括与SEQ ID NO:2的氨基酸序列至少大约75%同源的氨基酸序列。优选地,由核酸编码的蛋白质与SEQ ID NO:2至少大约80%同源,更优选与SEQ ID NO:2至少大约90%、95%、98%,以及最优选至少大约99%同源。
可通过将一个或多个核苷酸取代、添加或缺失导入到SEQ ID NO:1的核苷酸序列中,以将一个或多个氨基酸的取代、添加或缺失导入到编码的蛋白质中,而产生编码与SEQ ID NO:2的蛋白质同源的BFLP0169蛋白质的分离核酸分子。
可通过常规技术,例如定点诱变和PCR-介导的诱变将突变导入SEQ ID NO:1的核苷酸序列。优选地,在一个或多个预期的非必需氨基酸残基产生保守的氨基酸取代。″保守的氨基酸取代″是其中氨基酸残基用具有相似侧链的氨基酸残基替换的取代。具有相似侧链的氨基酸残基家族已经是本领域中确定的。这些家族包括具有碱性侧链(例如,赖氨酸、精氨酸、组氨酸)、酸性侧链(例如,天冬氨酸、谷氨酸)、不带电的极性侧链(例如甘氨酸、天门冬酰胺、谷氨酰胺、丝氨酸、苏氨酸、酪氨酸、半胱氨酸)、非极性的侧链(例如,丙氨酸、缬氨酸、亮氨酸、异亮氨酸、脯氨酸、苯丙氨酸、甲硫氨酸、色氨酸)、β-分支侧链(例如,苏氨酸、缬氨酸、异亮氨酸)和芳族侧链(例如,酪氨酸、苯丙氨酸、色氨酸、组氨酸)的氨基酸。因此,BFLP0169中预期的非必需氨基酸残基用来自相同侧链家族的另一个氨基酸残基替换。备选地,在另一个实施方案中,例如通过饱和诱变,可向全部或部分的BFLP0169编码序列随机导入突变,并且可筛选所得到的突变体的BFLP0169生物活性以鉴定保留活性的突变体。SEQ ID NO:1的诱变后可通过本领域已知的任何重组技术表达编码的蛋白质并且确定蛋白质的活性。
在一个实施方案中,可分析突变BFLP0169蛋白质的(1)与其它BFLP0169蛋白质、其它细胞表面蛋白质、或其生物活性部分形成蛋白质:蛋白质相互作用的能力,(2)突变BFLP0169蛋白质和BFLP0169受体之间的复合物形成;(3)突变BFLP0169蛋白质结合胞内靶蛋白质或其生物活性部分的能力;(例如,抗生物素蛋白的蛋白质);(4)结合BFLP0169蛋白质的能力;或(5)特异结合抗-蛋白质抗体的能力。
反义BFLP0169核酸
本发明的另一个方面涉及分离的反义核酸分子,其与包括SEQ IDNO:1的核苷酸序列、或其片段、类似物或衍生物的核酸分子杂交或互补。″反义″核酸包括与编码蛋白质的″有义″核酸互补的核苷酸序列,例如与双链cDNA分子的编码链互补或互补于mRNA序列。在特定的方面,反义核酸分子包括与BFLP0169编码链有至少大约10、25、50、100、250或500个核苷酸或全部的BFLP0169编码链,或只有其部分互补的序列。另外也提供编码SEQ ID NO:2的BFLP0169蛋白质的片段、同系物、衍生物和类似物的核酸分子,或与SEQ ID NO:1的BFLP0169核酸序列互补的反义核酸。
在一个实施方案中,反义核酸分子是编码BFLP0169的核苷酸序列编码链的″编码区″的反义。术语″编码区″是指包括翻译成为氨基酸残基的密码子的核苷酸序列区域(例如,相应于SEQ ID NO:2的人BFLP0169蛋白质编码区)。 在另一个实施方案中,反义核酸分子反义于编码BFLP0169的核苷酸序列编码链的″非编码区域″。术语″非编码区″是指编码区两侧不被翻译成氨基酸的5′和3′序列(即,也称为5′和3′非翻译区)。
考虑到在此公开的编码BFLP0169的编码链序列(例如,SEQ IDNO:1),可根据Watson和Crick或Hoogsteen碱基配对规律设计本发明的反义核酸。反义核酸分子可以是与BFLP0169 mRNA的全部编码区互补的,但更优选地是只与BFLP0169 mRNA的编码或非编码区部分反义的寡核苷酸。例如,反义寡核苷酸可与BFLP0169 mRNA翻译起始位点周围的区域互补。反义寡核苷酸的长度可以是例如大约5、10、15、20、25、30、35、40、45或50个核苷酸。可利用本领域已知的方法利用化学合成或酶促连接反应构建本发明的反义核酸。例如,可利用天然存在的核苷酸或设计成能增加分子的生物稳定性或增加在反义和有义核酸之间形成双螺旋的物理稳定性而不同修饰的核苷酸化学合成反义核酸(例如,反义寡核苷酸),例如可使用硫代磷酸衍生物和吖啶取代的核苷酸。
可用于产生反义核酸的修饰核苷酸的实例包括:5-氟尿嘧啶、5-溴尿嘧啶、5-氯尿嘧啶、5-碘尿嘧啶、次黄嘌呤、黄嘌呤、4-乙酰胞密啶、5-(羧羟甲基)尿嘧啶、5-羧甲基氨甲基-2-硫尿核苷、5-羧甲基氨甲基尿嘧啶、二氢尿嘧啶、β-D-半乳糖基辫苷、次黄嘌呤核苷、N6-异戊烯基腺嘌呤、1-甲基鸟嘌呤、1-甲基次黄嘌呤苷、2,2-二甲基鸟嘌呤、2-甲基腺嘌呤、2-甲基鸟嘌呤、3-甲胞嘧啶、5-甲胞嘧啶、N6-腺嘌呤、7-甲基鸟嘌呤、5-甲基氨甲尿嘧啶、5-甲氧基氨甲基-2-硫尿嘧啶、β-D-甘露糖基辫苷、5′-甲氧基羧甲尿嘧啶、5-甲氧基尿嘧啶、2-甲硫基-N6-异戊烯基腺嘌呤、尿嘧啶-5-羟丙酸(v)、wybutoxosine、假尿嘧啶、辫苷、2-巯基胞嘧啶、5-甲基-2-硫尿嘧啶、2-硫尿嘧啶、4-硫尿嘧啶、5-甲基尿嘧啶、尿嘧啶-5-羟丙酸甲酯、尿嘧啶-5-羟丙酸(v)、5-甲基-2-硫尿嘧啶、3-(3-氨基-3-N-2-羧丙基)尿嘧啶、((acp3)w,和2,6-二氨基嘌呤。备选地,可利用已经被以反义方向亚克隆入核酸的表达载体以生物的方式产生反义核酸(即,从插入的核酸转录的RNA可以是令人感兴趣的靶核酸的反义方向,其将在下文的小节中进一步描述)。
一般将本发明的反义核酸分子施用于受试个体或原位产生,以使得它们与编码BFLP0169蛋白质的细胞mRNA和/或基因组DNA杂交或结合,由此通过抑制转录和/或翻译而抑制该蛋白质的表达。可通过传统的核苷酸互补性杂交而形成稳定的双螺旋或例如,就结合DNA双螺旋的反义核酸分子来说,通过双螺旋宽沟中特异的相互作用而形成稳定的双螺旋。本发明的反义核酸分子的给药途径实例包括在组织位点直接注入。备选地,可修饰反义核酸分子以靶向所选择的细胞然后全身性施用。例如,对于全身性给药,可改进反义分子以使得它们特异结合受体或在所选择细胞表面上表达的抗原,例如使反义核酸分子与结合细胞表面受体或抗原的肽或抗体连接。也可利用在此所描述的载体将反义核酸分子递送至细胞。为了获得足够胞内浓度的反义分子,其中将反义核酸分子放置在强pol II或pol III启动子调控下的载体构建体是优选的。
在另一个实施方案中,本发明的反义核酸分子是α-端基异构核酸分子。α-端基异构核酸分子与互补RNA形成特异的双链杂合物,其中与通常的β-单元相反,该链是相互平行的。反义核酸分子也可包括2′-o-甲基核糖核苷酸。
这种修饰包括,作为非限制性的实施例,修饰的碱基,以及修饰或衍生糖磷酸骨架的核酸。至少部分地进行这些修饰以增强修饰核酸的化学稳定性,以使得例如可使用它们作为受试个体的治疗应用中的反义结合核酸。
BFLP0169核酶和PNA部分
在另一个实施方案中,本发明的反义核酸是核酶。核酶是具有核糖核酸酶活性的催化RNA分子,其能够切割对其具有互补区域的单链核酸,例如mRNA。因此,核酶(例如锤状核酶)可用于催化切割BFLP0169 mRNA转录本而由此抑制BFLP0169 mRNA的翻译。可根据在此公开的BFLP0169 DNA的核苷酸序列设计特异于编码BFLP0169的核酸的核酶(即,SEQ ID NO:1)。例如,可构建四膜虫的L-19 IVS RNA的衍生物,其中活性位点的核苷酸序列与在编码BFLP0169的mRNA中待切割的核苷酸序列是互补的。备选地,BFLP0169 mRNA可用于从RNA分子库选择具有特异核糖核酸酶活性的催化RNA。
备选地,可通过指导核苷酸序列互补于BFLP0169的调节区(例如BFLP0169启动子和/或增强子)以形成三螺旋结构,防止BFLP0169基因在靶细胞中转录而抑制BFLP0169基因表达。
在不同的实施方案中,可在碱基部分、糖部分或磷酸酯骨架上对BFLP0169的核酸进行修饰以改善例如分子的稳定性、杂交作用或溶解度。例如,可改变核酸的脱氧核糖核苷磷酸酯骨架以产生缩氨酸核酸。如在此所使用的,术语″肽核酸″或″PNAs″是指核酸模拟物,例如DNA模拟物,其中脱氧核糖核苷磷酸酯骨架由假缩氨酸骨架替代而只保留4个天然的核碱基。已经显示PNAs的中性骨架容许在低离子强度的条件下与DNA和RNA特异杂交。可利用标准的固相肽合成方法进行PNA低聚物的合成。
BFLP0169的PNAs可用于治疗和诊断应用。例如,可使用PNAs作为通过例如诱导转录或翻译停滞或抑制复制而序列特异地调节基因表达的反义或抗基因剂。BFLP0169的PNAs也可用于,例如,通过例如PNA指导的PCR定位而分析基因中单个碱基对的突变;当与其它酶,例如S1核酸酶组合时,作为人工的限制性内切酶;或作为用于DNA测序和杂交的探针或引物。
在另一个实施方案中,可修饰BFLP0169的PNAs,例如通过使亲脂性或其它辅助基团附着于PNA、通过形成PNA-DNA嵌合体,或通过利用本领域已知的药物递送的脂质体或其它技术而增强其稳定性或细胞的摄取。例如,可产生可能组合PNA和DNA的有利特性的BFLP0169的PNA-DNA嵌合体。
寡核苷酸可包括其它的附加基团,例如肽(例如,用于体内导向宿主细胞受体),或帮助转运跨越细胞膜或血脑屏障的试剂。此外,可用杂交触发裂解剂或插入剂对寡核苷酸进行修饰。所以,可以使寡核苷酸结合另一个分子,例如肽、杂交触发交联剂、转运试剂、杂交触发裂解剂等。
BFLP0169干扰核酸
本发明也提供能够介导BFLP0169基因表达的特异性抑制的分离双链核酸(DNA或RNA)。在优选的实施方案中,双链分子的一条或两条链是RNA分子。优选地,每个RNA链长度为19-25个,特别是19-23个核苷酸,更特别的是20-22个核苷酸,并且能够介导BFLP0169的靶特异性核酸修饰,特别是RNA干扰和/或DNA甲基化。双链BFLP0169分子可以是双链的或在5′和/或3′末端具有突出的末端。例如,该分子可具有3′突出。3-突出的长度可以是例如1-6个核苷酸、2-5个核苷酸、3-4个核苷酸或2个核苷酸。对于每个链该突出的长度可以是相同或不同的。在一个实施方案中,dsRNAs由2个成对的21个核苷酸链组成,以使得双链RNA的两个末端突出1、2、或3个核苷酸。
优选该RNA链具有3′-羟基。5′-末端优选包括磷酸酯、二磷酸、三磷酸或羟基。如果需要,可针对降解作用稳定化3′-突出。例如,可进行选择以使得它们由嘌呤核苷酸,特别是腺苷酸或鸟嘌呤核苷核苷酸组成。备选地,可用修饰的类似物替换嘧啶核苷酸,例如容许由2-脱氧胸腺嘧啶核苷取代尿嘧啶核苷-2核苷酸3′突出,并且不影响RNA干扰的效能。RNA分子可包含至少一个修饰的核苷酸类似物。核苷酸类似物可位于基本上不影响靶特异活性,例如RNAi调节活性的位置。修饰的核苷酸优选存在于双链RNA分子的5′-末端和/或3′-末端区域。在一些实施方案中,通过掺入修饰的核苷酸类似物稳定化突出。
核苷酸类似物可包括修饰糖-或骨架的核糖核苷酸。其它合适的核苷酸包括非天然存在的核酶而不是天然存在的核酶。例如,类似物可包括在5-位置修饰的尿嘧啶核苷或胞嘧啶,例如5-(2-氨基)丙基尿嘧啶核苷、5-溴基尿嘧啶核苷;在8-位置修饰的腺苷酸和鸟嘌呤核苷,例如8-溴基鸟嘌呤核苷;脱氮核苷酸,例如7-脱氮-腺苷酸;O-和N-烷基化的核苷酸,例如N6-甲基腺苷酸是合适的。在优选的糖修饰的核糖核苷酸中,以选自H、OR、R、卤素、SH、SR、NH2、NHR、NR2或CN的基团替代2′OH-基团,其中R是C1-C6烷基、烯基或炔基,而卤素是F、Cl、Br或I。在优选的实施方案中,使用修饰骨架的核糖核苷酸作为与邻近的核糖核苷酸连接的磷酸酯基团,其以修饰的基团替代,例如硫代磷酸基团。应注意到可以组合上述修饰。
BFLP0169干扰RNA分子可以是天然的分离RNA分子或可以是合成的RNA分子。优选地,BFLP0169干扰RNA分子基本上不含存在于细胞抽提物中,例如来自果蝇胚胎的杂质。进一步的,BFLP0169干扰RNA分子优选基本上不含任何非靶特异性的杂质,特别是非靶特异的RNA分子,例如来自存在于细胞抽提物的杂质。
分离的双链BFLP0169干扰分子可用于在哺乳动物细胞,特别是人细胞中介导BFLP0169靶特异的核酸修饰,特别是RNAi。
本发明的双链BFLP0169干扰分子的序列具有与核酸BFLP0169靶分子足够的同一性以便增强BFLP0169基因表达和/或DNA甲基化的靶特异性干扰。优选地,该序列与RNA分子双链部分中所需要的靶分子具有至少50%,特别是至少70%的同一性。更优选地,在RNA分子的双链部分中同一性是至少85%,以及最优选是100%。BFLP0169双链干扰RNA分子与预定的核酸靶分子,例如具有SEQ ID NO:1所示序列的BFLP0169mRNA靶分子的同一性可利用等式确定:I=(n/L)×100,其中I是同一性百分数,n是ds RNA和靶的双链部分中相同核苷酸的数目,以及L是dsRNA和靶的双链部分中序列重叠的长度。
备选地,也可限定双链RNA分子相对于靶序列的同一性包括3′突出,特别是长度为1-3个核苷酸的突出。在这种情况下该序列与靶序列的同一性优选是至少50%,更优选至少70%,以及最优选至少85%。例如,可修饰从3′突出的核苷酸和直到双链5′和/或3′末端的2个核苷酸而不使活性有显著损失。
可通过包括合成每个长度为19-25,例如19-23个核苷酸的2条RNA链的方法制备双链BFLP0169 RNA分子,其中所述的RNA链能够形成双链RNA分子,其中优选地至少一条链具有1-5个核苷酸的3′-突出,以及(b)在形成双链RNA分子的条件下组合合成的RNA链。双链RNA分子能够介导靶特异性的核酸修饰,特别是RNA干扰和/或DNA甲基化。
合成RNA分子的方法是本领域已知的。也可通过从合成的DNA模板或从分离自重组细菌的DNA质粒进行酶促转录来制备单链RNAs。一般使用噬菌体RNA聚合酶,例如T7、T3或SP6 RNA聚合酶。
本发明进一步的方面涉及在细胞或生物体中通过将细胞或生物体与本发明的双链RNA分子在可能发生靶特异性的核酸修饰的条件下接触介导BFLP0169-特异的核酸修饰,特别是RNA干扰和/或DNA甲基化的方法,以及介导受到双链RNA对BFLP0169靶核酸影响的靶特异性核酸修饰的方法。
BFLP0169多肽
本发明的BFLP0169多肽包括SEQ ID NO:2所提供的BFLP0169样蛋白质。本发明也包括公开的BFLP0169多肽的突变体或变体形式,或在此公开的BFLP0169多肽序列的任何片段。
因此,BFLP0169多肽包括其中可从相应于SEQ ID NO:2所示的残基而变化任何残基,同时仍然编码保持其BFLP0169样活性和生理功能的蛋白质,或其功能性片段的BFLP0169多肽。在一些实施方案中,在突变体或变体蛋白质中达到20%或更多的残基的变化。在一些实施方案中,根据本发明的BFLP0169多肽是成熟多肽。
雷帕霉素结合结构域
为了鉴定包含雷帕霉素结合结构域的BFLP0169多肽序列的区域(例如,包括所有或部分的SEQ ID NO:2的多肽),测试BFLP0169多肽序列的全部编码序列或片段的结合雷帕霉素的能力。可使用本领域已知的用于确定多肽结合小分子的任何技术。例如,可标记雷帕霉素(即,用非放射性的标记或放射性标记(例如,14C、32P、3H或125I标记),并且与包含一些或全部的BFLP0169多肽序列的多肽混合。任选地多肽包括便于检测的部分,例如该多肽可以是包括BFLP0169序列和非BFLP0169多肽序列的融合多肽。
向混合物加入特异于包含BFLP0169多肽序列的多肽的试剂(例如就融合多肽来说,特异于BFLP0169的抗体或特异于非BFLP0169多肽的探针)。分离结合试剂的复合物,确定标记的存在,从而显示存在雷帕霉素。
通常,保持BFLP0169样功能的BFLP0169样变体包括其中序列特定位置的残基已经由其他氨基酸取代的任何变体,并且进一步包括插入附加残基或亲本蛋白质的2个残基之间的残基的可能性,从亲本序列缺失一个或多个残基的可能性。本发明包括任何氨基酸取代、插入或缺失。 在有利的情况中,取代是如上所限定的保守取代。
本发明的一个方面涉及分离的BFLP0169蛋白质,以及其生物活性部分,或其衍生物、片段、类似物或同系物。片段可包括SEQ ID NO:2的连续的一段序列,或SEQ ID NO:2的散在节段。也提供适合用作产生抗BFLP0169抗体的免疫原的多肽片段。在一个实施方案中,可通过适当的纯化方案利用标准的蛋白质纯化技术从细胞或组织来源分离天然的BFLP0169蛋白质。在另一个实施方案中,通过重组DNA技术产生BFLP0169蛋白质。对于重组表达的备选,可利用标准的肽合成技术化学合成BFLP0169蛋白质或多肽。
″纯化的″蛋白质或其生物活性部分基本上不含细胞物质或来自从中衍生出BFLP0169蛋白质的细胞或组织来源的其它杂质蛋白质,或当化学合成时,基本上不含化学前体或其它化学品。术语″基本上不含细胞物质″包括BFLP0169蛋白质的制品,其中从分离或重组产生该蛋白质的细胞的细胞组分分离所述的蛋白质。在一个实施方案中,术语″基本上不含细胞物质″包括制备具有小于大约30%(以干重计)的非BFLP0169蛋白质(在此也称为″污染蛋白质″)的BFLP0169蛋白质,更优选小于大约20%的非BFLP0169蛋白质,更优选地小于大约10%的非BFLP0169蛋白质,以及最优选地小于大约5%的非BFLP0169蛋白质。当BFLP0169蛋白质或其生物活性部分是重组产生的时,也优选基本上不含培养基,即,存在的培养基小于蛋白质制品体积的大约20%,更优选小于大约10%,以及最优选小于大约5%。
术语″基本上不含化学品前体或其它化学品″包括BFLP0169蛋白质的制品,其中该蛋白质是从涉及该蛋白质合成的化学品前体或其它化学品分离的。 在一个实施方案中,术语″基本上不含化学品前体或其它化学品″包括制备的BFLP0169蛋白质具有小于大约30%(以干重计)的化学品前体或非BFLP0169化学品,更优选地小于大约20%的化学品前体或非BFLP0169化学品,更优选地小于大约1 0%的化学品前体或非BFLP0169化学品,以及最优选地小于大约5%的化学品前体或非BFLP0169化学品。
BFLP0169蛋白质的生物活性部分包括包含与BFLP0169蛋白质的氨基酸序列,例如SEQ ID NO:2所示的氨基酸序列足够同源或来源于该BFLP0169蛋白质氨基酸序列的肽,其包括少于全长的BFLP0169蛋白质的氨基酸,并且显示出BFLP0169蛋白质的至少一种活性。一般生物活性部分包括具有BFLP0169蛋白质的至少一种活性的结构域或基序。BFLP0169蛋白质的生物活性部分可以是长度为例如10、25、50、100或更多个氨基酸的多肽。
本发明的BFLP0169蛋白质的生物活性部分可包含BFLP0169蛋白质中间的至少一个上述鉴定的保守结构域。此外,可通过重组技术以及评估天然BFLP0169蛋白质的一种或多种功能活性来制备删除蛋白质其它区域的其它生物活性部分。
在一个实施方案中,BFLP0169蛋白质具有SEQ ID NO:2所示的氨基酸序列。在其他的实施方案中,BFLP0169蛋白质是与SEQ ID NO:2基本上同源的,并且保持SEQ ID NO:2的蛋白质的功能活性,然而由于天然的等位变体或诱变而在氨基酸序列上有差异,如下进行详细描述。因此,在另一个实施方案中,BFLP0169蛋白质是包含与SEQ IDNO:2的氨基酸序列至少大约45%同源的氨基酸序列,并且保持SEQID NO:2的BFLP0169蛋白质功能活性的蛋白质。
确定两个或多个序列之间的同源性
为了确定2个氨基酸序列或2个核酸序列的同源性百分数,将序列排序以进行最佳比较(例如,可在待进行序列间的最佳序列对比的任何一个序列中导入缺口)。然后比较相应氨基酸位置或核苷酸位置的氨基酸残基或核苷酸。当第一个序列的一个位置被与第二个序列中相应位置的相同氨基酸残基或核苷酸占据时,则在该位置分子是同源的(即,如在此所使用的,氨基酸或核酸″同源性″相当于氨基酸或核酸的″同一性″)。
可确定核酸序列的同源性作为2个序列之间同一性的程度。可利用该领域已知的计算机程序确定同源性,例如GCG程序包中提供的GAP软件。利用GCG缺口软件,其用于核酸序列比较的设置如下:缺口产生罚分为5.0,缺口延伸罚分为0.3,参考上述的类似核酸序列的编码区与SEQ ID NO:1所示的DNA序列CDS(编码)部分显示的同一性程度优选为至少70%、75%、80%、85%、90%、95%、98%、或99%。
术语″序列同一性″是指在特定区域比较的逐个残基的碱基上2个多核苷酸或多肽序列相同的程度。术语″序列同一性的百分比″是如下计算的:比较在比较区域进行最佳排列的2个序列,确定在两个序列中存在相同核酸碱基的位置的数目(例如,就核酸来说为A、T、C、G、U、I),以产生相配位置的数目,将相配位置的数目除以比较区域中位置的总数(即读框的大小),并且将结果乘以100以产生序列同一性的百分比。如在此所使用的术语″基本上的同一性″表示多核苷酸序列的特征,其中该多核苷酸包含与对照序列就比较区域相比,具有至少80%序列同一性,优选至少85%同一性,以及经常为90%至95%序列同一性,更通常为至少99%序列同一性的序列。术语″阳性残基的百分比″是如下计算的:比较在比较区域进行最佳排列的2个序列,确定在两个序列中存在相同的和如上所限定的保守氨基酸取代的位置的数目以产生相配位置的数目,将相配位置的数目除以比较区域中位置的总数(即,读框大小),并且将结果乘以100以产生阳性残基的百分比。
嵌合和融合的蛋白质
本发明也提供BFLP0169嵌合或融合的蛋白质。如在此所使用的,BFLP0169″嵌合蛋白质″或″融合蛋白质″包括与非BFLP0169多肽可操作连接的BFLP0169多肽。″BFLP0169多肽″是指具有相应于BFLP0169的氨基酸序列的多肽,而″非BFLP0169多肽″是指具有相应于基本上不与BFLP0169蛋白质同源的蛋白质,例如不同于BFLP0169蛋白质以及来源于相同或不同生物体的蛋白质的氨基酸序列的多肽。在BFLP0169融合蛋白内,BFLP0169多肽可相应于BFLP0169蛋白质的全部或部分。BFLP0169融合蛋白多肽的实例是该多肽包括SEQ IDNO:2的第21-230位氨基酸(例如,包括SEQ ID NO:2的第1-246位氨基酸或第21-246位氨基酸的多肽)。在一个实施方案中,BFLP0169融合蛋白包括BFLP0169蛋白质的至少一个生物活性部分。在另一个实施方案中,BFLP0169融合蛋白包括BFLP0169蛋白质的至少2个生物活性部分。在融合蛋白内,术语″可操作地连接″是用来表明BFLP0169多肽和非BFLP0169多肽是在读框中相互融合的。非BFLP0169多肽可融合到BFLP0169多肽的N-末端或C-末端。
例如,在一个实施方案中,BFLP0169融合蛋白包括与第二蛋白质,即非BFLP0169蛋白质的胞外结构域,或第二蛋白质,即非BFLP0169蛋白质的跨膜和胞内结构域可操作连接的BFLP0169多肽。这种融合蛋白可进一步用于筛选调节BFLP0169活性的化合物的分析(下文中将详细描述这种分析)。
在另一个实施方案中,融合蛋白是GST-BFLP0169融合蛋白,其中BFLP0169序列融合到GST序列(即,谷胱甘肽S-转移酶)的C末端。这种融合蛋白可有助于纯化重组的BFLP0169。
在另一个实施方案中,融合蛋白是BFLP0169-免疫球蛋白融合蛋白,其中包括一个或多个结构域的BFLP0169序列与来源于免疫球蛋白家族成员的序列融合。
BFLP0169配体/BFLP0169相互作用的抑制可治疗性地用于增殖和分化紊乱,例如癌症的治疗,通过改变细胞因子和趋化因子级联机理调节(例如促进或抑制)细胞存活以及治疗免疫调节紊乱,自身免疫、移植和炎症。此外,本发明的BFLP0169-免疫球蛋白的融合蛋白可用作免疫原以在受试个体中产生抗-BFLP0169的抗体,来纯化BFLP0169配体,并用于筛选分析来鉴定抑制BFLP0169与BFLP0169配体相互作用的分子。
可通过标准的重组DNA技术产生本发明的BFLP0169嵌合或融合蛋白。例如,根据常规方法,例如使用钝末端或交错末端连接,进行限制性内切酶消化以提供适当的末端,酌情补平粘末端,碱性磷酸酶处理以避免不合需要的连接,并进行酶促连接而将编码不同多肽序列的DNA片段在读框内连接在一起。在另一个实施方案中,可通过常规方法,包括自动化的DNA合成仪合成融合基因。备选地,可利用在2个连续的基因片段之间产生互补突出的锚定引物进行基因片段的PCR扩增,随后可进行退火和再扩增以产生嵌合的基因序列。 此外,已经编码融合蛋白的许多表达载体是可商购的(例如,GST多肽)。可将编码BFLP0169的核酸克隆到这种表达载体中,以使得融合部分在读框内与BFLP0169蛋白质连接。
如果需要,可使用BFLP0169蛋白质编码序列片段的文库来产生BFLP0169片段的多样化群体而用于筛选和后继的选择BFLP0169蛋白质的变体。
BFLP0169抗体
本发明也包括针对BFLP0169蛋白质或BFLP0169蛋白质片段的抗体。如在此所使用的术语″抗体″是指免疫球蛋白分子和免疫球蛋白(Ig)分子的免疫活性部分,即包含特异结合(免疫反应)抗原的抗原结合位点的分子。这种抗体包括但不限于,多克隆、单克隆、嵌合、单链、Fab、Fab′和F(ab′)2片段、以及Fab表达文库。通常,获得自人的抗体分子涉及任何种类的IgG、IgM、IgA、IgE和IgD,其相互之间由于存在于分子中的重链的特性而不同。某些种类也具有亚类,例如,IgG1、IgG2等。此外在人中,轻链可以是κ链或λ链。在此参考的抗体包括参考所有这些种类、亚类和类型的人抗体种类。
本发明的分离BFLP0169相关蛋白质可用作抗原或其部分或片段,并且另外可利用多克隆和单克隆抗体制备的常规技术,用作免疫原以产生特异地免疫结合该抗原的抗体。可使用全长的蛋白质,或备选地,本发明提供用作免疫原的抗原的抗原性肽片段。抗原性的肽片段包括全长蛋白质氨基酸序列,例如SEQ ID NO:2所示的氨基酸序列的至少6个氨基酸残基,并且包括其表位,以使得产生的针对肽的抗体与全长蛋白质或与包含表位的任何片段形成特异的免疫复合物。优选地,抗原性的肽包括至少10个氨基酸残基,或至少15个氨基酸残基,或至少20个氨基酸残基,或至少30个氨基酸残基。抗原性肽包括的优选表位是位于其表面的蛋白质的区域;通常是亲水的区域。
在本发明的某些实施方案中,抗原性肽包括至少一个表位是BFLP0169相关蛋白质的位于蛋白质表面的区域,例如亲水的区域。人BFLP0169相关蛋白质序列的疏水性分析将表明BFLP0169相关蛋白质的哪些区域是特别亲水的,并且因此很可能编码可用于靶抗体生产的表面残基。作为靶抗体生产的方式,亲水性曲线图显示可通过本领域公知的任何方法产生亲水性和疏水性的区域,包括例如伴随有或没有Fourier变换法的Kyte Doolittle或Hopp Woods方法。产生关于BFLP0169蛋白质的Kylte和Doolitle曲线图,并如下列表5所示。
表5.BFLP0169的Kyte和Doolittle曲线图
本发明的编码BFLP0169蛋白质的新核酸或其片段可进一步用于评估核酸或蛋白质的存在或数量的诊断应用。这些材料进一步可用于产生特异地免疫结合本发明的新物质的抗体而用于治疗或诊断方法。公开的BFLP0169蛋白质具有多个亲水区域,每个都可用作免疫原。在一个实施方案中,预期BFLP0169表位是大约第20至90位氨基酸。在另一个实施方案中,预期BFLP0169表位是大约第100至130位氨基酸。在另外的实施方案中,BFLP0169表位是大约第140至220位氨基酸、大约第240至250位氨基酸、大约第280至290位氨基酸、大约第330至340位氨基酸、大约第370至380位氨基酸、大约第400至410位氨基酸、大约第450至520位氨基酸、大约第530至540位氨基酸、大约第640至650位氨基酸、大约第720至730位氨基酸、大约第800至820位氨基酸、大约第850至855位氨基酸、大约第900至910位氨基酸、大约第920至930位氨基酸、大约第940至950位氨基酸、大约第970至990位氨基酸、大约第1000至1030位氨基酸、大约第1060至1080位氨基酸、大约第1100至1110位氨基酸、大约第1170至1180位氨基酸、大约第1190至1210位氨基酸、大约第1250至1280位氨基酸、大约第1310至1320位氨基酸、大约第1350至1370位氨基酸、大约第1400至1420位氨基酸、大约第1430至1440位氨基酸、大约第1500至1560位氨基酸、大约第1600至1610位氨基酸、大约第1650至1690位氨基酸、大约第1700至1710位氨基酸、以及大约第1720至1730位氨基酸。
在此也提供特异于抗原性蛋白质、或其衍生物、片段、类似物或同系物内的一个或多个结构域的抗体。
本发明的蛋白质,或其衍生物、片段、类似物、同系物或直向同源物可用作产生特异地免疫结合这些蛋白质成分的抗体中的免疫原。
本领域内已知的多种方法可用于生产直接针对本发明蛋白质、或针对其衍生物、片段、类似物、同系物或直向同源物的多克隆或单克隆抗体。术语″单克隆抗体″(MAb)或″单克隆抗体组合物″,如在此所使用的,是指只包含由唯一的轻链基因产物和唯一的重链基因产物组成的抗体分子的一个分子种类的抗体分子群。
直接针对本发明的蛋白质抗原的抗体可进一步包括人化的抗体或人抗体。人化形式的抗体包括嵌合的免疫球蛋白、免疫球蛋白链或其片段(例如Fv、Fab、Fab′、F(ab′)2或抗体的其它抗原结合亚序列),其主要由人免疫球蛋白的序列组成,并且包含来源于非人免疫球蛋白的最小序列。
抗体也可以是人抗体,例如其中轻链和重链,包括CDRs的基本上全部序列都由人基因产生。 可通过三源杂交瘤技术、人B细胞杂交瘤技术和EBV杂交瘤技术制备人单克隆抗体。
也可利用噬菌体展示文库,或通过将人免疫球蛋白基因座导入转基因动物,例如内源免疫球蛋白基因已经部分或完全失活的小鼠中而产生人抗体。另外可利用修饰的转基因非人类的动物产生人抗体,以便产生完全地人抗体而不是通过抗原激发而应答产生的动物内源抗体。
本发明也提供特异于本发明的抗原性蛋白质的单链抗体。此外,可改进方法使其适合于构建Fab表达文库以容许快速和有效的鉴定具有针对蛋白质或其衍生物、片段、类似物或同系物的所需要特异性的单克隆Fab片段。可通过本领域已知的技术产生包含针对蛋白质抗原的个体基因型的抗体片段,包括但不限于:(i)通过胃蛋白酶消化抗体分子而产生的F(ab′)2片段;(ii)通过还原F(ab′)2片段的二硫桥产生的Fab片段;(iii)通过用木瓜蛋白酶和还原剂处理抗体分子产生的Fab片段以及(iv)Fv片段。
本发明也提供双特异性的抗体。双特异性抗体是单克隆的,优选人或人化的抗体,其具有针对至少2种不同抗原的结合特异性。一个结合特异性是针对本发明的抗原性蛋白质。第二结合靶任何其它抗原,以及有益地是细胞表面蛋白质或受体或受体亚基。
如果需要,具有所需要的结合特异性(抗体-抗原结合部位)的抗体可变域可与免疫球蛋白的恒定结构域序列融合。优选与至少包括部分的铰链、CH2、和CH3区域的免疫球蛋白的重链恒定结构域融合。优选具有包含存在于至少一个融合体中为轻链结合所必需的位点的第一重链恒定区(CH1)。
可提供作为全长抗体或抗体片段的双特异性抗体(例如F(ab′)2双特异性抗体)。
本发明也包括具有多于2价的抗体(例如三特异性抗体)。
例证性的双特异性抗体结合2个不同的表位,其中至少一个起源于本发明的蛋白质抗原。
本发明也包括异共轭配合物抗体,其包括2个共价连接的抗体。
可修饰本发明的抗体以改变(例如,增强或减弱)其功能。例如,可将半胱氨酸残基导入Fc区域,由此容许在这个区域中形成链间二硫键。本发明也包括包含与细胞毒素试剂,例如化疗剂、毒素(例如,细菌、真菌、植物、或动物来源的酶促活性毒素,或其片段)、或放射性同位素(即,放射性共轭物)共轭的抗体的免疫共轭物。
可使用的酶促活性的毒素及其片段包括白喉A链、白喉毒素的非结合活性片段、外毒素A链(来自绿脓假单胞菌)、蓖麻毒A链、相思豆毒素A链、蒴莲根毒素A链、α-八叠球菌素、油桐蛋白质、石竹素蛋白质、美国商陆蛋白质(PAPI、PAPII、和PAP-S)、苦瓜抑制剂、麻风树毒蛋白、巴豆毒素、sapaonaria officinalis抑制剂、白树毒素、米托洁林、局限曲菌素、酚霉素、伊诺霉素、和tricothecenes。对于生产放射性共轭物的抗体多种放射性核素是有效的。实例包括212Bi、131I、131In、90Y、和186Re。
抗体可与″受体″共轭(例如链霉抗生物素)而用于肿瘤的预导向,其中将抗体受体共轭物施用于患者,然后利用清除剂从循环除去未结合的共轭物,然后施用随后结合细胞毒素试剂的″配体″(例如,抗生物素蛋白)。
BFLP0169重组表达载体和宿主细胞
本发明的另一个方面涉及载体,优选包含编码BFLP0169蛋白质,或其衍生物、片段、类似物或同系物的核酸的表达载体。如在此所使用的,术语″载体″是指能够转运已经连接的另一个核酸的核酸分子。一个类型的载体是″质粒″,其是指其中可连接附加的DNA节段的环状双链DNA环。另一类型的载体是病毒载体,其中附加的DNA节段可连接到病毒基因组中。某些载体能够在其被导入的宿主细胞中自发复制(例如,具有细菌复制原点的细菌载体和游离基因的哺乳动物载体)。将其它载体(例如,非游离基因哺乳动物载体)在导入到宿主细胞中时整合到宿主细胞的基因组中,并由此与其整合的宿主基因组序列一起复制。此外,某些载体能够指导与其进行可操作地连接的基因进行表达。这种载体在此称为″表达载体″。″质粒″和″载体″可互换使用,因为质粒是载体最通常使用的形式。然而,本发明旨在包括这种其它形式的表达载体,例如病毒载体(例如,复制缺陷型反向病毒、腺病毒和腺伴随病毒),其发挥相等的功能。
在重组表达载体内,″可操作地连接″是指将令人感兴趣的核苷酸序列与调节序列连接,其连接方式允许核苷酸序列的表达(例如,在体外转录/翻译系统或当将载体导入宿主细胞时,在宿主细胞中表达)。术语″调节序列″旨在包括启动子、增强子和其他表达控制元件(例如,多聚腺苷酸信号)。调节序列包括在许多类型的宿主细胞中指导核苷酸序列组成性表达,以及只在某些宿主细胞中指导核苷酸序列表达的调节序列(例如,组织特异性调节序列)。可将本发明的表达载体导入宿主细胞,由此产生蛋白质或肽,包括由如在此所描述的核酸编码的融合蛋白或肽(例如,BFLP0169蛋白质、BFLP0169蛋白质的突变体形式、融合蛋白等)。
本发明的重组表达载体可设计成在原核或真核细胞中表达BFLP0169蛋白质。例如,BFLP0169蛋白质可以在细菌细胞,例如大肠杆菌,昆虫细胞(利用杆状病毒表达载体)、酵母细胞或哺乳动物细胞中表达。备选地,可例如利用T7启动子调节序列和T7聚合酶体外转录和翻译重组表达载体。
在另一实施方案中,利用哺乳动物表达载体在哺乳动物中表达本发明的核酸。哺乳动物表达载体的实例包括pCDM8和pMT2PC。当用于哺乳动物细胞时,经常由病毒调控元件提供表达载体的控制功能。例如,通常所使用的启动子来源于多形瘤、腺病毒2、巨细胞病毒、和猿猴病毒40。对于其它合适的表达系统适于原核和真核细胞。
在另一个实施方案中,重组的哺乳动物表达载体能够优选在特定的细胞类型中指导核酸的表达(例如,使用组织特异性调控元件表达核酸)。组织特异性调控元件是本领域已知的。合适的组织特异性启动子的非限制性实例包括白蛋白启动子(肝特异性)、淋巴特异性启动子、特别是T细胞受体和免疫球蛋白的启动子、神经元特异性启动子(例如,神经丝启动子)、胰腺特异性启动子,和乳腺特异性启动子(例如,牛奶乳清启动子)。也包括发育性调控启动子,例如鼠的hox启动子和α-甲胎蛋白启动子。
本发明进一步提供包括以反义方向克隆到表达载体中的本发明DNA分子的重组表达载体。也就是说,使DNA分子以容许表达与BFLP0169 mRNA反义的RNA分子的方式(通过DNA分子的转录)可操作地连接调控序列。可选择可操作地与以反义方向克隆的核酸连接的调控序列来指导反义RNA分子在多种细胞类型中连续表达,例如病毒启动子和/或增强子,或可选择调控序列来指反义RNA的组成性、组织特异的或细胞类型特异性表达。反义表达载体可以是重组质粒、噬菌粒或减毒病毒的形式,其中在高效调控区域的控制下产生反义核酸,可通过导入载体的细胞类型来确定其活性。
本发明的另一个方面涉及已经导入本发明的重组表达载体的宿主细胞。术语″宿主细胞″和″重组宿主细胞″在此是可互换使用的。可以理解这个术语不仅是指特定的受试个体细胞而且是指这种细胞的后代或潜在后代。因为由于突变或环境影响在后继的世代中可能存在某些改变,实际上这种后代可能与亲本细胞未必相同,但是仍然包括在在此所使用的术语的范围内。
宿主细胞可以是任何的原核或真核细胞。例如,可在细菌细胞中表达BFLP0169蛋白质,例如大肠杆菌、昆虫细胞酵母或哺乳动物细胞(例如人,中国仓鼠卵巢细胞(CHO)或COS细胞)。其他合适的宿主细胞是本领域技术人员公知的。
一般将编码可选择的标记(例如抗生素的抗药性)的基因与令人感兴趣的基因一起导入宿主细胞。多种可选择的标记包括赋予抗药性,例如G418、潮霉素和氨甲蝶呤抗性的标记。可在与编码BFLP0169的载体相同的载体上,将编码可选择标记的核酸导入宿主细胞,或可在分开的载体上导入。可通过药物选择鉴定用导入的核酸稳定转染的细胞(例如,具有整合的可选择标记基因的细胞将存活,而其它的细胞将死亡)。
本发明的宿主细胞,例如培养中的原核或真核宿主细胞,可用于生产(即表达)BFLP0169蛋白质。因此,本发明进一步提供利用本发明的宿主细胞生产BFLP0169蛋白质的方法。在一个实施方案中,该方法包括在合适的培养基中培养本发明的宿主细胞(其中已经导入了编码BFLP0169蛋白质的重组表达载体),以生产BFLP0169蛋白质。在另一个实施方案中,该方法进一步包括从培养基或宿主细胞分离BFLP0169蛋白质。
转基因的BFLP0169动物
本发明的宿主细胞也可用来生产非人的转基因动物。例如,在一个实施方案中,本发明的宿主细胞是已经导入编码BFLP0169蛋白质的序列的受精卵母细胞或胚胎干细胞。然后这种宿主细胞可用于产生其中已经在其基因组中导入外源BFLP0169序列的非人转基因动物或其中已经改变了内源BFLP0169序列的同源重组动物。这种动物可用于研究BFLP0169蛋白质的功能和/或活性,并用于鉴定和/或评估BFLP0169蛋白质活性的调节剂。如在此所使用的,″转基因的动物″是非人的动物,优选哺乳动物,更优选啮齿类,例如大鼠或小鼠,其中该动物的一种或多种细胞包括转基因。转基因动物的其它实例包括非人的灵长类、绵羊、狗、牛、山羊、鸡、两栖类等。转基因是整合到来自发育的转基因动物的细胞基因组中,并且保持在成熟动物的基因组中的外源性DNA,由此在转基因动物的一个或多个细胞类型或组织中指导编码基因产物的表达。如在此所使用的,″同源的重组动物″是非人的动物,优选哺乳动物,更优选小鼠,其中已经通过在内源基因和在动物发育前导入动物细胞,例如动物的胚细胞的外源性DNA分子之间的同源重组而改变了内源的BFLP0169基因。
可通过将编码BFLP0169的核酸导入到受精卵母细胞的精原核中(例如,通过微注射、反向病毒感染),并容许卵母细胞在假孕的雌性哺育动物中发育产生本发明的转基因动物。可将包括SEQ ID NO:1的序列作为转基因导入非人动物的基因组中。备选地,可根据与人BFLP0169cDNA(上文所述)的杂交作用分离人BFLP0169基因的非人同系物,例如小鼠BFLP0169基因,并用作转基因。内含子序列和多聚腺苷酸信号也可包括在转基因内以增加转基因表达的效力。可将组织特异性调控序列可操作地与BFLP0169转基因连接以指导BFLP0169蛋白质至特定的细胞表达。借助于胚胎操作和微注射产生转基因动物,特别是例如小鼠的动物的方法已经成为本领域的常规方法。类似的方法可用于产生其它的转基因动物。可根据其基因组中BFLP0169转基因的存在和/或该动物的组织或细胞中BFLP0169mRNA的表达鉴定转基因的建立动物。然后转基因的建立动物可用来繁殖携带该转基因的附加动物。此外,可进一步使携带编码BFLP0169蛋白质的转基因的转基因动物与携带其他转基因的其它转基因动物进行繁殖。
为了产生同源的重组动物,所制备的载体包含至少部分的BFLP0169基因,而该基因中已经导入了缺失、添加或取代,由此改变,例如功能性破坏BFLP0169基因。BFLP0169基因可以是人基因(例如,SEQ ID NO:1的DNA),但更优选地是人BFLP0169基因的非人同系物。 例如,SEQ ID NO:1的人BFLP0169基因的小鼠同系物可用于构建适于改变小鼠基因组中的内源BFLP0169基因的同源重组载体。在一个实施方案中,设计该载体以使得在同源重组时,内源的BFLP0169基因功能性断裂(即,不再编码功能蛋白;也称为″敲除″载体)。
备选地,可设计该载体以使得在同源重组时,内源的BFLP0169基因突变或其它改变,但仍编码功能蛋白(例如,可改变上游调控区由此改变内源BFLP0169蛋白质的表达)。在同源的重组载体中,BFLP0169基因的改变部分是BFLP0169基因附加核酸5′-和3′-末端侧翼的部分,以容许同源重组发生在由载体携带的外源BFLP0169基因和胚胎干细胞的内源BFLP0169基因之间。BFLP0169核酸的附加侧翼对于与内源基因的成功同源重组具有足够的长度。一般DNA侧翼的几千个碱基(在5′和3′-末端)包括在载体中。然后将载体导入胚胎干细胞系(例如,通过电穿孔),并且选择导入的BFLP0169基因已经与内源的BFLP0169基因同源重组的细胞。
然后将所选择的细胞注射到动物(例如小鼠)的胚囊中以形成聚集的嵌合体。然后可将嵌合的胚胎移植到合适的假孕雌性哺育动物中,并且使胚胎生长至妊娠期满。使同源重组的DNA停泊在其生殖细胞中的后代可用于繁殖其中该动物的所有细胞通过生殖系传输该转基因而都包含同源重组的DNA的动物。
在另一个实施方案中,可产生转基因的非人动物,其包含容许转基因的调控表达的选择系统。这种系统的一个实例是细菌噬菌体P1的cre/loxP重组酶系统。关于cre/loxP重组酶系统的说明。重组酶系统的另一个实例是酿酒酵母的FLP重组酶系统。如果使用cre/loxP重组酶系统调节转基因的表达,需要包含编码Cre重组酶和选择蛋白质的转基因的动物。可通过构建″双″转基因的动物,例如通过使2种转基因动物交配来提供这种动物,其中一种包含编码选择蛋白质的转基因,而另一种包含编码重组酶的转基因。
也可根据本领域所描述的方法生产在此所描述的非人转基因动物的克隆。 简言之,可从转基因的动物分离细胞(例如体细胞),并诱导至离开生长周期而进入Go期。然后例如通过使用电脉冲使休眠细胞与来自分离休眠细胞的相同种类动物的卵母细胞融合。然后培养重构的卵母细胞,以使得其发育至桑椹胚或胚细胞,然后转入假孕的雌性哺育动物。这雌性哺育动物生产的后代将成为分离该细胞(例如体细胞)的动物的克隆。
检测BFLP0169核酸和诊断狼疮肾炎的方法
检测BFLP0169核酸和/或多肽的试剂可用于检测样品中BFLP0169RNA和/或蛋白质序列的水平。因为在患有狼疮肾炎的动物中发现BFLP0169 RNA水平升高,检测到BFLP0169 RNA和/或BFLP0169多肽水平增强表明受试个体中存在狼疮或易患狼疮的体质。此外,与未经治疗狼疮的相比,治疗狼疮的受试个体中BFLP0169 RNA的水平降低表明恢复到非狼疮状态。因此,可通过与患病但未经治疗的样品(或来自已经短期治疗过的个体的样品)比较,来自治疗群体的样品中BFLP0169 RNA或蛋白质的水平监测狼疮治疗的效果。
可通过与已知狼疮状态的参考细胞群的水平比较来自未知狼疮状态的受试个体的测试细胞群中的水平来评估BFLP0169 RNA的水平。因此,一般测试细胞群将包括能够表达BFLP0169基因的至少一个细胞。″能够表达″是指该基因以完整的形式存在于细胞中,并且可以表达。然后检测BFLP0169序列的表达,如果存在,优选地利用本领域已知的方法测量。例如,在此公开的BFLP0169序列可用于构建在例如northern印迹杂交分析或特异地并且优选地定量扩增BFLP0169特异性核酸序列的方法中检测BFLP0169 RNA序列的探针。备选地,该序列可用于构建在例如,基于扩增的检测方法,例如基于逆转录的聚合酶链式反应中用于特异扩增BFLP0169序列的引物。
也可在蛋白质水平,即通过测量BFLP0169多肽的水平来测量BFLP0169表达。这种方法是本领域已知的,包括例如基于针对由该基因编码的蛋白质的抗体的免疫测定。
可利用任何本领域公认用于比较核酸序列表达的方法来比较测试和对照细胞群体中序列的表达。在测试细胞群对参照细胞群的基因表达图谱的比较中是否显示测量参数的存在或程度取决于参照细胞群的组成。例如,如果参照细胞群由来自没有狼疮的受试个体的细胞组成,测试细胞群和参照细胞群中类似的基因表达水平表明测来自于没有狼疮的受试个体。相反地,如果参照细胞群由来自患病的受试个体的细胞组成,测试细胞群和参照细胞群之间类似的基因表达图谱表明测试细胞群来自于患有狼疮的受试个体。
在多种实施方案中,如果测试细胞群的表达水平比参照细胞群中BFLP0169转录本的水平变化在2.0、1.5、或1.0倍的系数内,则认为测试细胞群中BFLP0169序列与参照细胞群中ADIPO序列的表达水平相当。在多种实施方案中,如果测试细胞群的表达水平比参照细胞群体中相应的BFLP0169序列表达水平变化大于1.0、1.5、2.0以上的倍数,则认为测试细胞群体中BFLP0169序列在表达水平发生改变。
如果需要,相对于其表达与测量的参数或条件无关的对照核酸,可比较测试细胞群和参照细胞群之间差异表达的序列。测试和参照核酸中对照核酸的表达水平可用于校正所比较的群体中的信号水平。本领域的普通技术人员可容易地确定合适的对照核酸。
在一些实施方案中,测试细胞群与多个参照细胞群进行比较。每一多重的参照群体可能在已知的参数中有差异。因此,测试细胞群可与来自已知患有狼疮的受试个体的第一参照细胞群,以及已知不患有狼疮的第二参照群进行比较。
所暴露的测试细胞群可以是任何数目的细胞,即一个或多个细胞,并且可以是体外、体内或自体内提供的。
优选地,参照细胞群中的细胞来源于与测试细胞尽可能类似的组织类型,例如肾组织。在一些实施方案中,对照细胞来源于与测试细胞相同的受试个体。在其他的实施方案中,参照细胞群来源于来自多个受试个体的细胞多元群。例如,参照细胞群可以是来自先前测试细胞的表达模式的数据库。
受试个体优选是哺乳动物。哺乳动物可以是例如人、非人灵长类、小鼠、大鼠、狗、猫、马或牛。
药物组合物
本发明的BFLP0169核酸分子、BFLP0169蛋白质、和抗BFLP0169(在此也称为″活性化合物″),以及其衍生物、片段、类似物和同系物,可掺入到适于给药的药物组合物中。这种组合物一般包括核酸分子、蛋白质、或抗体和药物学上可接受的载体。如在此所使用的,″药物学上可接受的载体″旨在包括与药物给药相适应的任何和所有的溶剂,分散介质、包衣、抗细菌剂和抗真菌剂、等渗剂和吸收延迟剂等。在最近出版的Remington′s Pharmaceutical Sciences,本领域的标准参考教科书中描述了合适的载体,其在此引入作为参考。这种载体或稀释剂的优选实例包括但不限于水、盐水、Ringer′s溶液、葡萄糖溶液、和5%的人血清白蛋白。也可使用脂质体和无水的溶剂,例如固定油类。这种介质和试剂用作药物学上的活性物质是本领域公知的。 除非任何常规的介质或试剂与该活性化合物不相容,否则将其使用在组合物中是可以预料得到的。也可将辅助的活性化合物掺入到组合物中。
配制本发明的药物组合物以与其预定的给药途径相适应。给药途径的实例包括非胃肠道的,例如静脉内的、皮内的、皮下的、口服的(例如吸入)、透过皮肤的(即局部的)、转化粘液质的和直肠给药。
适合注射用途的药物组合物包括无菌的水溶液(水溶性的)或分散剂和用于临时制备无菌的可注射溶液或分散剂的无菌粉剂。
如在此所使用的剂量单位形式是指对待治疗的受试者适合作为单一剂量的物理上非连续的单位;每种单位包含经计算的预先确定量的活性化合物以产生与要求的药物载体相应的所需治疗效果。本发明剂量单位形式的规格决定于和直接依赖于活性化合物的独特特性和所需获得的特定治疗效果,以及在化合物领域中这种活性化合物对于个体治疗所固有的局限性。
可制备持续释放的制剂。持续释放制剂的合适实例包括包含抗体的固体疏水性聚合物的半透性基质,其中基质是加工成形的物品形式,例如薄膜或微胶囊。持续释放基质的实例包括聚酯、水凝胶(例如,聚(2-羟乙基-异丁烯酸)、或聚(乙烯醇))、聚交酯、L-谷氨酸和γ乙基-L-谷氨酸的共聚物、不可降解的乙烯-醋酸乙烯酯、可降解的乳酸-羟基乙酸共聚物,例如LUPRON DEPOT TM(由乳酸-羟基乙酸共聚物和醋酸亮丙瑞林乙酸酯组成的可注射的微球体)、和聚-D-(-)-3-羟丁酸。当聚合物,例如乙烯-醋酸乙烯酯和乳酸-羟基乙酸能够释放分子100天时,某些水凝胶释放蛋白质较短的时间段。
该药物组合物可被包括在与给药说明一起的容器、包装或分散剂中。
筛选和检测方法
本发明的分离核酸分子可用于表达BFLP0169蛋白质(例如借助于基因治疗应用的宿主细胞中的重组表达载体),以检测BFLP0169mRNA(例如,在生物样品中)或BFLP0169基因中的遗传学病变,以及调节BFLP0169活性,如下进行进一步的描述。此外,BFLP0169蛋白质可用于筛选调节BFLP0169蛋白质活性或表达,以及治疗病症的药物或化合物,其中该病症的特征是产生的BFLP0169蛋白质不足或过量、或与BFLP0169野生型蛋白质相比,产生活性降低或异常的BFLP0169蛋白质形式。此外,本发明的抗BFLP0169抗体可用于检测和分离BFLP0169蛋白质以及调节BFLP0169活性。例如,BFLP0169活性包括T细胞或NK细胞的生长和分化、抗体产生和肿瘤生长。
本发明进一步涉及通过在此所描述的筛选分析鉴定的新试剂及其用于如上所述的治疗的用途。
筛选分析
本发明提供用于鉴定结合BFLP0169蛋白质或对例如BFLP0169蛋白质表达或BFLP0169蛋白质活性具有刺激或抑制效果的调节剂,即候选或测试化合物或试剂(例如、肽、肽模拟物、小分子或其它药物)的方法(在此也称为″筛选分析″)。本发明也包括在在此所描述的筛选分析中鉴定的化合物。
在一个实施方案中,使用筛选分析来鉴定用于治疗自身免疫疾病的治疗剂。该自身免疫性疾病可以是例如狼疮,包括狼疮肾炎。
在一个实施方案中,本发明提供用于筛选结合或调节膜结合形式的BFLP0169蛋白质或多肽的活性或其生物活性部分的候选或测试化合物的分析。可利用本领域已知的任何多种途径组合的文库方法来获得本发明的测试化合物,包括:生物学文库;空间可选址的并联的固相或液相文库;需要反演的合成文库方法;″一珠子-一化合物″的文库方法;以及利用亲和色谱法选择的合成文库方法。生物学文库方法限于肽文库,而另4个方法适用于肽、非肽低聚物或化合物的小分子文库。
如在此使用的″小分子″,是指分子量小于大约5kD以及最优选小于大约4kD的组合物。小分子可以是例如,雷帕霉素、核酸、肽、多肽、肽模拟物、碳水化合物、脂类或其它有机或无机分子。 化学品和/或生物学混合物,例如真菌、细菌、或海藻提取物的文库,是本领域已知的,并且可用本发明的任何分析筛选。化合物的文库可存在于溶液中、或珠子上、芯片上、细菌、孢子、质粒或噬菌体上。
在一个实施方案中,分析是基于细胞的分析,其中将在细胞表面上表达膜结合形式的BFLP0169蛋白质、或其生物活性部分的细胞与测试化合物接触,并且确定测试化合物结合BFLP0169蛋白质的能力。细胞例如可以是哺乳动物起源或酵母细胞。可例如通过使测试化合物与放射性同位素或酶促标记偶联,以使得可通过检测复合物中的标记化合物来测试化合物与BFLP0169蛋白质或其生物活性部分的结合而实现对测试化合物结合BFLP0169蛋白质的能力的确定。例如,可用125I、35S、14C、或3H直接或间接地标记测试化合物,并通过放射性发射的直接计数或通过闪烁计数检测放射性同位素。备选地,可用例如辣根过氧化物酶、碱性磷酸酶、或荧光素酶来酶促标记测试化合物,并通过确定适当底物向产物的转化而检测酶促标记。在一个实施方案中,该分析包括将在细胞表面上表达膜结合形式的BFLP0169蛋白质、或其生物活性部分的细胞与结合BFLP0169形成分析混合物的已知化合物接触,将分析混合物与测试化合物接触,并且确定测试化合物与BFLP0169蛋白质相互作用的能力,其中对测试化合物与BFLP0169蛋白质相互作用的能力的确定包括确定测试化合物与已知化合物相比,优先结合BFLP0169蛋白质或其生物活性部分的能力。
在另一个实施方案中,分析是基于细胞的分析,包括将在细胞表面上表达膜结合形式的BFLP0169蛋白质、或其生物活性部分的细胞与测试化合物接触,并且确定测试化合物调节(例如刺激或抑制)BFLP0169蛋白质的活性或其生物活性部分的能力。可通过例如确定BFLP0169蛋白质结合或与BFLP0169靶分子相互作用的能力来实现对测试化合物调节BFLP0169的活性或其生物活性部分的能力的确定。如在此使用的,″靶分子″是BFLP0169蛋白质天然结合或相互作用的分子,例如在表达BFLP0169相互作用蛋白质的细胞表面上的分子、在第二细胞表面上的分子、在胞外环境中的分子、与细胞膜内表面相关的分子或细胞质分子。BFLP0169靶分子可以是非BFLP0169分子或本发明的BFLP0169蛋白质或多肽。在一个实施方案中,BFLP0169靶分子是帮助转导胞外信号(例如通过化合物结合膜结合得BFLP0169分子而产生的信号)通过细胞膜并进入细胞内的信号转导途径的成分。该靶,例如可以是具有催化活性的第二胞间蛋白质或帮助下游信号分子与BFLP0169缔合的蛋白质。
可通过如上所述用于确定直接结合的方法中的一个来完成对BFLP0169蛋白质结合或与BFLP0169靶分子相互作用的能力的确定。在一个实施方案中,可通过确定靶分子的活性来完成对BFLP0169蛋白质结合或与BFLP0169靶分子相互作用的能力的确定。例如,可通过检测靶的细胞第二信使的诱导(即胞内Ca2+、二酰甘油、IP3等),检测靶对适当底物的催化/酶促活性,检测报告基因(包括可操作地与编码可检测标记,例如荧光素酶的核酸连接的BFLP0169应答性调控元件)的诱导,或检测细胞反应,例如细胞存活、细胞分化,或细胞增殖来确定靶分子的活性。
在另一实施方案中,本发明的分析是基于无细胞的分析,包括将BFLP0169蛋白质、或其生物活性部分与测试化合物接触,并且确定测试化合物结合BFLP0169蛋白质或其生物活性部分的能力。可如上所述直接或间接地确定测试化合物与BFLP0169蛋白质的结合。在一个这种实施方案中,该分析包括将BFLP0169蛋白质或其生物活性部分与结合BFLP0169形成分析混合物的已知化合物接触,将分析混合物与测试化合物接触,并且确定测试化合物与BFLP0169蛋白质相互作用的能力,其中对测试化合物与BFLP0169蛋白质相互作用的能力的确定包括确定测试化合物与已知化合物相比,优先结合BFLP0169蛋白质或其生物活性部分的能力。
在另一个实施方案中,分析是无细胞的分析,包括将BFLP0169蛋白质或其生物活性部分与测试化合物接触,并且确定测试化合物调节(例如刺激或抑制)BFLP0169蛋白质或其生物活性部分的活性的能力。可通过例如通过如上所述用于确定直接结合的方法中的一个来确定BFLP0169蛋白质结合BFLP0169靶分子的能力而完成对测试化合物调节BFLP0169活性的能力的确定。在备选的实施方案中,可通过确定BFLP0169蛋白质进一步调节BFLP0169靶分子的能力来完成对测试化合物调节BFLP0169蛋白质活性的能力的确定。例如,可如上所述确定靶分子对适当底物的催化/酶促活性。
在另一实施方案中,无细胞分析包括将BFLP0169蛋白质或其生物活性部分与结合BFLP0169蛋白质形成分析混合物的已知化合物接触,将分析混合物与测试化合物接触,并且确定测试化合物与BFLP0169蛋白质相互作用的能力,其中对测试化合物与BFLP0169蛋白质相互作用的能力的确定包括确定BFLP0169蛋白质优先结合或调节BFLP0169靶分子活性的能力。
本发明的无细胞分析可顺应地用作BFLP0169蛋白质的可溶形式或膜结合形式。就包括膜结合形式的BFLP0169蛋白质的无细胞分析来说,可能需要利用增溶剂以使得膜结合形式的BFLP0169蛋白质保持在溶液中。这种增溶剂的实例包括非离子洗涤剂,例如n-辛基葡糖苷、n-十二烷基葡糖苷、n-十二烷基麦芽糖苷、辛酰基-N-甲基葡糖胺、癸酰基-N-甲基葡糖胺、Triton_X-100、Triton_X-114、Thesit_、Isotridecypoly(乙烯基乙二醇醚)n、N-十二烷基-N,N-二甲基-3-胺基-1-丙烷磺酸盐、3-(3-胆胺丙基)二甲基氨合-1-丙烷磺酸盐(CHAPS)、或3-(3-胆胺丙基)二甲基氨合-2-羟基-1-丙烷磺酸盐(CHAPSO)。
在本发明上述测定法的一个以上的实施方案中,可能需要固定BFLP0169蛋白质或其靶分子以便于从未复合形式的一个或两个蛋白质分离复合物,以及提供自动操作的分析。在存在和缺少候选化合物时,可在任何适于容纳反应物的容器中完成测试化合物与BFLP0169蛋白质的结合,或BFLP0169蛋白质与靶分子的相互作用。这种容器的实例包括微量滴定板、试管、和微离心管。在一个实施方案中,提供的融合蛋白可加入了容许一个或两个蛋白质结合基质的结构域。例如,可使GST-BFLP0169融合蛋白或GST-靶融合蛋白吸附到谷胱甘肽琼脂糖凝胶珠子(Sigma Chemical,St.Louis,MO)或谷胱甘肽衍生的微量滴定板上,然后与测试化合物或测试化合物与非吸附的靶蛋白质或BFLP0169蛋白质结合,并且在有助于复合物形成的条件(例如,在盐和pH的生理条件)下孵育混合物。孵育后,洗涤珠子或微量滴定板的孔以除去任何未结合的成分,就固定基质为珠子的情形来说,例如如上文所描述的直接或间接地确定复合物。备选地,可从基质分离复合物,并利用常规技术确定BFLP0169蛋白结合或活性的水平。
用于使蛋白质固定在基质上的其它技术也可用于本发明的筛选分析。例如,可利用生物素和链霉抗生物素的接合作用固定BFLP0169蛋白质或其靶分子。可利用本领域众所周知的技术从生物素-NHS(N-羟基-琥珀酰亚胺)制备生物素酰化的BFLP0169蛋白质或靶分子(例如,生物素酰化试剂盒,Pierce Chemicals,Rockford,Ill.),并且固定在涂有链霉抗生物素的96孔平板的孔中(Pierce Chemical)。备选地,与BFLP0169蛋白质或靶分子反应、但不防碍BFLP0169蛋白质结合其靶分子的抗体可以是平板的孔衍生的,并且不结合通过抗体接合作用截留在孔中的靶或BFLP0169蛋白质。用于检测这种复合物的检测方法,除如上所述用于GST固定复合物的方法之外,包括利用与BFLP0169蛋白质或靶分子反应的抗体免疫检测复合物以及依赖于检测与BFLP0169蛋白质或靶分子相关的酶活性的酶联测定。
在另一个实施方案中,在将细胞接触候选化合物并且确定细胞中BFLP0169 mRNA或蛋白质表达的方法中鉴定BFLP0169蛋白质表达的调节剂。将在存在候选化合物时,BFLP0169 mRNA或蛋白质表达的水平与缺乏候选化合物时BFLP0169 mRNA或蛋白质表达的水平相比。然后根据这个比较可确定候选化合物是BFLP0169 mRNA或蛋白质表达的调节剂。例如,当存在候选化合物时BFLP0169 mRNA或蛋白质的表达大于缺乏该候选化合物时,(即,统计学上显著大于),则确定该候选化合物为BFLP0169 mRNA或蛋白质表达的刺激剂。备选地,当存在候选化合物时BFLP0169 mRNA或蛋白质的表达低于缺乏该候选化合物时,(即,统计学上显著地小于),则确定该候选化合物为BFLP0169 mRNA或蛋白质表达的抑制剂。可通过在此所描述的用于检测BFLP0169 mRNA或蛋白质的方法确定细胞中BFLP0169mRNA或蛋白质表达的水平。
在本发明的另一方面,可使用BFLP0169蛋白质作为双-杂合测定或3杂合测定中的″饵蛋白质″,以鉴定结合或与BFLP0169(″BFLP0169-结合蛋白″或″BFLP0169-bp″)相互作用,以及调节BFLP0169活性的其它蛋白质。这种BFLP0169-结合蛋白也可能通过BFLP0169蛋白质,例如BFLP0169途径的上游或下游元件而涉及信号的增殖。
双杂合系统是基于大多数转录因子的调节特性,该转录因子由可分离的DNA-结合和活化结构域组成。简而言之,本测定利用2个不同的DNA构建体。在一个构建体中,编码BFLP0169的基因与编码已知转录因子(例如GAL-4)的DNA结合结构域的基因融合。在另一个构建体中,来自DNA序列文库、编码未鉴别的蛋白质(″捕获″或″样品″)的DNA序列与编码已知转录因子的活化结构域的基因融合。如果″饵″和″捕获″蛋白质能够相互作用,体内形成BFLP0169-依赖的复合物,则使转录因子的DNA-结合和活化结构域更为紧密相邻。这种接近度容许转录与应答转录因子的转录调节位点可操作地连接的报告基因(例如LacZ)。可检测报告基因的表达,可分离包含功能性转录因子的细胞集落并用于获得编码与BFLP0169相互作用的蛋白质的克隆基因。
本发明进一步涉及通过上述的筛选分析鉴定的新试剂及其用于在此所述的治疗的用途。
在下列的非限制性实施例中说明本发明。
实施例1.无病的、狼疮肾炎模拟疾病、和雷帕霉素治疗的患病小鼠中鼠BFLP0169序列的表达模式
在本领域公认的NZB×NZW鼠模型的发展狼疮肾炎样症状的小鼠中检验鼠BFLP0169序列的表达(参见例如,Drake等人,Geneticanalysis the NZB contribution to lupus-like autoimmune disease in(NZB xNZI FI mice,.Proc Natl Acad Sci U S A 91:4062-66,1994;Finck等人,Interleukin 6 promotes murine lupus in NZB/NZWF1 mice,J.Clin.Invest 94:585-91,1994;Gμglielmotti等人,Bindarit prlongssurvival and reduces renal damage ofNSB/W lupus mice.Clin.Exp.RheμMatol.16:149,1998;Yang等人,Dietary conjugated linoleicacidprotects against end stage disease of systemic lupus erythematosus inthe NZB/WF1 mouse,Immunopharmacol.Immunotoxicol.22:433-49,2000。将患病小鼠中的表达与年龄不同的非患病小鼠、和用雷帕霉素或抗-B7的抗体治疗后其狼疮肾炎样症状减弱的小鼠中序列的表达进行比较。
从Jackson实验室获得6至8周龄的小鼠并且在原地老化。从小鼠的肾脏获得数据并且在标明的时间点收获数据:C57BL/6雌性小鼠为8和32周龄;F1(NZB×NZW)雌性小鼠为12、25和42周龄;用雷帕霉素处理的小鼠为42和55周龄;用B7.1和B7.2的抗体处理的小鼠为52周龄。每组包含3个小鼠。
雷帕霉素处理的小鼠每周接受3次5mg/kg雷帕霉素的皮下注射,在29周龄开始,持续8周。对照小鼠按照相同的时间表接受溶剂(甲基纤维素)的注射。通过蛋白尿和肾组织结构(数据未显示)的标准化确定治疗的有效性。在治疗过程结束(36周龄,数据未显示),和42周龄(处理后6周)和55周龄(处理后20周)时,对杀死的小鼠预先形成基因表达分析。
用抗-B7处理的小鼠通过腹膜内注射接受每周3次200μg的抗-B7.1(1G10F9单克隆)和200μg的抗-B7.2(GL1单克隆),在29周龄开始,持续2周。处理后21周进行基因表达分析。
RNA分离和与寡聚核苷酸阵列杂交
从雄性和雌性小鼠收集肾脏并迅速冷冻用于RNA分离。使用每个肾脏的一半。对于每个个体动物使用左肾的纵切面和右肾的横切面。
利用匀浆器使迅速冷冻的小鼠肾脏组织悬浮在加2ME的RLT缓冲液中匀浆30至45秒。利用Qiagen Midi试剂盒按照制造商的方案制备总RNA。使RNA悬浮在用DEPC处理的H2O中,并且通过OD2180定量。
利用Superscript试剂盒(BRL)从5μg的总RNA合成cDNA。利用Phage lock gel管用酚∶氯仿∶异戊醇(25∶24∶1)按照Phage lock方案纯化cDNA。收集上清液并利用乙醇澄清。使样品重悬浮在DEPC处理的H2O中。
体外T7聚合酶驱动合成的转录反应和反义cRNA的生物素标记。使用Qiagen RNeasy离心柱的纯化作用来纯化cRNA。按照每个制造商的用法说明,基因芯片杂交混合物包含在1×MES缓冲液中的15μgcRNA片段、0.5mg/ml乙酰化BSA、0.1mg/ml鲱鱼精DNA,总体积为200μl。将反应混合物与Affymetrix Mul 1KsubA和Mul 1KsubB寡聚核苷酸阵列在45℃杂交16小时。除去杂交混合物,洗涤阵列,利用GeneChip Fluidics Station 400用抗生蛋白链菌素R-藻红蛋白(Molecular Probes)染色,并用Hewlett Packard GeneArray扫描仪按照制造商的指导扫描。收集荧光数据,并利用MicroArray Suite软件转换为基因特异性差异的平均数。
寡聚核苷酸阵列数据的分析
使由来源于克隆细菌和噬菌体序列的基因片段组成的11个元素的标准曲线对于每个杂交混合物在表示RNA频率为大约百万分之3.3至1000(ppm)的0.5pm至150pM的浓度范围成峰波状。通过T7聚合酶从基于质粒的模板驱动IVT反应来合成生物素酰化的标准曲线片段。峰状的生物素酰化RNA片段不仅作为评估芯片灵敏性的内标准而且作为如由Hill等人所描述的将测量的荧光差异平均数从个别基因转换成为ppm的RNA频率的标准曲线。
测量来自每个个体小鼠肾脏的基因表达频率,并对表达数据进行统计分析。对于给定的小鼠组取根据个体测量所确定的频率值的平均值。将在12和32周龄的C57B16肾脏之间其频率有显著差异的基因分类为由于自然老化过程,而不是由于疾病过程而产生的变化。
显示了通过限定标准aaO02653_s_at,在Affymetrix Murine 11K芯片上鉴定的寡聚核苷酸序列在年轻的(无病的)、年老的(患病的)、和有效治疗的年老的(无病的)F1(NZB×NZW)小鼠和C57BL6对照小鼠中的表达频率。这些序列表示未知的小鼠基因。
结果如图1所示。所显示的是表示来自标明小鼠的肾脏中基因表达水平的直方图。在12周龄的C57BL/6肾脏和32周龄的肾脏之间,BFLP0169的表达水平没有显著差异,表明在不患病的小鼠肾脏中该表达水平不随年龄而增加。在(NXB×NZW)F1肾脏中,在疾病发作前(12周龄)基因以正常的水平表达。随着小鼠年龄和疾病的发展,在25周、36周(36周的数据未显示),和42周观察到表达水平增加。到55周龄,小鼠由于肾衰竭而死亡。在29周龄开始用雷帕霉素处理小鼠8周,保持健康状态度过55周龄。已经接受有效治疗(雷帕霉素治疗或抗-B7治疗)的小鼠肾脏表达正常水平的BFLP0169,并且在停止雷帕霉素治疗20周后和停止抗-B7治疗15周后在无症状的肾脏中保持该正常水平。当肾脏功能是正常的时,观察到表达水平恢复正常,表明升高的水平与疾病进展相关,并且可诊断疾病的进展。阻断这些基因的功能可能抑制或延迟疾病进展。表达水平也可用于评估和比较各种治疗介入的有效性。
实施例2.表2中所示的人BFLP0169多肽序列的变体
从存在于表2中的BFLP0169氨基酸序列变化一个氨基酸的多肽序列显示如下。对于显示的序列,表2中所示的BFLP0169序列的第78位的L已经替换为V,其以粗体显示。
MIRKSKITSVLSFCRSSRELWTILLGRSALRELSQIEAELNKHWRRLLEGLSYYKPPSPSSAEKVKANKDVASPLKEV
GLRISKFLGLDEEQSVQLLQCYLQEDYRGTRDSVKTVLQDERQSQALILKIADYYYEERTCILRCVLHLLTYFQDERH
PYRVEYADCVDKLEKELVSKYRQQFEELYKTEAPTWETHGNLMTERQVSRWFVQCLREQSMLLEIIFLYYAYFEMAPS
DLLVLTKMFKEQGFGSRQTNRHLVDETMDPFVDRIGYFSALILVEGMDIESLHKCALDDRRELHQFAQDGLICQDMDC
LMLTFGDIPHHAPVLLAWALLRHTLNPEETSSVVRKIGGTAIQLNVFQYLTRLLQSLASGGNDCTTSTACMCVYGLLS
FVLTSLELHTLGNQQDIIDTACEVLADPSLPELFWGTEPTSGLGIILDSVCGMFPHLLSPLLQLLRALVSGKSTAKKV
YSFLDKMSFYNELYKHKPHDVISHEDGTLWRRQTPKLLYPLGGQTNLRIPQGTVGQVMLDDRAYLVRWEYSYSSWTLF
TCEIEMLLHVVSTADVIQHCQRVKPIIDLVHKVISTDLSIADCLLPITSRIYMLLQRLTTVISPPVDVIASCVNCLTV
LAARNPAKVWTDLRHTGFLPFVAHPVSSLSQMISAEGMNAGGYGNLLMNSEQPQGEYGVTIAFLRLITTLVKGQLGST
QSQGLVPCVMFVLKEMLPSYHKWRYNSHGVREQIGCLILELIHAILNLCHETDLHSSHTPSLQFLCICSLAYTEAGQT
VINIMGIGVDTIDMVMAAQPRSDGAEGQGQGQLLIKTVKLAFSVTNNVIRLKPPSNVVSPLEQALSQHGAHGNNLIAV
LAKYIYHKHDPALPRLAIQLLKRLATVAPMSVYACLGNDAAAIRDAFLTRLQSKIEDMRIKVMILEFLTVAVETQPGL
IELFLNLEVKDGSDGSKEFSLGMWSCLHAVLELIDSQQQDRYWCPPLLHRAAIAFLHALWQDRRDSAMLVLRTKPKFW
ENLTSPLFGTLSPPSETSEPSILETCALIMKIICLEIYYVVKGSLDQSLKDTLKKFSIEKRFAYWSGYVKSLAVHVAE
TEGSSCTSLLEYQMLVSAWRMLLIIATTHADIMHLTDSVVRRQLFLDVLDGTKALLLVPASVNCLRLGSMKCTLLLIL
LRQWKRELGSVDEILGPLTEILEGVLQADQQLMEKTKAKVFSAFITVLQMKEMKVSDIPQYSQLVLNVCETLQEEVIA
LFDQTRHSLALGSATEDKDSMETDDCSRSRHRDQRDGVCVLGLHLAKELCEVDEDGDSWLQVTRRLPILPTLLTTLEV
SLRMKQNLHFTEATLHLLLTLARTQQGATAVAGAGITQSICLPLLSVYQLSTNGTAQTPSASRKSLDAPSWPGVYRLS
MSLMEQLLKTLRYNFLPEALDFVGVHQERTLQCLNAVRTVQSLACLEEADHTVGFILQLSNFMKEWHFHLPQLMRDIQ
VNLGYLCQACTSLLHSRKMLQHYLQNKNGDGLPSAVAQRVQRPPSAASAAPSSSKQPAADTEASEQQALHTVQYGLLK
ILSKTLAALRHFTPDVCQILLDQSLDLAEYNFLFALSFTTPTFDSEVAPSFGTLLATVNVALNMLGELDKKKEPLTQA
VGLSTQAEGTRTLKSLLMFTMENCFYLLISQAMRYLRDPAVHPRDKQRMKQELSSELSTLLSSLSRYFRRGAPSSPAT
GVLPSPQGKSTSLSKASPESQEPLIQLVQAFVRHMQR(SEQ ID NO:3)
实施例3.表2中所示的人BFLP0169多肽序列的变体
从存在于表2中的BFLP0169氨基酸序列变化一个氨基酸的多肽序列显示如下。对于显示的序列,表2中所示的BFLP0169序列的第198位的L已经替换为I,其以粗体显示。
MIRKSKITSVLSFCRSSRELWTILLGRSALRELSQIEAELNKHWRRLLEGLSYYKPPSPSSAEKVKANKDVASPLKEL
GLRISKFLGLDEEQSVQLLQCYLQEDYRGTRDSVKTVLQDERQSQALILKIADYYYEERTCILRCVLHLLTYFQDERH
PYRVEYADCVDKLEKELVSKYRQQFEELYKTEAPTWETHGNTMTERQVSRWFVQCLREQSMLLEIIFLYYAYFEMAPS
DLLVLTKMFKEQGFGSRQTNRHLVDETMDPFVDRIGYFSALILVEGMDIESLHKCALDDRRELHQFAQDGLICQDMDC
LMLTFGDIPHHAPVLLAWALLRHTLNPEETSSVVRKIGGTAIQLNVFQYLTRLLQSLASGGNDCTTSTACMCVYGLLS
FVLTSLELHTLGNQQDIIDTACEVLADPSLPELFWGTEPTSGLGIILDSVCGMFPHLLSPLLQLLRALVSGKSTAKKV
YSFLDKMSFYNELYKHKPHDVISHEDGTLWRRQTPKLLYPLGGQTNLRIPQGTVGQVMLDDRAYLVRWEYSYSSWTLF
TCEIEMLLHVVSTADVIQHCQRVKPIIDLVHKVISTDLSIADCLLPITSRIYMLLQRLTTVISPPVDVIASCVNCLTV
LAARNPAKVWTDLRHTGFLPFVAHPVSSLSQMISAEGMNAGGYGNLLMNSEQPQGEYGVTIAFLRLITTLVKGQLGST
QSQGLVPCVMFVLKEMLPSYHKWRYNSHGVREQIGCLILELIHAILNLCHETDLHSSHTPSLQFLCICSLAYTEAGQT
VINIMGIGVDTIDMVMAAQPRSDGAEGQGQGQLLIKTVKLAFSVTNNVIRLKPPSNVVSPLEQALSQHGAHGNNLIAV
LAKYIYHKHDPALPRLAIQLLKRLATVAPMSVYACLGNDAAAIRDAFLTRLQSKIEDMRIKVMILEFLTVAVETQPGL
IELFLNLEVKDGSDGSKEFSLGMWSCLHAVLELIDSQQQDRYWCPPLLHRAAIAFLHALWQDRRDSAMLVLRTKPKFW
ENLTSPLFGTLSPPSETSEPSILETCALIMKIICLEIYYVVKGSLDQSLKDTLKKFSIEKRFAYWSGYVKSLAVHVAE
TEGSSCTSLLEYQMLVSAWRMLLIIATTHADIMHLTDSVVRRQLFLDVLDGTKALLLVPASVNCLRLGSMKCTLLLIL
LRQWKPELGSVDEILGPLTEILEGVLQADQQLMEKTKAKVFSAFITVLQMKEMKVSDIPQYSQLVLNVCETLQEEVIA
LFDQTRHSLALGSATEDKDSMETDDCSRSRHRDQRDGVCVLGLHLAKELCEVDEDGDSWLQVTRRLPILPTLLTTLEV
SLRMKQNLHFTEATLHLLLTLARTQQGATAVAGAGITQSICLPLLSVYQLSTNGTAQTPSASRKSLDAPSWPGVYRLS
MSLMEQLLKTLRYNFLPEALDFVGVHQERTLQCLNAVRTVQSLACLEEADHTVGFILQLSNFMKEWHFHLPQLMRDIQ
VNLGYLCQACTSLLHSRKMLQHYLQNKNGDGLPSAVAQRVQRPPSAASAAPSSSKQPAADTEASEQQALHTVQYGLLK
ILSKTIAALRHFTPDVCQILLDQSLDLAEYNFLFALSFTTPTFDSEVAPSFGTLLATVNVALNMLGELDKKKEPLTQA
VGLSTQAEGTRTLKSLLMFTMENCFYLLISQAMRYLRDPAVHPRDKQRMKQELSSELSTLLSSLSRYFRRGAPSSPAT
GVLPSPQGKSTSLSKASPESQEPLIQLVQAFVRHMQR(SEQ ID NO:4)
实施例4.表2中所示的人BFLP0169多肽序列的变体
从存在于表2中的BFLP0169氨基酸序列变化一个氨基酸的多肽序列显示如下。对于显示的序列,表2中所示的BFLP0169序列的第267位的R已经替换为K,其以粗体显示。
MIRKSKITSVLSFCRSSRELWTILLGRSALRELSQIEAELNKHWRRLLEGLSYYKPPSPSSAEKVKANKDVASPLKEL
GLRISKFLGLDEEQSVQLLQCYLQEDYRGTRDSVKTVLQDERQSQALILKIADYYYEERTCILRCVLHLLTYFQDERP
YRVEYADCVDKLEKELVSKYRQQFEELYKTEAPTWETHGNLMTERQVSRWFVQCLREQSMLLEIIFLYYAYFEMAPSD
LLVLTKMFKEQGFGSRQTNRHLVDETMDPFVDKIGYFSALILVEGMDIESLHKCALDDRRELHQFAQDGLICQDMDCL
MLTFGDIPHHAPVLLAWALLRHTLNPEETSSVVRKIGGTAIQLNVFQYLTRLLQSLASGGNDCTTSTACMCVYGLLSF
VLTSLELHTLGNQQDIIDTACEVLADPSLPELFWGTEPTSGLGIILDSVCGMFPHLLSPLLQLLRALVSGKSTAKKVY
SFLDKMSFYNELYKHKPHDVISHEDGTLWRRQTPKLLYPLGGQTNLRIPQGTVGQVMLDDRAYLVRWEYSYSSWTLFT
CEIEMLLHVVSTADVIQHCQRVKPIIDLVHKVISTDLSIADCLLPITSRIYMLLQRLTTVISPPVDVIASCVNCLTVL
AARNPAKVWTDLRHTGFLPFVAHPVSSLSQMISAEGMNAGGYGNLLMNSEQPQGEYGVTIAFLRLITTLVKGQLGSTQ
SQGLVPCVMFVLKEMLPSYHKWRYNSHGVREQIGCLILELIHAILNLCHETDLHSSHTPSLQFLCICSLAYTEAGQTV
INIMGIGVDTIDMVMAAQPRSDGAEGQGQGQLLIKTVKLAFSVTNNVIRLKPPSNVVSPLEQALSQHGAHGNNLIAVL
AKYIYHKHDPALPRLAIQLLKRLATVAPMSVYACLGNDAAAIRDAFLTRLQSKIEDMRIKVMILEFLTVAVETQPGLI
ELFLNLEVKDGSDGSKEFSLGMWSCLHAVLELIDSQQQDRYWCPPLLHRAAIAFLHALWQDRRDSAMLVLRTKPKFWE
NLTSPLFGTLSPPSETSEPSILETCALIMKIICLEIYYVVKGSLDQSLKDTLKKFSIEKRFAYWSGYVKSLAVHVAET
EGSSCTSLLEYQMLVSAWRMLLIIATTHADIMHLTDSVVRRQLFLDVLDGTKALLLVPASVNCLRLGSMKCTLLLILL
RQWKRELGSVDEILGPLTEILEGVLQADQQLMEKTKAKVFSAFITVLQMKEMKVSDIPQYSQLVLNVCETLQEEVIAL
FDQTRHSLALGSATEDKDSMETDDCSRSRHRDQRDGVCVLGLHLAKELCEVDEDGDSWLQVTRRLPILPTLLTTLEVS
LRMKQNLHFTEATLHLLLTLARTQQGATAVAGAGITQSICLPLLSVYQLSTNGTAQTPSASRKSLDAPSWPGVYRLSM
SLMEQLLKTLRYNFLPEALDFVGVHQERTLQCLNAVRTVQSLACLEEADHTVGFILQLSNFMKEWHFHLPQLMRDIQV
NLGYLCQACTSLLHSRKMLQHYLQNKNGDGLPSAVAQRVQRPPSAASAAPSSSKQPAADTEASEQQALHTVQYGLLKI
LSKTLAALRHFTPDVCQILLDQSLDLAEYNFLFALSFTTPTFDSEVAPSFGTLLATVNVALNMLGELDKKKEPLTQAV
GLSTQAEGTRTLKSLLMFTMENCFYLLISQAMRYLRDPAVHPRDKQRMKQELSSELSTLLSSLSRYFRRGAPSSPATG
VLPSPQGKSTSLSKASPESQEPLIQLVQAFVRHMQR(SEQ ID NO:5)
实施例5.表2中所示的人BFLP0169多肽序列的变体
从存在于表2中的BFLP0169氨基酸序列变化一个氨基酸的多肽序列显示如下。对于显示的序列,表2中所示的BFLP0169序列的第355位的Q已经替换为N,其以粗体显示。
MIRKSKITSVLSFCRSSRELWTILLGRSALRELSQIEAELNKHWRRLLEGLSYYKPPSPSSAEKVKANKDVASPLKEL
GLRISKFLGLDEEQSVQLLQCYLQEDYRGTRDSVKTVLQDERQSQALILKIADYYYEERTCILRCVLHLLTYFQDERH
PYRVEYADCVDKLEKELVSKYRQQFEELYKTEAPTWETHGNLMTERQVSRWFVQCLREQSMLLEIIFLYYAYFEMAPS
DLLVLTKMFKEQGFGSRQTNRHLVDETMDPFVDRIGYFSALILVEGMDIESLHKCALDDRRELHQFAQDGLICQDMDC
LMLTFGDIPHHAPVLLAWALLRHTLNPEETSSVVRKIGGTAINLNVFQYLTRLLQSLASGGNDCTTSTACMCVYGLLS
FVLTSLELHTLGNQQDIIDTACEVLADPSLPELFWGTEPTSGLGIILDSVCGMFPHLLSPLLQLLRALVSGKSTAKKV
YSFLDKMSFYNELYKHKPHDVISHEDGTLWRRQTPKLLYPLGGQTNLRIPQGTVGQVMLDDRAYLVRWEYSYSSWTLF
TCEIEMLLHVVSTADVIQHCQRVKPIIDLVHKVISTDLSIADCLLPITSRIYMLLQPLTTVISPPVDVIASCVNCLTV
LAARNPAKVWTDLRHTGFLPFVAHPVSSLSQMISAEGMNAGGYGNLLMNSEQPQGEYGVTIAFLRLITTLVKGQLGST
QSQGLVPCVMFVLKEMLPSYHKWRYNSHGVREQIGCLILELIHAILNLCHETDLHSSHTPSLQFLCICSLAYTEAGQT
VINIMGIGVDTIDMVMAAQPRSDGAEGQGQGQLLIKTVKLAFSVTNNVIRLKPPSNVVSPLEQALSQHGAHGNNLIAV
LAKYIYHKHDPALPRLAIQLLKRLATVAPMSVYACLGNDAAAIRDAFLTRLQSKIEDMRIKVMILEFLTVAVETQPGL
IELFLNLEVKDGSDGSKEFSLGMWSCLHAVLELIDSQQQDRYWCPPLLHRAAIAFLHALWQDRRDSAMLVLRTKPKFW
ENLTSPLFGTLSPPSETSEPSILETCALIMKIICLEIYYVVKGSLDQSLKDTLKKFSIEKRFAYWSGYVKSLAVHVAE
TEGSSCTSLLEYQMLVSAWRMLLIIATTHADIMHLTDSVVRRQLFLDVLDGTKALLLVPASVNCLRLGSMKCTLLLIL
LRQWKRELGSVDEILGPLTEILEGVLQADQQLMEKTKAKVFSAFITVLQMKEMKVSDIPQYSQLVLNVCETLQEEVIA
LFDQTRHSLALGSATEDKDSMETDDCSRSRHRDQRDGVCVLGLHLAKELCEVDEDGDSWLQVTRRLPILPTLLTTLEV
SLRMKQNLHFTEATLHLLLTLARTQQGATAVAGAGITQSICLPLLSVYQLSTNGTAQTPSASRKSLDAPSWPGVYRLS
MSLMEQLLKTLRYNFLPEALDFVGVHQERTLQCLNAVRTVQSLACLEEADHTVGFILQLSNFMKEWHFHLPQLMRDIQ
VNLGYLCQACTSLLHSRKMLQHYLQNKNGDGLPSAVAQRVQRPPSAASAAPSSSKQPAADTEASEQQALHTVQYGLLK
ILSKTLAALRHFTPDVCQILLDQSLDLAEYNFLFALSFTTPTFDSEVAPSFGTLLATVNVALNMLGELDKKKEPLTQA
VGLSTQAEGTRTLKSLLMFTMENCFYLLISQAMRYLRDPAVHPRDKQRMKQELSSELSTLLSSLSRYFRRGAPSSPAT
GVLPSPQGKSTSLSKASPESQEPLIQLVQAFVRHMQR(SEQ ID NO:6)
实施例6.表2中所示的人BFLP0169多肽序列的变体
从存在于表2中的BFLP0169氨基酸序列变化一个氨基酸的多肽序列显示如下。对于显示的序列,表2中所示的BFLP0169序列的第446位的H已经替换为R,其以粗体显示。
MIRKSKITSVLSFCRSSRELWTILLGRSALRELSQIEAELNKHWRRLLFGLSYYKPPSPSSAEKVKANKDVASPLKEL
GLRISKFLGLDEEQSVQLLQCYLQEDYRGTRDSVKTVLQDERQSQALILKIADYYYEERTCILRCVLHLLTYFQDERH
PYRVEYADCVDKLEKELVSKYRQQFEELYKTEAPTWETHGNLMTERQVSRWFVQCLREQSMLLEIIFLYYAYFEMAPS
DLLVLTKMFKEQGFGSRQTNRHLVDETMDPFVDRIGYFSALILVEGMDIESLHKCALDDRRELHQFAQDGLICQDMDC
LMLTFGDIPHHAPVLLAWALLRHTLNPEETSSVVRKIGGTAIQLNVFQYLTRLLQSLASGGNDCTTSTACMCVYGLLS
FVLTSLELHTLGNQQDIIDTACEVLADPSLPELFWGTEPTSGLGIILDSVCGMFPRLLSPLLQLLRALVSGKSTAKKV
YSFLDKMSFYNELYKHKPHDVISHEDGTLWRRQTPKLLYPLGGQTNLRIPQGTVGQVMLDDRAYLVRWEYSYSSWTLF
TCEIEMLLHVVSTADVIQHCQRVKPIIDLVHKVISTDLSIADCLLPITSRIYMLLQRLTTVISPPVDVIASCVNCLTV
LAARNPAKVWTDLRHTGFLPFVAHPVSSLSQMISAEGMNAGGYGNLLMNSEQPQGEYGVTIAFLRLITTLVKGQLGST
QSQGLVPCVMFVLKEMLPSYHKWRYNSHGVREQIGCLILELIHAILNLCHETDLHSSHTPSLQFLCICSLAYTEAGQT
VINIMGIGVDTIDMVMAAQPRSDGAEGQGQGQLLIKTVKLAFSVTNNVIRLKPPSNVVSPLEQALSQHGAHGNNLIAV
LAKYIYHKHDPALPRLAIQLLKRLATVAPMSVYACLGNDAAAIRDAFLTRLQSKIEDMRIKVMILEFLTVAVETQPGL
IELFLNLEVKDGSDGSKEFSLGMWSCLHAVLELIDSQQQDRYWCPPLLHRAAIAFLHALWQDRRDSAMLVLRTKPKFW
ENLTSPLFGTLSPPSETSEPSILETCALIMKIICLEIYYVVKGSLDQSLKDTLKKFSIEKRFAYWSGYVKSLAVHVAE
TEGSSCTSLLEYQMLVSAWRMLLIIATTHADIMHLTDSVVRRQLFLDVLDGTKALLLVPASVNCLRLGSMKCTLLLIL
LRQWKRELGSVDEILGPLTEILEGVLQADQQLMEKTKAKVFSAFITVLQMKEMKVSDIPQYSQLVLNVCETLQEEVIA
LFDQTRHSLALGSATEDKDSMETDDCSRSRHRDQRDGVCVLGLHLAKELCEVDEDGDSWLQVTRRLPILPTLLTTLEV
SLRMKQNLHFTEATLHLLLTLARTQQGATAVAGAGITQSICLPLLSVYQLSTNGTAQTPSASRKSLDAPSWPGVYRLS
MSLMEQLLKTLRYNFLPEALDFVGVHQERTLQCLNAVRTVQSLACLEEADHTVGFILQLSNFMKEWHFHLPQLMRDIQ
VNLGYLCQACTSLLHSRKMLQHYLQNKNGDGLPSAVAQRVQRPPSAASAAPSSSKQPAADTEASEQQALHTVQYGLLK
ILSKTLAALRHFTPDVCQILLDQSLDLAEYNFLFALSFTTPTFDSEVAPSFGTLLATVNVALNMLGELDKKKEPLTQA
VGLSTQAEGTRTLKSLLMFTMENCFYLLISQAMRYLRDPAVHPRDKQRMKQELSSELSTLLSSLSRYFRRGAPSSPAT
GVLPSPQGKSTSLSKASPESQEPLIQLVQAFVRHMQR(SEQ ID NO:7)
实施例7.表2中所示的人BFLP0169多肽序列的变体
从存在于表2中的BFLP0169氨基酸序列变化一个氨基酸的多肽序列显示如下。对于显示的序列,表2中所示的BFLP01 69序列的第553位的L已经替换为I,其以粗体显示。
MIRKSKITSVLSFCRSSRELWTILLGRSALRELSQIEAELNKHWRRLLEGLSYYKPPSPSSAEKVKANKDVASPLKEL
GLRISKFLGLDEEQSVQLLQCYLQEDYRGTRDSVKTVLQDERQSQALILKIADYYYEERTCILRCVLHLLTYFQDERH
PYRVEYADCVDKLEKELVSKYRQQFEELYKTEAPTWETHGNLMTERQVSRWFVQCLREQSMLLEIIFLYYAYFEMAPS
DLLVLTKMFKEQGFGSRQTNRHLVDETMDPFVDRIGYFSALILVEGMDIESLHKCALDDRRELHQFAQDGLICQDMDC
LMLTFGDIPHHAPVLLAWALLRHTLNPEETSSVVRKIGGTAIQLNVFQYLTRLLQSLASGGNDCTTSTACMCVYGLLS
FVLTSLELHTLGNQQDIIDTACEVLADPSLPELFWGTEPTSGLGIILDSVCGMFPHLLSPLLQLLRALVSGKSTAKKV
YSFLDKMSFYNELYKHKPHDVISHEDGTLWRRQTPKLLYPLGGQTNLRIPQGTVGQVMLDDRAYLVRWEYSYSSWTLF
TCEIEMILHVVSTADVIQHCQRVKPIIDLVHKVISTDLSIADCLLPITSRIYMLLQRLTTVISPPVDVIASCVNCLTV
LAARNPAKVWTDLRHTGFLPFVAHPVSSLSQMISAEGMNAGGYGNLLMNSEQPQGEYGVTIAFLRLITTLVKGQLGST
QSQGLVPCVMFVLKEMLPSYHKWRYNSHGVREQIGCLILELIHAILNLCHETDLHSSHTPSLQFLCICSLAYTEAGQT
VINIMGIGVDTIDMVMAAQPRSDGAEGQGQGQLLIKTVKLAFSVTNNVIRLKPPSNVVSPLEQALSQHGAHGNNLIAV
LAKYIYHKHDPALPRLAIQLLKRLATVAPMSVYACLGNDAAAIRDAFLTRLQSKIEDMRIKVMILEFLTVAVETQPGL
IELFLNLEVKDGSDGSKEFSLGMWSCLHAVLELIDSQQQDRYWCPPLLHRAAIAFLHALWQDRRDSAMLVLRTKPKFW
ENLTSPLFGTLSPPSETSEPSILETCALIMKIICLEIYYVVKGSLDQSLKDTLKKFSIEKRFAYWSGYVKSLAVHVAE
TEGSSCTSLLEYQMLVSAWRMLLIIATTHADIMHLTDSVVRRQLFLDVLDGTKALLLVPASVNCLRLGSMKCTLLLIL
LRQWKRELGSVDEILGPLTEILEGVLQADQQLMEKTKAKVFSAFITVLQMKEMKVSDIPQYSQLVLNVCETLQEEVIA
LFDQTRHSLALGSATEDKDSMETDDCSRSRHRDQRDGVCVLGLHLAKELCEVDEDGDSWLQVTRRLPILPTLLTTLEV
SLRMKQNLHFTEATLHLLLTLARTQQGATAVAGAGITQSICLPLLSVYQLSTNGTAQTPSASRKSLDAPSWPGVYRLS
MSLMEQLLKTLRYNFLPEALDFVGVHQERTLQCLNAVRTVQSLACLEEADHTVGFILQLSNFMKEWHFHLPQLMRDIQ
VNLGYLCQACTSLLHSRKMLQHYLQNKNGDGLPSAVAQRVQRPPSAASAAPSSSKQPAADTEASEQQALHTVQYGLLK
ILSKTLAALRHFTPDVCQILLDQSLDLAEYNFLFALSFTTPTFDSEVAPSFGTLLATVNVALNMLGELDKKKEPLTQA
VGLSTQAEGTRTLKSLLMFTMENCFYLLISQAMRYLRDPAVHPRDKQRMKQELSSELSTLLSSLSRYFRRGAPSSPAT
GVLPSPQGKSTSLSKASPESQEPLIQLVQAFVRHMQR(SEQ ID NO:8)
实施例8.表2中所示的人BFLP0169多肽序列的变体
从存在于表2中的BFLP0169氨基酸序列变化一个氨基酸的多肽序列显示如下。对于显示的序列,表2中所示的BFLP0169序列的第634位的W已经替换为F,其以粗体显示。
MIRKSKITSVLSFCRSSRELWTILLGRSALRELSQIEAELNKHWRRLLEGLSYYKPPSPSSAEKVKANKDVASPLKEL
GLRISKFLGLDEEQSVQLLQCYLQEDYRGTRDSVKTVLQDERQSQALILKIADYYYEERTCILRCVLHLLTYFQDERH
PYRVEYADCVDKLEKELVSKYRQQFEELYKTEAPTWETHGNLMTERQVSRWFVQCLREQSMLLEIIFLYYAYFEMAPS
DLLVLTKMFKEQGFGSRQTNRHLVDETMDPFVDRIGYFSALILVEGMDIESLHKCALDDRRELHQFAQDGLICQDMDC
LMLTFGDIPHHAPVLLAWALLRHTLNPEETSSVVRKIGGTAIQLNVFQYLTRLLQSLASGGNDCTTSTACMCVYGLLS
FVLTSLELHTLGNQQDIIDTACEVLADPSLPELFWGTEPTSGLGIILDSVCGMFPHLLSPLLQLLRALVSGKSTAKKV
YSFLDKMSFYNELYKHKPHDVISHEDGTLWRRQTPKLLYPLGGQTNLRIPQGTVGQVMLDDRAYLVRWEYSYSSWTLF
TCEIEMLLHVVSTADVIQHCQRVKPIIDLVHKVISTDLSIADCLLPITSRIYMLLQRLTTVISPPVDVIASCVNCLTV
LAARNPAKVFTDLRHTGFLPFVAHPVSSLSQMISAEGMNAGGYGNLLMNSEQPQGEYGVTIAFLRLITTLVKGQLGST
QSQGLVPCVMFVLKEMLPSYHKWRYNSHGVREQIGCLILELIHAILNLCHETDLHSSHTPSLQFLCICSLAYTEAGQT
VINIMGIGVDTIDMVMAAQPRSDGAEGQGQGQLLIKTVKLAFSVTNNVIRLKPPSNVVSPLEQALSQHGAHGNNLIAV
LAKYIYHKHDPALPRLAIQLLKRLATVAPMSVYACLGNDAAAIRDAFLTRLQSKIEDMRIKVMILEFLTVAVETQPGL
IELFLNLEVKDGSDGSKEFSLGMWSCLHAVLELIDSQQQDRYWCPPLLHRAAIAFLHALWQDRRDSAMLVLRTKPKEW
ENLTSPLFGTLSPPSETSEPSILETCALIMKIICLEIYYVVKGSLDQSLKDTLKKFSIEKRFAYWSGYVKSLAVHVAE
TEGSSCTSLLEYQMLVSAWRMLLIIATTHADIMHLTDSVVRRQLFLDVLDGTKALLLVPASVNCLRLGSMKCTLLLIL
LRQWKRELGSVDEILGPLTEILEGVLQADQQLMEKTKAKVFSAFITVLQMKEMKVSDIPQYSQLVLNVCETLQEEVIA
LFDQTRHSLALGSATEDKDSMETDDCSRSRHRDQRDGVCVLGLHLAKELCEVDEDGDSWLQVTRRLPILPTLLTTLEV
SLRMKQNLHFTEATLHLLLTLARTQQGATAVAGAGITQSICLPLLSVYQLSTNGTAQTPSASRKSLDAPSWPGVYRLS
MSLMEQLLKTLRYNFLPEALDFVGVHQERTLQCLNAVRTVQSLACLEEADHTVGFILQLSNFMKEWHFHLPQLMRDIQ
VNLGYLCQACTSLLHSRKMLQHYLQNKNGDGLPSAVAQRVQRPPSAASAAPSSSKQPAADTEASEQQALHTVQYGLLK
ILSKTLAALRHFTPDVCQILLDQSLDLAEYNFLFALSFTTPTFDSEVAPSFGTLLATVNVALNMLGELDKKKEPLTQA
VGLSTQAEGTRTLKSLLMFTMENCFYLLISQAMRYLRDPAVHPRDKQRMKQELSSELSTLLSSLSRYFRRGAPSSPAT
GVLPSPQGKSTSLSKASPESQEPLIQLVQAFVRHMQR(SEQ ID NO:9)
实施例9.表2中所示的人BFLP0169多肽序列的变体
从存在于表2中的BFLP0169氨基酸序列变化一个氨基酸的多肽序列显示如下。对于显示的序列,表2中所示的BFLP0169序列的第749位的N已经替换为D,其以粗体显示。
MIRKSKITSVLSFCRSSRELWTILLGRSALRELSQIEAELNKHWRRLLEGLSYYKPPSPSSAEKVKANKDVASPLKEL
GLRISKFLGLDEEQSVQLLQCYLQEDYRGTRDSVKTVLQDERQSQALILKIADYYYEERTCILRCVLHLLTYFQDERH
PYRVEYADCVDKLEKELVSKYRQQFEELYKTEAPTWETHGNLMTERQVSRWFVQCLREQSMLLEIIFLYYAYFEMAPS
DLLVLTKMFKEQGFGSRQTNRHLVDETMDPFVDRIGYFSALILVEGMDIESLHKCALDDRRELHQFAQDGLICQDMDC
LMLTFGDIPHHAPVLLAWALLRHTLNPEETSSVVRKIGGTAIQLNVFQYLTRLLQSLASGGNDCTTSTACMCVYGLLS
FVLTSLELHTLGNQQDIIDTACEVLADPSLPELFWGTEPTSGLGIILDSVCGMFPHLLSPLLQLLRALVSGKSTAKKV
YSFLDKMSFYNELYKHKPHDVISHEDGTLWRRQTPKLLYPLGGQTNLRIPQGTVGQVMLDDRAYLVRWEYSYSSWTLF
TCEIEMLLHVVSTADVIQHCQRVKPIIDLVHKVISTDLSIADCLLPITSRIYMLLQRLTTVISPPVDVIASCVNCLTV
LAARNPAKVWTDLRHTGFLPFVAHPVSSLSQMISAEGMNAGGYGNLLMNSEQPQGEYGVTIAFLRLITTLVKGQLGST
QSQGLVPCVMFVLKEMLPSYHKWRYNSHGVREQIGCLILELIHAILDLCHETDLHSSHTPSLQFLCICSLAYTEAGQT
VINIMGIGVDTIDMVMAAQPRSDGAEGQGQGQLLIKTVKLAFSVTNNVIRLKPPSNVVSPLEQALSQHGAHGNNLIAV
LAKYIYHKHDPALPRLAIQLLKRLATVAPMSVYACLGNDAAAIRDAFLTRLQSKIEDMRIKVMILEFLTVAVETQPGL
IELFLNLEVKDGSDGSKEFSLGMWSCLHAVLELIDSQQQDRYWCPPLLHRAAIAFLHALWQDRRDSAMLVLRTKPKFW
ENLTSELFGTLSPPSETSEPSILETCALIMKIICLEIYYVVKGSLDQSLKDTLKKFSIEKRFAYWSGYVKSLAVHVAE
TEGSSCTSLLEYQMLVSAWRMLLIIATTHADIMHLTDSVVRRQLFLDVLDGTKALLLVPASVNCLRLGSMKCTLLLIL
LRQWKRELGSVDEILGPLTEILEGVLQADQQLMEKTKAKVFSAFITVLQMKEMKVSDIPQYSQLVLNVCETLQEEVIA
LFDQTRHSLALGSATEDKDSMETDDCSRSRHRDQRDGVCVLGLHLAKELCEVDEDGDSWLQVTRRLPILPTLLTTLEV
SLRMKQNLHFTEATLHLLLTLARTQQGATAVAGAGITQSICLPLLSVYQLSTNGTAQTPSASRKSLDAPSWPGVYRLS
MSLMEQLLKTLRYNFLPEALDFVGVHQERTLQCLNAVRTVQSLACLEEADHTVGFILQLSNFMKEWHFHLPQLMRDIQ
VNLGYLCQACTSLLHSRKMLQHYLQNKNGDGLPSAVAQRVQRPPSAASAAPSSSKQPAADTEASEQQALHTVQYGLLK
ILSKTLAALRHFTPDVCQILLDQSLDLAEYNFLFALSFTTPTFDSEVAPSFGTLLATVNVALNMLGELDKKKEPLTQA
VGLSTQAEGTRTLKSLLMFTMENCFYLLISQAMRYLRDPAVHPRDKQRMKQELSSELSTLLSSLSRYFRRGAPSSPAT
GVLPSPQGKSTSLSKASPESQEPLIQLVQAFVRHMQR(SEQ ID NO:10)
实施例10.表2中所示的人BFLP0169多肽序列的变体
从存在于表2中的BFLP0169氨基酸序列变化一个氨基酸的多肽序列显示如下。对于显示的序列,表2中所示的BFLP0169序列的第838位的V已经替换为M,其以粗体显示。
MIRKSKITSVLSFCRSSRELWTILLGRSALRELSQIEAELNKHWRRLLEGLSYYKPPSPSSAEKVKANKDVASPLKEL
GLRISKFLGLDEEQSVQLLQCYLQEDYRGTRDSVKTVLQDERQSQALILKIADYYYEERTCILRCVLHLLTYFQDERH
PYRVEYADCVDKLEKELVSKYRQQFEELYKTEAPTWETHGNLMTERQVSRWFVQCLREQSMLLEIIFLYYAYFEMAPS
DLLVLTKMFKEQGFGSRQTNRHLVDETMDPFVDRIGYFSALILVEGMDIESLHKCALDDRRELHQFAQDGLICQDMDC
LMLTFGDIPHHAPVLLAWALLRHTLNPEETSSVVRKIGGTAIQLNVFQYLTRLLQSLASGGNDCTTSTACMCVYGLLS
FVLTSLELHTLGNQQDIIDTACEVLADPSLPELFWGTEPTSGLGIILDSVCGMFPHLLSPLLQLLRALVSGKSTAKKV
YSFLDKMSFYNELYKHKPHDVISHEDGTLWRRQTPKLLYPLGGQTNLRIPQGTVGQVMLDDRAYLVRWEYSYSSWTLF
TCEIEMLLHVVSTADVIQHCQRVKPIIDLVRKVISTDLSIADGLLPITSRIYMLLQRLTTVISPPVDVIASCVNCLTV
LAARNPAKVWTDLRHTGFLPFVAHPVSSLSQMISAEGMNAGGYGNLLMNSEQPQGEYGVTIAFLRLITTLVKGQLGST
QSQGLVPCVMFVLKEMLPSYHKWRYNSHGVREQIGCLILELIHAILNLCHETDLHSSHTPSLQFLCICSLAYTEAGQT
VINIMGIGVDTIDMVMAAQPRSDGAEGQGQGQLLIKTVKLAFSVTNNVIRLKPPSNVMSPLEQALSQHGAHGNNLIAV
LAKYIYHKHDPALPRLAIQLLKRLATVAPMSVYACLGNDAAAIRDAFLTRLQSKIEDMRIKVMILEFLTVAVETQPGL
IELFLNLEVKDGSDGSKEFSLGMWSCLHAVLELIDSQQQDRYWCPPLLHRAAIAFLHALWQDRRDSAMLVLRTKPKFW
ENLTSPLFGTLSPPSETSEPSILETCALIMKIICLEIYYVVKGSLDQSLKDTLKKFSIEKRFAYWSGYVKSLAVHVAE
TEGSSCTSLLEYQMLVSAWRMLLIIATTHADIMHLTDSVVRRQLFLDVLDGTKALLLVPASVNCLRLGSMKCTLLLIL
LRQWKRELGSVDEILGPLTEILEGVLQADQQLMEKTKAKVFSAFITVLQMKEMKVSDIPQYSQLVLNVCETLQEEVIA
LFDQTRHSLALGSATEDKDSMETDDCSRSRHRDQRDGVCVLGLHLAKELCEVDEDGDSWLQVTRRLPILPTLLTTLEV
SLRMKQNLHFTEATLHLLLTLARTQQGATAVAGAGITQSICLPLLSVYQLSTNGTAQTPSASRKSLDAPSWPGVYRLS
MSLMEQLLKTLRYNFLPEALDFVGVHQERTLQCLNAVRTVQSLACLEEADHTVGFILQLSNFMKEWHFHLPQLMRDIQ
VNLGYLCQACTSLLHSRKMLQHYLQNKNGDGLPSAVAQRVQRPPSAASAAPSSSKQPAADTEASEQQALHTVQYGLLK
ILSKTLAALRHFTPDVCQILLDQSLDLAEYNFLFALSFTTPTFDSEVAPSFGTLLATVNVALNMLGELDKKKEPLTQA
VGLSTQAEGTRTLKSLLMFTMENCFYLLISQAMRYLRDPAVHPRDKQRMKQELSSELSTLLSSLSRYERRGAPSSPAT
GVLPSPQGKSTSLSKASPESQEPLIQLVQAFVRHMQR(SEQ ID NO:11)
实施例11.表2中所示的人BFLP01 69多肽序列的变体
从存在于表2中的BFLP0169氨基酸序列变化一个氨基酸的多肽序列显示如下。对于显示的序列,表2中所示的BFLP0169序列的第958位的G已经替换为T,其以粗体显示。
MIRKSKITSVLSFCRSSRELWTILLGRSALRELSQIEAELNKHWRRLLEGLSYYKPPSPSSAEKVKANKDVASPLKEL
GLRISKFLGLDEEQSVQLLQCYLQEDYRGTRDSVKTVLQDERQSQALILKIADYYYEERTCILRCVLHLLTYFQDERH
PYRVEYADCVDKLEKELVSKYRQQFEELYKTEAPTWETHGNLMTERQVSRWFVQCLREQSMLLEIIFLYYAYFEMAPS
DLLVLTKMFKEQGFGSRQTNRHLVDETMDPFVDRIGYFSALILVEGMDIESLHKCALDDRRELHQFAQDGLICQDMDC
LMLTFGDIPHHAPVLLAWALLRHTLNPEETSSVVRKIGGTAIQLNVFQYLTRLLQSLASGGNDCTTSTACMCVYGLLS
FVLTSLELHTLGNQQDIIDTACEVLADPSLPELFWGTEPTSGLGIILDSVCGMFPHLLSPLLQLLRALVSGKSTAKKV
YSFLDKMSFYNELYKHKPHDVISHEDGTLWRRQTPKLLYPLGGQTNLRIPQGTVGQVMLDDRAYLVRWEYSYSSWTLF
TCEIEMLLHVVSTADVIQHCQRVKPIIDLVHKVISTDLSIADCLLPITSRIYMLLQRLTTVISPPVDVIASCVNCLTV
LAARNPAKVWTDLRHTGFLPFVAHPVSSLSQMISAEGMNAGGYGNLLMNSEQPQGEYGVTIAFLRLITTLVKGQLGST
QSQGLVPCVMFVLKEMLPSYHKWRYNSHGVREQIGCLILELIHAILNLCHETDLHSSHTPSLQFLCICSLAYTEAGQT
VINIMGIGVDTIDMVMAAQPRSDGAEGQGQGQLLIKTVKLAFSVTNNVIRLKPPSNVVSPLEQALSQHGAHGNNLIAV
LAKYIYHKHDPALPRLAIQLLKRLATVAPMSVYACLGNDAAAIRDAFLTRLQSKIEDMRIKVMILEFLTVAVETQPGL
IELFLNLEVKDGSDGSKEFSLTMWSCLHAVLELIDSQQQDRYWCPPLLHRAAIAFLHALWQDRRDSAMLVLRTKPKFW
ENLTSPLFGTLSPPSETSEPSILETCALIMKIICLEIYYVVKGSLDQSLKDTLKKFSIEKRFAYWSGYVKSLAVHVAE
TEGSSCTSLLEYQMLVSAWRMLLIIATTHADIMHLTDSVVRRQLFLDVLDGTKALLLVPASVNCLRLGSMKCTLLLIL
LRQWKRELGSVDEILGPLTEILEGVLQADQQLMEKTKAKVFSAFITVLQMKEMKVSDIPQYSQLVLNVCETLQEEVIA
LFDQTRHSLALGSATEDKDSMETDDCSRSRHRDQRDGVCVLGLHLAKELCEVDEDGDSWLQVTRRLPILPTLLTTLEV
SLRMKQNLHFTEATLHLLLTLARTQQGATAVAGAGITQSICLPLLSVYQLSTNGTAQTPSASRKSLDAPSWPGVYRLS
MSLMEQLLKTLRYNFLPEALDFVGVHQERTLQCLNAVRTVQSLACLEEADHTVGFILQLSNFMKEWHFHLPQLMRDIQ
VNLGYLCQACTSLLHSRKMLQHYLQNKNGDGLPSAVAQRVQRPPSAASAAPSSSKQPAADTEASEQQALHTVQYGLLK
ILSKTLAALRHFTPDVCQILLDQSLDLAEYNFLFALSFTTPTFDSEVAPSFGTLLATVNVALNMLGELDKKKEPLTQA
VGLSTQAEGTRTLKSLLMFTMENCFYLLISQAMRYLRDPAVHPRDKQRMKQELSSELSTLLSSLSRYFRRGAPSSPAT
GVLPSPQGKSTSLSKASPESQEPLIQLVQAFVRHMQR(SEQ ID NO:12)
实施例12.表2中所示的人BFLP0169多肽序列的变体
从存在于表2中的BFLP0169氨基酸序列变化一个氨基酸的多肽序列显示如下。对于显示的序列,表2中所示的BFLP0169序列的第1084位的K已经替换为R,其以粗体显示。
MIRKSKITSVLSFCRSSRELWTILLGRSALRELSQIEAELNKHWRRLLEGLSYYKPPSPSSAEKVKANKDVASPLKEL
GLRISKFLGLDEEQSVQLLQCYLQEDYRGTRDSVKTVLQDERQSQALILKIADYYYEERTCILRCVLHLLTYFQDERH
PYRVEYADCVDKLEKELVSKYRQQFEELYKTEAPTWETHGNLMTERQVSRWFVQCLREQSMLLEIIFLYYAYFEMAPS
DLLVLTKMFKEQGFGSRQTNRHLVDETMDPFVDRIGYFSALILVEGMDIESLHKCALDDRRELHQFAQDGLICQDMDC
LMLTFGDIPHHAPVLLAWALLRHTLNPEETSSVVRKIGGTAIQLNVFQYLTRLLQSLASGGNDCTTSTACMCVYGLLS
FVLTSLELHTLGNQQDIIDTACEVLADPSLPELFWGTEPTSGLGIILDSVCGMFPHLLSPLLQLLRALVSGKSTAKKV
YSFLDKMSFYNELYKHKPHDVISHEDGTLWRRQTPKLLYPLGGQTNLRIPQGTVGQVMLDDRAYLVRWEYSYSSWTLF
TCEIEMLLHVVSTADVIQHCQRVKPIIDLVHKVISTDLSIADCLLPITSRIYMLLQRLTTVISPPVDVIASCVNCLTV
LAARNPAKVWTDLRHTGFLPFVAHPVSSLSQMISAEGMNAGGYGNLLMNSEQPQGEYGVTIAFLRLITTLVKGQLGST
QSQGLVPCVMFVLKEMLPSYHKWRYNSHGVREQIGCLILELIHAILNLCHETDLHSSHTPSLQFLCICSLAYTEAGQT
VINIMGIGVDTIDMVMAAQPRSDGAEGQGQGQLLIKTVKLAFSVTNNVIRLKPPSNVVSPLEQALSQHGAHGNNLIAV
LAKYIYHKHDPALPRLAIQLLKRLATVAPMSVYACLGNDAAAIRDAFLTRLQSKIEDMRIKVMILEFLTVAVETQPGL
IELFLNLEVKDGSDGSKEFSLGMWSCLHAVLELIDSQQQDRYWCPPLLHRAAIAFLHALWQDRRDSAMLVLRTKPKFW
ENLTSPLFGTLSPPSETSEPSILETCALIMKIICLEIYYVVKGSLDQSLKDTLKKFSIEKRFAYWSGYVRSLAVHVAE
TEGSSCTSLLEYQMLVSAWRMLLIIATTHADIMHLTDSVVRRQLFLDVLDGTKALLLVPASVNCLRLGSMKCTLLLIL
LRQWKRELGSVDEILGPLTEILEGVLQADQQLMEKTKAKVFSAFITVLQMKEMKVSDIPQYSQLVLNVCETLQEEVIA
LFDQTRHSLALGSATEDKDSMETDDCSRSRHRDQRDGVCVLGLHLAKELCEVDEDGDSWLQVTRRLPILPTLLTTLEV
SLRMKQNLHFTEATLHLLLTLARTQQGATAVAGAGITQSICLPLLSVYQLSTNGTAQTPSASRKSLDAPSWPGVYRLS
MSLMEQLLKTLRYNFLPEALDFVGVHQERTLQCLNAVRTVQSLACLEEADHTVGFILQLSNFMKEWHFHLPQLMRDIQ
VNLGYLCQACTSLLHSRKMLQHYLQNKNGDGLPSAVAQRVQRPPSAASAAPSSSKQPAADTEASEQQALHTVQYGLLK
ILSKTLAALRHFTPDVCQILLDQSLDLAEYNFLFALSFTTPTFDSEVAPSFGTLLATVNVALNMLGELDKKKEPLTQA
VGLSTQAEGTRTLKSLLMFTMENCFYLLISQAMRYLRDPAVHPRDKQRMKQELSSELSTLLSSLSRYFRRGAPSSPAT
GVLPSPQGKSTSLSKASPESQEPLIQLVQAFVRHMQR(SEQ ID NO:13)
实施例13.表2中所示的人BFLP0169多肽序列的变体
从存在于表2中的BFLP0169氨基酸序列变化一个氨基酸的多肽序列显示如下。对于显示的序列,表2中所示的BFLP0169序列的第1152位的A已经替换为S,其以粗体显示。
MIRKSKITSVLSFCRSSRELWTILLGRSALRELSQIEAELNKHWRRLLEGLSYYKPPSPSSAEKVKANKDVASPLKEL
GLRISKFLGLDEEQSVQLLQCYLQEDYRGTRDSVKTVLQDERQSQALILKIADYYYEERTCILRCVLHLLTYFQDERH
PYRVEYADCVDKLEKELVSKYRQQFEELYKTEAPTWETHGNLMTERQVSRWFVQCLREQSMLLEIIFLYYAYFEMAPS
DLLVLTKMFKEQGFGSRQTNRHLVDETMDPFVDRIGYFSALILVEGMDIESLHKCALDDRRELHQFAQDGLICQDMDC
LMLTFGDIPHHAPVLLAWALLRHTLNPEETSSVVRKIGGTAIQLNVFQYLTRLLQSLASGGNDCTTSTACMCVYGLLS
FVLTSLELHTLGNQQDIIDTACEVLADPSLPELFWGTEPTSGLGIILDSVCGMFPHLLSPLLQLLRALVSGKSTAKKV
YSFLDKMSFYNELYKHKPHDVISHEDGTLWRRQTPKLLYPLGGQTNLRIPQGTVGQVMLDDRAYLVRWEYSYSSWTLF
TCEIEMLLHVVSTADVIQHCQRVKPIIDLVHKVISTDLSIADCLLPITSRIYMLLQRLTTVISPPVDVIASCVNCLTV
LAARNPAKVWTDLRHTGFLPFVAHPVSSLSQMISAEGMNAGGYGNLLMNSEQPQGEYGVTIAFLRLITTLVKGQLGST
QSQGLVPCVMFVLKEMLPSYHKWRYNSHGVPEQIGCLILELIHAILNLCHETDLHSSHTPSLQFLCICSLAYTEAGQT
VINIMGIGVDTIDMVMAAQPRSDGAEGQGQGQLLIKTVKLAFSVTNNVIRLKPPSNVVSPLEQALSQHGAHGNNLIAV
LAKYIYHKHDPALPRLAIQLLKRLATVAPMSVYACLGNDAAAIRDAFLTRLQSKIEDMRIKVMILEFLTVAVETQPGL
IELFLNLEVKDGSDGSKEFSLGMWSCLHAVLELIDSQQQDRYWCPPLLHRAAIAFLHALWQDRRDSAMLVLRTKPKFW
ENLTSPLFGTLSPPSETSEPSILETCALIMKIICLEIYYVVKGSLDQSLKDTLKKFSIEKRFAYWSGYVKSLAVHVAE
TEGSSCTSLLEYQMLVSAWRMLLIIATTHADIMHLTDSVVRRQLFLDVLDGTKALLLVPSSVNCLRLGSMKCTLLLIL
LRQWKRELGSVDEILGPLTEILEGVLQADQQLMEKTKAKVFSAFITVLQMKEMKVSDIPQYSQLVLNVCETLQEEVIA
LFDQTRHSLALGSATEDKDSMETDDCSRSRHRDQRDGVCVLGLHLAKELCEVDEDGDSWLQVTRRLPILPTLLTTLEV
SLRMKQNLHFTEATLHLLLTLARTQQGATAVAGAGITQSICLPLLSVYQLSTNGTAQTPSASRKSLDAPSWPGVYRLS
MSLMEQLLKTLRYNFLPEALDFVGVHQERTLQCLNAVRTVQSLACLEEADHTVGFILQLSNFMKEWHFHLPQLMRDIQ
VNLGYLCQACTSLLHSRKMLQHYLQNKNGDGLPSAVAQRVQRPPSAASAAPSSSKQPAADTEASEQQALHTVQYGLLK
ILSKTLAALRHFTPDVCQILLDQSLDLAEYNFLFALSFTTPTFDSEVAPSFGTLLATVNVALNMLGELDKKKEPLTQA
VGLSTQAEGTRTLKSLLMFTMENCFYLLISQAMRYLRDPAVHPRDKQRMKQELSSELSTLLSSLSRYFRRGAPSSPAT
GVLPSPQGKSTSLSKASPESQEPLIQLVQAFVRHMQR(SEQ ID NO:14)
实施例14.表2中所示的人BFLP0169多肽序列的变体
从存在于表2中的BFLP0169氨基酸序列变化一个氨基酸的多肽序列显示如下。对于显示的序列,表2中所示的BFLP01 69序列的第1247位的I已经替换为V,其以粗体显示。
MIRKSKITSVLSFCRSSRELWTILLGRSALRELSQIEAELNKHWRRLLEGLSYYKPPSPSSAEKVKANKDVASPLKEL
GLRISKFLGLDEEQSVQLLQCYLQEDYRGTRDSVKTVLQDERQSQALILKIADYYYEERTCILRCVLHLLTYFQDERH
PYRVEYADCVDKLEKELVSKYRQQFEELYKTEAPTWETHGNLMTERQVSRWFVQCLREQSMLLEIIFLYYAYFEMAPS
DLLVLTKMFKEQGFGSRQTNRHLVDETMDPFVDRIGYFSALILVEGMDIESLHKCALDDRRELHQFAQDGLICQDMDC
LMLTFGDIPHHAPVLLAWALLRHTLNPEETSSVVRKIGGTAIQLNVFQYLTRLLQSLASGGNDCTTSTACMCVYGLLS
FVLTSLELHTLGNQQDIIDTACEVLADPSLPELFWGTEPTSGLGIILDSVCGMFPHLLSPLLQLLRALVSGKSTAKKV
YSFLDKMSFYNELYKHKPHDVISHEDGTLWRRQTPKLLYPLGGQTNLRIPQGTVGQVMLDDRAYLVRWEYSYSSWTLF
TCEIEMLLHVVSTADVIQHCQRVKPIIDLVHKVISTDLSIADCLLPITSRIYMLLQRLTTVISPPVDVIASCVNCLTV
LAARNPAKVWTDLRHTGFLPFVAHPVSSLSQMISAEGMNAGGYGNLLMNSEQPQGEYGVTIAFLRLITTLVKGQLGST
QSQGLVPCVMFVLKEMLPSYHKWRYNSHGVREQIGCLILELIHAILNLCHETDLHSSHTPSLQFLCICSLAYTEAGQT
VINIMGIGVDTIDMVMAAQPRSDGAEGQGQGQLLIKTVKLAFSVTNNVIRLKPPSNVVSPLEQALSQHGAHGNNLIAV
LAKYIYHKHDPALPRLAIQLLKRLATVAPMSVYACLGNDAAAIRDAFLTRLQSKIEDMRIKVMILEFLTVAVETQPGL
IELFLNLEVKDGSDGSKEFSLGMWSCLHAVLELIDSQQQDRYWCPPLLHRAAIAFLHALWQDRRDSAMLVLRTKPKFW
ENLTSPLFGTLSPPSETSEPSILETCALIMKIICLEIYYVVKGSLDQSLKDTLKKFSIEKRFAYWSGYVKSLAVHVAE
TEGSSCTSLLEYQMLVSAWRMLLIIATTHADIMHLTDSVVRRQLFLDVLDGTKALLLVPSSVNCLRLGSMKCTLLLIL
LRQWKRELGSVDEILGPLTEILEGVLQADQQLMEKTKAKVFSAFITVLQMKEMKVSDIPQYSQLVLNVCETLQEEVVA
LFDQTRHSLALGSATEDKDSMETDDCSRSRHRDQRDGVCVLGLHLAKELCEVDEDGDSWLQVTRRLPILPTLLTTLEV
SLRMKQNLHFTEATLHLLLTLARTQQGATAVAGAGITQSICLPLLSVYQLSTNGTAQTPSASRKSLDAPSWPGVYRLS
MSLMEQLLKTLRYNFLPFALDFVGVHQERTLQCLNAVRTVQSLACLEEADHTVGFILQLSNFMKEWHFHLPQLMRDIQ
VNLGYLCQACTSLLHSRKMLQHYLQNKNGDGLPSAVAQRVQRPPSAASAAPSSSKQPAADTEASEQQALHTVQYGLLK
ILSKTLAALRHFTPDVCQILLDQSLDLAEYNFLFALSFTTPTFDSEVAPSFGTLLATVNVALNMLGELDKKKEPLTQA
VGLSTQAEGTRTLKSLLMFTMENCFYLLISQAMRYLRDRAVHPRDKQRMKQELSSELSTLLSSLSRYFRRGAPSSPAT
GVLPSPQGKSTSLSKASPESQEPLIQLVQAFVRHMQR(SEQ ID NO:15)
实施例15.表2中所示的人BFLP0169多肽序列的变体
从存在于表2中的BFLP0169氨基酸序列变化一个氨基酸的多肽序列显示如下。对于显示的序列,表2中所示的BFLP0169序列的第1331位的K已经替换为R,其以粗体显示。
MIRKSKITSVLSFCRSSRELWTILLGRSALRELSQIEAELNKHWRRLLEGLSYYKPPSPSSAEKVKANKDVASPLKEL
GLRISKFLGLDEEQSVQLLQCYLQEDYRGTRDSVKTVLQDERQSQALILKIADYYYEERTCILRCVLHLLTYFQDERH
PYRVEYADCVDKLEKELVSKYRQQFEELYKTEAPTWETHGNLMTERQVSRWFVQCLREQSMLLEIIFLYYAYFEMAPS
DLLVLTKMFKEQGFGSRQTNRHLVDETMDPFVDRIGYFSALILVEGMDIESLHKCALDDRRELHQFAQDGLICQDMDC
LMLTFGDIPHHAPVLLAWALLRHTLNPEETSSVVRKIGGTAIQLNVFQYLTRLLQSLASGGNDCTTSTACMCVYGLLS
FVLTSLELHTLGNQQDIIDTACEVLADPSLPELFWGTEPTSGLGIILDSVCGMFPHLLSPLLQLLRALVSGKSTAKKV
YSFLDKMSFYNELYKHKPHDVISHEDGTLWRRQTPKLLYPLGGQTNLRIPQGTVGQVMLDDRAYLVRWEYSYSSWTLF
TCEIEMLLHVVSTADVIQHCQRVKPIIDLVHKVISTDLSIADCLLPITSRIYMLLQRLTTVISPPVDVIASCVNCLTV
LAARNPAKVWTDLRHTGFLPFVAHPVSSLSQMISAEGMNAGGYGNLLMNSEQPQGEYGVTIAFLRLITTLVKGQLGST
QSQGLVPCVMFVLKEMLPSYHKWRYNSHGVREQIGCLILELIHAILNLCHETDLHSSHTPSLQFLCICSLAYTEAGQT
VINIMGIGVDTIDMVMAAQPRSDGAEGQGQGQLLIKTVKLAFSVTNNVIRLKPPSNVVSPLEQALSQHGAHGNNLIAV
LAKYIYHKHDPALPRLAIQLLKRLATVAPMSVYACLGNDAAAIRDAFLTRLQSKIEDMRIKVMILEFLTVAVETQPGL
IELFLNLEVKDGSDGSKEFSLGMWSCLHAVLELIDSQQQDRYWCPPLLHRAAIAFLHALWQDRRDSAMLVLRTKPKFW
ENLTSPLFGTLSPPSETSEPSILETCALIMKIICLEIYYVVKGSLDQSLKDTLKKFSIEKRFAYWSGYVKSLAVHVAE
TEGSSCTSLLEYQMLVSAWRMLLIIATTHADIMHLTDSVVRRQLFLDVLDGTKALLLVPSSVNCLRLGSMKCTLLLIL
LRQWKRELGSVDEILGPLTEILEGVLQADQQLMEKTKAKVFSAFITVLQMKEMKVSDIPQYSQLVLNVCETLQEEVIA
LFDQTRHSLALGSATEDKDSMETDDCSRSRHRDQRDGVCVLGLHLAKELCEVDEDGDSWLQVTRRLPILPTLLTTLEV
SLRMRQNLHFTEATLHLLLTLARTQQGATAVAGAGITQSICLPLLSVYQLSTNGTAQTPSASRKSLDAPSWPGVYRLS
MSLMEQLLKTLRYNFLPEALDFVGVHQERTLQCLNAVRTVQSLACLEEADHTVGFILQLSNFMKEWHFHLPQLMRDIQ
VNLGYLCQACTSLLHSRKMLQHYLQNKNGDGLPSAVAQRVQRPPSAASAAPSSSKQPAADTEASEQQALHTVQYGLLK
ILSKTLAALRHFTPDVCQILLDQSLDLAEYNFLFALSFTTPTFDSEVAPSFGTLLATVNVALNMLGELDKKKEPLTQA
VGLSTQAEGTRTLKSLLMFTMENCFYLLISQAMRYLRDPAVHPRDKQRMKQELSSELSTLLSSLSRYFRRGAPSSPAT
GVLPSPQGKSTSLSKASPESQEPLIQLVQAFVRHMQR(SEQ ID NO:16)
实施例16.表2中所示的人BFLP0169多肽序列的变体
从存在于表2中的BFLP0169氨基酸序列变化一个氨基酸的多肽序列显示如下。对于显示的序列,表2中所示的BFLP0169序列的第1449位的C已经替换为Y,其以粗体显示。
MIRKSKITSVLSFCRSSRELWTILLGRSALRELSQIEAELNKHWRRLLEGLSYYKPPSPSSAEKVKANKDVASPLKEL
GLRISKFLGLDEEQSVQLLQCYLQEDYRGTRDSVKTVLQDERQSQALILKIADYYYEERTCILRCVLHLLTYFQDERH
PYRVEYADCVDKLEKELVSKYRQQFEELYKTEAPTWETHGNLMTERQVSRWFVQCLREQSMLLEIIFLYYAYFEMAPS
DLLVLTKMFKEQGFGSRQTNRHLVDETMDPFVDRIGYFSALILVEGMDIESLHKCALDDRRELHQFAQDGLICQDMDC
LMLTFGDIPHHAPVLLAWALLRHTLNPEETSSVVRKIGGTAIQLNVFQYLTRLLQSLASGGNDCTTSTACMCVYGLLS
FVLTSLELHTLGNQQDIIDTACEVLADPSLPELFWGTEPTSGLGIILDSVCGMFPHLLSPLLQLLRALVSGKSTAKKV
YSFLDKMSFYNELYKHKPHDVISHEDGTLWRRQTPKLLYPLGGQTNLRIPQGTVGQVMLDDRAYLVRWEYSYSSWTLF
TCEIEMLLHVVSTADVIQHCQRVKPIIDLVHKVISTDLSIADCLLPITSRIYMLLQRLTTVISPPVDVIASCVNCLTV
LAARNPAKVWTDLRHTGFLPFVAHPVSSLSQMISAEGMNAGGYGNLLMNSEQPQGEYGVTIAFLRLITTLVKGQLGST
QSQGLVPGVMFVLKEMLPSYHKWRYNSHGVREQIGCLILELIHAILNLCHETDLHSSHTPSLQFLCICSLAYTEAGQT
VINIMGIGVDTIDMVMAAQPRSDGAEGQGQGQLLIKTVKLAFSVTNNVIRLKPPSNVVSPLEQALSQHGAHGNNLIAV
LAKYIYHKHDPALPRLAIQLLKRLATVAPMSVYACLGNDAAAIRDAFLTRLQSKIEDMRIKVMILEFLTVAVETQPGL
IELFLNLEVKDGSDGSKEFSLGMWSCLHAVLELIDSQQQDRYWCPPLLHRAAIAFLHALWQDRRDSAMLVLRTKPKFW
ENLTSPLFGTLSPPSETSEPSILETCALIMKIICLEIYYVVKGSLDQSLKDTLKKFSIEKRFAYWSGYVKSLAVHVAE
TEGSSCTSLLEYQMLVSAWRMLLIIATTHADIMHLTDSVVRRQLFLDVLDGTKALLLVPSSVNCLRLGSMKCTLLLIL
LRQWKRELGSVDEILGPLTEILEGVLQADQQLMEKTKAKVFSAFITVLQMKEMKVSDIPQYSQLVLNVCETLQEEVIA
LFDQTRHSLALGSATEDKDSMETDDCSRSRHRDQRDGVCVLGLHLAKELCEVDEDGDSWLQVTRRLPILPTLLTTLEV
SLRMKQNLHFTEATLHLLLTLARTQQGATAVAGAGITQSICLPLLSVYQLSTNGTAQTPSASRKSLDAPSWPGVYRLS
MSLMEQLLKTLRYNFLPEALDFVGVHQERTLQCLNAVRTVQSLAYLEEADHTVGFILQLSNFMKEWHFHLPQLMRDIQ
VNLGYLCQACTSLLHSRKMLQHYLQNKNGDGLPSAVAQRVQRPPSAASAAPSSSKQPAADTEASEQQALHTVQYGLLK
ILSKTLAALRHFTPDVCQILLDQSLDLAEYNFLFALSFTTPTFDSEVAPSFGTLLATVNVALNMLGELDKKKEPLTQA
VGLSTQAEGTRTLKSLLMFTMENCFYLLISQAMRYLRDPAVHPRDKQRMKQELSSELSTLLSSLSRYFRRGAPSSPAT
GVLPSPQGKSTSLSKASPESQEPLIQLVQAFVRHMQR(SEQ ID NO:17)
实施例17.表2中所示的人BFLP0169多肽序列的变体
从存在于表2中的BFLP0169氨基酸序列变化一个氨基酸的多肽序列显示如下。对于显示的序列,表2中所示的BFLP0169序列的第1542位的D已经替换为Q,其以粗体显示。
MIRKSKITSVLSFCRSSRELWTILLGRSALRELSQIEAELNKHWRRLLEGLSYYKPPSPSSAEKVKANKDVASPLKEL
GLRISKFLGLDEEQSVQLLQCYLQEDYRGTRDSVKTVLQDERQSQALILKIADYYYEERTCILRCVLHLLTYFQDERH
PYRVEYADCVDKLEKELVSKYRQQFEELYKTEAPTWETHGNLMTERQVSRWFVQCLREQSMLLEIIFLYYAYFEMAPS
DLLVLTKMFKEQGFGSRQTNRHLVDETMDPFVDRIGYFSALILVEGMDIESLHKCALDDRRELHQFAQDGLICQDMDC
LMLTFGDIPHHAPVLLAWALLRHTLNPEETSSVVRKIGGTAIQLNVFQYLTRLLQSLASGGNDCTTSTACMCVYGLLS
FVLTSLELHTLGNQQDIIDTACEVLADPSLPELFWGTEPTSGLGIILDSVCGMFPHLLSPLLQLLRALVSGKSTAKKV
YSFLDKMSFYNELYKHKPHDVISHEDGTLWRRQTPKLLYPLGGQTNLRIPQGTVGQVMLDDRAYLVRWEYSYSSWTLF
TCEIEMLLHVVSTADVIQHCQRVKPIIDLVHKVISTDLSIADCLLPITSRIYMLLQRLTTVISPPVDVIASCVNCLTV
LAARNPAKVWTDLRHTGFLPFVAHPVSSLSQMISAEGMNAGGYGNLLMNSEQPQGEYGVTIAFLRLITTLVKGQLGST
QSQGLVPCVMFVLKEMLPSYHKWRYNSHGVREQIGCLILELIHAILNLCHETDLHSSHTPSLQFLCICSLAYTEAGQT
VINIMGIGVDTIDMVMAAQPRSDGAEGQGQGQLLIKTVKLAFSVTNNVIRLKPPSNVVSPLEQALSQHGAHGNNLIAV
LAKYIYHKHDPALPRLAIQLLKRLATVAPMSVYACLGNDAAAIRDAFLTRLQSKIEDMRIKVMILEFLTVAVETQPGL
IELFLNLEVKDGSDGSKEFSLGMWSCLHAVLELIDSQQQDRYWCPPLLHRAAIAFLHALWQDRRDSAMLVLRTKPKFW
ENLTSPLFGTLSPPSETSEPSILETCALIMKIICLEIYYVVKGSLDQSLKDTLKKFSIEKRFAYWSGYVKSLAVHVAE
TEGSSCTSLLEYQMLVSAWRMLLIIATTHADIMHLTDSVVRRQLFLDVLDGTKALLLVPSSVNCLRLGSMKCTLLLIL
LRQWKRELGSVDEILGPLTEILEGVLQADQQLMEKTKAKVFSAFITVLQMKEMKVSDIPQYSQLVLNVCETLQEEVIA
LFDQTRHSLALGSATEDKDSMETDDCSRSRHRDQRDGVCVLGLHLAKELCEVDEDGDSWLQVTRRLPILPTLLTTLEV
SLRMKQNLHFTEATLHLLLTLARTQQGATAVAGAGITQSICLPLLSVYQLSTNGTAQTPSASRKSLDAPSWPGVYRLS
MSLMEQLLKTLRYNFLPEALDFVGVHQERTLQCLNAVRTVQSLACLEEADHTVGFILQLSNFMKEWHFHLPQLMRDIQ
VNLGYLCQACTSLLHSRKMLQHYLQNKNGDGLPSAVAQRVQRPPSAASAAPSSSKQPAAQTEASEQQALHTVQYGLLK
ILSKTLAALRHFTPDVCQILLDQSLDLAEYNFLFALSFTTPTFDSEVAPSFGTLLATVNVALNMLGELDKKKEPLTQA
VGLSTQAEGTRTLKSLLMFTMENCFYLLISQAMRYLRDPAVHPRDKQRMKQELSSELSTLLSSLSRYFRRGAPSSPAT
GVLPSPQGKSTSLSKASPESQEPLIQLVQAFVRHMQR(SEQ ID NO:18)
实施例18.表2中所示的人BFLP0169多肽序列的变体
从存在于表2中的BFLP0169氨基酸序列变化一个氨基酸的多肽序列显示如下。对于显示的序列,表2中所示的BFLP0169序列的第1706位的F已经替换为H,其以粗体显示。
MIRKSKITSVLSFCRSSRELWTILLGRSALRELSQIEAELNKHWRRLLEGLSYYKPPSPSSAEKVKANKDVASPLKEL
GLRISKFLGLDEEQSVQLLQCYLQEDYRGTRDSVKTVLQDERQSQALILKIADYYYEERTCILRCVLHLLTYFQDERH
PYRVEYADCVDKLEKELVSKYRQQFEELYKTEAPTWETHGNLMTERQVSRWFVQCLREQSMLLEIIFLYYAYFEMAPS
DLLVLTKMFKEQGFGSRQTNRHLVDETMDPFVDRIGYFSALILVEGMDIESLHKCALDDRRELHQFAQDGLICQDMDC
LMLTFGDIPHHAPVLLAWALLRHTLNPEETSSVVRKIGGTAIQLNVFQYLTRLLQSLASGGNDCTTSTACMCVYGLLS
FVLTSLELHTLGNQQDIIDTACEVLADPSLPELFWGTEPTSGLGIILDSVCGMFPHLLSPLLQLLRALVSGKSTAKKV
YSFLDKMSFYNELYKHKPHDVISHEDGTLWRRQTPKLLYPLGGQTNLRIPQGTVGQVMLDDRAYLVRWEYSYSSWTLF
TCEIEMLLHVVSTADVIQHCQRVKPIIDLVHKVISTDLSIADCLLPITSRIYMLLQRLTTVISPPVDVIASCVNCLTV
LAARNPAKVWTDLRHTGFLPFVAHPVSSLSQMISAEGMNAGGYGNLLMNSEQPQGEYGVTIAFLRLITTLVKGQLGST
QSQGLVPCVMFVLKEMLPSYHKWRYNSHGVREQIGCLILELIHAILNLCHETDLHSSHTPSLQFLCICSLAYTEAGQT
VINIMGIGVDTIDMVMAAQPRSDGAEGQGQGQLLIKTVKLAFSVTNNVIRLKPPSNVVSPLEQALSQHGAHGNNLIAV
LAKYIYHKHDPALPRLAIQLLKRLATVAPMSVYACLGNDAAAIRDAFLTRLQSKIEDMRIKVMILEFLTVAVETQPGL
IELFLNLEVKDGSDGSKEFSLGMWSCLHAVLELIDSQQQDRYWCPPLLHRAAIAFLHALWQDRRDSAMLVLRTKPKFW
ENLTSPLFGTLSPPSETSEPSILETCALIMKIICLEIYYVVKGSLDQSLKDTLKKFSIEKRFAYWSGYVKSLAVHVAE
TEGSSCTSLLEYQMLVSAWRMLLIIATTHADIMHLTDSVVRRQLFLDVLDGTKALLLVPSSVNCLRLGSMKCTLLLIL
LRQWKRELGSVDEILGPLTEILEGVLQADQQLMEKTKAKVFSAFITVLQMKEMKVSDIPQYSQLVLNVCETLQEEVIA
LFDQTRHSLALGSATEDKDSMETDDCSRSRHRDQRDGVCVLGLHLAKELCEVDEDGDSWLQVTRRLPILPTLLTTLEV
SLRMKQNLHFTEATLHLLLTLARTQQGATAVAGAGITQSICLPLLSVYQLSTNGTAQTPSASRKSLDAPSWPGVYRLS
MSLMEQLLKTLRYNFLPEALDFVGVHQERTLQCLNAVRTVQSLACLEEADHTVGFILQLSNFMKEWHFHLPQLMRDIQ
VNLGYLCQACTSLLHSRKMLQHYLQNKNGDGLPSAVAQRVQRPPSAASAAPSSSKQPAAQTEASEQQALHTVQYGLLK
ILSKTLAALRHFTPDVCQILLDQSLDLAEYNFLFALSFTTPTFDSEVAPSFGTLLATVNVALNMLGELDKKKEPLTQA
VGLSTQAEGTRTLKSLLMFTMENCFYLLISQAMRYLRDPAVHPRDKQRMKQELSSELSTLLSSLSRYHRRGAPSSPAT
GVLPSPQGKSTSLSKASPESQEPLIQLVQAFVRHMQR(SEQ ID NO:19)
其他的实施方案
本发明已经结合其发明详述而进行了描述,上述说明书意在说明而非限制本发明的范围,本发明的范围通过所附的权利要求的范围来加以限定。其他的方面、优势和改变是在下列权利要求的范围之内的。
序列表
<110>Wyeth
<120>用于治疗狼疮肾炎的组合物和方法
<130>22058-582-061
<140>PCT/US03/37339
<141>2003-11-21
<150>60/428,094
<151>2002-11-21
<160>26
<170>PatentIn Ver.2.1
<210>1
<211>5987
<212>DNA
<213>人
<400>1
atgatcagaa agagcaaaat tacctctgtt ctctcatttt gcaggagcag tagagaactg 60
tggactattc tgcttggaag gtcagctctg agagagctga gtcagattga ggcagaactg 120
aataaacatt ggcggcgatt gttagagggg ctttcttact acaaacctcc cagtccaagt 180
tcagctgaaa aagtgaaagc taataaagat gtagcttcac cattgaagga actgggttta 240
agaatcagca agtttttggg tcttgatgaa gaacagagtg tgcagttact ccagtgttac 300
ctgcaagagg actacagggg tactcgggac tcagtaaaga cagtactgca agatgagagg 360
cagagccagg ccttaatcct gaagattgca gattattatt atgaagaaag aacctgtatt 420
cttcgttgtg tcttacacct tctcacttac ttccaagatg aaagacaccc ctatagggtt 480
gaatatgcag actgtgttga taaattggag aaggaactag tttcaaaata cagacagcag 540
ttcgaagagc tttataaaac tgaagcacca acttgggaga cacatggaaa tctcatgaca 600
gagcgccaag tgtctcgctg gtttgttcag tgccttcggg aacagtccat gctgctagaa 660
attattttcc tttattatgc atactttgag atggcaccca gtgacttact tgtattaacc 720
aagatgttta aagagcaagg atttggtagt aggcagacca ataggcacct ggtggatgag 780
actatggatc cttttgtaga tcggattggc tacttcagtg ccctcatcct ggtggagggc 840
atggatatcg agtccttgca taagtgtgct ttggatgaca gaagagaact gcatcagttt 900
gcgcaggatg ggcttatttg tcaggatatg gactgtttaa tgttgacctt tggggacatt 960
ccacatcatg ccccagtgct tttggcctgg gctctcctcc gtcacactct gaacccagaa 1020
gagacaagca gtgtggtccg gaagataggt ggcacagcca tccagctgaa tgtgtttcag 1080
tacttgaccc gattgctcca gtcccttgcc agtgggggaa atgattgcac caccagcact 1140
gcatgcatgt gtgtctatgg actgctctct ttcgttctga cctcgttgga gctgcacacc 1200
ctgggcaatc agcaggatat aattgataca gcatgtgaag tattggccga cccttctctt 1260
ccggaactgt tctggggaac agagccaact tctggccttg ggatcattct ggacagtgtg 1320
tgtggaatgt ttccccacct tctctcccca ctcctgcaac tgctccgagc cctggtatca 1380
gggaagtcca cagccaaaaa ggtgtatagc ttcttggata agatgtcttt ctacaatgaa 1440
ctttataaac acaagcctca tgatgtgatc tcccatgaag atggaactct ttggcggaga 1500
caaacaccca aactccttta tccccttggg ggtcaaacca accttcgcat acctcaaggc 1560
actgtgggcc aagtaatgtt ggatgatagg gcatacctgg tacgctggga atactcctat 1620
agcagctgga ccctctttac ctgcgagatt gaaatgttgc ttcatgttgt ttcaactgca 1680
gatgtgattc agcactgcca gcgagtcaaa cccatcattg atctcgtcca taaggtcatc 1740
agtacagacc tgtcgatagc agactgtctc ctgcccatca catctcgcat ctacatgctg 1800
ctgcagcggt taacgacagt gatctcccca cctgtggatg tcattgcttc ttgtgtcaac 1860
tgcttaactg ttttggctgc ccgcaatcca gcaaaggtct ggactgatct tcgtcacaca 1920
ggttttttac catttgtggc ccatcctgtc tccagcctga gtcagatgat tagtgcggaa 1980
gggatgaatg ctggagggta cggaaacctc ttgatgaaca gtgaacagcc tcagggcgag 2040
tatggggtta ctattgcctt tctgcgcttg atcaccaccc ttgtcaaggg gcaacttggt 2100
agtacccaga gccaaggact tgtaccctgt gtaatgtttg tgctgaagga gatgcttccc 2160
agctaccata agtggcgcta caactctcat ggagtgaggg aacagattgg ttgcctgatc 2220
ttggagctga ttcatgcgat actgaacctg tgccacgaga cagacctgca cagcagtcat 2280
actcccagcc tgcagtttct ctgcatctgc agcctggcat acacagaagc aggacagaca 2340
gttatcaata tcatgggcat tggcgtggac accattgaca tggtgatggc tgctcagcct 2400
cgaagtgatg gggcagaggg ccaggggcag ggccagctgc tgatcaagac agtgaaactg 2460
gcattctccg tcaccaacaa tgttattcgg ctgaaacctc cttctaatgt ggtgtccccc 2520
ctggaacagg ctctctcaca acatggtgct catggaaaca acctcattgc tgttctagcc 2580
aaatacatct accacaaaca tgaccctgct ttgccacgtc ttgccattca gctgctgaaa 2640
cgtctggcca cggtggcccc aatgtcagtg tatgcttgtc tgggcaatga tgcggctgcc 2700
attcgtgatg ccttcctgac ccgattgcag agcaaaattg aggacatgcg catcaaagtc 2760
atgattctag agttcctcac tgttgcagta gagacccagc caggcctcat cgaactgttt 2820
ctgaacctgg aagttaagga tggcagtgat ggctcaaagg aattcagcct tgggatgtgg 2880
agctgtctcc atgcagtgct ggagctgatt gattcccaac agcaagatcg atactggtgc 2940
ccacccctgc tgcatcgtgc cgccattgcc tttttgcatg ctctgtggca ggatcggagg 3000
gacagtgcca tgctggtcct ccgaaccaaa cccaagtttt gggaaaattt aaccagtccg 3060
ctgtttggaa ccctttctcc tccctctgaa acatcagagc ccagcatcct ggaaacctgt 3120
gccctaatca tgaagataat ttgcttggag atatactatg tagtaaaggg ttcattagac 3180
cagtcattaa aggatacact gaagaaattt tccatcgaga aacgctttgc ctactggtca 3240
gggtatgtca agtcattggc agttcacgtg gccgaaacag aaggcagcag ctgcacctcc 3300
ttgttagagt accagatgct ggtgtccgcc tggaggatgc ttctcatcat tgccaccact 3360
catgcagata taatgcacct gactgactct gtggtgcgtc gccagctctt tcttgacgtg 3420
cttgatggaa ccaaagcatt actcctagtt ccagcctcag tgaactgcct tcgccttggc 3480
tccatgaagt gcactctgct gcttatcctc ctccggcagt ggaagagaga gttaggttct 3540
gtggatgaaa tccttggacc cttgacggag atcctggagg gagtgctgca ggccgaccag 3600
caactcatgg agaagaccaa ggccaaggtg ttctcagcat tcatcacagt gttgcaaatg 3660
aaggagatga aagtaagtga catcccccag tactcccagc tggtgctgaa tgtctgtgag 3720
accctccaag aggaagtgat tgcactcttc gaccagaccc gccacagtct ggcattaggc 3780
agtgccacag aggacaagga cagcatggag actgacgact gttctcggtc ccggcacagg 3840
gaccagcgtg atggggtgtg tgtcctgggc ctgcacctgg ccaaggagct gtgtgaggta 3900
gacgaggatg gtgactcctg gctgcaggta acccgcaggc tccccatcct acccaccctc 3960
ctcaccactc tagaggtgag ccttcgcatg aagcagaacc tgcatttcac tgaggccaca 4020
ttgcatctgc tcctcaccct ggctcgcact cagcagggag ccacagcagt ggctggagct 4080
ggcatcaccc agagcatttg tttgcccctt ctgagtgtgt accagctgag caccaacggc 4140
acagcacaga cacctagtgc ctctcggaag tccctggatg ccccctcttg gccaggagtc 4200
taccgcctgt ccatgtccct gatggagcag ctgctcaaaa ctctgcgcta caacttcctg 4260
cctgaggccc tggacttcgt gggtgtccac caggagcgga ccttacagtg cctcaacgca 4320
gtgaggacag tgcagagtct ggcctgcctg gaggaggcgg accacaccgt gggttttatt 4380
ctgcagctct ctaacttcat gaaggagtgg cacttccacc tgcctcagct catgcgtgat 4440
atccaggtca acctgggtta cttgtgccag gcatgtacct ctctcctgca cagtcgaaag 4500
atgctgcagc attacttaca gaacaaaaat ggggatggcc tcccctcagc tgttgcccag 4560
cgagtccaga ggccaccgtc tgctgcttct gctgccccct cctcctcaaa gcagcccgct 4620
gctgacacag aggcatcaga gcagcaggcc ttgcacacag tccagtatgg ccttctcaag 4680
atcctcagca agacgctggc agccctgcgc cacttcaccc cagatgtctg ccagattctg 4740
ctggatcagt ccctggacct tgctgaatac aacttcctgt ttgccctgag ctttaccact 4800
cccacctttg actccgaagt ggccccctcc ttcgggaccc ttctggccac agtgaatgtg 4860
gccctcaaca tgcttggaga gctggacaag aaaaaggagc ccctcaccca ggcagtgggg 4920
ctcagcacac aggcagaagg gaccaggacg ttaaagtccc tcctgatgtt taccatggaa 4980
aactgcttct acctgctcat ctctcaggcg atgcggtacc ttagggaccc ggctgtgcac 5040
ccccgggaca aacagcggat gaagcaggag ctcagctctg agttgagcac gctgctgtcc 5100
agcctctcgc gctacttccg ccggggagcc cccagctccc ctgccactgg tgtcctcccc 5160
tcgccgcagg gcaagtccac ctctctctcc aaagccagcc ctgagagtca ggagcctctg 5220
atccagttgg tgcaggcgtt tgtccggcat atgcaaagat agggcagtgc tgttctgccc 5280
acctacccct ctccaccagc ctacactgca ccctggctgg caggggtgct gctggctgct 5340
agggcctata caatggaggg cacctcctgt cacccccctc ccggagtagc cacgactcca 5400
gccaccaccc actgacgtta tttttatact agatgaagag gtcaacagca ggcatgggga 5460
gccgagtctt ctgtgctcag gtcctcacgc tgcagacgcc ccctagagga actttccttc 5520
ctttccagca ttccccacag cactgccggc caggggagag gcggcagccc agcagagggc 5580
tctatgcacg ggtttcaaac ctgttttcca cactctgtct ttgcagtttt ggtaattctg 5640
tggtctattt atacagatat taaaatcttg tttatagaca gctgtgtgat gtttaacttc 5700
aaagcccagg gatgacaacg tggctctcag aacctagaaa actcccctgg ccaggcgcct 5760
gggagtgggg ctgcagcctc gggggaaggc aggtactgat ggatggctag ttcaccagca 5820
tctcctcatt cctgtccttg ggctgagggt ttggctgggt gggcgctgtc agatattccc 5880
ttccttggcc tgcgctggtc ctgtccttga ccctgctttc attggcccag tgggctgagc 5940
tcatccctgg gtgagccttt cttgaagctc tgtgccttcc tatttat 5987
<210>2
<211>1753
<212>PRT
<213>人
<400>2
Met Ile Arg Lys Ser Lys Ile Thr Ser Val Leu Ser Phe Cys Arg Ser
1 5 10 15
Ser Arg Glu Leu Trp Thr Ile Leu Leu Gly Arg Ser Ala Leu Arg Glu
20 25 30
Leu Ser Gln Ile Glu Ala Glu Leu Asn Lys His Trp Arg Arg Leu Leu
35 40 45
Glu Gly Leu Ser Tyr Tyr Lys Pro Pro Ser Pro Ser Ser Ala Glu Lys
50 55 60
Val Lys Ala Asn Lys Asp Val Ala Ser Pro Leu Lys Glu Leu Gly Leu
65 70 75 80
Arg Ile Ser Lys Phe Leu Gly Leu Asp Glu Glu Gln Ser Val Gln Leu
85 90 95
Leu Gln Cys Tyr Leu Gln Glu Asp Tyr Arg Gly Thr Arg Asp Ser Val
100 105 110
Lys Thr Val Leu Gln Asp Glu Arg Gln Ser Gln Ala Leu Ile Leu Lys
115 120 125
Ile Ala Asp Tyr Tyr Tyr Glu Glu Arg Thr Cys Ile Leu Arg Cys Val
130 135 140
Leu His Leu Leu Thr Tyr Phe Gln Asp Glu Arg His Pro Tyr Arg Val
145 150 155 160
Glu Tyr Ala Asp Cys Val Asp Lys Leu Glu Lys Glu Leu Val Ser Lys
165 170 175
Tyr Arg Gln Gln Phe Glu Glu Leu Tyr Lys Thr Glu Ala Pro Thr Trp
180 185 190
Glu Thr His Gly Asn Leu Met Thr Glu Arg Gln Val Ser Arg Trp Phe
195 200 205
Val Gln Cys Leu Arg Glu Gln Ser Met Leu Leu Glu Ile Ile Phe Leu
210 215 220
Tyr Tyr Ala Tyr Phe Glu Met Ala Pro Ser Asp Leu Leu Val Leu Thr
225 230 235 240
Lys Met Phe Lys Glu Gln Gly Phe Gly Ser Arg Gln Thr Asn Arg His
245 250 255
Leu Val Asp Glu Thr Met Asp Pro Phe Val Asp Arg Ile Gly Tyr Phe
260 265 270
Ser Ala Leu Ile Leu Val Glu Gly Met Asp Ile Glu Ser Leu His Lys
275 280 285
Cys Ala Leu Asp Asp Arg Arg Glu Leu His Gln Phe Ala Gin Asp Gly
290 295 300
Leu Iie Cys Gln Asp Met Asp Cys Leu Met Leu Thr Phe Gly Asp Ile
305 310 315 320
Pro His His Ala Pro Val Leu Leu Ala Trp Ala Leu Leu Arg His Thr
325 330 335
Leu Asn Pro Glu Glu Thr Ser Ser Val Val Arg Lys Ile Gly Gly Thr
340 345 350
Ala Ile Gln Leu Asn Val Phe Gln Tyr Leu Thr Arg Leu Leu Gln Ser
355 360 365
Leu Ala Ser Gly Gly Asn Asp Cys Thr Thr Ser Thr Ala Cys Met Cys
370 375 380
Val Tyr Gly Leu Leu Ser Phe Val Leu Thr Ser Leu Glu Leu His Thr
385 390 395 400
Leu Gly Asn Gln Gln Asp Ile Ile Asp Thr Ala Cys Glu Val Leu Ala
405 410 415
Asp Pro Ser Leu Pro Glu Leu Phe Trp Gly Thr Glu Pro Thr Ser Gly
420 425 430
Leu Gly Ile Ile Leu Asp Ser Val Cys Gly Met Phe Pro His Leu Leu
435 440 445
Ser Pro Leu Leu Gln Leu Leu Arg Ala Leu Val Ser Gly Lys Ser Thr
450 455 460
Ala Lys Lys Val Tyr Ser Phe Leu Asp Lys Met Ser Phe Tyr Asn Glu
465 470 475 480
Leu Tyr Lys His Lys Pro His Asp Val Ile Ser His Glu Asp Gly Thr
485 490 495
Leu Trp Arg Arg Gln Thr Pro Lys Leu Leu Tyr Pro Leu Gly Gly Gln
500 505 510
Thr Asn Leu Arg Ile Pro Gln Gly Thr Val Gly Gln Val Met Leu Asp
515 520 525
Asp Arg Ala Tyr Leu Val Arg Trp Glu Tyr Ser Tyr Ser Ser Trp Thr
530 535 540
Leu Phe Thr Cys Glu Ile Glu Met Leu Leu His Val Val Ser Thr Ala
545 550 555 560
Asp Val Ile Gln His Cys Gln Arg Val Lys Pro Ile Ile Asp Leu Val
565 570 575
His Lys Val Ile Ser Thr Asp Leu Ser Ile Ala Asp Cys Leu Leu Pro
580 585 590
Ile Thr Ser Arg Ile Tyr Met Leu Leu Gln Arg Leu Thr Thr Val Ile
595 600 605
Ser Pro Pro Val Asp Val Ile Ala Ser Cys Val Asn Cys Leu Thr Val
610 615 620
Leu Ala Ala Arg Asn Pro Ala Lys Val Trp Thr Asp Leu Arg His Thr
625 630 635 640
Gly Phe Leu Pro Phe Val Ala His Pro Val Ser Ser Leu Ser Gln Met
645 650 655
Ile Ser Ala Glu Gly Met Asn Ala Gly Gly Tyr Gly Asn Leu Leu Met
660 665 670
Asn Ser Glu Gln Pro Gln Gly Glu Tyr Gly Val Thr Ile Ala Phe Leu
675 680 685
Arg Leu Ile Thr Thr Leu Val Lys Gly Gln Leu Gly Ser Thr Gln Ser
690 695 700
Gln Gly Leu Val Pro Cys Val Met Phe Val Leu Lys Glu Met Leu Pro
705 710 715 720
Ser Tyr His Lys Trp Arg Tyr Asn Ser His Gly Val Arg Glu Gln Ile
725 730 735
Gly Cys Leu Ile Leu Glu Leu Ile His Ala Ile Leu Asn Leu Cys His
740 745 750
Glu Thr Asp Leu His Ser Ser His Thr Pro Ser Leu Gln Phe Leu Cys
755 760 765
Ile Cys Ser Leu Ala Tyr Thr Glu Ala Gly Gln Thr Val Ile Asn Ile
770 775 780
Met Gly Ile Gly Val Asp Thr Ile Asp Met Val Met Ala Ala Gln Pro
785 790 795 800
Arg Ser Asp Gly Ala Glu Gly Gln Gly Gln Gly Gln Leu Leu Ile Lys
805 810 815
Thr ValLys Leu Ala Phe Ser Val Thr Asn Asn Val Ile Arg Leu Lys
820 825 830
Pro Pro Ser Asn Val Val Ser Pro Leu Glu Gln Ala Leu Ser Gln His
835 840 845
Gly Ala His Gly Asn Asn Leu Ile Ala Val Leu Ala Lys Tyr Ile Tyr
850 855 860
His Lys His Asp Pro Ala Leu Pro Arg Leu Ala Ile Gln Leu Leu Lys
865 870 875 880
Arg Leu Ala Thr Val Ala Pro Met Ser Val Tyr Ala Cys Leu Gly Asn
885 890 895
Asp Ala Ala Ala Ile Arg Asp Ala Phe Leu Thr Arg Leu Gln Ser Lys
900 905 910
Ile Glu Asp Met Arg Ile Lys Val Met Ile Leu Glu Phe Leu Thr Val
915 920 925
Ala Val Glu Thr Gln Pro Gly Leu Ile Glu Leu Phe Leu Asn Leu Glu
930 935 940
Val Lys Asp Gly Ser Asp Gly Ser Lys Glu Phe Ser Leu Gly Met Trp
945 950 955 960
Ser Cys Leu His Ala Val Leu Glu Leu Ile Asp Ser Gln Gln Gln Asp
965 970 975
Arg Tyr Trp Cys Pro Pro Leu Leu His Arg Ala Ala Ile Ala Phe Leu
980 985 990
His Ala Leu Trp Gln Asp Arg Arg Asp Ser Ala Met Leu Val Leu Arg
995 1000 1005
Thr Lys Pro Lys Phe Trp Glu Asn Leu Thr Ser Pro Leu Phe Gly Thr
1010 1015 1020
Leu Ser Pro Pro Ser Glu Thr Ser Glu Pro Ser Ile Leu Glu Thr Cys
1025 1030 1035 1040
Ala Leu Ile Met Lys Ile Ile Cys Leu Glu Ile Tyr Tyr Val Val Lys
1045 1050 1055
Gly Ser Leu Asp Gln Ser Leu Lys Asp Thr Leu Lys Lys Phe Ser Ile
1060 1065 1070
Glu Lys Arg Phe Ala Tyr Trp Ser Gly Tyr Val Lys Ser Leu Ala Val
1075 1080 1085
His Val Ala Glu Thr Glu Gly Ser Ser Cys Thr Ser Leu Leu Glu Tyr
1090 1095 1100
Gln Met Leu Val Ser Ala Trp Arg Met Leu Leu Ile Ile Ala Thr Thr
1105 1110 1115 1120
His Ala Asp Ile Met His Leu Thr Asp Ser Val Val Arg Arg Gln Leu
1125 1130 1135
Phe Leu Asp Val Leu Asp Gly Thr Lys Ala Leu Leu Leu Val Pro Ala
1140 1145 1150
Ser Val Asn Cys Leu Arg Leu Gly Ser Met Lys Cys Thr Leu Leu Leu
1155 1160 1165
Ile Leu Leu Arg Gln Trp Lys Arg Glu Leu Gly Ser Val Asp Glu Ile
1170 1175 1180
Leu Gly Pro Leu Thr Glu Ile Leu Glu Gly Val Leu Gln Ala Asp Gln
1185 1190 1195 1200
Gln Leu Met Glu Lys Thr Lys Ala Lys Val Phe Ser Ala Phe Ile Thr
1205 1210 1215
Val Leu Gln Met Lys Glu Met Lys Val Ser Asp Ile Pro Gln Tyr Ser
1220 1225 1230
Gln Leu Val Leu Asn Val Cys Glu Thr Leu Gln Glu Glu ValIle Ala
1235 1240 1245
Leu Phe Asp Gln Thr Arg His Ser Leu Ala Leu Gly Ser Ala Thr Glu
1250 1255 1260
Asp Lys Asp Ser Mer Glu Thr Asp Asp Cys Ser Arg Ser Arg His Arg
1265 1270 1275 1280
Asp Gln Arg Asp Gly Val Cys Va1 Leu Gly Leu His Leu Ala Lys Glu
1285 1290 1295
Leu Cys Glu Val Asp Glu Asp Gly Asp Ser Trp Leu Gln Val Thr Arg
1300 1305 1310
Arg Leu Pro Ile Leu Pro Thr Leu Leu Thr Thr Leu Glu Val Ser Leu
1315 1320 1325
Arg Met Lys Gln Asn Leu His Phe Thr Glu Ala Thr Leu His Leu Leu
1330 1335 1340
Leu Thr Leu Ala Arg Thr Gln Gln Gly Ala Thr Ala Val Ala Gly Ala
1345 1350 1355 1360
Gly Ile Thr Gln Ser Ile Cys Leu Pro Leu Leu Ser Val Tyr Gln Leu
1365 1370 1375
Ser Thr Asn Gly Thr Ala Gln Thr Pro Ser Ala Ser Arg Lys Ser Leu
1380 1385 1390
Asp Ala Pro Ser Trp Pro Gly Val Tyr Arg Leu Ser Met Ser Leu Met
1395 1400 1405
Glu Gln Leu Leu Lys Thr Leu Arg Tyr Asn Phe Leu Pro Glu Ala Leu
1410 1415 1420
Asp Phe Val Gly Val His Gln Glu Arg Thr Leu Gln Cys Leu Asn Ala
1425 1430 1435 1440
Val Arg Thr Val Gln Ser Leu Ala Cys Leu Glu Glu Ala Asp His Thr
1445 1450 1455
Val Gly Phe Ile Leu Gln Leu Ser Asn Phe Met Lys Glu Trp His Phe
1460 1465 1470
His Leu Pro Gln Leu Met Arg Asp Ile Gln Val Asn Leu Gly Tyr Leu
1475 1480 1485
Cys Gln Ala Cys Thr Ser Leu Leu His Ser Arg Lys Met Leu Gln His
1490 1495 1500
Tyr Leu Gln Asn Lys Asn Gly Asp Gly Leu Pro Ser Ala Val Ala Gln
1505 1510 1515 1520
Arg Val Gln Arg Pro Pro Ser Ala Ala Ser Ala Ala Pro Ser Ser Ser
1525 1530 1535
Lys Gln Pro Ala Ala Asp Thr G1u Ala Ser Glu Gln Gln Ala Leu His
1540 1545 1550
Thr Val Gln Tyr Gly Leu Leu Lys Ile Leu Ser Lys Thr Leu Ala Ala
1555 1560 1565
Leu Arg His Phe Thr Pro Asp Val Cys Gln Ile Leu Leu Asp Gln Ser
1570 1575 1580
Leu Asp Leu Ala Glu Tyr Asn Phe Leu Phe Ala Leu Ser Phe Thr Thr
1585 1590 1595 1600
Pro Thr Phe Asp Ser Glu Val Ala Pro Ser Phe Gly Thr Leu Leu Ala
1605 1610 1615
Thr ValAsn Val Ala Leu Asn Met Leu Gly Glu Leu Asp Lys Lys Lys
1620 1625 1630
Glu Pro Leu Thr Gln Ala Val Gly Leu Ser Thr Gln Ala Glu Gly Thr
1635 1640 1645
Arg Thr Leu Lys Ser Leu Leu Met Phe Thr Met Glu Asn Cys Phe Tyr
1650 1655 1660
Leu Leu Ile Ser Gln Ala Met Arg Tyr Leu Arg Asp Pro Ala Val His
1665 1670 1675 1680
Pro Arg Asp Lys Gln Arg Met Lys Gln Glu Leu Ser Ser Glu Leu Ser
1685 1690 1695
Thr Leu Leu Ser Ser Leu Ser Arg Tyr Phe Arg Arg Gly Ala Pro Ser
1700 1705 1710
Ser Pro Ala Thr Gly Val Leu Pro Ser Pro Gln Gly Lys Ser Thr Ser
1715 1720 1725
Leu Ser Lys Ala Ser Pro Glu Ser Gln Glu Pro Leu Ile Gln Leu Val
1730 1735 1740
Gln Ala Phe Val Arg His Met Gln Arg
1745 1750
<210>3
<211>1753
<212>PRT
<213>人
<400>3
Met Ile Arg Lys Ser Lys Ile Thr Ser Val Leu Ser Phe Cys Arg Ser
1 5 10 15
Ser Arg Glu Leu Trp Thr Ile Leu Leu Gly Arg Ser Ala Leu Arg Glu
20 25 30
Leu Ser Gln Ile Glu Ala Glu Leu Asn Lys His Trp Arg Arg Leu Leu
35 40 45
Glu Gly Leu Ser Tyr Tyr Lys Pro Pro Ser Pro Ser Ser Ala Glu Lys
50 55 60
Val Lys Ala Asn Lys Asp Val Ala Ser Pro Leu Lys Glu Val Gly Leu
65 70 75 80
Arg Ile Ser Lys Phe Leu Gly Leu Asp Glu Glu Gln Ser Val Gln Leu
85 90 95
Leu Gln Cys Tyr Leu Gln Glu Asp Tyr Arg Gly Thr Arg Asp Ser Val
100 105 110
Lys Thr Val Leu Gln Asp Glu Arg Gln Ser Gln Ala Leu Ile Leu Lys
115 120 125
Ile Ala Asp Tyr Tyr Tyr Glu Glu Arg Thr Cys Ile Leu Arg Cys Val
130 135 140
Leu His Leu Leu Thr Tyr Phe Gln Asp Glu Arg His Pro Tyr Arg Val
145 150 155 160
Glu Tyr Ala Asp Cys Val Asp Lys Leu Glu Lys Glu Leu Val Ser Lys
165 170 175
Tyr Arg Gln Gln Phe Glu Glu Leu Tyr Lys Thr Glu Ala Pro Thr Trp
180 185 190
Glu Thr His Gly Asn Leu Met Thr Glu Arg Gln Val Ser Arg Trp Phe
195 200 205
Val Gln Cys Leu Arg Glu Gln Ser Met Leu Leu Glu Ile Ile Phe Leu
210 215 220
Tyr Tyr Ala Tyr Phe Glu Met Ala Pro Ser Asp Leu Leu Val Leu Thr
225 230 235 240
Lys Met Phe Lys Glu Gln Gly Phe Gly Ser Arg Gln Thr Asn Arg His
245 250 255
Leu Val Asp Glu Thr Met Asp Pro Phe Val Asp Arg Ile Gly Tyr Phe
260 265 270
Ser Ala Leu Ile Leu Val Glu Gly Met Asp Ile Glu Ser Leu His Lys
275 280 285
Cys Ala Leu Asp Asp Arg Arg Glu Leu His Gln Phe Ala Gln Asp Gly
290 295 300
Leu Ile Cys Gln Asp Met Asp Cys Leu Met Leu Thr Phe Gly Asp Ile
305 310 315 320
Pro His His Ala Pro Val Leu Leu Ala Trp Ala Leu Leu Arg His Thr
325 330 335
Leu Asn Pro Glu Glu Thr Ser Ser Val Val Arg Lys Ile Gly Gly Thr
340 345 350
Ala Ile Gln Leu Asn Val Phe Gln Tyr Leu Thr Arg Leu Leu Gln Ser
355 360 365
Leu Ala Ser Gly Gly Asn Asp Cys Thr Thr Ser Thr Ala Cys Met Cys
370 375 380
Val Tyr Gly Leu Leu Ser Phe Val Leu Thr Ser Leu Glu Leu His Thr
385 390 395 400
Leu Gly Asn Gln Gln Asp Ile Ile Asp Thr Ala Cys Glu Val Leu Ala
405 410 415
Asp Pro Ser Leu Pro Glu Leu Phe Trp Gly Thr Glu Pro Thr Ser Gly
420 425 430
Leu Gly Ile Ile Leu Asp Ser Val Cys Gly Met Phe Pro His Leu Leu
435 440 445
Ser Pro Leu Leu Gln Leu Leu Arg Ala Leu Val Ser Gly Lys Ser Thr
450 455 460
Ala Lys Lys Val Tyr Ser Phe Leu Asp Lys Met Ser Phe Tyr Asn Glu
465 470 475 480
Leu Tyr Lys His Lys Pro His Asp Val Ile Ser His Glu Asp Gly Thr
485 490 495
Leu Trp Arg Arg Gln Thr Pro Lys Leu Leu Tyr Pro Leu Gly Gly Gln
500 505 510
Thr Asn Leu Arg Ile Pro Gln Gly Thr Val Gly Gln Val Met Leu Asp
515 520 525
Asp Arg Ala Tyr Leu Val Arg Trp Glu Tyr Ser Tyr Ser Ser Trp Thr
530 535 540
Leu Phe Thr Cys Glu Ile Glu Met Leu Leu His Val Val Ser Thr Ala
545 550 555 560
Asp Val Ile Gln His Cys Gln Arg Val Lys Pro Ile Ile Asp Leu Val
565 570 575
His Lys Val Ile Ser Thr Asp Leu Ser Ile Ala Asp Cys Leu Leu Pro
580 585 590
Ile Thr Ser Arg Ile Tyr Met Leu Leu Gln Arg Leu Thr Thr Val Ile
595 600 605
Ser Pro Pro Val Asp Val Ile Ala Ser Cys Val Asn Cys Leu Thr Val
610 615 620
Leu Ala Ala Arg Asn Pro Ala Lys Val Trp Thr Asp Leu Arg His Thr
625 630 635 640
Gly Phe Leu Pro Phe Val Ala His Pro Val Ser Ser Leu Ser Gln Met
645 650 655
Ile Ser Ala Glu Gly Met Asn Ala Gly Gly Tyr Gly Asn Leu Leu Met
660 665 670
Asn Ser Glu Gln Pro Gln Gly Glu Tyr Gly Val Thr Ile Ala Phe Leu
675 680 685
Arg Leu Ile Thr Thr Leu Val Lys Gly Gln Leu Gly Ser Thr Gln Ser
690 695 700
Gln Gly Leu Val Pro Cys Val Met Phe Val Leu Lys Glu Met Leu Pro
705 710 715 720
Ser Tyr His Lys Trp Arg Tyr Asn Ser His Gly Val Arg Glu Gln Ile
725 730 735
Gly Cys Leu Ile Leu Glu Leu Ile His Ala Ile Leu Asn Leu Cys His
740 745 750
Glu Thr Asp Leu His Ser Ser His Thr Pro Ser Leu Gln Phe Leu Cys
755 760 765
Ile Cys Ser Leu Ala Tyr Thr Glu Ala Gly Gln Thr Val Ile Asn Ile
770 775 780
Met Gly Ile Gly Val Asp Thr Ile Asp Met Val Met Ala Ala Gln Pro
785 790 795 800
Arg Ser Asp Gly Ala Glu Gly Gln Gly Gln Gly Gln Leu Leu Ile Lys
805 810 815
Thr Val Lys Leu Ala Phe Ser Val Thr Asn Asn Val Ile Arg Leu Lys
820 825 830
Pro Pro Ser Asn Val Val Ser Pro Leu Glu Gln Ala Leu Ser Gln His
835 840 845
Gly Ala His Gly Asn Asn Leu Ile Ala Val Leu Ala Lys Tyr Ile Tyr
850 855 860
His Lys His Asp Pro Ala Leu Pro Arg Leu Ala Ile Gln Leu Leu Lys
865 870 875 880
Arg Leu Ala Thr Val Ala Pro Met Ser Val Tyr Ala Cys Leu Gly Asn
885 890 895
Asp Ala Ala Ala Ile Arg Asp Ala Phe Leu Thr Arg Leu Gln Ser Lys
900 905 910
Ile Glu Asp Met Arg Ile Lys Val Met Ile Leu Glu Phe Leu Thr Val
915 920 925
Ala Val Glu Thr Gln Pro Gly Leu Ile Glu Leu Phe Leu Asn Leu Glu
930 935 940
Val Lys Asp Gly Ser Asp Gly Ser Lys Glu Phe Ser Leu Gly Met Trp
945 950 955 960
Ser Cys Leu His Ala Val Leu Glu Leu Ile Asp Ser Gln Gln Gln Asp
965 970 975
Arg Tyr Trp Cys Pro Pro Leu Leu His Arg Ala Ala Ile Ala Phe Leu
980 985 990
His Ala Leu Trp Gln Asp Arg Arg Asp Ser Ala Met Leu Val Leu Arg
995 1000 1005
Thr Lys Pro Lys Phe Trp Glu Asn Leu Thr Ser Pro Leu Phe Gly Thr
1010 1015 1020
Leu Ser Pro Pro Ser Glu Thr Ser Glu Pro Ser Ile Leu Glu Thr Cys
1025 1030 1035 1040
Ala Leu Ile Met Lys Ile Ile Cys Leu Glu Ile Tyr Tyr Val Val Lys
1045 1050 1055
Gly Ser Leu Asp Gln Ser Leu Lys Asp Thr Leu Lys Lys Phe Ser Ile
1060 1065 1070
Glu Lys Arg Phe Ala Tyr Trp Ser Gly Tyr Val Lys Ser Leu Ala Val
1075 1080 1085
His Val Ala Glu Thr Glu Gly Ser Ser Cys Thr Ser Leu Leu Glu Tyr
1090 1095 1100
Gln Met Leu Val Ser Ala Trp Arg Met Leu Leu Ile Ile Ala Thr Thr
1105 1110 1115 1120
His Ala Asp Ile Met His Leu Thr Asp Ser Val Val Arg Arg Gln Leu
1125 1130 1135
Phe Leu Asp Val Leu Asp Gly Thr Lys Ala Leu Leu Leu Val Pro Ala
1140 1145 1150
Ser Val Asn Cys Leu Arg Leu Gly Ser Met Lys Cys Thr Leu Leu Leu
1155 1160 1165
Ile Leu Leu Arg Gln Trp Lys Arg Glu Leu Gly Ser Val Asp Glu Ile
1170 1175 1180
Leu Gly Pro Leu Thr Glu Ile Leu Glu Gly Val Leu Gln Ala Asp Gln
1185 1190 1195 1200
Gln Leu Met Glu Lys Thr Lys Ala Lys Val Phe Ser Ala Phe Ile Thr
1205 1210 1215
Val Leu Gln Met Lys Glu Met Lys Val Ser Asp Ile Pro Gln Tyr Ser
1220 1225 1230
Gln Leu Val Leu Asn Val Cys Glu Thr Leu Gln Glu Glu Val Ile Ala
1235 1240 1245
Leu Phe Asp Gln Thr Arg His Ser Leu Ala Leu Gly Ser Ala Thr Glu
1250 1255 1260
Asp Lys Asp Ser Met Glu Thr Asp Asp Cys Ser Arg Ser Arg His Arg
1265 1270 1275 1280
Asp Gln Arg Asp Gly Val Cys Val Leu Gly Leu His Leu Ala Lys Glu
1285 1290 1295
Leu Cys Glu Val Asp Glu Asp Gly Asp Ser Trp Leu Gln Val Thr Arg
1300 1305 1310
Arg Leu Pro Ile Leu Pro Thr Leu Leu Thr Thr Leu Glu Val Ser Leu
1315 1320 1325
Arg Met Lys Gln Asn Leu His Phe Thr Glu Ala Thr Leu His Leu Leu
1330 1335 1340
Leu Thr Leu Ala Arg Thr Gln Gln Gly Ala Thr Ala Val Ala Gly Ala
1345 1350 1355 1360
Gly Ile Thr Gln Ser Ile Cys Leu Pro Leu Leu Ser Val Tyr Gln Leu
1365 1370 1375
Ser Thr Asn Gly Thr Ala Gln Thr Pro Ser Ala Ser Arg Lys Ser Leu
1380 1385 1390
Asp Ala Pro Ser Trp Pro Gly Val Tyr Arg Leu Ser Met Ser Leu Met
1395 1400 1405
Glu Gln Leu Leu Lys Thr Leu Arg Tyr Asn Phe Leu Pro Glu Ala Leu
1410 1415 1420
Asp Phe Val Gly Val His Gln Glu Arg Thr Leu Gln Cys Leu Asn Ala
1425 1430 1435 1440
Val Arg Thr Val Gln Ser Leu Ala Cys Leu Glu Glu Ala Asp His Thr
1445 1450 1455
Val Gly Phe Ile Leu Gln Leu Ser Asn Phe Met Lys Glu Trp His Phe
1460 1465 1470
His Leu Pro Gln Leu Met Arg Asp Ile Gln Val Asn Leu Gly Tyr Leu
1475 1480 1485
Cys Gln Ala Cys Thr Ser Leu Leu His Ser Arg Lys Met Leu Gln His
1490 1495 1500
Tyr Leu Gln Asn Lys Asn Gly Asp Gly Leu Pro Ser Ala Val Ala Gln
1505 1510 1515 1520
Arg ValGln Arg Pro Pro Ser Ala Ala Ser Ala Ala Pro Ser Ser Ser
1525 1530 1535
Lys Gln Pro Ala Ala Asp Thr Glu Ala Ser Glu Gln Gln Ala Leu His
1540 1545 1550
Thr Val Gln Tyr Gly Leu Leu Lys Ile Leu Ser Lys Thr Leu Ala Ala
1555 1560 1565
Leu Arg His Phe Thr Pro Asp Val Cys Gln Ile Leu Leu Asp Gln Ser
1570 1575 1580
Leu Asp Leu Ala Glu Tyr Asn Phe Leu Phe Ala Leu Ser Phe Thr Thr
158 1590 1595 1600
Pro Thr Phe Asp Ser Glu Val Ala Pro Ser Phe Gly Thr Leu Leu Ala
1605 1610 1615
Thr Val Asn Val Ala Leu Asn Met Leu Gly Glu Leu Asp Lys Lys Lys
1620 1625 1630
Glu Pro Leu Thr Gln Ala Val Gly Leu Ser Thr Gln Ala Glu Gly Thr
1635 1640 1645
Arg Thr Leu Lys Ser Leu Leu Met Phe Thr Met Glu Asn Cys Phe Tyr
1650 1655 1660
Leu Leu Ile Ser Gln Ala Met Arg Tyr Leu Arg Asp Pro Ala Val His
1665 1670 1675 1680
Pro Arg Asp Lys Gln Arg Met Lys Gln Glu Leu Ser Ser Glu Leu Ser
1685 1690 1695
Thr Leu Leu Ser Ser Leu Ser Arg Tyr Phe Arg Arg Gly Ala Pro Ser
1700 1705 1710
Ser Pro Ala Thr Gly Val Leu Pro Ser Pro Gln Gly Lys Ser Thr Ser
1715 1720 1725
Leu Ser Lys Ala Ser Pro Glu Ser Gln Glu Pro Leu Ile Gln Leu Val
1730 1735 1740
Gln Ala Phe Val Arg His Met Gln Arg
1745 1750
<210>4
<211>1753
<212>PRT
<213>人
<400>4
Met Ile Arg Lys Ser Lys Ile Thr Ser Val Leu Ser Phe Cys Arg Ser
1 5 10 15
Ser Arg Glu Leu Trp Thr Ile Leu Leu Gly Arg Ser Ala Leu Arg Glu
20 25 30
Leu Ser Gln Ile Glu Ala Glu Leu Asn Lys His Trp Arg Arg Leu Leu
35 40 45
Glu Gly Leu Ser Tyr Tyr Lys Pro Pro Ser Pro Ser Ser Ala Glu Lys
50 55 60
Val Lys Ala Asn Lys Asp Val Ala Ser Pro Leu Lys Glu Leu Gly Leu
65 70 75 80
Arg Ile Ser Lys Phe Leu Gly Leu Asp Glu Glu Gln Ser Val Gln Leu
85 90 95
Leu Gln Cys Tyr Leu Gln Glu Asp Tyr Arg Gly Thr Arg Asp Ser Val
100 105 110
Lys Thr Val Leu Gln Asp Glu Arg Gln Ser Gln Ala Leu Ile Leu Lys
115 120 125
Ile Ala Asp Tyr Tyr Tyr Glu Glu Arg Thr Cys Ile Leu Arg Cys Val
130 135 140
Leu His Leu Leu Thr Tyr Phe Gln Asp Glu Arg His Pro Tyr Arg Val
145 150 155 160
Glu Tyr Ala Asp Cys Val Asp Lys Leu Glu Lys Glu Leu Val Ser Lys
165 170 175
Tyr Arg Gln Gln Phe Glu Glu Leu Tyr Lys Thr Glu Ala Pro Thr Trp
180 185 190
Glu Thr His Gly Asn Ile Met Thr Glu Arg Gln Val Ser Arg Trp Phe
195 200 205
Val Gln Cys Leu Arg Glu Gln Ser Met Leu Leu Glu Ile Ile Phe Leu
210 215 220
Tyr Tyr Ala Tyr Phe Glu Met Ala Pro Ser Asp Leu Leu Val Leu Thr
225 230 235 240
Lys Met Phe Lys Glu Gln Gly Phe Gly Ser Arg Gln Thr Asn Arg His
245 250 255
Leu Val Asp Glu Thr Met Asp Pro Phe Val Asp Arg Ile Gly Tyr Phe
260 265 270
Ser Ala Leu Ile Leu Val Glu Gly Met Asp Ile Glu Ser Leu His Lys
275 280 285
Cys Ala Leu Asp Asp Arg Arg Glu Leu His Gln Phe Ala Gln Asp Gly
290 295 300
Leu Ile Cys Gln Asp Met Asp Cys Leu Met Leu Thr Phe Gly Asp Ile
305 310 315 320
Pro His His Ala Pro Val Leu Leu Ala Trp Ala Leu Leu Arg His Thr
325 330 335
Leu Asn Pro Glu Glu Thr Ser Ser Val Val Arg Lys Ile Gly Gly Thr
340 345 350
Ala Ile Gln Leu Asn Val Phe Gln Tyr Leu Thr Arg Leu Leu Gln Ser
355 360 365
Leu Ala Ser Gly Gly Asn Asp Cys Thr Thr Ser Thr Ala Cys Met Cys
370 375 380
Val Tyr Gly Leu Leu Ser Phe Val Leu Thr Ser Leu Glu Leu His Thr
385 390 395 400
Leu Gly Asn Gln Gln Asp Ile Ile Asp Thr Ala Cys Glu Val Leu Ala
405 410 415
Asp Pro Ser Leu Pro Glu Leu Phe Trp Gly Thr Glu Pro Thr Ser Gly
420 425 430
Leu Gly Ile Ile Leu Asp Ser Val Cys Gly Met Phe Pro His Leu Leu
435 440 445
Ser Pro Leu Leu Gln Leu Leu Arg Ala Leu Val Ser Gly Lys Ser Thr
450 455 460
Ala Lys Lys Val Tyr Ser Phe Leu Asp Lys Met Ser Phe Tyr Asn Glu
465 470 475 480
Leu Tyr Lys His Lys Pro His Asp Val Ile Ser His Glu Asp Gly Thr
485 490 495
Leu Trp Arg Arg Gln Thr Pro Lys Leu Leu Tyr Pro Leu Gly Gly Gln
500 505 510
Thr Asn Leu Arg Ile Pro Gln Gly Thr Val Gly Gln Val Met Leu Asp
515 520 525
Asp Arg Ala Tyr Leu Val Arg Trp Glu Tyr Ser Tyr Ser Ser Trp Thr
530 535 540
Leu Phe Thr Cys Glu Ile Glu Met Leu Leu His Val Val Ser Thr Ala
545 550 555 560
Asp Val Ile Gln His Cys Gln Arg Val Lys Pro Ile Ile Asp Leu Val
565 570 575
His Lys Val Ile Ser Thr Asp Leu Ser Ile Ala Asp Cys Leu Leu Pro
580 585 590
Ile Thr Ser Arg Ile Tyr Met Leu Leu Gln Arg Leu Thr Thr Val Ile
595 600 605
Ser Pro Pro Val Asp Val Ile Ala Ser Cys Val Asn Cys Leu Thr Val
610 615 620
Leu Ala Ala Arg Asn Pro Ala Lys Val Trp Thr Asp Leu Arg His Thr
625 630 635 640
Gly Phe Leu Pro Phe Val Ala His Pro Val Ser Ser Leu Ser Gln Met
645 650 655
Ile Ser Ala Glu Gly Met Asn Ala Gly Gly Tyr Gly Asn Leu Leu Met
660 665 670
Asn Ser Glu Gln Pro Gln Gly Glu Tyr Gly Val Thr Ile Ala Phe Leu
675 680 685
Arg Leu Ile Thr Thr Leu Val Lys Gly Gln Leu Gly Ser Thr Gln Ser
690 695 700
Gln Gly Leu Val Pro Cys Val Met Phe Val Leu Lys Glu Met Leu Pro
705 710 715 720
Ser Tyr His Lys Trp Arg Tyr Asn Ser His Gly Val Arg Glu Gln Ile
725 730 735
Gly Cys Leu Ile Leu Glu Leu Ile His Ala Ile Leu Asn Leu Cys His
740 745 750
Glu Thr Asp Leu His Ser Ser His Thr Pro Ser Leu Gln Phe Leu Cys
755 760 765
Ile Cys Ser Leu Ala Tyr Thr Glu Ala Gly Gln Thr Val Ile Asn Ile
770 775 780
Met Gly Ile Gly Val Asp Thr Ile Asp Met Val Met Ala Ala Gln Pro
785 790 795 800
Arg Ser Asp Gly Ala Glu Gly Gln Gly Gln Gly Gln Leu Leu Ile Lys
805 810 815
Thr ValLys Leu Ala Phe Ser Val Thr Asn Asn Val Ile Arg Leu Lys
820 825 830
Pro Pro Ser Asn Val Val Ser Pro Leu Glu Gln Ala Leu Ser Gln His
835 840 845
Gly Ala His Gly Asn Asn Leu Ile Ala Val Leu Ala Lys Tyr Ile Tyr
850 855 860
His Lys His Asp Pro Ala Leu Pro Arg Leu Ala Ile Gln Leu Leu Lys
865 870 875 880
Arg Leu Ala Thr Val Ala Pro Met Ser Val Tyr Ala Cys Leu Gly Asn
885 890 895
Asp Ala Ala Ala Ile Arg Asp Ala Phe Leu Thr Arg Leu Gln Ser Lys
900 905 910
Ile Glu Asp Met Arg Ile Lys Val Met Ile Leu Glu Phe Leu Thr Val
915 920 925
Ala Val Glu Thr Gln Pro Gly Leu Ile Glu Leu Phe Leu Asn Leu Glu
930 935 940
Val Lys Asp Gly Ser Asp Gly Ser Lys Glu Phe Ser Leu Gly Met Trp
945 950 955 960
Ser Cys Leu His Ala Val Leu Glu Leu Ile Asp Ser Gln Gln Gln Asp
965 970 975
Arg Tyr Trp Cys Pro Pro Leu Leu His Arg Ala Ala Ile Ala Phe Leu
980 985 990
His Ala Leu Trp Gln Asp Arg Arg Asp Ser Ala Met Leu Val Leu Arg
995 1000 1005
Thr Lys Pro Lys Phe Trp Glu Asn Leu Thr Ser Pro Leu Phe Gly Thr
1010 1015 1020
Leu Ser Pro Pro Ser Glu Thr Ser Glu Pro Ser Ile Leu Glu Thr Cys
1025 1030 1035 1040
Ala Leu Ile Met Lys Ile Ile Cys Leu Glu Ile Tyr Tyr Val Val Lys
1045 1050 1055
Gly Ser Leu Asp Gln Ser Leu Lys Asp Thr Leu Lys Lys Phe Ser Ile
1060 1065 1070
Glu Lys Arg Phe Ala Tyr Trp Ser Gly Tyr Val Lys Ser Leu Ala Val
1075 1080 1085
His Val Ala Glu Thr Glu Gly Ser Ser Cys Thr Ser Leu Leu Glu Tyr
1090 1095 1100
Gln Met Leu Val Ser Ala Trp Arg Met Leu Leu Ile Ile Ala Thr Thr
1105 1110 1115 1120
His Ala Asp Ile Met His Leu Thr Asp Ser Val Val Arg Arg Gln Leu
1125 1130 1135
Phe Leu Asp Val Leu Asp Gly Thr Lys Ala Leu Leu Leu Val Pro Ala
1140 1145 1150
Ser Val Asn Cys Leu Arg Leu Gly Ser Met Lys Cys Thr Leu Leu Leu
1155 1160 1165
Ile Leu Leu Arg Gln Trp Lys Arg Glu Leu Gly Ser Val Asp Glu Ile
1170 1175 1180
Leu Gly Pro Leu Thr Glu Ile Leu Glu G1y Val Leu Gln Ala Asp Gln
1185 1190 1195 1200
Gln Leu Met Glu Lys Thr Lys Ala Lys Val Phe Ser Ala Phe Ile Thr
1205 1210 1215
Val Leu Gln Met Lys Glu Met Lys Val Ser Asp Ile Pro Gln Tyr Ser
1220 1225 1230
Gln Leu Val Leu Asn Val Cys Glu Thr Leu Gln Glu Glu Val Ile Ala
1235 1240 1245
Leu Phe Asp Gln Thr Arg His Ser Leu Ala Leu Gly Ser Ala Thr Glu
1250 1255 1260
Asp Lys Asp Ser Met Glu Thr Asp Asp Cys Ser Arg Ser Arg His Arg
1265 1270 1275 1280
Asp Gln Arg Asp Gly Val Cys Val Leu Gly Leu His Leu Ala Lys Glu
1285 1290 1295
Leu Cys Glu Val Asp Glu Asp Gly Asp Ser Trp Leu Gln Val Thr Arg
1300 1305 1310
Arg Leu Pro Ile Leu Pro Thr Leu Leu Thr Thr Leu Glu Val Ser Leu
1315 1320 1325
Arg Met Lys Gln Asn Leu His Phe Thr Glu Ala Thr Leu His Leu Leu
1330 1335 1340
Leu Thr Leu Ala Arg Thr Gln Gln Gly Ala Thr Ala Val Ala Gly Ala
1345 1350 1355 1360
Gly Ile Thr Gln Ser Ile Cys Leu Pro Leu Leu Ser Val Tyr Gln Leu
1365 1370 1375
Ser Thr Asn Gly Thr Ala Gln Thr Pro Ser Ala Ser Arg Lys Ser Leu
1380 1385 1390
Asp Ala Pro Ser Trp Pro Gly Val Tyr Arg Leu Ser Met Ser Leu Met
1395 1400 1405
Glu Gln Leu Leu Lys Thr Leu Arg Tyr Asn Phe Leu Pro Glu Ala Leu
1410 1415 1420
Asp Phe Val Gly Val His Gln Glu Arg Thr Leu Gln Cys Leu Asn Ala
1425 1430 1435 1440
Val Arg Thr Val Gln Ser Leu Ala Cys Leu Glu Glu Ala Asp His Thr
1445 1450 1455
Val Gly Phe Ile Leu Gln Leu Ser Asn Phe Met Lys Glu Trp His Phe
1460 1465 1470
His Leu Pro Gln Leu Met Arg Asp Ile Gln Val Asn Leu Gly Tyr Leu
1475 1480 1485
Cys Gln Ala Cys Thr Ser Leu Leu His Ser Arg Lys Met Leu Gln His
1490 1495 1500
Tyr Leu Gln Asn Lys Asn Gly Asp Gly Leu Pro Ser Ala Val Ala Gln
1505 1510 1515 1520
Arg Val Gln Arg Pro Pro Ser Ala Ala Ser Ala Ala Pro Ser Ser Ser
1525 1530 1535
Lys Gln Pro Ala Ala Asp Thr Glu Ala Ser Glu Gln Gln Ala Leu His
1540 1545 1550
Thr Val Gln Tyr Gly Leu Leu Lys Ile Leu Ser Lys Thr Leu Ala Ala
1555 1560 1565
Leu Arg His Phe Thr Pro Asp Val Cys Gln Ile Leu Leu Asp Gln Ser
1570 1575 1580
Leu Asp Leu Ala Glu Tyr Ash Phe Leu Phe Ala Leu Ser Phe Thr Thr
1585 1590 1595 1600
Pro Thr Phe Asp Ser Glu Val Ala Pro Ser Phe Gly Thr Leu Leu Ala
1605 1610 1615
Thr Val Asn Val Ala Leu Asn Met Leu Gly Glu Leu Asp Lys Lys Lys
1620 1625 1630
Glu Pro Leu Thr Gln Ala Val Gly Leu Ser Thr Gln Ala Glu Gly Thr
1635 1640 1645
Arg Thr Leu Lys Ser Leu Leu Met Phe Thr Met Glu Asn Cys Phe Tyr
1650 1655 1660
Leu Leu Ile Ser Gln Ala Met Arg Tyr Leu Arg Asp Pro Ala Val His
1665 1670 1675 1680
Pro Arg Asp Lys Gln Arg Met Lys Gln Glu Leu Ser Ser Glu Leu Ser
1685 1690 1695
Thr Leu Leu Ser Ser Leu Ser Arg Tyr Phe Arg Arg Gly Ala Pro Ser
1700 1705 1710
Ser Pro Ala Thr Gly Val Leu Pro Ser Pro Gln Gly Lys Ser Thr Ser
1715 1720 1725
Leu Ser Lys Ala Ser Pro Glu Ser Gln Glu Pro Leu Ile Gln Leu Val
1730 1735 1740
Gln Ala Phe Val Arg His Met Gln Arg
1745 1750
<210>5
<211>1752
<212>PRT
<213>人
<400>5
Met Ile Arg Lys Ser Lys Ile Thr Ser Val Leu Ser Phe Cys Arg Ser
1 5 10 15
Ser Arg Glu Leu Trp Thr Ile Leu Leu Gly Arg Ser Ala Leu Ara Glu
20 25 30
Leu Ser Gln Ile Glu Ala Glu Leu Asn Lys His Trp Arg Arg Leu Leu
35 40 45
Glu Gly Leu Ser Tyr Tyr Lys Pro Pro Ser Pro Ser Ser Ala Glu Lys
50 55 60
Val Lys Ala Asn Lys Asp Val Ala Ser Pro Leu Lys Glu Leu Gly Leu
65 70 75 80
Arg Ile Ser Lys Phe Leu Gly Leu Asp Glu Glu Gln Ser Val Gln Leu
85 90 95
Leu Gln Cys Tyr Leu Gln Glu Asp Tyr Arg Gly Thr Arg Asp Ser Val
100 105 110
Lys Thr Val Leu Gln Asp Glu Arg Gln Ser Gln Ala Leu Ile Leu Lys
115 120 125
Ile Ala Asp Tyr Tyr Tyr Glu Glu Arg Thr Cys Ile Leu Arg Cys Val
130 135 140
Leu His Leu Leu Thr Tyr Phe Gln Asp Glu Arg Pro Tyr Arg Val Glu
145 150 155 160
Tyr Ala Asp Cys Val Asp Lys Leu Glu Lys Glu Leu Val Ser Lys Tyr
165 170 175
Arg Gln Gln Phe Glu Glu Leu Tyr Lys Thr Glu Ala Pro Thr Trp Glu
180 185 190
Thr His Gly Asn Leu Met Thr Glu Arg Gln Val Ser Arg Trp Phe Val
195 200 205
Gln Cys Leu Arg Glu Gln Ser Met Leu Leu Glu Ile Ile Phe Leu Tyr
210 215 220
Tyr Ala Tyr Phe Glu Met Ala Pro Ser Asp Leu Leu Val Leu Thr Lys
225 230 235 240
Met Phe Lys Glu Gln Gly Phe Gly Ser Arg Gln Thr Asn Arg His Leu
245 250 255
Val Asp Glu Thr Met Asp Pro Phe Val Asp Lys Ile Gly Tyr Phe Ser
260 265 270
Ala Leu Ile Leu Val Glu Gly Met Asp Ile Glu Ser Leu His Lys Cys
275 280 285
Ala Leu Asp Asp Arg Arg Glu Leu His Gln Phe Ala Gln Asp Gly Leu
290 295 300
Ile Cys Gln Asp Met Asp Cys Leu Met Leu Thr Phe Gly Asp Ile Pro
305 310 315 320
His His Ala Pro Val Leu Leu Ala Trp Ala Leu Leu Arg His Thr Leu
325 330 335
Asn Pro Glu Glu Thr Ser Ser Val Val Arg Lys Ile Gly Gly Thr Ala
340 345 350
Ile Gln Leu Asn Val Phe Gln Tyr Leu Thr Arg Leu Leu Gln Ser Leu
355 360 365
Ala Ser Gly Gly Asn Asp Cys Thr Thr Ser Thr Ala Cys Met Cys Val
370 375 380
Tyr Gly Leu Leu Ser Phe Val Leu Thr Ser Leu Glu Leu His Thr Leu
385 390 395 400
Gly Asn Gln Gln Asp Ile Ile Asp Thr Ala Cys Glu Val Leu Ala Asp
405 410 415
Pro Ser Leu Pro Glu Leu Phe Trp Gly Thr Glu Pro Thr Ser Gly Leu
420 425 430
Gly Ile Ile Leu Asp Ser Val Cys Gly Met Phe Pro His Leu Leu Ser
435 440 445
Pro Leu Leu Gln Leu Leu Arg Ala Leu Val Ser Gly Lys Ser Thr Ala
450 455 460
Lys Lys Val Tyr Ser Phe Leu Asp Lys Met Ser Phe Tyr Asn Glu Leu
465 470 475 480
Tyr Lys His Lys Pro His Asp Val Ile Ser His Glu Asp Gly Thr Leu
485 490 495
Trp Arg Arg Gln Thr Pro Lys Leu Leu Tyr Pro Leu Gly Gly Gln Thr
500 505 510
Asn Leu Arg Ile Pro Gln Gly Thr Val Gly Gln Val Met Leu Asp Asp
515 520 525
Arg Ala Tyr Leu Val Arg Trp Glu Tyr Ser Tyr Ser Ser Trp Thr Leu
530 535 540
Phe Thr Cys Glu Ile Glu Met Leu Leu His Val Val Ser Thr Ala Asp
545 550 555 560
Val Ile Gln His Cys Gln Arg Val Lys Pro Ile Ile Asp Leu Val His
565 570 575
Lys Val Ile Ser Thr Asp Leu Ser Ile Ala Asp Cys Leu Leu Pro Ile
580 585 590
Thr Ser Arg Ile Tyr Met Leu Leu Gln Arg Leu Thr Thr Val Ile Ser
595 600 605
Pro Pro Val Asp Val Ile Ala Ser Cys Val Asn Cys Leu Thr Val Leu
610 615 620
Ala Ala Arg Asn Pro Ala Lys Val Trp Thr Asp Leu Arg His Thr Gly
625 630 635 640
Phe Leu Pro Phe Val Ala His Pro Val Ser Ser Leu Ser Gln Met Ile
645 650 655
Ser Ala Glu Gly Met Asn Ala Gly Gly Tyr Gly Asn Leu Leu Met Asn
660 665 670
Ser Glu Gln Pro Gln Gly Glu Tyr Gly Val Thr Ile Ala Phe Leu Arg
675 680 685
Leu Ile Thr Thr Leu Val Lys Gly Gln Leu Gly Ser Thr Gln Ser Gln
690 695 700
Gly Leu Val Pro Cys Val Met Phe Val Leu Lys Glu Met Leu Pro Ser
705 710 715 720
Tyr His Lys Trp Arg Tyr Asn Ser His Gly Val Arg Glu Gln Ile Gly
725 730 735
Cys Leu Ile Leu Glu Leu Ile His Ala Ile Leu Asn Leu Cys His Glu
740 745 750
Thr Asp Leu His Ser Ser His Thr Pro Ser Leu Gln Phe Leu Cys Ile
755 760 765
Cys Ser Leu Ala Tyr Thr Glu Ala Gly Gln Thr Val Ile Asn Ile Met
770 775 780
Gly Ile Gly Val Asp Thr Ile Asp Met Val Met Ala Ala Gln Pro Arg
785 790 795 800
Ser Asp Gly Ala Glu Gly Gln Gly Gln Gly Gln Leu Leu Ile Lys Thr
805 810 815
ValLys Leu Ala Phe Ser Val Thr Asn Asn Val Ile Arg Leu Lys Pro
820 825 830
Pro Ser Asn Val Val Ser Pro Leu Glu Gln Ala Leu Ser Gln His Gly
835 840 845
Ala His Gly Asn Asn Leu Ile Ala Val Leu Ala Lys Tyr Ile Tyr His
850 855 860
Lys His Asp Pro Ala Leu Pro Arg Leu Ala Ile Gln Leu Leu Lys Arg
865 870 875 880
Leu Ala Thr Val Ala Pro Met Ser Val Tyr Ala Cys Leu Gly Asn Asp
885 890 895
Ala Ala Ala Ile Arg Asp Ala Phe Leu Thr Arg Leu Gln Ser Lys Ile
900 905 910
Glu Asp Met Arg Ile Lys Val Met Ile Leu Glu Phe Leu Thr Val Ala
915 920 925
Val Glu Thr Gln Pro Gly Leu Ile Glu Leu Phe Leu Asn Leu Glu Val
930 935 940
Lys Asp Gly Ser Asp Gly Ser Lys Glu Phe Ser Leu Gly Met Trp Ser
945 950 955 960
Cys Leu His Ala Val Leu Glu Leu Ile Asp Ser Gln Gln Gln Asp Arg
965 970 975
Tyr Trp Cys Pro Pro Leu Leu His Arg Ala Ala Ile Ala Phe Leu His
980 985 990
Ala Leu Trp Gln Asp Arg Arg Asp Ser Ala Met Leu Val Leu Arg Thr
995 1000 1005
Lys Pro Lys Phe Trp Glu Asn Leu Thr Ser Pro Leu Phe Gly Thr Leu
1010 1015 1020
Ser Pro Pro Ser Glu Thr Ser Glu Pro Ser Ile Leu Glu Thr Cys Ala
1025 1030 1035 1040
Leu Ile Met Lys Ile Ile Cys Leu Glu Ile Tyr Tyr Val Val Lys Gly
1045 1050 1055
Ser Leu Asp Gln Ser Leu Lys Asp Thr Leu Lys Lys Phe Ser Ile Glu
1060 1065 1070
Lys Arg Phe Ala Tyr Trp Ser Gly Tyr Val Lys Ser Leu Ala Val His
1075 1080 1085
Val Ala Glu Thr Glu Gly Ser Ser Cys Thr Ser Leu Leu Glu Tyr Gln
1090 1095 1100
Met Leu Val Ser Ala Trp Arg Met Leu Leu Ile Ile Ala Thr Thr His
1105 1110 1115 1120
Ala Asp Ile Met His Leu Thr Asp Ser Val Val Arg Arg Gln Leu Phe
1125 1130 1135
Leu Asp Val Leu Asp Gly Thr Lys Ala Leu Leu Leu Val Pro Ala Ser
1140 1145 1150
Val Asn Cys Leu Arg Leu Gly Ser Met Lys Cys Thr Leu Leu Leu Ile
1155 1160 1165
Leu Leu Arg Gln Trp Lys Arg Glu Leu G1y Ser Val Asp Glu Ile Leu
1170 1175 1180
Gly Pro Leu Thr Glu Ile Leu Glu Gly Val Leu Gln Ala Asp Gln Gln
1185 1190 1195 1200
Leu Met Glu Lys Thr Lys Ala Lys Val Phe Ser Ala Phe Ile Thr Val
1205 1210 1215
Leu Gln Met Lys Glu Met Lys Val Ser Asp Ile Pro Gln Tyr Ser Gln
1220 1225 1230
Leu Val Leu Asn Val Cys Glu Thr Leu Gln Glu Glu Val Ile Ala Leu
1235 1240 1245
Phe Asp Gln Thr Arg His Ser Leu Ala Leu Gly Ser Ala Thr Glu Asp
1250 1255 1260
Lys Asp Ser Met Glu Thr Asp Asp Cys Ser Arg Ser Arg His Arg Asp
1265 1270 1275 1280
Gln Arg Asp Gly Val Cys Val Leu Gly Leu His Leu Ala Lys Glu Leu
1285 1290 1295
Cys Glu Val Asp Glu Asp Gly Asp Ser Trp Leu Gln Val Thr Arg Arg
1300 1305 1310
Leu Pro Ile Leu Pro Thr Leu Leu Thr Thr Leu Glu Val Ser Leu Arg
1315 1320 1325
Met Lys Gln Asn Leu His Phe Thr Glu Ala Thr Leu His Leu Leu Leu
1330 1335 1340
Thr Leu Ala Arg Thr Gln Gln Gly Ala Thr Ala Val Ala Gly Ala Gly
1345 1350 1355 1360
Ile Thr Gln Ser Ile Cys Leu Pro Leu Leu Ser Val Tyr Gln Leu Ser
1365 1370 1375
Thr Asn Gly Thr Ala Gln Thr Pro Ser Ala Ser Arg Lys Ser Leu Asp
1380 1385 1390
Ala Pro Ser Trp Pro Gly Val Tyr Arg Leu Ser Met Ser Leu Met Glu
1395 1400 1405
Gln Leu Leu Lys Thr Leu Arg Tyr Asn Phe Leu Pro Glu Ala Leu Asp
1410 1415 1420
Phe Val Gly Val His Gln Glu Arg Thr Leu Gln Cys Leu Asn Ala Val
1425 1430 1435 1440
Arg Thr Val Gln Ser Leu Ala Cys Leu Glu Glu Ala Asp His Thr Val
1445 1450 1455
Gly Phe Ile Leu Gln Leu Ser Asn Phe Met Lys Glu Trp His Phe His
1460 1465 1470
Leu Pro Gln Leu Met Arg Asp Ile Gln Val Asn Leu Gly Tyr Leu Cys
1475 1480 1485
Gln Ala Cys Thr Ser Leu Leu His Ser Arg Lys Met Leu Gln His Tyr
1490 1495 1500
Leu Gln Asn Lys Asn Gly Asp Gly Leu Pro Ser Ala Val Ala Gln Arg
1505 1510 1515 1520
Val Gln Arg Pro Pro Ser Ala Ala Ser Ala Ala Pro Ser Ser Ser Lys
1525 1530 1535
Gln Pro Ala Ala Asp Thr Glu Ala Ser Glu Gln Gln Ala Leu His Thr
1540 1545 1550
Val Gln Tyr Gly Leu Leu Lys Ile Leu Ser Lys Thr Leu Ala Ala Leu
1555 1560 1565
Arg His Phe Thr Pro Asp Val Cys Gln Ile Leu Leu Asp Gln Ser Leu
1570 1575 1580
Asp Leu Ala Glu Tyr Asn Phe Leu Phe Ala Leu Ser Phe Thr Thr Pro
1585 1590 1595 1600
Thr Phe Asp Ser Glu Val Ala Pro Ser Phe Gly Thr Leu Leu Ala Thr
1605 1610 1615
Val Asn Val Ala Leu Asn Met Leu Gly Glu Leu Asp Lys Lys Lys Glu
1620 1625 1630
Pro Leu Thr Gln Ala Val Gly Leu Ser Thr Gln Ala Glu Gly Thr Arg
1635 1640 1645
Thr Leu Lys Ser Leu Leu Met Phe Thr Met Glu Asn Cys Phe Tyr Leu
1650 1655 1660
Leu Ile Ser Gln Ala Met Arg Tyr Leu Arg Asp Pro Ala Val His Pro
1665 1670 1675 1680
Arg Asp Lys Gln Arg Met Lys Gln Glu Leu Ser Ser Glu Leu Ser Thr
1685 1690 1695
Leu Leu Ser Ser Leu Ser Arg Tyr Phe Arg Arg Gly Ala Pro Ser Ser
1700 1705 1710
Pro Ala Thr Gly Val Leu Pro Ser Pro Gln Gly Lys Ser Thr Ser Leu
1715 1720 1725
Ser Lys Ala Ser Pro Glu Ser Gln Glu Pro Leu Ile Gln Leu Val Gln
1730 1735 1740
Ala Phe Val Arg His Met Gln Arg
1745 1750
<210>6
<211>1753
<212>PRT
<213>人
<400>6
Met Ile Arg Lys Ser Lys Ile Thr Ser Val Leu Ser Phe Cys Arg Ser
1 5 10 15
Ser Arg Glu Leu Trp Thr Ile Leu Leu Gly Arg Ser Ala Leu Arg Glu
20 25 30
Leu Ser Gln Ile Glu Ala Glu Leu Asn Lys His Trp Arg Arg Leu Leu
35 40 45
Glu Gly Leu Ser Tyr Tyr Lys Pro Pro Ser Pro Ser Ser Ala Glu Lys
50 55 60
Val Lys Ala Asn Lys Asp Val Ala Ser Pro Leu Lys Glu Leu Gly Leu
65 70 75 80
Arg Ile Ser Lys Phe Leu Gly Leu Asp Glu Glu Gln Ser Val Gln Leu
85 90 95
Leu Gln Cys Tyr Leu Gln Glu Asp Tyr Arg Gly Thr Arg Asp Ser Val
100 105 110
Lys Thr Val Leu Gln Asp Glu Arg Gln Ser Gln Ala Leu Ile Leu Lys
115 120 125
Ile Ala Asp Tyr Tyr Tyr Glu Glu Arg Thr Cys Ile Leu Arg Cys Val
130 135 140
Leu His Leu Leu Thr Tyr Phe Gln Asp Glu Arg His Pro Tyr Arg Val
145 150 155 160
Glu Tyr Ala Asp Cys Val Asp Lys Leu Glu Lys Glu Leu Val Ser Lys
165 170 175
Tyr Arg Gln Gln Phe Glu Glu Leu Tyr Lys Thr Glu Ala Pro Thr Trp
180 185 190
Glu Thr His Gly Asn Leu Met Thr Glu Arg Gln Val Ser Arg Trp Phe
195 200 205
Val Gln Cys Leu Ara Glu Gln Ser Met Leu Leu Glu Ile Ile Phe Leu
210 215 220
Tyr Tyr Ala Tyr Phe Glu Met Ala Pro Ser Asp Leu Leu Val Leu Thr
225 230 235 240
Lys Met Phe Lys Glu Gln Gly Phe Gly Ser Arg Gln Thr Asn Arg His
245 250 255
Leu Val Asp Glu Thr Met Asp Pro Phe Val Asp Arg Ile Gly Tyr Phe
260 265 270
Ser Ala Leu Ile Leu ValGlu Gly Met Asp Ile Glu Ser Leu His Lys
275 280 285
Cys Ala Leu Asp Asp Arg Arg Glu Leu His Gln Phe Ala Gln Asp Gly
290 295 300
Leu Ile Cys Gln Asp Met Asp Cys Leu Met Leu Thr Phe Gly Asp Ile
305 310 315 320
Pro His His Ala Pro Val Leu Leu Ala Trp Ala Leu Leu Arg His Thr
325 330 335
Leu Asn Pro Glu Glu Thr Ser Ser Val Val Arg Lys Ile Gly Gly Thr
340 345 350
Ala Ile Asn Leu Asn Val Phe Gln Tyr Leu Thr Arg Leu Leu Gln Ser
355 360 365
Leu Ala Ser Gly Gly Asn Asp Cys Thr Thr Ser Thr Ala Cys Met Cys
370 375 380
Val Tyr Gly Leu Leu Ser Phe Val Leu Thr Ser Leu Glu Leu His Thr
385 390 395 400
Leu Gly Asn Gln Gln Asp Ile Ile Asp Thr Ala Cys Glu Val Leu Ala
405 410 415
Asp Pro Ser Leu Pro Glu Leu Phe Trp Gly Thr Glu Pro Thr Ser Gly
420 425 430
Leu Gly Ile Ile Leu Asp Ser Val Cys Gly Met Phe Pro His Leu Leu
435 440 445
Ser Pro Leu Leu Gln Leu Leu Arg Ala Leu Val Ser Gly Lys Ser Thy
450 455 460
Ala Lys Lys Val Tyr Ser Phe Leu Asp Lys Met Ser Phe Tyr Asn Glu
465 470 475 480
Leu Tyr Lys His Lys Pro His Asp Val Ile Ser His Glu Asp Gly Thr
485 490 495
Leu Trp Arg Arg Gln Thr Pro Lys Leu Leu Tyr Pro Leu Gly Gly Gln
500 505 510
Thr Asn Leu Arg Ile Pro Gln Gly Thr Val Gly Gln Val Met Leu Asp
515 520 525
Asp Arg Ala Tyr Leu Val Arg Trp Glu Tyr Ser Tyr Ser Ser Trp Thr
530 535 540
Leu Phe Thr Cys Glu Ile Glu Met Leu Leu His Val Val Ser Thr Ala
545 550 555 560
Asp Val Ile Gln His Cys Gln Arg Val Lys Pro Ile Ile Asp Leu Val
565 570 575
His Lys Val Ile Ser Thr Asp Leu Ser Ile Ala Asp Cys Leu Leu Pro
580 585 590
Ile Thr Ser Arg Ile Tyr Met Leu Leu Gln Arg Leu Thr Thr Val Ile
595 600 605
Ser Pro Pro Val Asp Val Ile Ala Ser Cys Val Asn Cys Leu Thr Val
610 615 620
Leu Ala Ala Arg Asn Pro Ala Lys Val Trp Thr Asp Leu Arg His Thr
625 630 635 640
Gly Phe Leu Pro Phe Val Ala His Pro Val Ser Ser Leu Ser Gln Met
645 650 655
Ile Ser Ala Glu Gly Met Asn Ala Gly Gly Tyr Gly Asn Leu Leu Met
660 665 670
Asn Ser Glu Gln Pro Gln Gly Glu Tyr Gly Val Thr Ile Ala Phe Leu
675 680 685
Arg Leu Ile Thr Thr Leu Val Lys Gly Gln Leu Gly Ser Thr Gln Ser
690 695 700
Gln Gly Leu Val Pro Cys Val Met Phe Val Leu Lys Glu Met Leu Pro
705 710 715 720
Ser Tyr His Lys Trp Arg Tyr Asn Ser His Gly Val Arg Glu Gln Ile
725 730 735
Gly Cys Leu Ile Leu Glu Leu Ile His Ala Ile Leu Asn Leu Cys His
740 745 750
Glu Thr Asp Leu His Ser Ser His Thr Pro Ser Leu Gln Phe Leu Cys
755 760 765
Ile Cys Ser Leu Ala Tyr Thr Glu Ala Gly Gln Thr Val Ile Asn Ile
770 775 780
Met Gly Ile Gly Val Asp Thr Ile Asp Met Val Met Ala Ala Gln Pro
785 790 795 800
Arg Ser Asp Gly Ala Glu Gly Gln Gly Gln Gly Gln Leu Leu Ile Lys
805 810 815
Thr Val Lys Leu Ala Phe Ser Val Thr Asn Asn Val Ile Arg Leu Lys
820 825 830
Pro Pro Ser Asn Val Val Ser Pro Leu Glu Gln Ala Leu Ser Gln His
835 840 845
Gly Ala His Gly Asn Asn Leu Ile Ala Val Leu Ala Lys Tyr Ile Tyr
850 855 860
His Lys His Asp Pro Ala Leu Pro Arg Leu Ala Ile Gln Leu Leu Lys
865 870 875 880
Arg Leu Ala Thr Val Ala Pro Met Ser Val Tyr Ala Cys Leu Gly Asn
885 890 895
Asp Ala Ala Ala Ile Arg Asp Ala Phe Leu Thr Arg Leu Gln Ser Lys
900 905 910
Ile Glu Asp Met Arg Ile Lys Val Met Ile Leu Glu Phe Leu Thr Val
915 920 925
Ala Val Glu Thr Gln Pro Gly Leu Ile Glu Leu Phe Leu Asn Leu Glu
930 935 940
Val Lys Asp Gly Ser Asp Gly Ser Lys Glu Phe Ser Leu Gly Met Trp
945 950 955 960
Ser Cys Leu His Ala Val Leu Glu Leu Ile Asp Ser Gln Gln Gln Asp
965 970 975
Arg Tyr Trp Cys Pro Pro Leu Leu His Arg Ala Ala Ile Ala Phe Leu
980 985 990
His Ala Leu Trp Gln Asp Arg Arg Asp Ser Ala Met Leu Val Leu Arg
995 1000 1005
Thr Lys Pro Lys Phe Trp Glu Asn Leu Thr Ser Pro Leu Phe Gly Thr
1010 1015 1020
Leu Ser Pro Pro Ser Glu Thr Ser Glu Pro Ser Ile Leu Glu Thr Cys
1025 1030 1035 1040
Ala Leu Ile Met Lys Ile Ile Cys Leu Glu Ile Tyr Tyr Val Val Lys
1045 1050 1055
Gly Ser Leu Asp Gln Ser Leu Lys Asp Thr Leu Lys Lys Phe Ser Ile
1060 1065 1070
Glu Lys Arg Phe Ala Tyr Trp Ser Gly Tyr Val Lys Ser Leu Ala Val
1075 1080 1085
His Val Ala Glu Thr Glu Gly Ser Ser Cys Thr Ser Leu Leu Glu Tyr
1090 1095 1100
Gln Met Leu Val Ser Ala Trp Arg Met Leu Leu Ile Ile Ala Thr Thr
1105 1110 1115 1120
His Ala Asp Ile Met His Leu Thr Asp Ser Val Val Arg Arg Gln Leu
1125 1130 1135
Phe Leu Asp Val Leu Asp Gly Thr Lys Ala Leu Leu Leu Val Pro Ala
1140 1145 1150
Ser Val Asn Cys Leu Arg Leu Gly Ser Met Lys Cys Thr Leu Leu Leu
1155 1160 1165
Ile Leu Leu Arg Gln Trp Lys Arg Glu Leu Gly Ser Val Asp Glu Ile
1170 1175 1180
Leu Gly Pro Leu Thr Glu Ile Leu Glu Gly Val Leu Gln Ala Asp Gln
1185 1190 1195 1200
Gln Leu Met Glu Lys Thr Lys Ala Lys Val Phe Ser Ala Phe Ile Thr
1205 1210 1215
Val Leu Gln Met Lys Glu Met Lys Val Ser Asp Ile Pro Gln Tyr Ser
1220 1225 1230
Gln Leu Val Leu Asn Val Cys Glu Thr Leu Gln Glu Glu Val Ile Ala
1235 1240 1245
Leu Phe Asp Gln Thr Arg His Ser Leu Ala Leu Gly Ser Ala Thr Glu
1250 1255 1260
Asp Lys Asp Ser Met Glu Thr Asp Asp Cys Ser Arg Ser Arg His Arg
1265 1270 1275 1280
Asp Gln Arg Asp Gly Val Cys Val Leu Gly Leu His Leu Ala Lys Glu
1285 1290 1295
Leu Cys Glu Val Asp Glu Asp Gly Asp Ser Trp Leu Gln Val Thr Arg
1300 1305 1310
Arg Leu Pro Ile Leu Pro Thr Leu Leu Thr Thr Leu Glu Val Ser Leu
1315 1320 1325
Arg Met Lys Gln Asn Leu His Phe Thr Glu Ala Thr Leu His Leu Leu
1330 1335 1340
Leu Thr Leu Ala Arg Thr Gln Gln Gly Ala Thr Ala Val Ala Gly Ala
1345 1350 1355 1360
Gly Ile Thr Gln Ser Ile Cys Leu Pro Leu Leu Ser Val Tyr Gln Leu
1365 1370 1375
Ser Thr Asn Gly Thr Ala Gln Thr Pro Ser Ala Ser Arg Lys Ser Leu
1380 1385 1390
Asp Ala Pro Ser Trp Pro Gly Val Tyr Arg Leu Ser Met Ser Leu Met
1395 1400 1405
Glu Gln Leu Leu Lys Thr Leu Arg Tyr Asn Phe Leu Pro Glu Ala Leu
1410 1415 1420
Asp Phe Val Gly Val His Gln Glu Arg Thr Leu Gln Cys Leu Asn Ala
1425 1430 1435 1440
Val Arg Thr Val Gln Ser Leu Ala Cys Leu Glu Glu Ala Asp His Thr
1445 1450 1455
Val Gly Phe Ile Leu Gln Leu Ser Asn Phe Met Lys Glu Trp His Phe
1460 1465 1470
His Leu Pro Gln Leu Met Arg Asp Ile Gln Val Asn Leu Gly Tyr Leu
1475 1480 1485
Cys Gln Ala Cys Thr Ser Leu Leu His Ser Arg Lys Met Leu Gln His
1490 1495 1500
Tyr Leu Gln Asn Lys Asn Gly Asp Gly Leu Pro Ser Ala Val Ala Gln
1505 1510 1515 1520
Arg Val Gln Arg Pro Pro Ser Ala Ala Ser Ala Ala Pro Ser Ser Ser
1525 1530 1535
Lys Gln Pro Ala Ala Asp Thr Glu Ala Ser Glu Gln Gln Ala Leu His
1540 1545 1550
Thr Val Gln Tyr Gly Leu Leu Lys Ile Leu Ser Lys Thr Leu Ala Ala
1555 1560 1565
Leu Arg His Phe Thr Pro Asp Val Cys Gln Ile Leu Leu Asp Gln Ser
1570 1575 1580
Leu Asp Leu Ala Glu Tyr Asn Phe Leu Phe Ala Leu Ser Phe Thr Thr
1585 1590 1595 1600
Pro Thr Phe Asp Ser Glu Val Ala Pro Ser Phe Gly Thr Leu Leu Ala
1605 1610 1615
Thr Val Asn Val Ala Leu Asn Met Leu Gly Glu Leu Asp Lys Lys Lys
1620 1625 1630
Glu Pro Leu Thr Gln Ala Val Gly Leu Ser Thr Gln Ala Glu Gly Thr
1635 1640 1645
Arg Thr Leu Lys Ser Leu Leu Met Phe Thr Met Glu Asn Cys Phe Tyr
1650 1655 1660
Leu Leu Ile Ser Gln Ala Met Arg Tyr Leu Arg Asp Pro Ala Val His
1665 1670 1675 1680
Pro Arg Asp Lys Gln Arg Met Lys Gln Glu Leu Ser Ser Glu Leu Ser
1685 1690 1695
Thr Leu Leu Ser Ser Leu Ser Arg Tyr Phe Arg Arg Gly Ala Pro Ser
1700 1705 1710
Ser Pro Ala Thr Gly Val Leu Pro Ser Pro Gln Gly Lys Ser Thr Ser
1715 1720 1725
Leu Ser Lys Ala Ser Pro Glu Ser Gln Glu Pro Leu Ile Gln Leu Val
1730 1735 1740
Gln Ala Phe Val Arg His Met Gln Arg
1745 1750
<210>7
<211>1753
<212>PRT
<213>人
<400>7
Met Ile Arg Lys Ser Lys Ile Thr Ser Val Leu Ser Phe Cys Arg Ser
1 5 10 15
Ser Arg Glu Leu Trp Thr Ile Leu Leu Gly Arg Ser Ala Leu Arg Glu
20 25 30
Leu Ser Gln Ile Glu Ala Glu Leu Asn Lys His Trp Arg Arg Leu Leu
35 40 45
Glu Gly Leu Ser Tyr Tyr Lys Pro Pro Ser Pro Ser Ser Ala Glu Lys
50 55 60
Val Lys Ala Asn Lys Asp Val Ala Ser Pro Leu Lys Glu Leu Gly Leu
65 70 75 80
Arg Ile Ser Lys Phe Leu Gly Leu Asp Glu Glu Gln Ser Val Gln Leu
85 90 95
Leu Gln Cys Tyr Leu Gln Glu Asp Tyr Arg Gly Thr Arg Asp Ser Val
100 105 110
Lys Thr Val Leu Gln Asp Glu Arg Gln Ser Gln Ala Leu Ile Leu Lys
115 120 125
Ile Ala Asp Tyr Tyr Tyr Glu Glu Arg Thr Cys Ile Leu Arg Cys Val
130 135 140
Leu His Leu Leu Thr Tyr Phe Gln Asp Glu Arg His Pro Tyr Arg Val
145 150 155 160
Glu Tyr Ala Asp Cys Val Asp Lys Leu Glu Lys Glu Leu Val Ser Lys
165 170 175
Tyr Arg Gln Gln Phe Glu Glu Leu Tyr Lys Thr Glu Ala Pro Thr Trp
180 185 190
Glu Thr His Gly Asn Leu Met Thr Glu Arg Gln Val Ser Arg Trp Phe
195 200 205
Val Gln Cys Leu Arg Glu Gln Ser Met Leu Leu Glu Ile Ile Phe Leu
210 215 220
Tyr Tyr Ala Tyr Phe Glu Met Ala Pro Ser Asp Leu Leu Val Leu Thr
225 230 235 240
Lys Met Phe Lys Glu Gln Gly Phe Gly Ser Arg Gln Thr Asn Arg His
245 250 255
Leu Val Asp Glu Thr Met Asp Pro Phe Val Asp Arg Ile Gly Tyr Phe
260 265 270
Ser Ala Leu Ile Leu Val Glu Gly Met Asp Ile Glu Ser Leu His Lys
275 280 285
Cys Ala Leu Asp Asp Arg Arg Glu Leu His Gln Phe Ala Gln Asp Gly
290 295 300
Leu Ile Cys Gln Asp Met Asp Cys Leu Met Leu Thr Phe Gly Asp Ile
305 310 315 320
Pro His His Ala Pro Val Leu Leu Ala Trp Ala Leu Leu Arg His Thr
325 330 335
Leu Asn Pro Glu Glu Thr Ser Ser Val Val Arg Lys Ile Gly Gly Thr
340 345 350
Ala Ile Gln Leu Asn Val Phe Gln Tyr Leu Thr Arg Leu Leu Gln Ser
355 360 365
Leu Ala Ser Gly Gly Asn Asp Cys Thr Thr Ser Thr Ala Cys Met Cys
370 375 380
Val Tyr Gly Leu Leu Ser Phe Val Leu Thr Ser Leu Glu Leu His Thr
385 390 395 400
Leu Gly Asn Gln Gln Asp Ile Ile Asp Thr Ala Cys Glu Val Leu Ala
405 410 415
Asp Pro Ser Leu Pro Glu Leu Phe Trp Gly Thr Glu Pro Thr Ser Gly
420 425 430
Leu Gly Ile Ile Leu Asp Ser Val Cys Gly Met Phe Pro Arg Leu Leu
435 440 445
Ser Pro Leu Leu Gln Leu Leu Arg Ala Leu Val Ser Gly Lys Ser Thr
450 455 460
Ala Lys Lys Val Tyr Ser Phe Leu Asp Lys Met Ser Phe Tyr Asn Glu
465 470 475 480
Leu Tyr Lys His Lys Pro His Asp Val Ile Ser His Glu Asp Gly Thr
485 490 495
Leu Trp Arg Arg Gln Thr Pro Lys Leu Leu Tyr Pro Leu Gly Gly Gln
500 505 510
Thr Asn Leu Arg Ile Pro Gln Gly Thr ValGly Gln Val Met Leu Asp
515 520 525
Asp Arg Ala Tyr Leu Val Arg Trp Glu Tyr Ser Tyr Ser Ser Trp Thr
530 535 540
Leu Phe Thr Cys Glu Ile Glu Met Leu Leu His Val Val Ser Thr Ala
545 550 555 560
Asp Val Ile Gln His Cys Gln Arg ValLys Pro He Ile Asp Leu Val
565 570 575
His Lys Val Ile Ser Thr Asp Leu Ser Ile Ala Asp Cys Leu Leu Pro
580 585 590
Ile Thr Ser Arg Ile Tyr Met Leu Leu Gln Arg Leu Thr Thr Val Ile
595 600 605
Ser Pro Pro Val Asp Val Ile Ala Ser Cys Val Asn Cys Leu Thr Val
610 615 620
Leu Ala Ala Arg Asn Pro Ala Lys Val Trp Thr Asp Leu Arg His Thr
625 630 635 640
Gly Phe Leu Pro Phe Val Ala His Pro Val Ser Ser Leu Ser Gln Met
645 650 655
Ile Ser Ala Glu Gly Met Asn Ala Gly Gly Tyr Gly Asn Leu Leu Met
660 665 670
Asn Ser Glu Gln Pro Gln Gly Glu Tyr Gly Val Thr Ile Ala Phe Leu
675 680 685
Arg Leu Ile Thr Thr Leu Val Lys Gly Gln Leu Gly Ser Thr Gln Ser
690 695 700
Gln Gly Leu Val Pro Cys Val Met Phe Val Leu Lys Glu Met Leu Pro
705 710 715 720
Ser Tyr His Lys Trp Arg Tyr Asn Ser His Gly Val Arg Glu Gln Ile
725 730 735
Gly Cys Leu Ile Leu Glu Leu Ile His Ala Ile Leu Asn Leu Cys His
740 745 750
Glu Thr Asp Leu His Ser Ser His Thr Pro Ser Leu Gln Phe Leu Cys
755 760 765
Ile Cys Ser Leu Ala Tyr Thr Glu Ala Gly Gln Thr Val Ile Asn Ile
770 775 780
Met Gly Ile Gly Val Asp Thr Ile Asp Met Val Met Ala Ala Gln Pro
785 790 795 800
Arg Ser Asp Gly Ala Glu Gly Gln Gly Gln Gly Gln Leu Leu Ile Lys
805 810 815
Thr Val Lys Leu Ala Phe Ser Val Thr Asn Asn Val Ile Arg Leu Lys
820 825 830
Pro Pro Ser Asn Val Val Ser Pro Leu Glu Gln Ala Leu Ser Gln His
835 840 845
Gly Ala His Gly Asn Asn Leu Ile Ala Val Leu Ala Lys Tyr Ile Tyr
850 855 860
His Lys His Asp Pro Ala Leu Pro Arg Leu Ala Ile Gln Leu Leu Lys
865 870 875 880
Arg Leu Ala Thr Val Ala Pro Met Ser Val Tyr Ala Cys Leu Gly Asn
885 890 895
Asp Ala Ala Ala Ile Arg Asp Ala Phe Leu Thr Arg Leu Gln Ser Lys
900 905 910
Ile Glu Asp Met Arg Ile Lys Val Met Ile Leu Glu Phe Leu Thr Val
915 920 925
Ala Val Glu Thr Gln Pro Gly Leu Ile Glu Leu Phe Leu Asn Leu Glu
930 935 940
Val Lys Asp Gly Ser Asp Gly Ser Lys Glu Phe Ser Leu Gly Met Trp
945 950 955 960
Ser Cys Leu His Ala Val Leu Glu Leu Ile Asp Ser Gln Gln Gln Asp
965 970 975
Arg Tyr Trp Cys Pro Pro Leu Leu His Arg Ala Ala Ile Ala Phe Leu
980 985 990
His Ala Leu Trp Gln Asp Arg Arg Asp Ser Ala Met Leu Val Leu Arg
995 1000 1005
Thr Lys Pro Lys Phe Trp Glu Asn Leu Thr Ser Pro Leu Phe Gly Thr
1010 1015 1020
Leu Ser Pro Pro Ser Glu Thr Ser Glu Pro Ser Ile Leu Glu Thr Cys
1025 1030 1035 1040
Ala Leu Ile Met Lys Ile Ile Cys Leu Glu Ile Tyr Tyr Val Val Lys
1045 1050 1055
Gly Ser Leu Asp Gln Ser Leu Lys Asp Thr Leu Lys Lys Phe Ser Ile
1060 1065 1070
Glu Lys Arg Phe Ala Tyr Trp Ser Gly Tyr Val Lys Ser Leu Ala Val
1075 1080 1085
His Val Ala Glu Thr Glu Gly Ser Ser Cys Thr Ser Leu Leu Glu Tyr
1090 1095 1100
Gln Met Leu Val Ser Ala Trp Arg Met Leu Leu Ile Ile Ala Thr Thr
1105 1110 1115 1120
His Ala Asp Ile Met His Leu Thr Asp Ser Val Val Arg Arg Gln Leu
1125 1130 1135
Phe Leu Asp Val Leu Asp Gly Thr Lys Ala Leu Leu Leu Val Pro Ala
1140 1145 1150
Ser Val Asn Cys Leu Arg Leu Gly Ser Met Lys Cys Thr Leu Leu Leu
1155 1160 1165
Ile Leu Leu Arg Gln Trp Lys Arg Glu Leu Gly Ser Val Asp Glu Ile
1170 1175 1180
Leu Gly Pro Leu Thr Glu Ile Leu Glu Gly Val Leu Gln Ala Asp Gln
1185 1190 1195 1200
Gln Leu Met Glu Lys Thr Lys Ala Lys Val Phe Ser Ala Phe Ile Thr
1205 1210 1215
Val Leu Gln Met Lys Glu Met Lys Val Ser Asp Ile Pro Gln Tyr Ser
1220 1225 1230
Gln Leu Val Leu Asn Val Cys Glu Thr Leu Gln Glu Glu Val Ile Ala
1235 1240 1245
Leu Phe Asp Gln Thr Arg His Ser Leu Ala Leu Gly Ser Ala Thr Glu
1250 1255 1260
Asp Lys Asp Ser Met Glu Thr Asp Asp Cys Ser Arg Ser Arg His Arg
1265 1270 1275 1280
Asp Gln Arg Asp Gly Val Cys Val Leu Gly Leu His Leu Ala Lys Glu
1285 1290 1295
Leu Cys Glu Val Asp Glu Asp Gly Asp Ser Trp Leu Gln Val Thr Arg
1300 1305 1310
Arg Leu Pro Ile Leu Pro Thr Leu Leu Thr Thr Leu Glu Val Ser Leu
1315 1320 1325
Arg Met Lys Gln Asn Leu His Phe Thr Glu Ala Thr Leu His Leu Leu
1330 1335 1340
Leu Thr Leu Ala Arg Thr Gln Gln Gly Ala Thr Ala Val Ala Gly Ala
1345 1350 1355 1360
Gly Ile Thr Gln Ser Ile Cys Leu Pro Leu Leu Ser Val Tyr Gln Leu
1365 1370 1375
Ser Thr Asn Gly Thr Ala Gln Thr Pro Ser Ala Ser Arg Lys Ser Leu
1380 1385 1390
Asp Ala Pro Ser Trp Pro Gly Val Tyr Arg Leu Ser Met Ser Leu Met
1395 1400 1405
Glu Gln Leu Leu Lys Thr Leu Arg Tyr Asn Phe Leu Pro Glu Ala Leu
1410 1415 1420
Asp Phe Val Gly Val His Gln Glu Arg Thr Leu Gln Cys Leu Asn Ala
1425 1430 1435 1440
Val Arg Thr Val Gln Ser Leu Ala Cys Leu Glu Glu Ala Asp His Thr
1445 1450 1455
Va1Gly Phe Ile Leu Gln Leu Ser Asn Phe Met Lys Glu Trp His Phe
1460 1465 1470
His Leu Pro Gln Leu Met Arg Asp Ile Gln Val Asn Leu Gly Tyr Leu
1475 1480 1485
Cys Gln Ala Cys Thr Ser Leu Leu His Ser Arg Lys Met Leu Gln His
1490 1495 1500
Tyr Leu Gln Asn Lys Asn Gly Asp Gly Leu Pro Ser Ala Val Ala Gln
1505 1510 1515 1520
Arg Val Gln Arg Pro Pro Ser Ala Ala Ser Ala Ala Pro Ser Ser Ser
1525 1530 1535
Lys Gln Pro Ala Ala Asp Thr Glu Ala Ser Glu Gln Gln Ala Leu His
1540 1545 1550
Thr Val Gln Tyr Gly Leu Leu Lys Ile Leu Ser Lys Thr Leu Ala Ala
1555 1560 1565
Leu Arg His Phe Thr Pro Asp Val Cys Gln Ile Leu Leu Asp Gln Ser
1570 1575 1580
Leu Asp Leu Ala Glu Tyr Asn Phe Leu Phe Ala Leu Ser Phe Thr Thr
1585 1590 1595 1600
Pro Thr Phe Asp Ser Glu Val Ala Pro Ser Phe Gly Thr Leu Leu Ala
1605 1610 1615
Thr Val Asn Val Ala Leu Asn Met Leu Gly Glu Leu Asp Lys Lys Lys
1620 1625 1630
Glu Pro Leu Thr Gln Ala Val Gly Leu Ser Thr Gln Ala Glu Gly Thr
1635 1640 1645
Arg Thr Leu Lys Ser Leu Leu Met Phe Thr Met Glu Asn Cys Phe Tyr
1650 1655 1660
Leu Leu Ile Ser Gln Ala Met Arg Tyr Leu Arg Asp Pro Ala Val His
1665 1670 1675 1680
Pro Arg Asp Lys Gln Arg Met Lys Gln Glu Leu Ser Ser Glu Leu Ser
1685 1690 1695
Thr Leu Leu Ser Ser Leu Ser Arg Tyr Phe Arg Arg Gly Ala Pro Ser
1700 1705 1710
Ser Pro Ala Thr Gly Val Leu Pro Ser Pro Gln Gly Lys Ser Thr Ser
1715 1720 1725
Leu Ser Lys Ala Ser Pro Glu Ser Gln Glu Pro Leu Ile Gln Leu Val
1730 1735 1740
Gln Ala Phe Val Arg His Met Gln Arg
1745 1750
<210>8
<211>1753
<212>PRT
<213>人
<400>8
Met Ile Arg Lys Ser Lys Ile Thr Ser Val Leu Ser Phe Cys Arg Ser
1 5 10 15
Ser Arg Glu Leu Trp Thr Ile Leu Leu Gly Arg Ser Ala Leu Arg Glu
20 25 30
Leu Ser Gln Ile Glu Ala Glu Leu Asn Lys His Trp Arg Arg Leu Leu
35 40 45
Glu Gly Leu Ser Tyr Tyr Lys Pro Pro Ser Pro Ser Ser Ala Glu Lys
50 55 60
Val Lys Ala Asn Lys Asp Val Ala Ser Pro Leu Lys Glu Leu Gly Leu
65 70 75 80
Arg Ile Ser Lys Phe Leu Gly Leu Asp Glu Glu Gln Ser Val Gln Leu
85 90 95
Leu Gln Cys Tyr Leu Gln Glu Asp Tyr Arg Gly Thr Arg Asp Ser Val
100 105 110
Lys Thr Val Leu Gln Asp Glu Arg Gln Ser Gln Ala Leu Ile Leu Lys
115 120 125
Ile Ala Asp Tyr Tyr Tyr Glu Glu Arg Thr Cys Ile Leu Arg Cys Val
130 135 140
Leu His Leu Leu Thr Tyr Phe Gln Asp Glu Arg His Pro Tyr Arg Val
145 150 155 160
Glu Tyr Ala Asp Cys Val Asp Lys Leu Glu Lys Glu Leu Val Ser Lys
165 170 175
Tyr Arg Gln Gln Phe Glu Glu Leu Tyr Lys Thr Glu Ala Pro Thr Trp
180 185 190
Glu Thr His Gly Asn Leu Met Thr Glu Arg Gln Val Ser Arg Trp Phe
195 200 205
Val Gln Cys Leu Arg Glu Gln Ser Met Leu Leu Glu Ile Ile Phe Leu
210 215 220
Tyr Tyr Ala Tyr Phe Glu Met Ala Pro Ser Asp Leu Leu Val Leu Thr
225 230 235 240
Lys Met Phe Lys Glu Gln Gly Phe Gly Ser Arg Gln Thr Asn Arg His
245 250 255
Leu Val Asp Glu Thr Met Asp Pro Phe Val Asp Arg Ile Gly Tyr Phe
260 265 270
Ser Ala Leu Ile Leu Val Glu Gly Met Asp Ile Glu Ser Leu His Lys
275 280 285
Cys Ala Leu Asp Asp Arg Arg Glu Leu His Gln Phe Ala Gln Asp Gly
290 295 300
Leu Ile Cys Gln Asp Met Asp Cys Leu Met Leu Thr Phe Gly Asp Ile
305 310 315 320
Pro His His Ala Pro Val Leu Leu Ala Trp Ala Leu Leu Arg His Thr
325 330 335
Leu Asn Pro Glu Glu Thr Ser Ser Val Val Arg Lys Ile Gly Gly Thr
340 345 350
Ala Ile Gln Leu Asn Val Phe Gln Tyr Leu Thr Arg Leu Leu Gln Ser
355 360 365
Leu Ala Ser Gly Gly Asn Asp Cys Thr Thr Ser Thr Ala Cys Met Cys
370 375 380
Val Tyr Gly Leu Leu Ser Phe Val Leu Thr Ser Leu Glu Leu His Thr
385 390 395 400
Leu Gly Asn Gln Gln Asp Ile Ile Asp Thr Ala Cys Glu Val Leu Ala
405 410 415
Asp Pro Ser Leu Pro Glu Leu Phe Trp Gly Thr Glu Pro Thr Ser Gly
420 425 430
Leu Gly Ile Ile Leu Asp Ser Val Cys Gly Met Phe Pro His Leu Leu
435 440 445
Ser Pro Leu Leu Gln Leu Leu Arg Ala Leu Val Ser Gly Lys Ser Thr
450 455 460
Ala Lys Lys Val Tyr Ser Phe Leu Asp Lys Met Ser Phe Tyr Asn Glu
465 470 475 480
Leu Tyr Lys His Lys Pro His Asp Val Ile Ser His Glu Asp Gly Thr
485 490 495
Leu Trp Arg Arg Gln Thr Pro Lys Leu Leu Tyr Pro Leu Gly Gly Gln
500 505 510
Thr Asn Leu Arg Ile Pro Gln Gly Thr Val Gly Gln Val Met Leu Asp
515 520 525
Asp Arg Ala Tyr Leu Val Arg Trp Glu Tyr Ser Tyr Ser Ser Trp Thr
530 535 540
Leu Phe Thr Cys Glu Ile Glu Met Ile Leu His Val Val Ser Thr Ala
545 550 555 560
Asp Val Ile Gln His Cys Gln Arg Val Lys Pro Ile Ile Asp Leu Val
565 570 575
His Lys Val Ile Ser Thr Asp Leu Ser Ile Ala Asp Cys Leu Leu Pro
580 585 590
Ile Thr Ser Arg Ile Tyr Met Leu Leu Gln Arg Leu Thr Thr Val Ile
595 600 605
Ser Pro Pro Val Asp Val Ile Ala Ser Cys Val Asn Cys Leu Thr Val
610 615 620
Leu Ala Ala Arg Asn Pro Ala Lys Val Trp Thr Asp Leu Arg His Thr
625 630 635 640
Gly Phe Leu Pro Phe Val Ala His Pro Val Ser Ser Leu Ser Gln Met
645 650 655
Ile Ser Ala Glu Gly Met Asn Ala Gly Gly Tyr Gly Asn Leu Leu Met
660 665 670
Asn Ser Glu Gln Pro Gln Gly Glu Tyr Gly Val Thr Ile Ala Phe Leu
675 680 685
Arg Leu Ile Thr Thr Leu Val Lys Gly Gln Leu Gly Ser Thr Gln Ser
690 695 700
Gln Gly Leu Val Pro Cys Val Met Phe Val Leu Lys Glu Met Leu Pro
705 710 715 720
Ser Tyr His Lys Trp Arg Tyr Asn Ser His Gly Val Arg Glu Gln Ile
725 730 735
Gly Cys Leu Ile Leu Glu Leu Ile His Ala Ile Leu Asn Leu Cys His
740 745 750
Glu Thr Asp Leu His Ser Ser His Thr Pro Ser Leu Gln Phe Leu Cys
755 760 765
Ile Cys Ser Leu Ala Tyr Thr Glu Ala Gly Gln Thr Val Ile Asn Ile
770 775 780
Met Gly Ile Gly Val Asp Thr Ile Asp Met Val Met Ala Ala Gln Pro
785 790 795 800
Arg Ser Asp Gly Ala Glu Gly Gln Gly Gln Gly Gln Leu Leu Ile Lys
805 810 815
Thr Val Lys Leu Ala Phe Ser Val Thr Asn Asn Val Ile Arg Leu Lys
820 825 830
Pro Pro Ser Asn Val ValSer Pro Leu Glu Gln Ala Leu Ser Gln His
835 840 845
Gly Ala His Gly Asn Asn Leu Ile Ala Val Leu Ala Lys Tyr Ile Tyr
850 855 860
His Lys His Asp Pro Ala Leu Pro Arg Leu Ala Ile Gln Leu Leu Lys
865 870 875 880
Arg Leu Ala Thr Val Ala Pro Met Ser Val Tyr Ala Cys Leu Gly Asn
885 890 895
Asp Ala Ala Ala Ile Arg Asp Ala Phe Leu Thr Arg Leu Gln Ser Lys
900 905 910
Ile Glu Asp Met Arg Ile Lys Val Met Ile Leu Glu Phe Leu Thr Val
915 920 925
Ala Val Glu Thr Gln Pro Gly Leu Ile Glu Leu Phe Leu Asn Leu Glu
930 935 940
Val Lys Asp Gly Ser Asp Gly Ser Lys Glu Phe Ser Leu Gly Met Trp
945 950 955 960
Ser Cys Leu His Ala Val Leu Glu Leu Ile Asp Ser Gln Gln Gln Asp
965 970 975
Arg Tyr Trp Cys Pro Pro Leu Leu His Arg Ala Ala Ile Ala Phe Leu
980 985 990
His Ala Leu Trp Gln Asp Arg Arg Asp Ser Ala Met Leu Val Leu Arg
995 1000 1005
Thr Lys Pro Lys Phe Trp Glu Asn Leu Thr Ser Pro Leu Phe Gly Thr
1010 1015 1020
Leu Ser Pro Pro Ser Glu Thr Ser Glu Pro Ser Ile Leu Glu Thr Cys
1025 1030 1035 1040
Ala Leu Ile Met Lys Ile Ile Cys Leu Glu Ile Tyr Tyr Val Val Lys
1045 1050 1055
Gly Ser Leu Asp Gln Ser Leu Lys Asp Thr Leu Lys Lys Phe Ser Ile
1060 1065 1070
Glu Lys Arg Phe Ala Tyr Trp Ser Gly Tyr Val Lys Ser Leu Ala Val
1075 1080 1085
His Val Ala Glu Thr Glu Gly Ser Ser Cys Thr Ser Leu Leu Glu Tyr
1090 1095 1100
Gln Met Leu Val Ser Ala Trp Arg Met Leu Leu Ile Ile Ala Thr Thr
1105 1110 1115 1120
His Ala Asp Ile Met His Leu Thr Asp Ser Val Val Arg Arg Gln Leu
1125 1130 1135
Phe Leu Asp Val Leu Asp Gly Thr Lys Ala Leu Leu Leu Val Pro Ala
1140 1145 1150
Ser Val Asn Cys Leu Arg Leu Gly Ser Met Lys Cys Thr Leu Leu Leu
1155 1160 1165
Ile Leu Leu Arg Gln Trp Lys Arg Glu Leu Gly Ser Val Asp Glu Ile
1170 1175 1180
Leu Gly Pro Leu Thr Glu Ile Leu Glu Gly Val Leu Gln Ala Asp Gln
1185 1190 1195 1200
Gln Leu Met Glu Lys Thr Lys Ala Lys Val Phe Ser Ala Phe Ile Thr
1205 1210 1215
Val Leu Gln Met Lys Glu Met Lys Val Ser Asp Ile Pro Gln Tyr Ser
1220 1225 1230
Gln Leu Val Leu Asn Val Cys Glu Thr Leu Gln Glu Glu Val Ile Ala
1235 1240 1245
Leu Phe Asp Gln Thr Arg His Ser Leu Ala Leu Gly Ser Ala Thr Glu
1250 1255 1260
Asp Lys Asp Ser Met Glu Thr Asp Asp Cys Ser Arg Ser Arg His Arg
1265 1270 1275 1280
Asp Gln Arg Asp Gly Val Cys Val Leu Gly Leu His Leu Ala Lys Glu
1285 1290 1295
Leu Cys Glu Val Asp Glu Asp Gly Asp Ser Trp Leu Gln Val Thr Arg
1300 1305 1310
Arg Leu Pro Ile Leu Pro Thr Leu Leu Thr Thr Leu Glu Val Ser Leu
1315 1320 1325
Arg Met Lys Gln Asn Leu His Phe Thr Glu Ala Thr Leu His Leu Leu
1330 1335 1340
Leu Thr Leu Ala Arg Thr Gln Gln Gly Ala Thr Ala Val Ala Gly Ala
1345 1350 1355 1360
Gly Ile Thr Gln Ser Ile Cys Leu Pro Leu Leu Ser Val Tyr Gln Leu
1365 1370 1375
Ser Thr Asn Gly Thr Ala Gln Thr Pro Ser Ala Ser Arg Lys Ser Leu
1380 1385 1390
Asp Ala Pro Ser Trp Pro Gly Val Tyr Arg Leu Ser Met Ser Leu Met
1395 1400 1405
Glu Gln Leu Leu Lys Thr Leu Arg Tyr Asn Phe Leu Pro Glu Ala Leu
1410 1415 1420
Asp Phe Val Gly Val His Gln Glu Arg Thr Leu Gln Cys Leu Asn Ala
1425 1430 1435 1440
Val Arg Thr Val Gln Ser Leu Ala Cys Leu Glu Glu Ala Asp His Thr
1445 1450 1455
Val Gly Phe Ile Leu Gln Leu Ser Asn Phe Met Lys Glu Trp His Phe
1460 1465 1470
His Leu Pro Gln Leu Met Arg Asp Ile Gln Val Asn Leu Gly Tyr Leu
1475 1480 1485
Cys Gln Ala Cys Thr Ser Leu Leu His Ser Arg Lys Met Leu Gln His
1490 1495 1500
Tyr Leu Gln Asn Lys Asn Gly Asp Gly Leu Pro Ser Ala Val Ala Gln
1505 1510 1515 1520
Arg Val Gln Arg Pro Pro Ser Ala Ala Ser Ala Ala Pro Ser Ser Ser
1525 1530 1535
Lys Gln Pro Ala Ala Asp Thr Glu Ala Ser Glu Gln Gln Ala Leu His
1540 1545 1550
Thr Val Gln Tyr Gly Leu Leu Lys Ile Leu Ser Lys Thr Leu Ala Ala
1555 1560 1565
Leu Arg His Phe Thr Pro Asp Val Cys Gln Ile Leu Leu Asp Gln Ser
1570 1575 1580
Leu Asp Leu Ala Glu Tyr Asn Phe Leu Phe Ala Leu Ser Phe Thr Thr
1585 1590 1595 1600
Pro Thr Phe Asp Ser Glu Val Ala Pro Ser Phe Gly Thr Leu Leu Ala
1605 1610 1615
Thr Val Asn Val Ala Leu Asn Met Leu Gly Glu Leu Asp Lys Lys Lys
1620 1625 1630
Glu Pro Leu Thr Gln Ala ValGly Leu Ser Thr Gln Ala Glu Gly Thr
1635 1640 1645
Arg Thr Leu Lys Ser Leu Leu Met Phe Thr Met Glu Asn Cys Phe Tyr
1650 1655 1660
Leu Leu Ile Ser Gln Ala Met Arg Tyr Leu Arg Asp Pro Ala Val His
1665 1670 1675 1680
Pro Arg Asp Lys Gln Arg Met Lys Gln Glu Leu Ser Ser Glu Leu Ser
1685 1690 1695
Thr Leu Leu Ser Ser Leu Ser Arg Tyr Phe Arg Arg Gly Ala Pro Ser
1700 1705 1710
Ser Pro Ala Thr Gly Val Leu Pro Ser Pro Gln Gly Lys Ser Thr Ser
1715 1720 1725
Leu Ser Lys Ala Ser Pro Glu Ser Gln Glu Pro Leu Ile Gln Leu Val
1730 1735 1740
Gln Ala Phe Val Arg His Met Gln Arg
1745 1750
<210>9
<211>1753
<212>PRT
<213>人
<400>9
Met Ile Arg Lys Ser Lys Ile Thr Ser Val Leu Ser Phe Cys Arg Ser
1 5 10 15
Ser Arg Glu Leu Trp Thr Ile Leu Leu Gly Arg Ser Ala Leu Arg Glu
20 25 30
Leu Ser Gln Ile Glu Ala Glu Leu Asn Lys His Trp Arg Arg Leu Leu
35 40 45
Glu Gly Leu Ser Tyr Tyr Lys Pro Pro Ser Pro Ser Ser Ala Glu Lys
50 55 60
Val Lys Ala Asn Lys Asp Val Ala Ser Pro Leu Lys Glu Leu Gly Leu
65 70 75 80
Arg Ile Ser Lys Phe Leu Gly Leu Asp Glu Glu Gln Ser Val Gln Leu
85 90 95
Leu Gln Cys Tyr Leu Gln Glu Asp Tyr Arg Gly Thr Arg Asp Ser Val
100 105 110
Lys Thr Val Leu Gln Asp Glu Arg Gln Ser Gln Ala Leu Ile Leu Lys
115 120 125
Ile Ala Asp Tyr Tyr Tyr Glu Glu Arg Thr Cys Ile Leu Arg Cys Val
130 135 140
Leu His Leu Leu Thr Tyr Phe Gln Asp Glu Arg His Pro Tyr Arg Val
145 150 155 160
Glu Tyr Ala Asp Cys Val Asp Lys Leu Glu Lys Glu Leu Val Ser Lys
165 170 175
Tyr Arg Gln Gln Phe Glu Glu Leu Tyr Lys Thr Glu Ala Pro Thr Trp
180 185 190
Glu Thr His Gly Asn Leu Met Thr Glu Arg Gln Val Ser Arg Trp Phe
195 200 205
Val Gln Cys Leu Arg Glu Gln Ser Met Leu Leu Glu Ile Ile Phe Leu
210 215 220
Tyr Tyr Ala Tyr Phe Glu Met Ala Pro Ser Asp Leu Leu Val Leu Thr
225 230 235 240
Lys Met Phe Lys Glu Gln Gly Phe Gly Ser Arg Gln Thr Asn Arg His
245 250 255
Leu Val Asp Glu Thr Met Asp Pro Phe Val Asp Arg Ile Gly Tyr Phe
260 265 270
Ser Ala Leu Ile Leu Val Glu Gly Met Asp Ile Glu Ser Leu His Lys
275 280 285
Cys Ala Leu Asp Asp Arg Arg Glu Leu His Gln Phe Ala Gln Asp Gly
290 295 300
Leu Ile Cys Gln Asp Met Asp Cys Leu Met Leu Thr Phe Gly Asp Ile
305 310 315 320
Pro His His Ala Pro Val Leu Leu Ala Trp Ala Leu Leu Arg His Thr
325 330 335
Leu Asn Pro Glu Glu Thr Ser Ser Val Val Arg Lys Ile Gly Gly Thr
340 345 350
Ala Ile Gln Leu Asn ValPhe Gln Tyr Leu Thr Arg Leu Leu Gln Ser
355 360 365
Leu Ala Ser Gly Gly Asn Asp Cys Thr Thr Ser Thr Ala Cys Met Cys
370 375 380
Val Tyr Gly Leu Leu Ser Phe Val Leu Thr Ser Leu Glu Leu His Thr
385 390 395 400
Leu Gly Asn Gln Gln Asp Ile Ile Asp Thr Ala Cys Glu Val Leu Ala
405 410 415
Asp Pro Ser Leu Pro Glu Leu Phe Trp Gly Thr Glu Pro Thr Ser Gly
420 425 430
Leu Gly Ile Ile Leu Asp Ser Val Cys Gly Met Phe Pro His Leu Leu
435 440 445
Ser Pro Leu Leu Gln Leu Leu Arg Ala Leu Val Ser Gly Lys Ser Thr
450 455 460
Ala Lys Lys ValTyr Ser Phe Leu Asp Lys Met Ser Phe Tyr Asn Glu
465 470 475 480
Leu Tyr Lys His Lys Pro His Asp Val Ile Ser His Glu Asp Gly Thr
485 490 495
Leu Trp Arg Arg Gln Thr Pro Lys Leu Leu Tyr Pro Leu Gly Gly Gln
500 505 510
Thr Asn Leu Arg Ile Pro Gln Gly Thr Val Gly Gln Val Met Leu Asp
515 520 525
Asp Arg Ala Tyr Leu Val Arg Trp Glu Tyr Ser Tyr Ser Ser Trp Thr
530 535 540
Leu Phe Thr Cys Glu Ile Glu Met Leu Leu His Val Val Ser Thr Ala
545 550 555 560
Asp Val Ile Gln His Cys Gln Arg Val Lys Pro Ile Ile Asp Leu Val
565 570 575
His Lys Val Ile Ser Thr Asp Leu Ser Ile Ala Asp Cys Leu Leu Pro
580 585 590
Ile Thr Ser Arg Ile Tyr Met Leu Leu Gln Arg Leu Thr Thr Val Ile
595 600 605
Ser Pro Pro Val Asp Val Ile Ala Ser Cys Val Asn Cys Leu Thr Val
610 615 620
Leu Ala Ala Arg Asn Pro Ala Lys Val Phe Thr Asp Leu Arg His Thr
625 630 635 640
Gly Phe Leu Pro Phe Val Ala His Pro Val Ser Ser Leu Ser Gln Met
645 650 655
Ile Ser Ala Glu Gly Met Asn Ala Gly Gly Tyr Gly Asn Leu Leu Met
660 665 670
Asn Ser Glu Gln Pro Gln Gly Glu Tyr Gly Val Thr Ile Ala Phe Leu
675 680 685
Arg Leu Ile Thr Thr Leu Val Lys Gly Gln Leu Gly Ser Thr Gln Ser
690 695 700
Gln Gly Leu Val Pro Cys Val Met Phe Val Leu Lys Glu Met Leu Pro
705 710 715 720
Ser Tyr His Lys Trp Arg Tyr Asn Ser His Gly Val Arg Glu Gln Ile
725 730 735
Gly Cys Leu Ile Leu Glu Leu Ile His Ala Ile Leu Asn Leu Cys His
740 745 750
Glu Thr Asp Leu His Ser Ser His Thr Pro Ser Leu Gln Phe Leu Cys
755 760 765
Ile Cys Ser Leu Ala Tyr Thr Glu Ala Gly Gln Thr Val Ile Asn Ile
770 775 780
Met Gly Ile Gly Val Asp Thr Ile Asp Met Val Met Ala Ala Gln Pro
785 790 795 800
Arg Ser Asp Gly Ala Glu Gly Gln Gly Gln Gly Gln Leu Leu Ile Lys
805 810 815
Thr Val Lys Leu Ala Phe Ser Val Thr Asn Asn Val Ile Arg Leu Lys
820 825 830
Pro Pro Ser Asn Val Val Ser Pro Leu Glu Gln Ala Leu Ser Gln His
835 840 845
Gly Ala His Gly Asn Asn Leu Ile Ala Val Leu Ala Lys Tyr Ile Tyr
850 855 860
His Lys His Asp Pro Ala Leu Pro Arg Leu Ala Ile Gln Leu Leu Lys
865 870 875 880
Arg Leu Ala Thr Val Ala Pro Met Ser Val Tyr Ala Cys Leu Gly Asn
885 890 895
Asp Ala Ala Ala Ile Arg Asp Ala Phe Leu Thr Arg Leu Gln Ser Lys
900 905 910
Ile Glu Asp Met Arg Ile Lys Val Met Ile Leu Glu Phe Leu Thr Val
915 920 925
Ala Val Glu Thr Gln Pro Gly Leu Ile Glu Leu Phe Leu Asn Leu Glu
930 935 940
Val Lys Asp Gly Ser Asp Gly Ser Lys Glu Phe Ser Leu Gly Met Trp
945 950 955 960
Ser Cys Leu His Ala Val Leu Glu Leu Ile Asp Ser Gln Gln Gln Asp
965 970 975
Arg Tyr Trp Cys Pro Pro Leu Leu His Arg Ala Ala Ile Ala Phe Leu
980 985 990
His Ala Leu Trp Gln Asp Arg Arg Asp Ser Ala Met Leu Val Leu Arg
995 1000 1005
Thr Lys Pro Lys Phe Trp Glu Asn Leu Thr Ser Pro Leu Phe Gly Thr
1010 1015 1020
Leu Ser Pro Pro Ser Glu Thr Ser Glu Pro Ser Ile Leu Glu Thr Cys
1025 1030 1035 1040
Ala Leu Ile Met Lys Ile Ile Cys Leu Glu Ile Tyr Tyr Val Val Lys
1045 1050 1055
Gly Ser Leu Asp Gln Ser Leu Lys Asp Thr Leu Lys Lys Phe Ser Ile
1060 1065 1070
Glu Lys Arg Phe Ala Tyr Trp Ser Gly Tyr Val Lys Ser Leu Ala Val
1075 1080 1085
His Val Ala Glu Thr Glu Gly Ser Ser Cys Thr Ser Leu Leu Glu Tyr
1090 1095 1100
Gln Met Leu Val Ser Ala Trp Arg Met Leu Leu Ile Ile Ala Thr Thr
1105 1110 1115 1120
His Ala Asp Ile Met His Leu Thr Asp Ser Val Val Arg Arg Gln Leu
1125 1130 1135
Phe Leu Asp Val Leu Asp Gly Thr Lys Ala Leu Leu Leu Val Pro Ala
1140 1145 1150
Ser Val Asn Cys Leu Arg Leu Gly Ser Met Lys Cys Thr Leu Leu Leu
1155 1160 1165
Ile Leu Leu Arg Gln Trp Lys Arg Glu Leu Gly Ser Val Asp Glu Ile
1170 1175 1180
Leu Gly Pro Leu Thr Glu Ile Leu Glu Gly Val Leu Gln Ala Asp Gln
1185 1190 1195 1200
Gln Leu Met Glu Lys Thr Lys Ala Lys Val Phe Ser Ala Phe Ile Thr
1205 1210 1215
Val Leu Gln Met Lys Glu Met Lys Val Ser Asp Ile Pro Gln Tyr Ser
1220 1225 1230
Gln Leu Val Leu Asn ValCys Glu Thr Leu Gln Glu Glu Val Ile Ala
1235 1240 1245
Leu Phe Asp Gln Thr Arg His Ser Leu Ala Leu Gly Ser Ala Thr Glu
1250 1255 1260
Asp Lys Asp Ser Met Glu Thr Asp Asp Cys Ser Arg Ser Arg His Arg
1265 1270 1275 1280
Asp Gln Arg Asp Gly Val Cys Val Leu Gly Leu His Leu Ala Lys Glu
1285 1290 1295
Leu Cys Glu Val Asp Glu Asp Gly Asp Ser Trp Leu Gln Val Thr Arg
1300 1305 1310
Arg Leu Pro Ile Leu Pro Thr Leu Leu Thr Thr Leu Glu Val Ser Leu
1315 1320 1325
Arg Met Lys Gln Asn Leu His Phe Thr Glu Ala Thr Leu His Leu Leu
1330 1335 1340
Leu Thr Leu Ala Arg Thr Gln Gln Gly Ala Thr Ala Val Ala Gly Ala
1345 1350 1355 1360
Gly Ile Thr Gln Ser Ile Cys Leu Pro Leu Leu Ser Val Tyr Gln Leu
1365 1370 1375
Ser Thr Asn Gly Thr Ala Gln Thr Pro Ser Ala Ser Arg Lys Ser Leu
1380 1385 1390
Asp Ala Pro Ser Trp Pro Gly Val Tyr Arg Leu Ser Met Ser Leu Met
1395 1400 1405
Glu Gln Leu Leu Lys Thr Leu Arg Tyr Asn Phe Leu Pro Glu Ala Leu
1410 1415 1420
Asp Phe Val Gly Val His Gln Glu Arg Thr Leu Gln Cys Leu Asn Ala
1425 1430 1435 1440
Val Arg Thr Val Gln Ser Leu Ala Cys Leu Glu Glu Ala Asp His Thr
1445 1450 1455
Val Gly Phe Ile Leu Gln Leu Ser Asn Phe Met Lys Glu Trp His Phe
1460 1465 1470
His Leu Pro Gln Leu Met Arg Asp Ile Gln Val Asn Leu Gly Tyr Leu
1475 1480 1485
Cys Gln Ala Cys Thr Ser Leu Leu His Ser Arg Lys Met Leu Gln His
1490 1495 1500
Tyr Leu Gln Asn Lys Asn Gly Asp Gly Leu Pro Ser Ala Val Ala Gln
1505 1510 1515 1520
Arg Val Gln Arg Pro Pro Ser Ala Ala Ser Ala Ala Pro Ser Ser Ser
1525 1530 1535
Lys Gln Pro Ala Ala Asp Thr Glu Ala Ser Glu Gln Gln Ala Leu His
1540 1545 1550
Thr Val Gln Tyr Gly Leu Leu Lys Ile Leu Ser Lys Thr Leu Ala Ala
1555 1560 1565
Leu Arg His Phe Thr Pro Asp Val Cys Gln Ile Leu Leu Asp Gln Ser
1570 1575 1580
Leu Asp Leu Ala Glu Tyr Asn Phe Leu Phe Ala Leu Ser Phe Thr Thr
1585 1590 1595 1600
Pro Thr Phe Asp Ser Glu Val Ala Pro Ser Phe Gly Thr Leu Leu Ala
1605 1610 1615
Thr Val Asn Val Ala Leu Asn Met Leu Gly Glu Leu Asp Lys Lys Lys
1620 1625 1630
Glu Pro Leu Thr Gln Ala Val Gly Leu Ser Thr Gln Ala Glu Gly Thr
1635 1640 1645
Arg Thr Leu Lys Ser Leu Leu Met Phe Thr Met Glu Asn Cys Phe Tyr
1650 1655 1660
Leu Leu Ile Ser Gln Ala Met Arg Tyr Leu Arg Asp Pro Ala Val His
1665 1670 1675 1680
Pro Arg Asp Lys Gln Arg Met Lys Gln Glu Leu Ser Ser Glu Leu Ser
1685 1690 1695
Thr Leu Leu Ser Ser Leu Ser Arg Tyr Phe Arg Arg Gly Ala Pro Ser
1700 1705 1710
Ser Pro Ala Thr Gly Val Leu Pro Ser Pro Gln Gly Lys Ser Thr Ser
1715 1720 1725
Leu Ser Lys Ala Ser Pro Glu Ser Gln Glu Pro Leu Ile Gln Leu Val
1730 1735 1740
Gln Ala Phe Val Arg His Met Gln Arg
1745 1750
<210>10
<211>1753
<212>PRT
<213>人
<400>10
Met Ile Arg Lys Ser Lys Ile Thr Ser Val Leu Ser Phe Cys Arg Ser
1 5 10 15
Ser Arg Glu Leu Trp Thr Ile Leu Leu Gly Arg Ser Ala Leu Arg Glu
20 25 30
Leu Ser Gln Ile Glu Ala Glu Leu Asn Lys His Trp Arg Arg Leu Leu
35 40 45
Glu Gly Leu Ser Tyr Tyr Lys Pro Pro Ser Pro Ser Ser Ala Glu Lys
50 55 60
Val Lys Ala Asn Lys Asp Val Ala Ser Pro Leu Lys Glu Leu Gly Leu
65 70 75 80
Arg Ile Ser Lys Phe Leu Gly Leu Asp Glu Glu Gln Ser Val Gln Leu
85 90 95
Leu Gln Cys Tyr Leu Gln Glu Asp Tyr Arg Gly Thr Arg Asp Ser Val
100 105 110
Lys Thr Val Leu Gln Asp Glu Arg Gln Ser Gln Ala Leu Ile Leu Lys
115 120 125
Ile Ala Asp Tyr Tyr Tyr Glu Glu Arg Thr Cys Ile Leu Arg Cys Val
130 135 140
Leu His Leu Leu Thr Tyr Phe Gln Asp Glu Arg His Pro Tyr Arg Val
145 150 155 160
Glu Tyr Ala Asp Cys Val Asp Lys Leu Glu Lys Glu Leu Val Ser Lys
165 170 175
Tyr Arg Gln Gln Phe Glu Glu Leu Tyr Lys Thr Glu Ala Pro Thr Trp
180 185 190
Glu Thr His Gly Asn Leu Met Thr Glu Arg Gln Val Ser Arg Trp Phe
195 200 205
Val Gln Cys Leu Arg Glu Gln Ser Met Leu Leu Glu Ile Ile Phe Leu
210 215 220
Tyr Tyr Ala Tyr Phe Glu Met Ala Pro Ser Asp Leu Leu Val Leu Thr
225 230 235 240
Lys Met Phe Lys Glu Gln Gly Phe Gly Ser Arg Gln Thr Asn Arg His
245 250 255
Leu Val Asp Glu Thr Met Asp Pro Phe Val Asp Arg Ile Gly Tyr Phe
260 265 270
Ser Ala Leu Ile Leu Val Glu Gly Met Asp Ile Glu Ser Leu His Lys
275 280 285
Cys Ala Leu Asp Asp Arg Arg Glu Leu His Gln Phe Ala Gln Asp Gly
290 295 300
Leu Ile Cys Gln Asp Met Asp Cys Leu Met Leu Thr Phe Gly Asp Ile
305 310 315 320
Pro His His Ala Pro Val Leu Leu Ala Trp Ala Leu Leu Arg His Thr
325 330 335
Leu Asn Pro Glu Glu Thr Ser Ser Val Val Arg Lys Ile Gly Gly Thr
340 345 350
Ala Ile Gln Leu Asn Val Phe Gln Tyr Leu Thr Arg Leu Leu Gln Ser
355 360 365
Leu Ala Ser Gly Gly Asn Asp Cys Thr Thr Ser Thr Ala Cys Met Cys
370 375 380
Val Tyr Gly Leu Leu Ser Phe Val Leu Thr Ser Leu Glu Leu His Thr
385 390 395 400
Leu Gly Asn Gln Gln Asp Ile Ile Asp Thr Ala Cys Glu Val Leu Ala
405 410 415
Asp Pro Ser Leu Pro Glu Leu Phe Trp Gly Thr Glu Pro Thr Ser Gly
420 425 430
Leu Gly Ile Ile Leu Asp Ser Val Cys Gly Met Phe Pro His Leu Leu
435 440 445
Ser Pro Leu Leu Gln Leu Leu Arg Ala Leu Val Ser Gly Lys Ser Thr
450 455 460
Ala Lys Lys Val Tyr Ser Phe Leu Asp Lys Met Ser Phe Tyr Asn Glu
465 470 475 480
Leu Tyr Lys His Lys Pro His Asp Val Ile Ser His Glu Asp Gly Thr
485 490 495
Leu Trp Arg Arg Gln Thr Pro Lys Leu Leu Tyr Pro Leu Gly Gly Gln
500 505 510
Thr Asn Leu Arg Ile Pro Gln Gly Thr Val Gly Gln Val Met Leu Asp
515 520 525
Asp Arg Ala Tyr Leu Val Arg Trp Glu Tyr Ser Tyr Ser Ser Trp Thr
530 535 540
Leu Phe Thr Cys Glu Ile Glu Met Leu Leu His Val Val Ser Thr Ala
545 550 555 560
Asp Val Ile Gln His Cys Gln Arg Val Lys Pro Ile Ile Asp Leu Val
565 570 575
His Lys Val Ile Ser Thr Asp Leu Ser Ile Ala Asp Cys Leu Leu Pro
580 585 590
Ile Thr Ser Arg Ile Tyr Met Leu Leu Gln Arg Leu Thr Thr Val Ile
595 600 605
Ser Pro Pro Val Asp Val Ile Ala Ser Cys Val Asn Cys Leu Thr Val
610 615 620
Leu Ala Ala Arg Asn Pro Ala Lys Val Trp Thr Asp Leu Arg His Thr
625 630 635 640
Gly Phe Leu Pro Phe Val Ala His Pro Val Ser Ser Leu Ser Gln Met
645 650 655
Ile Ser Ala Glu Gly Met Asn Ala Gly Gly Tyr Gly Asn Leu Leu Met
660 665 670
Asn Ser Glu Gln Pro Gln Gly Glu Tyr Gly Val Thr Ile Ala Phe Leu
675 680 685
Arg Leu Ile Thr Thr Leu Val Lys Gly Gln Leu Gly Ser Thr Gln Ser
690 695 700
Gln Gly Leu Val Pro Cys Val Met Phe Val Leu Lys Glu Met Leu Pro
705 710 715 720
Ser Tyr His Lys Trp Arg Tyr Asn Ser His Gly Val Arg Glu Gln Ile
725 730 735
Gly Cys Leu Ile Leu Glu Leu Ile His Ala Ile Leu Asp Leu Cys His
740 745 750
Glu Thr Asp Leu His Ser Ser His Thr Pro Ser Leu Gln Phe Leu Cys
755 760 765
Ile Cys Ser Leu Ala Tyr Thr Glu Ala Gly Gln Thr Val Ile Asn Ile
770 775 780
Met Gly Ile Gly Val Asp Thr Ile Asp Met Val Met Ala Ala Gln Pro
785 790 795 800
Arg Ser Asp Gly Ala Glu Gly Gln Gly Gln Gly Gln Leu Leu Ile Lys
805 810 815
Thr Val Lys Leu Ala Phe Ser Val Thr Asn Asn Val Ile Arg Leu Lys
820 825 830
Pro Pro Ser Asn Val Val Ser Pro Leu Glu Gln Ala Leu Ser Gln His
835 840 845
Gly Ala His Gly Asn Asn Leu Ile Ala Val Leu Ala Lys Tyr Ile Tyr
850 855 860
His Lys His Asp Pro Ala Leu Pro Arg Leu Ala Ile Gln Leu Leu Lys
865 870 875 880
Arg Leu Ala Thr Val Ala Pro Met Ser Val Tyr Ala Cys Leu Gly Asn
885 890 895
Asp Ala Ala Ala Ile Arg Asp Ala Phe Leu Thr Arg Leu Gln Ser Lys
900 905 910
Ile Glu Asp Met Arg Ile Lys Val Met Ile Leu Glu Phe Leu Thr Val
915 920 925
Ala Val Glu Thr Gln Pro Gly Leu Ile Glu Leu Phe Leu Asn Leu Glu
930 935 940
Val Lys Asp Gly Ser Asp Gly Ser Lys Glu Phe Ser Leu Gly Met Trp
945 950 955 960
Ser Cys Leu His Ala Val Leu Glu Leu Ile Asp Ser Gln Gln Gln Asp
965 970 975
Arg Tyr Trp Cys Pro Pro Leu Leu His Arg Ala Ala Ile Ala Phe Leu
980 985 990
His Ala Leu Trp Gln Asp Arg Arg Asp Ser Ala Met Leu Val Leu Arg
995 1000 1005
Thr Lys Pro Lys Phe Trp Glu Asn Leu Thr Ser Pro Leu Phe Gly Thr
1010 1015 1020
Leu Ser Pro Pro Ser Glu Thr Ser Glu Pro Ser Ile Leu Glu Thr Cys
1025 1030 1035 1040
Ala Leu Ile Met Lys Ile Ile Cys Leu Glu Ile Tyr Tyr Val Val Lys
1045 1050 1055
Gly Ser Leu Asp Gln Ser Leu Lys Asp Thr Leu Lys Lys Phe Ser Ile
1060 1065 1070
Glu Lys Arg Phe Ala Tyr Trp Ser Gly Tyr Val Lys Ser Leu Ala Val
1075 1080 1085
His Val Ala Glu Thr Glu Gly Ser Ser Cys Thr Ser Leu Leu Glu Tyr
1090 1095 1100
Gln Met Leu ValSer Ala Trp Arg Met Leu Leu Ile Ile Ala Thr Thr
110 1110 1115 1120
His Ala Asp Ile Met His Leu Thr Asp Ser Val Val Arg Arg Gln Leu
1125 1130 1135
Phe Leu Asp Val Leu Asp Gly Thr Lys Ala Leu Leu Leu Val Pro Ala
1140 1145 1150
Ser Val Asn Cys Leu Arg Leu Gly Ser Met Lys Cys Thr Leu Leu Leu
1155 1160 1165
Ile Leu Leu Arg Gln Trp Lys Arg Glu Leu Gly Ser Val Asp Glu Ile
1170 1175 1180
Leu Gly Pro Leu Thr Glu Ile Leu Glu Gly Val Leu Gln Ala Asp Gln
1185 1190 1195 1200
Gln Leu Met Glu Lys Thr Lys Ala Lys Val Phe Ser Ala Phe Ile Thr
1205 1210 1215
Val Leu Gln Met Lys Glu Met Lys Val Ser Asp Ile Pro Gln Tyr Ser
1220 1225 1230
Gln Leu Val Leu Asn Val Cys Glu Thr Leu Gln Glu Glu Val Ile Ala
1235 1240 1245
Leu Phe Asp Gln Thr Arg His Ser Leu Ala Leu Gly Ser Ala Thr Glu
1250 1255 1260
Asp Lys Asp Ser Met Glu Thr Asp Asp Cys Ser Arg Ser Arg His Arg
1265 1270 1275 1280
Asp Gln Arg Asp Gly Val Cys Val Leu Gly Leu His Leu Ala Lys Glu
1285 1290 1295
Leu Cys Glu Val Asp Glu Asp Gly Asp Ser Trp Leu Gln Val Thr Arg
1300 1305 1310
Arg Leu Pro Ile Leu Pro Thr Leu Leu Thr Thr Leu Glu Val Ser Leu
1315 1320 1325
Arg Met Lys Gln Asn Leu His Phe Thr Glu Ala Thr Leu His Leu Leu
1330 1335 1340
Leu Thr Leu Ala Arg Thr Gln Gln Gly Ala Thr Ala Val Ala Gly Ala
1345 1350 1355 1360
Gly Ile Thr Gln Ser Ile Cys Leu Pro Leu Leu Ser Val Tyr Gln Leu
1365 1370 1375
Ser Thr Asn Gly Thr Ala Gln Thr Pro Ser Ala Ser Arg Lys Ser Leu
1380 1385 1390
Asp Ala Pro Ser Trp Pro Gly Val Tyr Arg Leu Ser Met Ser Leu Met
1395 1400 1405
Glu Gln Leu Leu Lys Thr Leu Arg Tyr Asn Phe Leu Pro Glu Ala Leu
1410 1415 1420
Asp Phe Val Gly Val His Gln Glu Arg Thr Leu Gln Cys Leu Asn Ala
1425 1430 1435 1440
Val Arg Thr Val Gln Ser Leu Ala Cys Leu Glu Glu Ala Asp His Thr
1445 1450 1455
Val Gly Phe Ile Leu Gln Leu Ser Asn Phe Met Lys Glu Trp His Phe
1460 1465 1470
His Leu Pro Gln Leu Met Arg Asp Ile Gln Val Asn Leu Gly Tyr Leu
1475 1480 1485
Cys Gln Ala Cys Thr Ser Leu Leu His Ser Arg Lys Met Leu Gln His
1490 1495 1500
Tyr Leu Gln Asn Lys Asn Gly Asp Gly Leu Pro Ser Ala Val Ala Gln
1505 1510 1515 1520
Arg Val Gln Arg Pro Pro Ser Ala Ala Ser Ala Ala Pro Ser Ser Ser
1525 1530 1535
Lys Gln Pro Ala Ala Asp Thr Glu Ala Ser Glu Gln Gln Ala Leu His
1540 1545 1550
Thr Val Gln Tyr Gly Leu Leu Lys Ile Leu Ser Lys Thr Leu Ala Ala
1555 1560 1565
Leu Arg His Phe Thr Pro Asp Val Cys Gln Ile Leu Leu Asp Gln Ser
1570 1575 1580
Leu Asp Leu Ala Glu Tyr Asn Phe Leu Phe Ala Leu Ser Phe Thr Thr
1585 1590 1595 1600
Pro Thr Phe Asp Ser G1u Val Ala Pro Ser Phe G1y Thr Leu Leu Ala
1605 1610 1615
Thr Val Asn Val Ala Leu Asn Met Leu Gly Glu Leu Asp Lys Lys Lys
1620 1625 1630
Glu Pro Leu Thr Gln Ala Val Gly Leu Ser Thr Gln Ala Glu Gly Thr
1635 1640 1645
Arg Thr Leu Lys Ser Leu Leu Met Phe Thr Met Glu Asn Cys Phe Tyr
1650 1655 1660
Leu Leu Ile Ser Gln Ala Met Arg Tyr Leu Arg Asp Pro Ala Val His
1665 1670 1675 1680
Pro Arg Asp Lys Gln Arg Met Lys Gln Glu Leu Ser Ser Glu Leu Ser
1685 1690 1695
Thr Leu Leu Ser Ser Leu Ser Arg Tyr Phe Arg Arg Gly Ala Pro Ser
1700 1705 1710
Ser Pro Ala Thr Gly Val Leu Pro Ser Pro Gln Gly Lys Ser Thr Ser
1715 1720 1725
Leu Ser Lys Ala Ser Pro Glu Ser Gln Glu Pro Leu Ile Gln Leu Val
1730 1735 1740
Gln Ala Phe Val Arg His Met Gln Arg
1745 1750
<210>11
<211>1753
<212>PRT
<213>人
<400>11
Met Ile Arg Lys Ser Lys Ile Thr Ser Val Leu Ser Phe Cys Arg Ser
1 5 10 15
Ser Arg Glu Leu Trp Thr Ile Leu Leu Gly Arg Ser Ala Leu Arg Glu
20 25 30
Leu Ser Gln Ile Glu Ala Glu Leu Asn Lys His Trp Arg Arg Leu Leu
35 40 45
Glu Gly Leu Ser Tyr Tyr Lys Pro Pro Ser Pro Ser Ser Ala Glu Lys
50 55 60
Val Lys Ala Asn Lys Asp Val Ala Ser Pro Leu Lys Glu Leu Gly Leu
65 70 75 80
Arg Ile Ser Lys Phe Leu Gly Leu Asp Glu Glu Gln Ser Val Gln Leu
85 90 95
Leu Gln Cys Tyr Leu Gln Glu Asp Tyr Arg Gly Thr Arg Asp Ser Val
100 105 110
Lys Thr Val Leu Gln Asp Glu Arg Gln Ser Gln Ala Leu Ile Leu Lys
115 120 125
Ile Ala Asp Tyr Tyr Tyr Glu Glu Arg Thr Cys Ile Leu Arg Cys Val
130 135 140
Leu His Leu Leu Thr Tyr Phe Gln Asp Glu Arg His Pro Tyr Arg Val
145 150 155 160
Glu Tyr Ala Asp Cys Val Asp Lys Leu Glu Lys Glu Leu Val Ser Lys
165 170 175
Tyr Arg Gln Gln Phe Glu Glu Leu Tyr Lys Thr Glu Ala Pro Thr Trp
180 185 190
Glu Thr His Gly Asn Leu Met Thr Glu Arg Gln Val Ser Arg Trp Phe
195 200 205
Val Gln Cys Leu Arg Glu Gln Ser Met Leu Leu Glu Ile Ile Phe Leu
210 215 220
Tyr Tyr Ala Tyr Phe Glu Met Ala Pro Ser Asp Leu Leu Val Leu Thr
225 230 235 240
Lys Met Phe Lys Glu Gln Gly Phe Gly Ser Arg Gln Thr Asn Arg His
245 250 255
Leu Val Asp Glu Thr Met Asp Pro Phe Val Asp Arg Ile Gly Tyr Phe
260 265 270
Ser Ala Leu Ile Leu Val Glu Gly Met Asp Ile Glu Ser Leu His Lys
275 280 285
Cys Ala Leu Asp Asp Arg Arg Glu Leu His Gln Phe Ala Gln Asp Gly
290 295 300
Leu Ile Cys Gln Asp Met Asp Cys Leu Met Leu Thr Phe Gly Asp Ile
305 310 315 320
Pro His His Ala Pro Val Leu Leu Ala Trp Ala Leu Leu Arg His Thr
325 330 335
Leu Asn Pro Glu Glu Thr Ser Ser Val Val Arg Lys Ile Gly Gly Thr
340 345 350
Ala Ile Gln Leu Asn Val Phe Gln Tyr Leu Thr Arg Leu Leu Gln Ser
355 360 365
Leu Ala Ser Gly Gly Asn Asp Cys Thr Thr Ser Thr Ala Cys Met Cys
370 375 380
Val Tyr Gly Leu Leu Ser Phe Val Leu Thr Ser Leu Glu Leu His Thr
385 390 395 400
Leu Gly Asn Gln Gln Asp Ile Ile Asp Thr Ala Cys Glu Val Leu Ala
405 410 415
Asp Pro Ser Leu Pro Glu Leu Phe Trp Gly Thr Glu Pro Thr Ser Gly
420 425 430
Leu Gly Ile Ile Leu Asp Ser ValCys Gly Met Phe Pro His Leu Leu
435 440 445
Ser Pro Leu Leu Gln Leu Leu Arg Ala Leu Val Ser Gly Lys Ser Thr
450 455 460
Ala Lys Lys Val Tyr Ser Phe Leu Asp Lys Met Ser Phe Tyr Asn Glu
465 470 475 480
Leu Tyr Lys His Lys Pro His Asp Val Ile Ser His Glu Asp Gly Thr
485 490 495
Leu Trp Arg Arg Gln Thr Pro Lys Leu Leu Tyr Pro Leu Gly Gly Gln
500 505 510
Thr Asn Leu Arg Ile Pro Gln Gly Thr Val Gly Gln Val Met Leu Asp
515 520 525
Asp Arg Ala Tyr Leu Val Arg Trp Glu Tyr Ser Tyr Ser Ser Trp Thr
530 535 540
Leu Phe Thr Cys Glu Ile Glu Met Leu Leu His Val Val Ser Thr Ala
545 550 555 560
Asp Val Ile Gln His Cys Gln Arg Val Lys Pro Ile Ile Asp Leu Val
565 570 575
His Lys Val Ile Ser Thr Asp Leu Ser Ile Ala Asp Cys Leu Leu Pro
580 585 590
Ile Thr Ser Arg Ile Tyr Met Leu Leu Gln Arg Leu Thr Thr Val Ile
595 600 605
Ser Pro Pro Val Asp Val Ile Ala Ser Cys Val Asn Cys Leu Thr Val
610 615 620
Leu Ala Ala Arg Asn Pro Ala Lys Val Trp Thr Asp Leu Arg His Thr
625 630 635 640
Gly Phe Leu Pro Phe Val Ala His Pro Val Ser Ser Leu Ser Gln Met
645 650 655
Ile Ser Ala Glu Gly Met Asn Ala Gly Gly Tyr Gly Asn Leu Leu Met
660 665 670
Asn Ser Glu Gln Pro Gln Gly Glu Tyr Gly Val Thr Ile Ala Phe Leu
675 680 685
Arg Leu Ile Thr Thr Leu Val Lys Gly Gln Leu Gly Ser Thr Gln Ser
690 695 700
Gln Gly Leu Val Pro Cys Val Met Phe Val Leu Lys Glu Met Leu Pro
705 710 715 720
Ser Tyr His Lys Trp Arg Tyr Asn Ser His Gly Val Arg Glu Gln Ile
725 730 735
Gly Cys Leu Ile Leu Glu Leu Ile His Ala Ile Leu Asn Leu Cys His
740 745 750
Glu Thr Asp Leu His Ser Ser His Thr Pro Ser Leu Gln Phe Leu Cys
755 760 765
Ile Cys Ser Leu Ala Tyr Thr Glu Ala Gly Gln Thr Val Ile Asn Ile
770 775 780
Met Gly Ile Gly Val Asp Thr Ile Asp Met Val Met Ala Ala Gln Pro
785 790 795 800
Arg Ser Asp Gly Ala Glu Gly Gln Gly Gln Gly Gln Leu Leu Ile Lys
805 810 815
Thr Val Lys Leu Ala Phe Ser Val Thr Asn Asn Val Ile Arg Leu Lys
820 825 830
Pro Pro Ser Asn Val Met Ser Pro Leu Glu Gln Ala Leu Ser Gln His
835 840 845
Gly Ala His Gly Asn Asn Leu Ile Ala Val Leu Ala Lys Tyr Ile Tyr
850 855 860
His Lys His Asp Pro Ala Leu Pro Arg Leu Ala Ile Gln Leu Leu Lys
865 870 875 880
Arg Leu Ala Thr Val Ala Pro Met Ser Val Tyr Ala Cys Leu Gly Asn
885 890 895
Asp Ala Ala Ala Ile Arg Asp Ala Phe Leu Thr Arg Leu Gln Ser Lys
900 905 910
Ile Glu Asp Met Arg Ile Lys Val Met Ile Leu Glu Phe Leu Thr Val
915 920 925
Ala Val Glu Thr Gln Pro Gly Leu Ile Glu Leu Phe Leu Asn Leu Glu
930 935 940
Val Lys Asp Gly Ser Asp Gly Ser Lys Glu Phe Ser Leu Gly Met Trp
945 950 955 960
Ser Cys Leu His Ala Val Leu Glu Leu Ile Asp Ser Gln Gln Gln Asp
965 970 975
Arg Tyr Trp Cys Pro Pro Leu Leu His Arg Ala Ala Ile Ala Phe Leu
980 985 990
His Ala Leu Trp Gln Asp Arg Arg Asp Ser Ala Met Leu Val Leu Arg
995 1000 1005
Thr Lys Pro Lys Phe Trp Glu Asn Leu Thr Ser Pro Leu Phe Gly Thr
1010 1015 1020
Leu Ser Pro Pro Ser Glu Thr Ser Glu Pro Ser Ile Leu Glu Thr Cys
1025 1030 1035 1040
Ala Leu Ile Met Lys Ile Ile Cys Leu Glu Ile Tyr Tyr Val Val Lys
1045 1050 1055
Gly Ser Leu Asp Gln Ser Leu Lys Asp Thr Leu Lys Lys Phe Ser Ile
1060 1065 1070
Glu Lys Arg Phe Ala Tyr Trp Ser Gly Tyr Val Lys Ser Leu Ala Val
1075 1080 1085
His Val Ala Glu Thr Glu Gly Ser Ser Cys Thr Ser Leu Leu Glu Tyr
1090 1095 1100
Gln Met Leu Val Ser Ala Trp Arg Met Leu Leu Ile Ile Ala Thr Thr
1105 1110 1115 1120
His Ala Asp Ile Met His Leu Thr Asp Ser Val Val Arg Arg Gln Leu
1125 1130 1135
Phe Leu Asp Val Leu Asp Gly Thr Lys Ala Leu Leu Leu Val Pro Ala
1140 1145 1150
Ser Val Asn Cys Leu Arg Leu Gly Ser Met Lys Cys Thr Leu Leu Leu
1155 1160 1165
Ile Leu Leu Arg Gln Trp Lys Arg Glu Leu Gly Ser Val Asp Glu Ile
1170 1175 1180
Leu Gly Pro Leu Thr Glu Ile Leu Glu Gly Val Leu Gln Ala Asp Gln
1185 1190 1195 1200
Gln Leu Met Glu Lys Thr Lys Ala Lys Val Phe Ser Ala Phe Ile Thr
1205 1210 1215
Val Leu Gln Met Lys Glu Met Lys Val Ser Asp Ile Pro Gln Tyr Ser
1220 1225 1230
Gln Leu Val Leu Asn Val Cys Glu Thr Leu Gln Glu Glu Val Ile Ala
1235 1240 1245
Leu Phe Asp Gln Thr Arg His Ser Leu Ala Leu Gly Ser Ala Thr Glu
1250 1255 1260
Asp Lys Asp Ser Met Glu Thr Asp Asp Cys Ser Arg Ser Arg His Arg
1265 1270 1275 1280
Asp Gln Arg Asp Gly Val Cys Val Leu Gly Leu His Leu Ala Lys Glu
1285 1290 1295
Leu Cys Glu Val Asp Glu Asp Gly Asp Ser Trp Leu Gln Val Thr Arg
1300 1305 1310
Arg Leu Pro Ile Leu Pro Thr Leu Leu Thr Thr Leu Glu Val Ser Leu
1315 1320 1325
Arg Met Lys Gln Asn Leu His Phe Thr Glu Ala Thr Leu His Leu Leu
1330 1335 1340
Leu Thr Leu Ala Arg Thr Gln Gln Gly Ala Thr Ala Val Ala Gly Ala
1345 1350 1355 1360
Gly Ile Thr Gln Ser Ile Cys Leu Pro Leu Leu Ser Val Tyr Gln Leu
1365 1370 1375
Ser Thr Asn Gly Thr Ala Gln Thr Pro Ser Ala Ser Arg Lys Ser Leu
1380 1385 1390
Asp Ala Pro Ser Trp Pro Gly Val Tyr Arg Leu Ser Met Ser Leu Met
1395 1400 1405
Glu Gln Leu Leu Lys Thr Leu Arg Tyr Asn Phe Leu Pro Glu Ala Leu
1410 1415 1420
Asp Phe Val Gly Val His Gln Glu Arg Thr Leu Gln Cys Leu Asn Ala
1425 1430 1435 1440
Val Arg Thr Val Gln Ser Leu Ala Cys Leu Glu Glu Ala Asp His Thr
1445 1450 1455
Val Gly Phe Ile Leu Gln Leu Ser Asn Phe Met Lys Glu Trp His Phe
1460 1465 1470
His Leu Pro Gln Leu Met Arg Asp Ile Gln Val Asn Leu Gly Tyr Leu
1475 1480 1485
Cys Gln Ala Cys Thr Ser Leu Leu His Ser Arg Lys Met Leu Gln His
1490 1495 1500
Tyr Leu Gln Asn Lys Asn Gly Asp Gly Leu Pro Ser Ala Val Ala Gln
150 1510 1515 1520
Arg Val Gln Arg Pro Pro Ser Ala Ala Ser Ala Ala Pro Ser Ser Ser
1525 1530 1535
Lys Gln Pro Ala Ala Asp Thr Glu Ala Ser Glu Gln Gln Ala Leu His
1540 1545 1550
Thr Val Gln Tyr Gly Leu Leu Lys Ile Leu Ser Lys Thr Leu Ala Ala
1555 1560 1565
Leu Arg His Phe Thr Pro Asp Val Cys Gln Ile Leu Leu Asp Gln Ser
1570 1575 1580
Leu Asp Leu Ala Glu Tyr Asn Phe Leu Phe Ala Leu Ser Phe Thr Thr
1585 1590 1595 1600
Pro Thr Phe Asp Ser Glu Val Ala Pro Ser Phe Gly Thr Leu Leu Ala
1605 1610 1615
Thr Val Asn Val Ala Leu Asn Met Leu Gly Glu Leu Asp Lys Lys Lys
1620 1625 1630
Glu Pro Leu Thr Gln Ala Val Gly Leu Ser Thr Gln Ala Glu Gly Thr
1635 1640 1645
Arg Thr Leu Lys Ser Leu Leu Met Phe Thr Met Glu Asn Cys Phe Tyr
1650 1655 1660
Leu Leu Ile Ser Gln Ala Met Arg Tyr Leu Arg Asp Pro Ala Val His
1665 1670 1675 1680
Pro Arg Asp Lys Gln Arg Met Lys Gln Glu Leu Ser Ser Glu Leu Ser
1685 1690 1695
Thr Leu Leu Ser Ser Leu Ser Arg Tyr Phe Arg Arg Gly Ala Pro Ser
1700 1705 1710
Ser Pro Ala Thr Gly Val Leu Pro Ser Pro Gln Gly Lys Ser Thr Ser
1715 1720 1725
Leu Ser Lys Ala Ser Pro Glu Ser Gln Glu Pro Leu Ile Gln Leu Val
1730 1735 1740
Gln Ala Phe Val Arg His Met Gln Arg
1745 1750
<210>12
<211>1753
<212>PRT
<213>人
<400>12
Met Ile Arg Lys Ser Lys Ile Thr Ser Val Leu Ser Phe Cys Arg Ser
1 5 10 15
Ser Arg Glu Leu Trp Thr Ile Leu Leu Gly Arg Ser Ala Leu Arg Glu
20 25 30
Leu Ser Gln Ile Glu Ala Glu Leu Asn Lys His Trp Arg Arg Leu Leu
35 40 45
Glu Gly Leu Ser Tyr Tyr Lys Pro Pro Ser Pro Ser Ser Ala Glu Lys
50 55 60
Val Lys Ala Asn Lys Asp Val Ala Ser Pro Leu Lys Glu Leu Gly Leu
65 70 75 80
Arg Ile Ser Lys Phe Leu Gly Leu Asp Glu Glu Gln Ser Val Gln Leu
85 90 95
Leu Gln Cys Tyr Leu Gln Glu Asp Tyr Arg Gly Thr Arg Asp Ser Val
100 105 110
Lys Thr Val Leu Gln Asp Glu Arg Gln Ser Gln Ala Leu Ile Leu Lys
115 120 125
Ile Ala Asp Tyr Tyr Tyr Glu Glu Arg Thr Cys Ile Leu Arg Cys Val
130 135 140
Leu His Leu Leu Thr Tyr Phe Gln Asp Glu Arg His Pro Tyr Arg Val
145 150 155 160
Glu Tyr Ala Asp Cys Val Asp Lys Leu Glu Lys Glu Leu Val Ser Lys
165 170 175
Tyr Arg Gln Gln Phe Glu Glu Leu Tyr Lys Thr Glu Ala Pro Thr Trp
180 185 190
Glu Thr His Gly Asn Leu Met Thr Glu Arg Gln Val Ser Arg Trp Phe
195 200 205
Val Gln Cys Leu Arg Glu Gln Ser Met Leu Leu Glu Ile Ile Phe Leu
210 215 220
Tyr Tyr Ala Tyr Phe Glu Met Ala Pro Ser Asp Leu Leu Val Leu Thr
225 230 235 240
Lys Met Phe Lys Glu Gln Gly Phe Gly Ser Arg Gln Thr Asn Arg His
245 250 255
Leu Val Asp Glu Thr Met Asp Pro Phe Val Asp Arg Ile Gly Tyr Phe
260 265 270
Ser Ala Leu Ile Leu ValGlu Gly Met Asp Ile Glu Ser Leu His Lys
275 280 285
Cys Ala Leu Asp Asp Arg Arg Glu Leu His Gln Phe Ala Gln Asp Gly
290 295 300
Leu Ile Cys Gln Asp Met Asp Cys Leu Met Leu Thr Phe Gly Asp Ile
305 310 315 320
Pro His His Ala Pro Val Leu Leu Ala Trp Ala Leu Leu Arg His Thr
325 330 335
Leu Asn Pro Glu Glu Thr Ser Ser Val Val Arg Lys Ile Gly Gly Thr
340 345 350
Ala Ile Gln Leu Asn Val Phe Gln Tyr Leu Thr Arg Leu Leu Gln Ser
355 360 365
Leu Ala Ser Gly Gly Asn Asp Cys Thr Thr Ser Thr Ala Cys Met Cys
370 375 380
Val Tyr Gly Leu Leu Ser Phe Val Leu Thr Ser Leu Glu Leu His Thr
385 390 395 400
Leu Gly Asn Gln Gln Asp Ile Ile Asp Thr Ala Cys Glu Val Leu Ala
405 410 415
Asp Pro Ser Leu Pro Glu Leu Phe Trp Gly Thr Glu Pro Thr Ser Gly
420 425 430
Leu Gly Ile Ile Leu Asp Ser Val Cys Gly Met Phe Pro His Leu Leu
435 440 445
Ser Pro Leu Leu Gln Leu Leu Arg Ala Leu Val Ser Gly Lys Ser Thr
450 455 460
Ala Lys Lys Val Tyr Ser Phe Leu Asp Lys Met Ser Phe Tyr Asn Glu
465 470 475 480
Leu Tyr Lys His Lys Pro His Asp Val Ile Ser His Glu Asp Gly Thr
485 490 495
Leu Trp Arg Arg Gln Thr Pro Lys Leu Leu Tyr Pro Leu Gly Gly Gln
500 505 510
Thr Asn Leu Arg Ile Pro Gln Gly Thr Val Gly Gln Val Met Leu Asp
515 520 525
Asp Arg Ala Tyr Leu Val Arg Trp Glu Tyr Ser Tyr Ser Ser Trp Thr
530 535 540
Leu Phe Thr Cys Glu Ile Glu Met Leu Leu His Val Val Ser Thr Ala
545 550 555 560
Asp Val Ile Gln His Cys Gln Arg Val Lys Pro Ile Ile Asp Leu Val
565 570 575
His Lys Val Ile Ser Thr Asp Leu Ser Ile Ala Asp Cys Leu Leu Pro
580 585 590
Ile Thr Ser Arg Ile Tyr Met Leu Leu Gln Arg Leu Thr Thr Val Ile
595 600 605
Ser Pro Pro Val Asp Val Ile Ala Ser Cys ValAsn Cys Leu Thr Val
610 615 620
Leu Ala Ala Arg Asn Pro Ala Lys Val Trp Thr Asp Leu Arg His Thr
625 630 635 640
Gly Phe Leu Pro Phe Val Ala His Pro Val Ser Ser Leu Ser Gln Met
645 650 655
Ile Ser Ala Glu Gly Met Asn Ala Gly Gly Tyr Gly Asn Leu Leu Met
660 665 670
Asn Ser Glu Gln Pro Gln Gly Glu Tyr Gly Val Thr Ile Ala Phe Leu
675 680 685
Arg Leu Ile Thr Thr Leu ValLys Gly Gln Leu Gly Ser Thr Gln Ser
690 695 700
Gln Gly Leu Val Pro Cys Val Met Phe Val Leu Lys Glu Met Leu Pro
705 710 715 720
Ser Tyr His Lys Trp Arg Tyr Asn Ser His Gly Val Arg Glu Gln Ile
725 730 735
Gly Cys Leu Ile Leu Glu Leu Ile His Ala Ile Leu Asn Leu Cys His
740 745 750
Glu Thr Asp Leu His Ser Ser His Thr Pro Ser Leu Gln Phe Leu Cys
755 760 765
Ile Cys Ser Leu Ala Tyr Thr Glu Ala Gly Gln Thr Val Ile Asn Ile
770 775 780
Met Gly Ile Gly Val Asp Thr Ile Asp Met Val Met Ala Ala Gln Pro
785 790 795 800
Arg Ser Asp Gly Ala Glu Gly Gln Gly Gln Gly Gln Leu Leu Ile Lys
805 810 815
Thr Val Lys Leu Ala Phe Ser Val Thr Asn Asn ValI le Arg Leu Lys
820 825 830
Pro Pro Ser Asn Val Val Ser Pro Leu Glu Gln Ala Leu Ser Gln His
835 840 845
Gly Ala His Gly Asn Asn Leu Ile Ala Val Leu Ala Lys Tyr Ile Tyr
850 855 860
His Lys His Asp Pro Ala Leu Pro Arg Leu Ala Ile Gln Leu Leu Lys
865 870 875 880
Arg Leu Ala Thr Val Ala Pro Met Ser Val Tyr Ala Cys Leu Gly Asn
885 890 895
Asp Ala Ala Ala Ile Arg Asp Ala Phe Leu Thr Arg Leu Gln Ser Lys
900 905 910
Ile Glu Asp Met Arg Ile Lys Val Met Ile Leu Glu Phe Leu Thr Val
915 920 925
Ala Val Glu Thr Gln Pro Gly Leu Ile Glu Leu Phe Leu Asn Leu Glu
930 935 940
Val Lys Asp Gly Ser Asp Gly Ser Lys Glu Phe Ser Leu Thr Met Trp
945 950 955 960
Ser Cys Leu His Ala Val Leu Glu Leu Ile Asp Ser Gln Gln Gln Asp
965 970 975
Arg Tyr Trp Cys Pro Pro Leu Leu His Arg Ala Ala Ile Ala Phe Leu
980 985 990
His Ala Leu Trp Gln Asp Arg Arg Asp Ser Ala Met Leu Val Leu Arg
995 1000 1005
Thr Lys Pro Lys Phe Trp Glu Asn Leu Thr Ser Pro Leu Phe Gly Thr
1010 1015 1020
Leu Ser Pro Pro Ser Glu Thr Ser Glu Pro Ser Ile Leu Glu Thr Cys
1025 1030 1035 1040
Ala Leu Ile Met Lys Ile Ile Cys Leu Glu Ile Tyr Tyr Val Val Lys
1045 1050 1055
Gly Ser Leu Asp Gln Ser Leu Lys Asp Thr Leu Lys Lys Phe Ser Ile
1060 1065 1070
Glu Lys Arg Phe Ala Tyr Trp Ser Gly Tyr Val Lys Ser Leu Ala Val
1075 1080 1085
His Val Ala Glu Thr Glu Gly Ser Ser Cys Thr Ser Leu Leu Glu Tyr
1090 1095 1100
Gln Met Leu Val Ser Ala Trp Arg Met Leu Leu Ile Ile Ala Thr Thr
1105 1110 1115 1120
His Ala Asp Ile Met His Leu Thr Asp Ser Val Val Arg Arg Gln Leu
1125 1130 1135
Phe Leu Asp Val Leu Asp Gly Thr Lys Ala Leu Leu Leu Val Pro Ala
1140 1145 1150
Ser Val Asn Cys Leu Arg Leu Gly Ser Met Lys Cys Thr Leu Leu Leu
1155 1160 1165
Ile Leu Leu Arg Gln Trp Lys Arg Glu Leu Gly Ser Val Asp Glu Ile
1170 1175 1180
Leu Gly Pro Leu Thr Glu Ile Leu Glu Gly Val Leu Gln Ala Asp Gln
1185 1190 1195 1200
Gln Leu Met Glu Lys Thr Lys Ala Lys Val Phe Ser Ala Phe Ile Thr
1205 1210 1215
Val Leu Gln Met Lys Glu Met Lys Val Ser Asp Ile Pro Gln Tyr Ser
1220 1225 1230
Gln Leu Val Leu Asn Val Cys Glu Thr Leu Gln Glu Glu Val Ile Ala
1235 1240 1245
Leu Phe Asp Gln Thr Arg His Ser Leu Ala Leu Gly Ser Ala Thr Glu
1250 1255 1260
Asp Lys Asp Ser Met Glu Thr Asp Asp Cys Ser Arg Ser Arg His Arg
1265 1270 1275 1280
Asp Gln Arg Asp Gly Val Cys Val Leu Gly Leu His Leu Ala Lys Glu
1285 1290 1295
Leu Cys Glu Val Asp Glu Asp Gly Asp Ser Trp Leu Gln Val Thr Arg
1300 1305 1310
Arg Leu Pro Ile Leu Pro Thr Leu Leu Thr Thr Leu Glu Val Ser Leu
1315 1320 1325
Arg Met Lys Gln Asn Leu His Phe Thr Glu Ala Thr Leu His Leu Leu
1330 1335 1340
Leu Thr Leu Ala Arg Thr Gln Gln Gly Ala Thr Ala Val Ala Gly Ala
1345 1350 1355 1360
Gly Ile Thr Gln Ser Ile Cys Leu Pro Leu Leu Ser Val Tyr Gln Leu
1365 1370 1375
Ser Thr Asn Gly Thr Ala Gln Thr Pro Ser Ala Ser Arg Lys Ser Leu
1380 1385 1390
Asp Ala Pro Ser Trp Pro Gly ValTyr Arg Leu Ser Met Ser Leu Met
1395 1400 1405
Glu Gln Leu Leu Lys Thr Leu Arg Tyr Asn Phe Leu Pro Glu Ala Leu
1410 1415 1420
Asp Phe ValGly Val His Gln Glu Arg Thr Leu Gln Cys Leu Asn Ala
1425 1430 1435 1440
Val Arg Thr Val Gln Ser Leu Ala Cys Leu Glu Glu Ala Asp His Thr
1445 1450 1455
Val Gly Phe Ile Leu Gln Leu Ser Asn Phe Met Lys Glu Trp His Phe
1460 1465 1470
His Leu Pro Gln Leu Met Arg Asp Ile Gln Val Asn Leu Gly Tyr Leu
1475 1480 1485
Cys Gln Ala Cys Thr Ser Leu Leu His Ser Arg Lys Met Leu Gln His
1490 1495 1500
Tyr Leu Gln Asn Lys Asn Gly Asp Gly Leu Pro Ser Ala Val Ala Gln
1505 1510 1515 1520
Arg Val Gln Arg Pro Pro Ser Ala Ala Ser Ala Ala Pro Ser Ser Ser
1525 1530 1535
Lys Gln Pro Ala Ala Asp Thr Glu Ala Ser Glu Gln Gln Ala Leu His
1540 1545 1550
Thr Val Gln Tyr Gly Leu Leu Lys Ile Leu Ser Lys Thr Leu Ala Ala
1555 1560 1565
Leu Arg His Phe Thr Pro Asp Val Cys Gln Ile Leu Leu Asp Gln Ser
1570 1575 1580
Leu Asp Leu Ala Glu Tyr Asn Phe Leu Phe Ala Leu Ser Phe Thr Thr
1585 1590 1595 1600
Pro Thr Phe Asp Ser Glu Val Ala Pro Ser Phe Gly Thr Leu Leu Ala
1605 1610 1615
Thr Val Asn Val Ala Leu Asn Met Leu Gly Glu Leu Asp Lys Lys Lys
1620 1625 1630
Glu Pro Leu Thr Gln Ala Val Gly Leu Ser Thr Gln Ala Glu Gly Thr
1635 1640 1645
Arg Thr Leu Lys Ser Leu Leu Met Phe Thr Met Glu Asn Cys Phe Tyr
1650 1655 1660
Leu Leu Ile Ser Gln Ala Met Arg Tyr Leu Arg Asp Pro Ala Val His
1665 1670 1675 1680
Pro Arg Asp Lys Gln Arg Met Lys Gln Glu Leu Ser Ser Glu Leu Ser
1685 1690 1695
Thr Leu Leu Ser Ser Leu Ser Arg Tyr Phe Arg Arg Gly Ala Pro Ser
1700 1705 1710
Ser Pro Ala Thr Gly Val Leu Pro Ser Pro Gln Gly Lys Ser Thr Ser
1715 1720 1725
Leu Ser Lys Ala Ser Pro Glu Ser Gln Glu Pro Leu Ile Gln Leu Val
1730 1735 1740
Gln Ala Phe Val Arg His Met Gln Arg
1745 1750
<210>13
<211>1753
<212>PRT
<213>人
<400>13
Met Ile Arg Lys Ser Lys Ile Thr Ser Val Leu Ser Phe Cys Arg Ser
1 5 10 15
Ser Arg Glu Leu Trp Thr Ile Leu Leu Gly Arg Ser Ala Leu Arg Glu
20 25 30
Leu Ser Gln Ile Glu Ala Glu Leu Asn Lys His Trp Arg Arg Leu Leu
35 40 45
Glu Gly Leu Ser Tyr Tyr Lys Pro Pro Ser Pro Ser Ser Ala Glu Lys
50 55 60
Val Lys Ala Asn Lys Asp Val Ala Ser Pro Leu Lys Glu Leu Gly Leu
65 70 75 80
Arg Ile Ser Lys Phe Leu Gly Leu Asp Glu Glu Gln Ser Val Gln Leu
85 90 95
Leu Gln Cys Tyr Leu Gln Glu Asp Tyr Arg Gly Thr Arg Asp Ser Val
100 105 110
Lys Thr Val Leu Gln Asp Glu Arg Gln Ser Gln Ala Leu Ile Leu Lys
115 120 125
Ile Ala Asp Tyr Tyr Tyr Glu Glu Arg Thr Cys Ile Leu Arg Cys Val
130 135 140
Leu His Leu Leu Thr Tyr Phe Gln Asp Glu Arg His Pro Tyr Arg Val
145 150 155 160
Glu Tyr Ala Asp Cys Val Asp Lys Leu Glu Lys Glu Leu Val Ser Lys
165 170 175
Tyr Arg Gln Gln Phe Glu Glu Leu Tyr Lys Thr Glu Ala Pro Thr Trp
180 185 190
Glu Thr His Gly Asn Leu Met Thr Glu Arg Gln Val Ser Arg Trp Phe
195 200 205
Val Gln Cys Leu Arg Glu Gln Ser Met Leu Leu Glu Ile Ile Phe Leu
210 215 220
Tyr Tyr Ala Tyr Phe Glu Met Ala Pro Ser Asp Leu Leu Val Leu Thr
225 230 235 240
Lys Met Phe Lys Glu Gln Gly Phe Gly Ser Arg Gln Thr Asn Arg His
245 250 255
Leu Val Asp Glu Thr Met Asp Pro Phe Val Asp Arg Ile Gly Tyr Phe
260 265 270
Ser Ala Leu Ile Leu Val Glu Gly Met Asp Ile Glu Ser Leu His Lys
275 280 285
Cys Ala Leu Asp Asp Arg Arg Glu Leu His Gln Phe Ala Gln Asp Gly
290 295 300
Leu Ile Cys Gln Asp Met Asp Cys Leu Met Leu Thr Phe Gly Asp Ile
305 310 315 320
Pro His His Ala Pro Val Leu Leu Ala Trp Ala Leu Leu Arg His Thr
325 330 335
Leu Asn Pro Glu Glu Thr Ser Ser Val Val Arg Lys Ile Gly Gly Thr
340 345 350
Ala Ile Gln Leu Asn Val Phe Gln Tyr Leu Thr Arg Leu Leu Gln Ser
355 360 365
Leu Ala Ser Gly Gly Asn Asp Cys Thr Thr Ser Thr Ala Cys Met Cys
370 375 380
Val Tyr Gly Leu Leu Ser Phe Val Leu Thr Ser Leu Glu Leu His Thr
385 390 395 400
Leu Gly Asn Gln Gln Asp Ile Ile Asp Thr Ala Cys Glu Val Leu Ala
405 410 415
Asp Pro Ser Leu Pro Glu Leu Phe Trp Gly Thr Glu Pro Thr Ser Gly
420 425 430
Leu Gly Ile Ile Leu Asp Ser Val Cys Gly Met Phe Pro His Leu Leu
435 440 445
Ser Pro Leu Leu Gln Leu Leu Arg Ala Leu Val Ser Gly Lys Ser Thr
450 455 460
Ala Lys Lys Val Tyr Ser Phe Leu Asp Lys Met Ser Phe Tyr Asn Glu
465 470 475 480
Leu Tyr Lys His Lys Pro His Asp Val Ile Ser His Glu Asp Gly Thr
485 490 495
Leu Trp Arg Arg Gln Thr Pro Lys Leu Leu Tyr Pro Leu Gly Gly Gln
500 505 510
Thr Asn Leu Arg Ile Pro Gln Gly Thr Val Gly Gln Val Met Leu Asp
515 520 525
Asp Arg Ala Tyr Leu Val Arg Trp Glu Tyr Ser Tyr Ser Ser Trp Thr
530 535 540
Leu Phe Thr Cys Glu Ile Glu Met Leu Leu His Val Val Ser Thr Ala
545 550 555 560
Asp Val Ile Gln His Cys Gln Arg Val Lys Pro Ile Ile Asp Leu Val
565 570 575
His Lys Val Ile Ser Thr Asp Leu Ser Ile Ala Asp Cys Leu Leu Pro
580 585 590
Ile Thr Ser Arg Ile Tyr Met Leu Leu Gln Arg Leu Thr Thr Val Ile
595 600 605
Ser Pro Pro Val Asp Val Ile Ala Ser Cys Val Asn Cys Leu Thr Val
610 615 620
Leu Ala Ala Arg Asn Pro Ala Lys Val Trp Thr Asp Leu Arg His Thr
625 630 635 640
Gly Phe Leu Pro Phe Val Ala His Pro Val Ser Ser Leu Ser Gln Met
645 650 655
Ile Ser Ala Glu Gly Met Asn Ala Gly Gly Tyr Gly Asn Leu Leu Met
660 665 670
Asn Ser Glu Gln Pro Gln Gly Glu Tyr Gly Val Thr Ile Ala Phe Leu
675 680 685
Arg Leu Ile Thr Thr Leu Val Lys Gly Gln Leu Gly Ser Thr Gln Ser
690 695 700
Gln Gly Leu Val Pro Cys Val Met Phe Val Leu Lys Glu Met Leu Pro
705 710 715 720
Ser Tyr His Lys Trp Arg Tyr Asn Ser His Gly Val Arg Glu Gln Ile
725 730 735
Gly Cys Leu Ile Leu Glu Leu Ile His Ala Ile Leu Asn Leu Cys His
740 745 750
Glu Thr Asp Leu His Ser Ser His Thr Pro Ser Leu Gln Phe Leu Cys
755 760 765
Ile Cys Ser Leu Ala Tyr Thr Glu Ala Gly Gln Thr Val Ile Asn Ile
770 775 780
Met Gly Ile Gly Val Asp Thr Ile Asp Met Val Met Ala Ala Gln Pro
785 790 795 800
Arg Ser Asp Gly Ala Glu Gly Gln Gly Gln Gly Gln Leu Leu Ile Lys
805 810 815
Thr Val Lys Leu Ala Phe Ser Val Thr Asn Asn Val Ile Arg Leu Lys
820 825 830
Pro Pro Ser Asn Val Val Ser Pro Leu Glu Gln Ala Leu Ser Gln His
835 840 845
Gly Ala His Gly Asn Asn Leu Ile Ala Val Leu Ala Lys Tyr Ile Tyr
850 855 860
His Lys His Asp Pro Ala Leu Pro Arg Leu Ala Ile Gln Leu Leu Lys
865 870 875 880
Arg Leu Ala Thr Val Ala Pro Met Ser Val Tyr Ala Cys Leu Gly Asn
885 890 895
Asp Ala Ala Ala Ile Arg Asp Ala Phe Leu Thr Arg Leu Gln Ser Lys
900 905 910
Ile Glu Asp Met Arg Ile Lys Val Met Ile Leu Glu Phe Leu Thr Val
915 920 925
Ala Val Glu Thr Gln Pro Gly Leu Ile Glu Leu Phe Leu Asn Leu Glu
930 935 940
Val Lys Asp Gly Ser Asp Gly Ser Lys Glu Phe Ser Leu Gly Met Trp
945 950 955 960
Ser Cys Leu His Ala Val Leu Glu Leu Ile Asp Ser Gln Gln Gln Asp
965 970 975
Arg Tyr Trp Cys Pro Pro Leu Leu His Arg Ala Ala Ile Ala Phe Leu
980 985 990
His Ala Leu Trp Gln Asp Arg Arg Asp Ser Ala Met Leu Val Leu Arg
995 1000 1005
Thr Lys Pro Lys Phe Trp Glu Asn Leu Thr Ser Pro Leu Phe Gly Thr
1010 1015 1020
Leu Ser Pro Pro Ser Glu Thr Ser Glu Pro Ser Ile Leu Glu Thr Cys
1025 1030 1035 1040
Ala Leu Ile Met Lys Ile Ile Cys Leu Glu Ile Tyr Tyr Val Val Lys
1045 1050 1055
Gly Ser Leu Asp Gln Ser Leu Lys Asp Thr Leu Lys Lys Phe Ser Ile
1060 1065 1070
Glu Lys Arg Phe Ala Tyr Trp Ser Gly Tyr Val Arg Ser Leu Ala Val
1075 1080 1085
His Val Ala Glu Thr Glu Gly Ser Ser Cys Thr Ser Leu Leu Glu Tyr
1090 1095 1100
Gln Met Leu Val Ser Ala Trp Arg Met Leu Leu Ile Ile Ala Thr Thr
1105 1110 1115 1120
His Ala Asp Ile Met His Leu Thr Asp Ser Val Val Arg Arg Gln Leu
1125 1130 1135
Phe Leu Asp Val Leu Asp Gly Thr Lys Ala Leu Leu Leu Val Pro Ala
1140 1145 1150
Ser Val Asn Cys Leu Arg Leu Gly Ser Met Lys Cys Thr Leu Leu Leu
1155 1160 1165
Ile Leu Leu Arg Gln Trp Lys Arg Glu Leu Gly Ser Val Asp Glu Ile
1170 1175 1180
Leu Gly Pro Leu Thr Glu Ile Leu Glu Gly Val Leu Gln Ala Asp Gln
1185 1190 1195 1200
Gln Leu Met Glu Lys Thr Lys Ala Lys Val Phe Ser Ala Phe Ile Thr
1205 1210 1215
Val Leu Gln Met Lys Glu Met Lys Val Ser Asp Ile Pro Gln Tyr Ser
1220 1225 1230
Gln Leu Val Leu Asn Val Cys Glu Thr Leu Gln Glu Glu Val Ile Ala
1235 1240 1245
Leu Phe Asp Gln Thr Arg His Ser Leu Ala Leu Gly Ser Ala Thr Glu
1250 1255 1260
Asp Lys Asp Ser Met Glu Thr Asp Asp Cys Ser Arg Ser Arg His Arg
1265 1270 1275 1280
Asp Gln Arg Asp Gly Val Cys Val Leu Gly Leu His Leu Ala Lys Glu
1285 1290 1295
Leu Cys Glu Val Asp Glu Asp Gly Asp Ser Trp Leu Gln Val Thr Arg
1300 1305 1310
Arg Leu Pro Ile Leu Pro Thr Leu Leu Thr Thr Leu Glu Val Ser Leu
1315 1320 1325
Arg Met Lys Gln Asn Leu His Phe Thr Glu Ala Thr Leu His Leu Leu
1330 1335 1340
Leu Thr Leu Ala Arg Thr Gln Gln Gly Ala Thr Ala Val Ala Gly Ala
1345 1350 1355 1360
Gly Ile Thr Gln Ser Ile Cys Leu Pro Leu Leu Ser Val Tyr Gln Leu
1365 1370 1375
Ser Thr Asn Gly Thr Ala Gln Thr Pro Ser Ala Ser Arg Lys Ser Leu
1380 1385 1390
Asp Ala Pro Ser Trp Pro Gly Val Tyr Arg Leu Ser Met Ser Leu Met
1395 1400 1405
Glu Gln Leu Leu Lys Thr Leu Arg Tyr Asn Phe Leu Pro Glu Ala Leu
1410 1415 1420
Asp Phe Val Gly Val His Gln Glu Arg Thr Leu Gln Cys Leu Asn Ala
1425 1430 1435 1440
Val Arg Thr Val Gln Ser Leu Ala Cys Leu Glu Glu Ala Asp His Thr
1445 1450 1455
Val Gly Phe Ile Leu Gln Leu Ser Asn Phe Met Lys Glu Trp His Phe
1460 1465 1470
His Leu Pro Gln Leu Met Arg Asp Ile Gln Val Asn Leu Gly Tyr Leu
1475 1480 1485
Cys Gln Ala Cys Thr Ser Leu Leu His Ser Arg Lys Met Leu Gln His
1490 1495 1500
Tyr Leu Gln Asn Lys Asn Gly Asp Gly Leu Pro Ser Ala Val Ala Gln
1505 1510 1515 1520
Arg Val Gln Arg Pro Pro Ser Ala Ala Ser Ala Ala Pro Ser Ser Ser
1525 1530 1535
Lys Gln Pro Ala Ala Asp Thr Glu Ala Ser Glu Gln Gln Ala Leu His
1540 1545 1550
Thr Val Gln Tyr Gly Leu Leu Lys Ile Leu Ser Lys Thr Leu Ala Ala
1555 1560 1565
Leu Arg His Phe Thr Pro Asp ValCys Gln Ile Leu Leu Asp Gln Ser
1570 1575 1580
Leu Asp Leu Ala Glu Tyr Asn Phe Leu Phe Ala Leu Ser Phe Thr Thr
1585 1590 1595 1600
Pro Thr Phe Asp Ser Glu Val Ala Pro Ser Phe Gly Thr Leu Leu Ala
1605 1610 1615
Thr Val Asn Val Ala Leu Asn Met Leu Gly Glu Leu Asp Lys Lys Lys
1620 1625 1630
Glu Pro Leu Thr Gln Ala Val Gly Leu Ser Thr Gln Ala Glu Gly Thr
1635 1640 1645
Arg Thr Leu Lys Ser Leu Leu Met Phe Thr Met Glu Asn Cys Phe Tyr
1650 1655 1660
Leu Leu Ile Ser Gln Ala Met Arg Tyr Leu Arg Asp Pro Ala Val His
1665 1670 1675 1680
Pro Arg Asp Lys Gln Arg Met Lys Gln Glu Leu Ser Ser Glu Leu Ser
1685 1690 1695
Thr Leu Leu Ser Ser Leu Ser Arg Tyr Phe Arg Arg Gly Ala Pro Ser
1700 1705 1710
Ser Pro Ala Thr Gly Val Leu Pro Ser Pro Gln Gly Lys Ser Thr Ser
1715 1720 1725
Leu Ser Lys Ala Ser Pro Glu Ser Gln Glu Pro Leu Ile Gln Leu Val
1730 1735 1740
Gln Ala Phe Val Arg His Met Gln Arg
1745 1750
<210>14
<211>1753
<212>PRT
<213>人
<400>14
Met Ile Arg Lys Ser Lys lle Thr Ser Val Leu Ser Phe Cys Arg Ser
1 5 10 15
Ser Arg Glu Leu Trp Thr Ile Leu Leu Gly Arg Ser Ala Leu Arg Glu
20 25 30
Leu Ser Gln Ile Glu Ala Glu Leu Asn Lys His Trp Arg Arg Leu Leu
35 40 45
Glu Gly Leu Ser Tyr Tyr Lys Pro Pro Ser Pro Ser Ser Ala Glu Lys
50 55 60
Val Lys Ala Asn Lys Asp Val Ala Ser Pro Leu Lys Glu Leu Gly Leu
65 70 75 80
Arg Ile Ser Lys Phe Leu Gly Leu Asp Glu Glu Gln Ser Val Gln Leu
85 90 95
Leu Gln Cys Tyr Leu Gln Glu Asp Tyr Arg Gly Thr Arg Asp Ser Val
100 105 110
Lys Thr Val Leu Gln Asp Glu Arg Gln Ser Gln Ala Leu Ile Leu Lys
115 120 125
Ile Ala Asp Tyr Tyr Tyr Glu Glu Arg Thr Cys Ile Leu Arg Cys Val
130 135 140
Leu His Leu Leu Thr Tyr Phe Gln Asp Glu Arg His Pro Tyr Arg Val
145 150 155 160
Glu Tyr Ala Asp Cys Val Asp Lys Leu Glu Lys Glu Leu Val Ser Lys
165 170 175
Tyr Arg Gln Gln Phe Glu Glu Leu Tyr Lys Thr Glu Ala Pro Thr Trp
180 185 190
Glu Thr His Gly Asn Leu Met Thr Glu Arg Gln Val Ser Arg Trp Phe
195 200 205
Val Gln Cys Leu Arg Glu Gln Ser Met Leu Leu Glu Ile Ile Phe Leu
210 215 220
Tyr Tyr Ala Tyr Phe Glu Met Ala Pro Ser Asp Leu Leu Val Leu Thr
225 230 235 240
Lys Met Phe Lys Glu Gln Gly Phe Gly Ser Arg Gln Thr Asn Arg His
245 250 255
Leu Val Asp Glu Thr Met Asp Pro Phe Val Asp Arg Ile Gly Tyr Phe
260 265 270
Ser Ala Leu Ile Leu Val Glu Gly Met Asp Ile Glu Ser Leu His Lys
275 280 285
Cys Ala Leu Asp Asp Arg Arg Glu Leu His Gln Phe Ala Gln Asp Gly
290 295 300
Leu Ile Cys Gln Asp Met Asp Cys Leu Met Leu Thr Phe Gly Asp Ile
305 310 315 320
Pro His His Ala Pro Val Leu Leu Ala Trp Ala Leu Leu Arg His Thr
325 330 335
Leu Asn Pro Glu Glu Thr Ser Ser Val Val Arg Lys Ile Gly Gly Thr
340 345 350
Ala Ile Gln Leu Asn Val Phe Gln Tyr Leu Thr Arg Leu Leu Gln Ser
355 360 365
Leu Ala Ser Gly Gly Asn Asp Cys Thr Thr Ser Thr Ala Cys Met Cys
370 375 380
Val Tyr Gly Leu Leu Ser Phe Val Leu Thr Ser Leu Glu Leu His Thr
385 390 395 400
Leu Gly Asn Gln Gln Asp Ile Ile Asp Thr Ala Cys Glu Val Leu Ala
405 410 415
Asp Pro Ser Leu Pro Glu Leu Phe Trp Gly Thr Glu Pro Thr Ser Gly
420 425 430
Leu Gly Ile Ile Leu Asp Ser Val Cys Gly Met Phe Pro His Leu Leu
435 440 445
Ser Pro Leu Leu Gln Leu Leu Arg Ala Leu Val Ser Gly Lys Ser Thr
450 455 460
Ala Lys Lys Val Tyr Ser Phe Leu Asp Lys Met Ser Phe Tyr Asn Glu
465 470 475 480
Leu Tyr Lys His Lys Pro His Asp Val Ile Ser His Glu Asp Gly Thr
485 490 495
Leu Trp Arg Arg Gln Thr Pro Lys Leu Leu Tyr Pro Leu Gly Gly Gln
500 505 510
Thr Asn Leu Arg Ile Pro Gln Gly Thr Val Gly Gln Val Met Leu Asp
515 520 525
Asp Arg Ala Tyr Leu Val Arg Trp Glu Tyr Ser Tyr Ser Ser Trp Thr
530 535 540
Leu Phe Thr Cys Glu Ile Glu Met Leu Leu His Val Val Ser Thr Ala
545 550 555 560
Asp Val Ile Gln His Cys Gln Arg Val Lys Pro Ile Ile Asp Leu Val
565 570 575
His Lys Val Ile Ser Thr Asp Leu Ser Ile Ala Asp Cys Leu Leu Pro
580 585 590
Ile Thr Ser Arg Ile Tyr Met Leu Leu Gln Arg Leu Thr Thr Val Ile
595 600 605
Ser Pro Pro Val Asp Val Ile Ala Ser Cys Val Asn Cys Leu Thr Val
610 615 620
Leu Ala Ala Arg Asn Pro Ala Lys Val Trp Thr Asp Leu Arg His Thr
625 630 635 640
Gly Phe Leu Pro Phe Val Ala His Pro Val Ser Ser Leu Ser Gln Met
645 650 655
Ile Ser Ala Glu Gly Met Asn Ala Gly Gly Tyr Gly Asn Leu Leu Met
660 665 670
Asn Ser Glu Gln Pro Gln Gly Glu Tyr Gly Val Thr Ile Ala Phe Leu
675 680 685
Arg Leu Ile Thr Thr Leu Val Lys Gly Gln Leu Gly Ser Thr Gln Ser
690 695 700
Gln Gly Leu Val Pro Cys Val Met Phe Val Leu Lys Glu Met Leu Pro
705 710 715 720
Ser Tyr His Lys Trp Arg Tyr Asn Ser His Gly Val Arg Glu Gln Ile
725 730 735
Gly Cys Leu Ile Leu Glu Leu Ile His Ala Ile Leu Asn Leu Cys His
740 745 750
Glu Thr Asp Leu His Ser Ser His Thr Pro Ser Leu Gln Phe Leu Cys
755 760 765
Ile Cys Ser Leu Ala Tyr Thr Glu Ala Gly Gln Thr Val Ile Asn Ile
770 775 780
Met Gly Ile Gly Val Asp Thr Ile Asp Met Val Met Ala Ala Gln Pro
785 790 795 800
Arg Ser Asp Gly Ala Glu Gly Gln Gly Gln Gly Gln Leu Leu Ile Lys
805 810 815
Thr Val Lys Leu Ala Phe Ser Val Thr Asn Asn Val Ile Arg Leu Lys
820 825 830
Pro Pro Ser Asn Val Val Ser Pro Leu Glu Gln Ala Leu Ser Gln His
835 840 845
Gly Ala His Gly Asn Asn Leu Ile Ala Val Leu Ala Lys Tyr Ile Tyr
850 855 860
His Lys His Asp Pro Ala Leu Pro Arg Leu Ala Ile Gln Leu Leu Lys
865 870 875 880
Arg Leu Ala Thr Val Ala Pro Met Ser Val Tyr Ala Cys Leu Gly Asn
885 890 895
Asp Ala Ala Ala Ile Arg Asp Ala Phe Leu Thr Arg Leu Gln Ser Lys
900 905 910
Ile Glu Asp Met Arg Ile Lys Val Met Ile Leu Glu Phe Leu Thr Val
915 920 925
Ala Val Glu Thr Gln Pro Gly Leu Ile Glu Leu Phe Leu Asn Leu Glu
930 935 940
Val Lys Asp Gly Ser Asp Gly Ser Lys Glu Phe Ser Leu Gly Met Trp
945 950 955 960
Ser Cys Leu His Ala Val Leu Glu Leu Ile Asp Ser Gln Gln Gln Asp
965 970 975
Arg Tyr Trp Cys Pro Pro Leu Leu His Arg Ala Ala Ile Ala Phe Leu
980 985 990
His Ala Leu Trp Gln Asp Arg Arg Asp Ser Ala Met Leu Val Leu Arg
995 1000 1005
Thr Lys Pro Lys Phe Trp Glu Asn Leu Thr Ser Pro Leu Phe Gly Thr
1010 1015 1020
Leu Ser Pro Pro Ser Glu Thr Ser Glu Pro Ser Ile Leu Glu Thr Cys
1025 1030 1035 1040
Ala Leu Ile Met Lys Ile Ile Cys Leu Glu Ile Tyr Tyr Val Val Lys
1045 1050 1055
Gly Ser Leu Asp Gln Ser Leu Lys Asp Thr Leu Lys Lys Phe Ser Ile
1060 1065 1070
Glu Lys Arg Phe Ala Tyr Trp Ser Gly Tyr Val Lys Ser Leu Ala Val
1075 1080 1085
His Val Ala Glu Thr Glu Gly Ser Ser Cys Thr Ser Leu Leu Glu Tyr
1090 1095 1100
Gln Met Leu Val Ser Ala Trp Arg Met Leu Leu Ile Ile Ala Thr Thr
1105 1110 1115 1120
His Ala Asp Ile Met His Leu Thr Asp Ser Val Val Arg Arg Gln Leu
1125 1130 1135
Phe Leu Asp Val Leu Asp Gly Thr Lys Ala Leu Leu Leu Val Pro Ser
1140 1145 1150
Ser Val Asn Cys Leu Arg Leu Gly Ser Met Lys Cys Thr Leu Leu Leu
1155 1160 1165
Ile Leu Leu Arg Gln Trp Lys Arg Glu Leu Gly Ser Val Asp Glu Ile
1170 1175 1180
Leu Gly Pro Leu Thr Glu Ile Leu Glu Gly Val Leu Gln Ala Asp Gln
1185 1190 1195 1200
Gln Leu Met Glu Lys Thr Lys Ala Lys Val Phe Ser Ala Phe Ile Thr
1205 1210 1215
Val Leu Gln Met Lys Glu Met Lys Val Ser Asp Ile Pro Gln Tyr Ser
1220 1225 1230
Gln Leu Val Leu Asn Val Cys Glu Thr Leu Gln Glu Glu Val Ile Ala
1235 1240 1245
Leu Phe Asp Gln Thr Arg His Ser Leu Ala Leu Gly Ser Ala Thr Glu
1250 1255 1260
Asp Lys Asp Ser Met Glu Thr Asp Asp Cys Ser Arg Ser Arg His Arg
1265 1270 1275 1280
Asp Gln Arg Asp Gly Val Cys Val Leu Gly Leu His Leu Ala Lys Glu
1285 1290 1295
Leu Cys Glu Val Asp Glu Asp Gly Asp Ser Trp Leu Gln Val Thr Arg
1300 1305 1310
Arg Leu Pro Ile Leu Pro Thr Leu Leu Thr Thr Leu Glu Val Ser Leu
1315 1320 1325
Arg Met Lys Gln Asn Leu His Phe Thr Glu Ala Thr Leu His Leu Leu
1330 1335 1340
Leu Thr Leu Ala Arg Thr Gln Gln Gly Ala Thr Ala Val Ala Gly Ala
1345 1350 1355 1360
Gly Ile Thr Gln Ser Ile Cys Leu Pro Leu Leu Ser Val Tyr Gln Leu
1365 1370 1375
Ser Thr Asn Gly Thr Ala Gln Thr Pro Ser Ala Ser Arg Lys Ser Leu
1380 1385 1390
Asp Ala Pro Ser Trp Pro Gly Val Tyr Arg Leu Ser Met Ser Leu Met
1395 1400 1405
Glu Gln Leu Leu Lys Thr Leu Arg Tyr Asn Phe Leu Pro Glu Ala Leu
1410 1415 1420
Asp Phe Val Gly Val His Gln Glu Arg Thr Leu Gln Cys Leu Asn Ala
1425 1430 1435 1440
Val Arg Thr Val Gln Ser Leu Ala Cys Leu Glu Glu Ala Asp His Thr
1445 1450 1455
Val Gly Phe Ile Leu Gln Leu Ser Asn Phe Met Lys Glu Trp His Phe
1460 1465 1470
His Leu Pro Gln Leu Met Arg Asp Ile Gln Val Asn Leu Gly Tyr Leu
1475 1480 1485
Cys Gln Ala Cys Thr Ser Leu Leu His Ser Arg Lys Met Leu Gln His
1490 1495 1500
Tyr Leu Gln Asn Lys Asn Gly Asp Gly Leu Pro Ser Ala Val Ala Gln
1505 1510 1515 1520
Arg Val Gln Arg Pro Pro Ser Ala Ala Ser Ala Ala Pro Ser Ser Ser
1525 1530 1535
Lys Gln Pro Ala Ala Asp Thr Glu Ala Ser Glu Gln Gln Ala Leu His
1540 1545 1550
Thr Val Gln Tyr Gly Leu Leu Lys Ile Leu Ser Lys Thr Leu Ala Ala
1555 1560 1565
Leu Arg His Phe Thr Pro Asp Val Cys Gln Ile Leu Leu Asp Gln Ser
1570 1575 1580
Leu Asp Leu Ala Glu Tyr Asn Phe Leu Phe Ala Leu Ser Phe Thr Thr
1585 1590 1595 1600
Pro Thr Phe Asp Ser Glu Val Ala Pro Ser Phe Gly Thr Leu Leu Ala
1605 1610 1615
Thr Val Asn Val Ala Leu Asn Met Leu Gly Glu Leu Asp Lys Lys Lys
1620 1625 1630
Glu Pro Leu Thr Gln Ala Val Gly Leu Ser Thr Gln Ala Glu Gly Thr
1635 1640 1645
Arg Thr Leu Lys Ser Leu Leu Met Phe Thr Met Glu Asn Cys Phe Tyr
1650 1655 1660
Leu Leu Ile Ser Gln Ala Met Arg Tyr Leu Arg Asp Pro Ala Val His
1665 1670 1675 1680
Pro Arg Asp Lys Gln Arg Met Lys Gln Glu Leu Ser Ser Glu Leu Ser
1685 1690 1695
Thr Leu Leu Ser Ser Leu Ser Arg Tyr Phe Arg Arg Gly Ala Pro Ser
1700 1705 1710
Ser Pro Ala Thr Gly Val Leu Pro Ser Pro Gln Gly Lys Ser Thr Ser
1715 1720 1725
Leu Ser Lys Ala Ser Pro Glu Ser Gln Glu Pro Leu Ile Gln Leu Val
1730 1735 1740
Gln Ala Phe Val Arg His Met Gln Arg
1745 1750
<210>15
<211>1753
<212>PRT
<213>人
<400>15
Met Ile Arg Lys Ser Lys Ile Thr Ser Val Leu Ser Phe Cys Arg Ser
1 5 10 15
Ser Arg Glu Leu Trp Thr Ile Leu Leu Gly Arg Ser Ala Leu Arg Glu
20 25 30
Leu Ser Gln Ile Glu Ala Glu Leu Asn Lys His Trp Arg Arg Leu Leu
35 40 45
Glu Gly Leu Ser Tyr Tyr Lys Pro Pro Ser Pro Ser Ser Ala Glu Lys
50 55 60
Val Lys Ala Asn Lys Asp Val Ala Ser Pro Leu Lys Glu Leu Gly Leu
65 70 75 80
Arg Ile Ser Lys Phe Leu Gly Leu Asp Glu Glu Gln Ser Val Gln Leu
85 90 95
Leu Gln Cys Tyr Leu Gln Glu Asp Tyr Arg Gly Thr Arg Asp Ser Val
100 105 110
Lys Thr Val Leu Gln Asp Glu Arg Gln Ser Gln Ala Leu Ile Leu Lys
115 120 125
Ile Ala Asp Tyr Tyr Tyr Glu Glu Arg Thr Cys Ile Leu Arg Cys Val
130 135 140
Leu His Leu Leu Thr Tyr Phe Gln Asp Glu Arg His Pro Tyr Arg Val
145 150 155 160
Glu Tyr Ala Asp Cys Val Asp Lys Leu Glu Lys Glu Leu Val Ser Lys
165 170 175
Tyr Arg Gln Gln Phe Glu Glu Leu Tyr Lys Thr Glu Ala Pro Thr Trp
180 185 190
Glu Thr His Gly Asn Leu Met Thr Glu Arg Gln Val Ser Arg Trp Phe
195 200 205
Val Gln Cys Leu Arg Glu Gln Ser Met Leu Leu Glu Ile Ile Phe Leu
210 215 220
Tyr Tyr Ala Tyr Phe Glu Met Ala Pro Ser Asp Leu Leu Val Leu Thr
225 230 235 240
Lys Met Phe Lys Glu Gln Gly Phe Gly Ser Arg Gln Thr Asn Arg His
245 250 255
Leu Val Asp Glu Thr Met Asp Pro Phe Val Asp Arg Ile Gly Tyr Phe
260 265 270
Ser Ala Leu Ile Leu Val Glu Gly Met Asp Ile Glu Ser Leu His Lys
275 280 285
Cys Ala Leu Asp Asp Arg Arg Glu Leu His Gln Phe Ala Gln Asp Gly
290 295 300
Leu Ile Cys Gln Asp Met Asp Cys Leu Met Leu Thr Phe Gly Asp Ile
305 310 315 320
Pro His His Ala Pro Val Leu Leu Ala Trp Ala Leu Leu Arg His Thr
325 330 335
Leu Asn Pro Glu Glu Thr Ser Ser Val Val Arg Lys Ile Gly Gly Thr
340 345 350
Ala Ile Gln Leu Asn Val Phe Gln Tyr Leu Thr Arg Leu Leu Gln Ser
355 360 365
Leu Ala Ser Gly Gly Asn Asp Cys Thr Thr Ser Thr Ala Cys Met Cys
370 375 380
Val Tyr Gly Leu Leu Ser Phe Val Leu Thr Ser Leu Glu Leu His Thr
385 390 395 400
Leu Gly Asn Gln Gln Asp Ile Ile Asp Thr Ala Cys Glu Val Leu Ala
405 410 415
Asp Pro Ser Leu Pro Glu Leu Phe Trp Gly Thr Glu Pro Thr Ser Gly
420 425 430
Leu Gly Ile Ile Leu Asp Ser Val Cys Gly Met Phe Pro His Leu Leu
435 440 445
Ser Pro Leu Leu Gln Leu Leu Arg Ala Leu Val Ser Gly Lys Ser Thr
450 455 460
Ala Lys Lys Val Tyr Ser Phe Leu Asp Lys Met Ser Phe Tyr Asn Glu
465 470 475 480
Leu Tyr Lys His Lys Pro His Asp Val Ile Ser His Glu Asp Gly Thr
485 490 495
Leu Trp Arg Arg Gln Thr Pro Lys Leu Leu Tyr Pro Leu Gly Gly Gln
500 505 510
Thr Asn Leu Arg Ile Pro Gln Gly Thr Val Gly Gln Val Met Leu Asp
515 520 525
Asp Arg Ala Tyr Leu Val Arg Trp Glu Tyr Ser Tyr Ser Ser Trp Thr
530 535 540
Leu Phe Thr Cys Glu Ile Glu Met Leu Leu His Val Val Ser Thr Ala
545 550 555 560
Asp Val Ile Gln His Cys Gln Arg Val Lys Pro Ile Ile Asp Leu Val
565 570 575
His Lys Val Ile Ser Thr Asp Leu Ser Ile Ala Asp Cys Leu Leu Pro
580 585 590
Ile Thr Ser Arg Ile Tyr Met Leu Leu Gln Arg Leu Thr Thr Val Ile
595 600 605
Ser Pro Pro Val Asp Val Ile Ala Ser Cys Val Asn Cys Leu Thr Val
610 615 620
Leu Ala Ala Arg Asn Pro Ala Lys Val Trp Thr Asp Leu Arg His Thr
625 630 635 640
Gly Phe Leu Pro Phe Val Ala His Pro Val Ser Ser Leu Ser Gln Met
645 650 655
Ile Ser Ala Glu Gly Met Asn Ala Gly Gly Tyr Gly Asn Leu Leu Met
660 665 670
Asn Ser Glu Gln Pro Gln Gly Glu Tyr Gly Val Thr Ile Ala Phe Leu
675 680 685
Arg Leu Ile Thr Thr Leu Val Lys Gly Gln Leu Gly Ser Thr Gln Ser
690 695 700
Gln Gly Leu Val Pro Cys Val Met Phe Val Leu Lys Glu Met Leu Pro
705 710 715 720
Ser Tyr His Lys Trp Arg Tyr Asn Ser His Gly Val Arg Glu Gln Ile
725 730 735
Gly Cys Leu Ile Leu Glu Leu Ile His Ala Ile Leu Asn Leu Cys His
740 745 750
Glu Thr Asp Leu His Ser Ser His Thr Pro Ser Leu Gln Phe Leu Cys
755 760 765
Ile Cys Ser Leu Ala Tyr Thr Glu Ala Gly Gln Thr Val Ile Asn Ile
770 775 780
Met Gly Ile Gly Val Asp Thr Ile Asp Met Val Met Ala Ala Gln Pro
785 790 795 800
Arg Ser Asp Gly Ala Glu Gly Gln Gly Gln Gly Gln Leu Leu Ile Lys
805 810 815
Thr Val Lys Leu Ala Phe Ser Val Thr Asn Asn Val Ile Arg Leu Lys
820 825 830
Pro Pro Ser Asn Val Val Ser Pro Leu Glu Gln Ala Leu Ser Gln His
835 840 845
Gly Ala His Gly Asn Asn Leu Ile Ala Val Leu Ala Lys Tyr Ile Tyr
850 855 860
His Lys His Asp Pro Ala Leu Pro Arg Leu Ala Ile Gln Leu Leu Lys
865 870 875 880
Arg Leu Ala Thr Val Ala Pro Met Ser Val Tyr Ala Cys Leu Gly Asn
885 890 895
Asp Ala Ala Ala Ile Arg Asp Ala Phe Leu Thr Arg Leu Gln Ser Lys
900 905 910
Ile Glu Asp Met Arg Ile Lys Val Met Ile Leu Glu Phe Leu Thr Val
915 920 925
Ala Val Glu Thr Gln Pro Gly Leu Ile Glu Leu Phe Leu Asn Leu Glu
930 935 940
Val Lys Asp Gly Ser Asp Gly Ser Lys Glu Phe Ser Leu Gly Met Trp
945 950 955 960
Ser Cys Leu His Ala Val Leu Glu Leu Ile Asp Ser Gln Gln Gln Asp
965 970 975
Arg Tyr Trp Cys Pro Pro Leu Leu His Arg Ala Ala Ile Ala Phe Leu
980 985 990
His Ala Leu Trp Gln Asp Arg Arg Asp Ser Ala Met Leu Val Leu Arg
995 1000 1005
Thr Lys Pro Lys Phe Trp Glu Asn Leu Thr Ser Pro Leu Phe Gly Thr
1010 1015 1020
Leu Ser Pro Pro Ser Glu Thr Ser Glu Pro Ser Ile Leu Glu Thr Cys
1025 1030 1035 1040
Ala Leu Ile Met Lys Ile Ile Cys Leu Glu Ile Tyr Tyr Val Val Lys
1045 1050 1055
Gly Ser Leu Asp Gln Ser Leu Lys Asp Thr Leu Lys Lys Phe Ser Ile
1060 1065 1070
Glu Lys Arg Phe Ala Tyr Trp Ser Gly Tyr Val Lys Ser Leu Ala Val
1075 1080 1085
His Val Ala Glu Thr Glu Gly Ser Ser Cys Thr Ser Leu Leu Glu Tyr
1090 1095 1100
Gln Met Leu Val Ser Ala Trp Arg Met Leu Leu Ile Ile Ala Thr Thr
1105 1110 1115 1120
His Ala Asp Ile Met His Leu Thr Asp Ser Val Val Arg Arg Gln Leu
1125 1130 1135
Phe Leu Asp Val Leu Asp Gly Thr Lys Ala Leu Leu Leu Val Pro Ser
1140 1145 1150
Ser Val Asn Cys Leu Arg Leu Gly Ser Met Lys Cys Thr Leu Leu Leu
1155 1160 1165
Ile Leu Leu Arg Gln Trp Lys Arg Glu Leu Gly Ser Val Asp Glu Ile
1170 1175 1180
Leu Gly Pro Leu Thr Glu Ile Leu Glu Gly Val Leu Gln Ala Asp Gln
1185 1190 1195 1200
Gln Leu Met Glu Lys Thr Lys Ala Lys Val Phe Ser Ala Phe Ile Thr
1205 1210 1215
Val Leu Gln Met Lys Glu Met Lys Val Ser Asp Ile Pro Gln Tyr Ser
1220 1225 1230
Gln Leu Val Leu Asn Val Cys Glu Thr Leu Gln Glu Glu Val Val Ala
1235 1240 1245
Leu Phe Asp Gln Thr Arg His Ser Leu Ala Leu Gly Ser Ala Thr Glu
1250 1255 1260
Asp Lys Asp Ser Met Glu Thr Asp Asp Cys Ser Arg Ser Arg His Arg
1265 1270 1275 1280
Asp Gln Arg Asp Gly Val Cys Val Leu Gly Leu His Leu Ala Lys Glu
1285 1290 1295
Leu Cys Glu Val Asp Glu Asp Gly Asp Ser Trp Leu Gln Val Thr Arg
1300 1305 1310
Arg Leu Pro Ile Leu Pro Thr Leu Leu Thr Thr Leu Glu Val Ser Leu
1315 1320 1325
Arg Met Lys Gln Asn Leu His Phe Thr Glu Ala Thr Leu His Leu Leu
1330 1335 1340
Leu Thr Leu Ala Arg Thr Gln Gln Gly Ala Thr Ala Val Ala Gly Ala
1345 1350 1355 1360
Gly Ile Thr Gln Ser Ile Cys Leu Pro Leu Leu Ser Val Tyr Gln Leu
1365 1370 1375
Ser Thr Asn Gly Thr Ala Gln Thr Pro Ser Ala Ser Arg Lys Ser Leu
1380 1385 1390
Asp Ala Pro Ser Trp Pro Gly Val Tyr Arg Leu Ser Met Ser Leu Met
1395 1400 1405
Glu Gln Leu Leu Lys Thr Leu Arg Tyr Asn Phe Leu Pro Glu Ala Leu
1410 1415 1420
Asp Phe Val Gly Val His Gln Glu Arg Thr Leu Gln Cys Leu Asn Ala
142 1430 1435 1440
Val Arg Thr Val Gln Ser Leu Ala Cys Leu Glu Glu Ala Asp His Thr
1445 1450 1455
Val Gly Phe Ile Leu Gln Leu Ser Asn Phe Met Lys Glu Trp His Phe
1460 1465 1470
His Leu Pro Gln Leu Met Arg Asp Ile Gln Val Asn Leu Gly Tyr Leu
1475 1480 1485
Cys Gln Ala Cys Thr Ser Leu Leu His Ser Arg Lys Met Leu Gln His
1490 1495 1500
Tyr Leu Gln Asn Lys Asn Gly Asp Gly Leu Pro Ser Ala Val Ala Gln
1505 1510 1515 1520
Arg Val Gln Arg Pro Pro Ser Ala Ala Ser Ala Ala Pro Ser Ser Ser
1525 1530 1535
Lys Gln Pro Ala Ala Asp Thr Glu Ala Ser Glu Gln Gln Ala Leu His
1540 1545 1550
Thr Val Gln Tyr Gly Leu Leu Lys Ile Leu Ser Lys Thr Leu Ala Ala
1555 1560 1565
Leu Arg His Phe Thr Pro Asp Val Cys Gln Ile Leu Leu Asp Gln Ser
1570 1575 1580
Leu Asp Leu Ala Glu Tyr Asn Phe Leu Phe Ala Leu Ser Phe Thr Thr
1585 1590 1595 1600
Pro Thr Phe Asp Ser Glu Val Ala Pro Ser Phe Gly Thr Leu Leu Ala
1605 1610 1615
Thr Val Asn Val Ala Leu Asn Met Leu Gly Glu Leu Asp Lys Lys Lys
1620 1625 1630
Glu Pro Leu Thr Gln Ala Val Gly Leu Ser Thr Gln Ala Glu Gly Thr
1635 1640 1645
Arg Thr Leu Lys Ser Leu Leu Met Phe Thr Met Glu Asn Cys Phe Tyr
1650 1655 1660
Leu Leu Ile Ser Gln Ala Met Arg Tyr Leu Arg Asp Pro Ala Val His
1665 1670 1675 1680
Pro Arg Asp Lys Gln Arg Met Lys Gln Glu Leu Ser Ser Glu Leu Ser
1685 1690 1695
Thr Leu Leu Ser Ser Leu Ser Arg Tyr Phe Arg Arg Gly Ala Pro Ser
1700 1705 1710
Ser Pro Ala Thr Gly Val Leu Pro Ser Pro Gln Gly Lys Ser Thr Ser
1715 1720 1725
Leu Ser Lys Ala Ser Pro Glu Ser Gln Glu Pro Leu Ile Gln Leu Val
1730 1735 1740
Gln Ala Phe Val Arg His Met Gln Arg
1745 1750
<210>16
<211>1753
<212>PRT
<213>人
<400>16
Met Ile Arg Lys Ser Lys Ile Thr Ser Val Leu Ser Phe Cys Arg Ser
1 5 10 15
Ser Arg Glu Leu Trp Thr Ile Leu Leu Gly Arg Ser Ala Leu Arg Glu
20 25 30
Leu Ser Gln Ile Glu Ala Glu Leu Asn Lys His Trp Arg Arg Leu Leu
35 40 45
Glu Gly Leu Ser Tyr Tyr Lys Pro Pro Ser Pro Ser Ser Ala Glu Lys
50 55 60
Val Lys Ala Asn Lys Asp Val Ala Ser Pro Leu Lys Glu Leu Gly Leu
65 70 75 80
Arg Ile Ser Lys Phe Leu Gly Leu Asp Glu Glu Gln Ser Val Gln Leu
85 90 95
Leu Gln Cys Tyr Leu Gln Glu Asp Tyr Arg Gly Thr Arg Asp Ser Val
100 105 110
Lys Thr Val Leu Gln Asp Glu Arg Gln Ser Gln Ala Leu Ile Leu Lys
115 120 125
Ile Ala Asp Tyr Tyr Tyr Glu Glu Arg Thr Cys Ile Leu Arg Cys Val
130 135 140
Leu His Leu Leu Thr Tyr Phe Gln Asp Glu Arg His Pro Tyr Arg Val
145 150 155 160
Glu Tyr Ala Asp Cys Val Asp Lys Leu Glu Lys Glu Leu Val Ser Lys
165 170 175
Tyr Arg Gln Gln Phe Glu Glu Leu Tyr Lys Thr Glu Ala Pro Thr Trp
180 185 190
Glu Thr His Gly Asn Leu Met Thr Glu Arg Gln Val Ser Arg Trp Phe
195 200 205
Val Gln Cys Leu Arg Glu Gln Ser Met Leu Leu Glu Ile Ile Phe Leu
210 215 220
Tyr Tyr Ala Tyr Phe Glu Met Ala Pro Ser Asp Leu Leu Val Leu Thr
225 230 235 240
Lys Met Phe Lys Glu Gln Gly Phe Gly Ser Arg Gln Thr Asn Arg His
245 250 255
Leu Val Asp Glu Thr Met Asp Pro Phe Val Asp Arg Ile Gly Tyr Phe
260 265 270
Ser Ala Leu Ile Leu Val Glu Gly Met Asp Ile Glu Ser Leu His Lys
275 280 285
Cys Ala Leu Asp Asp Arg Arg Glu Leu His Gln Phe Ala Gln Asp Gly
290 295 300
Leu Ile Cys Gln Asp Met Asp Cys Leu Met Leu Thr Phe Gly Asp Ile
305 310 315 320
Pro His His Ala Pro Val Leu Leu Ala Trp Ala Leu Leu Arg His Thr
325 330 335
Leu Asn Pro Glu Glu Thr Ser Ser Val Val Arg Lys Ile Gly Gly Thr
340 345 350
Ala Ile Gln Leu Asn Val Phe Gln Tyr Leu Thr Arg Leu Leu Gln Ser
355 360 365
Leu Ala Ser Gly Gly Asn Asp Cys Thr Thr Ser Thr Ala Cys Met Cys
370 375 380
Val Tyr Gly Leu Leu Ser Phe Val Leu Thr Ser Leu Glu Leu His Thr
385 390 395 400
Leu Gly Asn Gln Gln Asp Ile Ile Asp Thr Ala Cys Glu Val Leu Ala
405 410 415
Asp Pro Ser Leu Pro Glu Leu Phe Trp Gly Thr Glu Pro Thr Ser Gly
420 425 430
Leu Gly Ile Ile Leu Asp Ser Val Cys Gly Met Phe Pro His Leu Leu
435 440 445
Ser Pro Leu Leu Gln Leu Leu Arg Ala Leu Val Ser Gly Lys Ser Thr
450 455 460
Ala Lys Lys Val Tyr Ser Phe Leu Asp Lys Met Ser Phe Tyr Asn Glu
465 470 475 480
Leu Tyr Lys His Lys Pro His Asp Val Ile Ser His Glu Asp Gly Thr
485 490 495
Leu Trp Arg Arg Gln Thr Pro Lys Leu Leu Tyr Pro Leu Gly Gly Gln
500 505 510
Thr Asn Leu Arg Ile Pro Gln Gly Thr Val Gly Gln Val Met Leu Asp
515 520 525
Asp Arg Ala Tyr Leu Val Arg Trp Glu Tyr Ser Tyr Ser Ser Trp Thr
530 535 540
Leu Phe Thr Cys Glu Ile Glu Met Leu Leu His Val Val Ser Thr Ala
545 550 555 560
Asp Val Ile Gln His Cys Gln Arg Val Lys Pro Ile Ile Asp Leu Val
565 570 575
His Lys Val Ile Ser Thr Asp Leu Ser Ile Ala Asp Cys Leu Leu Pro
580 585 590
Ile Thr Ser Arg Ile Tyr Met Leu Leu Gln Arg Leu Thr Thr Val Ile
595 600 605
Ser Pro Pro Val Asp Val Ile Ala Ser Cys Val Asn Cys Leu Thr Val
610 615 620
Leu Ala Ala Arg Asn Pro Ala Lys Val Trp Thr Asp Leu Arg His Thr
625 630 635 640
Gly Phe Leu Pro Phe Val Ala His Pro Val Ser Ser Leu Ser Gln Met
645 650 655
Ile Ser Ala Glu Gly Met Asn Ala Gly Gly Tyr Gly Asn Leu Leu Met
660 665 670
Asn Ser Glu Gln Pro Gln Gly Glu Tyr Gly Val Thr Ile Ala Phe Leu
675 680 685
Arg Leu Ile Thr Thr Leu Val Lys Gly Gln Leu Gly Ser Thr Gln Ser
690 695 700
Gln Gly Leu Val Pro Cys Val Met Phe Val Leu Lys Glu Met Leu Pro
705 710 715 720
Ser Tyr His Lys Trp Arg Tyr Asn Ser His Gly Val Arg Glu Gln Ile
725 730 735
Gly Cys Leu Ile Leu Glu Leu Ile His Ala Ile Leu Asn Leu Cys His
740 745 750
Glu Thr Asp Leu His Ser Ser His Thr Pro Ser Leu Gln Phe Leu Cys
755 760 765
Ile Cys Ser Leu Ala Tyr Thr Glu Ala Gly Gln Thr Val Ile Asn Ile
770 775 780
Met Gly Ile Gly Val Asp Thr Ile Asp Met Val Met Ala Ala Gln Pro
785 790 795 800
Arg Ser Asp Gly Ala Glu Gly Gln Gly Gln Gly Gln Leu Leu Ile Lys
805 810 815
Thr Val Lys Leu Ala Phe Ser Val Thr Asn Asn Val Ile Arg Leu Lys
820 825 830
Pro Pro Ser Asn Val Val Ser Pro Leu Glu Gln Ala Leu Ser Gln His
835 840 845
Gly Ala His Gly Asn Asn Leu Ile Ala Val Leu Ala Lys Tyr Ile Tyr
850 855 860
His Lys His Asp Pro Ala Leu Pro Arg Leu Ala Ile Gln Leu Leu Lys
865 870 875 880
Arg Leu Ala Thr Val Ala Pro Met Ser Val Tyr Ala Cys Leu Gly Asn
885 890 895
Asp Ala Ala Ala Ile Arg Asp Ala Phe Leu Thr Arg Leu Gln Ser Lys
900 905 910
Ile Glu Asp Met Arg Ile Lys Val Met Ile Leu Glu Phe Leu Thr Val
915 920 925
Ala Val Glu Thr Gln Pro Gly Leu Ile Glu Leu Phe Leu Asn Leu Glu
930 935 940
Val Lys Asp Gly Ser Asp Gly Ser Lys Glu Phe Ser Leu Gly Met Trp
945 950 955 960
Ser Cys Leu His Ala Val Leu Glu Leu Ile Asp Ser Gln Gln Gln Asp
965 970 975
Arg Tyr Trp Cys Pro Pro Leu Leu His Arg Ala Ala Ile Ala Phe Leu
980 985 990
His Ala Leu Trp Gln Asp Arg Arg Asp Ser Ala Met Leu Val Leu Arg
995 1000 1005
Thr Lys Pro Lys Phe Trp Glu Asn Leu Thr Ser Pro Leu Phe Gly Thr
1010 1015 1020
Leu Ser Pro Pro Ser Glu Thr Ser Glu Pro Ser Ile Leu Glu Thr Cys
1025 1030 1035 1040
Ala Leu Ile Met Lys Ile Ile Cys Leu Glu Ile Tyr Tyr Val Val Lys
1045 1050 1055
Gly Ser Leu Asp Gln Ser Leu Lys Asp Thr Leu Lys Lys Phe Ser Ile
1060 1065 1070
Glu Lys Arg Phe Ala Tyr Trp Ser Gly Tyr Val Lys Ser Leu Ala Val
1075 1080 1085
His Val Ala Glu Thr Glu Gly Ser Ser Cys Thr Ser Leu Leu Glu Tyr
1090 1095 1100
Gln Met Leu Val Ser Ala Trp Arg Met Leu Leu Ile Ile Ala Thr Thr
1105 1110 1115 1120
His Ala Asp Ile Met His Leu Thr Asp Ser Val Val Arg Arg Gln Leu
1125 1130 1135
Phe Leu Asp Val Leu Asp Gly Thr Lys Ala Leu Leu Leu Val Pro Ser
1140 1145 1150
Ser Val Asn Cys Leu Arg Leu Gly Ser Met Lys Cys Thr Leu Leu Leu
1155 1160 1165
Ile Leu Leu Arg Gln Trp Lys Arg Glu Leu Gly Ser Val Asp Glu Ile
1170 1175 1180
Leu Gly Pro Leu Thr Glu Ile Leu Glu Gly Val Leu Gln Ala Asp Gln
1185 1190 1195 1200
Gln Leu Met Glu Lys Thr Lys Ala Lys Val Phe Ser Ala Phe Ile Thr
1205 1210 1215
Val Leu Gln Met Lys Glu Met Lys Val Ser Asp Ile Pro Gln Tyr Ser
1220 1225 1230
Gln Leu Val Leu Asn ValCys Glu Thr Leu Gln Glu Glu Val Ile Ala
1235 1240 1245
Leu Phe Asp Gln Thr Arg His Ser Leu Ala Leu Gly Ser Ala Thr Glu
1250 1255 1260
Asp Lys Asp Ser Met Glu Thr Asp Asp Cys Ser Arg Ser Arg His Arg
1265 1270 1275 1280
Asp Gln Arg Asp Gly Val Cys Val Leu Gly Leu His Leu Ala Lys Glu
1285 1290 1295
Leu Cys Glu Val Asp Glu Asp Gly Asp Ser Trp Leu Gln Val Thr Arg
1300 1305 1310
Arg Leu Pro Ile Leu Pro Thr Leu Leu Thr Thr Leu Glu Val Ser Leu
1315 1320 1325
Arg Met Arg Gln Asn Leu His Phe Thr Glu Ala Thr Leu His Leu Leu
1330 1335 1340
Leu Thr Leu Ala Arg Thr Gln Gln Gly Ala Thr Ala Val Ala Gly Ala
1345 1350 1355 1360
Gly Ile Thr Gln Ser Ile Cys Leu Pro Leu Leu Ser Val Tyr Gln Leu
1365 1370 1375
Ser Thr Asn Gly Thr Ala Gln Thr Pro Ser Ala Ser Arg Lys Ser Leu
1380 1385 1390
Asp Ala Pro Ser Trp Pro Gly Val Tyr Arg Leu Ser Met Ser Leu Met
1395 1400 1405
Glu Gln Leu Leu Lys Thr Leu Arg Tyr Asn Phe Leu Pro Glu Ala Leu
1410 1415 1420
Asp Phe Val Gly Val His Gln Glu Arg Thr Leu Gln Cys Leu Asn Ala
1425 1430 1435 1440
Val Arg Thr Val Gln Ser Leu Ala Cys Leu Glu Glu Ala Asp His Thr
1445 1450 1455
Val Gly Phe Ile Leu Gln Leu Ser Asn Phe Met Lys Glu Trp His Phe
1460 1465 1470
His Leu Pro Gln Leu Met Arg Asp Ile Gln Val Asn Leu Gly Tyr Leu
1475 1480 1485
Cys Gln Ala Cys Thr Ser Leu Leu His Ser Arg Lys Met Leu Gln His
1490 1495 1500
Tyr Leu Gln Asn Lys Asn Gly Asp Gly Leu Pro Ser Ala Val Ala Gln
1505 1510 1515 1520
Arg Val Gln Arg Pro Pro Ser Ala Ala Ser Ala Ala Pro Ser Ser Ser
1525 1530 1535
Lys Gln Pro Ala Ala Asp Thr Glu Ala Ser Glu Gln Gln Ala Leu His
1540 1545 1550
Thr Val Gln Tyr Gly Leu Leu Lys Ile Leu Ser Lys Thr Leu Ala Ala
1555 1560 1565
Leu Arg His Phe Thr Pro Asp Val Cys Gln Ile Leu Leu Asp Gln Ser
1570 1575 1580
Leu Asp Leu Ala Glu Tyr Asn Phe Leu Phe Ala Leu Ser Phe Thr Thr
1585 1590 1595 1600
Pro Thr Phe Asp Ser Glu Val Ala Pro Ser Phe Gly Thr Leu Leu Ala
1605 1610 1615
Thr Val Asn Val Ala Leu Asn Met Leu Gly Glu Leu Asp Lys Lys Lys
1620 1625 1630
Glu Pro Leu Thr Gln Ala Val Gly Leu Ser Thr Gln Ala Glu Gly Thr
1635 1640 1645
Arg Thr Leu Lys Ser Leu Leu Met Phe Thr Met Glu Asn Cys Phe Tyr
1650 1655 1660
Leu Leu Ile Ser Gln Ala Met Arg Tyr Leu Arg Asp Pro Ala Val His
1665 1670 1675 1680
Pro Arg Asp Lys Gln Arg Met Lys Gln Glu Leu Ser Ser Glu Leu Ser
1685 1690 1695
Thr Leu Leu Ser Ser Leu Ser Arg Tyr Phe Arg Arg Gly Ala Pro Ser
1700 1705 1710
Ser Pro Ala Thr Gly Val Leu Pro Ser Pro Gln Gly Lys Ser Thr Ser
1715 1720 1725
Leu Ser Lys Ala Ser Pro Glu Ser Gln Glu Pro Leu Ile Gln Leu Val
1730 1735 1740
Gln Ala Phe Val Arg His Met Gln Arg
1745 1750
<210>17
<211>1753
<212>PRT
<213>人
<400>17
Met Ile Arg Lys Ser Lys Ile Thr Ser Val Leu Ser Phe Cys Arg Ser
1 5 10 15
Ser Arg Glu Leu Trp Thr Ile Leu Leu Gly Arg Ser Ala Leu Arg Glu
20 25 30
Leu Ser Gln Ile Glu Ala Glu Leu Asn Lys His Trp Arg Arg Leu Leu
35 40 45
Glu Gly Leu Ser Tyr Tyr Lys Pro Pro Ser Pro Ser Ser Ala Glu Lys
50 55 60
Val Lys Ala Asn Lys Asp Val Ala Ser Pro Leu Lys Glu Leu Gly Leu
65 70 75 80
Arg Ile Ser Lys Phe Leu Gly Leu Asp Glu Glu Gln Ser Val Gln Leu
85 90 95
Leu Gln Cys Tyr Leu Gln Glu Asp Tyr Arg Gly Thr Arg Asp Ser Val
100 105 110
Lys Thr Val Leu Gln Asp Glu Arg Gln Ser Gln Ala Leu Ile Leu Lys
115 120 125
Ile Ala Asp Tyr Tyr Tyr Glu Glu Arg Thr Cys Ile Leu Arg Cys Val
130 135 140
Leu His Leu Leu Thr Tyr Phe Gln Asp Glu Arg His Pro Tyr Arg Val
145 150 155 160
Glu Tyr Ala Asp Cys Val Asp Lys Leu Glu Lys Glu Leu Val Ser Lys
165 170 175
Tyr Arg Gln Gln Phe Glu Glu Leu Tyr Lys Thr Glu Ala Pro Thr Trp
180 185 190
Glu Thr His Gly Asn Leu Met Thr Glu Arg Gln Val Ser Arg Trp Phe
195 200 205
Val Gln Cys Leu Arg Glu Gln Ser Met Leu Leu Glu Ile Ile Phe Leu
210 215 220
Tyr Tyr Ala Tyr Phe Glu Met Ala Pro Ser Asp Leu Leu Val Leu Thr
225 230 235 240
Lys Met Phe Lys Glu Gln Gly Phe Gly Ser Arg Gln Thr Asn Arg His
245 250 255
Leu Val Asp Glu Thr Met Asp Pro Phe Val Asp Arg Ile Gly Tyr Phe
260 265 270
Ser Ala Leu Ile Leu Val Glu Gly Met Asp Ile Glu Ser Leu His Lys
275 280 285
Cys Ala Leu Asp Asp Arg Arg Glu Leu His Gln Phe Ala Gln Asp Gly
290 295 300
Leu Ile Cys Gln Asp Met Asp Cys Leu Met Leu Thr Phe Gly Asp Ile
305 310 315 320
Pro His His Ala Pro Val Leu Leu Ala Trp Ala Leu Leu Arg His Thr
325 330 335
Leu Asn Pro Glu Glu Thr Ser Ser Val Val Arg Lys Ile Gly Gly Thr
340 345 350
Ala Ile Gln Leu Asn Val Phe Gln Tyr Leu Thr Arg Leu Leu Gln Ser
355 360 365
Leu Ala Ser Gly Gly Asn Asp Cys Thr Thr Ser Thr Ala Cys Met Cys
370 375 380
Val Tyr Gly Leu Leu Ser Phe Val Leu Thr Ser Leu Glu Leu His Thr
385 390 395 400
Leu Gly Asn Gln Gln Asp Ile Ile Asp Thr Ala Cys Glu Val Leu Ala
405 410 415
Asp Pro Ser Leu Pro Glu Leu Phe Trp Gly Thr Glu Pro Thr Ser Gly
420 425 430
Leu Gly Ile Ile Leu Asp Ser Val Cys Gly Met Phe Pro His Leu Leu
435 440 445
Ser Pro Leu Leu Gln Leu Leu Arg Ala Leu Val Ser Gly Lys Ser Thr
450 455 460
Ala Lys Lys Val Tyr Ser Phe Leu Asp Lys Met Ser Phe Tyr Asn Glu
465 470 475 480
Leu Tyr Lys His Lys Pro His Asp Val Ile Ser His Glu Asp Gly Thr
485 490 495
Leu Trp Arg Arg Gln Thr Pro Lys Leu Leu Tyr Pro Leu Gly Gly Gln
500 505 510
Thr Asn Leu Arg Ile Pro Gln Gly Thr Val Gly Gln Val Met Leu Asp
515 520 525
Asp Arg Ala Tyr Leu Val Arg Trp Glu Tyr Ser Tyr Ser Ser Trp Thr
530 535 540
Leu Phe Thr Cys Glu Ile Glu Met Leu Leu His Val Val Ser Thr Ala
545 550 555 560
Asp Val Ile Gln His Cys Gln Arg Val Lys Pro Ile Ile Asp Leu Val
565 570 575
His Lys Val Ile Ser Thr Asp Leu Ser Ile Ala Asp Cys Leu Leu Pro
580 585 590
Ile Thr Ser Arg Ile Tyr Met Leu Leu Gln Arg Leu Thr Thr Val Ile
595 600 605
Ser Pro Pro Val Asp Val Ile Ala Ser Cys Val Asn Cys Leu Thr Val
610 615 620
Leu Ala Ala Arg Asn Pro Ala Lys Val Trp Thr Asp Leu Arg His Thr
625 630 635 640
Gly Phe Leu Pro Phe Val Ala His Pro Val Ser Ser Leu Ser Gln Met
645 650 655
Ile Ser Ala Glu Gly Met Asn Ala Gly Gly Tyr Gly Asn Leu Leu Met
660 665 670
Asn Ser Glu Gln Pro Gln Gly Glu Tyr Gly Val Thr Ile Ala Phe Leu
675 680 685
Arg Leu Ile Thr Thr Leu Val Lys Gly Gln Leu Gly Ser Thr Gln Ser
690 695 700
Gln Gly Leu Val Pro Cys Val Met Phe Val Leu Lys Glu Met Leu Pro
705 710 715 720
Ser Tyr His Lys Trp Arg Tyr Asn Ser His Gly Val Arg Glu Gln Ile
725 730 735
Gly Cys Leu Ile Leu Glu Leu Ile His Ala Ile Leu Asn Leu Cys His
740 745 750
Glu Thr Asp Leu His Ser Ser His Thr Pro Ser Leu Gln Phe Leu Cys
755 760 765
Ile Cys Ser Leu Ala Tyr Thr Glu Ala Gly Gln Thr Val Ile Asn Ile
770 775 780
Met Gly Ile Gly Val Asp Thr Ile Asp Met Val Met Ala Ala Gln Pro
785 790 795 800
Arg Ser Asp Gly Ala Glu Gly Gln Gly Gln Gly Gln Leu Leu Ile Lys
805 810 815
Thr Val Lys Leu Ala Phe Ser Val Thr Asn Asn Val Ile Arg Leu Lys
820 825 830
Pro Pro Ser Asn Val Val Ser Pro Leu Glu Gln Ala Leu Ser Gln His
835 840 845
Gly Ala His Gly Asn Asn Leu Ile Ala Val Leu Ala Lys Tyr Ile Tyr
850 855 860
His Lys His Asp Pro Ala Leu Pro Arg Leu Ala Ile Gln Leu Leu Lys
865 870 875 880
Arg Leu Ala Thr Val Ala Pro Met Ser Val Tyr Ala Cys Leu Gly Asn
885 890 895
Asp Ala Ala Ala Ile Arg Asp Ala Phe Leu Thr Arg Leu Gln Ser Lys
900 905 910
Ile Glu Asp Met Arg Ile Lys Val Met Ile Leu Glu Phe Leu Thr Val
915 920 925
Ala Val Glu Thr Gln Pro Gly Leu Ile Glu Leu Phe Leu Asn Leu Glu
930 935 940
Val Lys Asp Gly Ser Asp Gly Ser Lys Glu Phe Ser Leu Gly Met Trp
945 950 955 960
Ser Cys Leu His Ala Val Leu Glu Leu Ile Asp Ser Gln Gln Gln Asp
965 970 975
Arg Tyr Trp Cys Pro Pro Leu Leu His Arg Ala Ala Ile Ala Phe Leu
980 985 990
His Ala Leu Trp Gln Asp Arg Arg Asp Ser Ala Met Leu Val Leu Arg
995 1000 1005
Thr Lys Pro Lys Phe Trp Glu Asn Leu Thr Ser Pro Leu Phe Gly Thr
1010 1015 1020
Leu Ser Pro Pro Ser Glu Thr Ser Glu Pro Ser Ile Leu Glu Thr Cys
1025 1030 1035 1040
Ala Leu Ile Met Lys Ile Ile Cys Leu Glu Ile Tyr Tyr Val Val Lys
1045 1050 1055
Gly Ser Leu Asp Gln Ser Leu Lys Asp Thr Leu Lys Lys Phe Ser Ile
1060 1065 1070
Glu Lys Arg Phe Ala Tyr Trp Ser Gly Tyr Val Lys Ser Leu Ala Val
1075 1080 1085
His Val Ala Glu Thr Glu Gly Ser Ser Cys Thr Ser Leu Leu Glu Tyr
1090 1095 1100
Gln Met Leu Val Ser Ala Trp Arg Met Leu Leu Ile Ile Ala Thr Thr
1105 1110 1115 1120
His Ala Asp Ile Met His Leu Thr Asp Ser Val Val Arg Arg Gln Leu
1125 1130 1135
Phe Leu Asp Val Leu Asp Gly Thr Lys Ala Leu Leu Leu Val Pro Ser
1140 1145 1150
Ser Val Asn Cys Leu Arg Leu Gly Ser Met Lys Cys Thr Leu Leu Leu
1155 1160 1165
Ile Leu Leu Arg Gln Trp Lys Arg Glu Leu Gly Ser Val Asp Glu Ile
1170 1175 1180
Leu Gly Pro Leu Thr Glu Ile Leu Glu Gly Val Leu Gln Ala Asp Gln
1185 1190 1195 1200
Gln Leu Met Glu Lys Thr Lys Ala Lys Val Phe Ser Ala Phe Ile Thr
1205 1210 1215
Val Leu Gln Met Lys Glu Met Lys Val Ser Asp Ile Pro Gln Tyr Ser
1220 1225 1230
Gln Leu Val Leu Asn Val Cys Glu Thr Leu Gln Glu Glu Val Ile Ala
1235 1240 1245
Leu Phe Asp Gln Thr Arg His Ser Leu Ala Leu Gly Ser Ala Thr Glu
1250 1255 1260
Asp Lys Asp Ser Met Glu Thr Asp Asp Cys Ser Arg Ser Arg His Arg
1265 1270 1275 1280
Asp Gln Arg Asp Gly Val Cys Val Leu Gly Leu His Leu Ala Lys Glu
1285 1290 1295
Leu Cys Glu Val Asp Glu Asp Gly Asp Ser Trp Leu Gln Val Thr Arg
1300 1305 1310
Arg Leu Pro Ile Leu Pro Thr Leu Leu Thr Thr Leu Glu Val Ser Leu
1315 1320 1325
Arg Met Lys Gln Asn Leu His Phe Thr Glu Ala Thr Leu His Leu Leu
1330 1335 1340
Leu Thr Leu Ala Arg Thr Gln Gln Gly Ala Thr Ala Val Ala Gly Ala
1345 1350 1355 1360
Gly Ile Thr Gln Ser Ile Cys Leu Pro Leu Leu Ser Val Tyr Gln Leu
1365 1370 1375
Ser Thr Asn Gly Thr Ala Gln Thr Pro Ser Ala Ser Arg Lys Ser Leu
1380 1385 1390
Asp Ala Pro Ser Trp Pro Gly Val Tyr Arg Leu Ser Met Ser Leu Met
1395 1400 1405
Glu Gln Leu Leu Lys Thr Leu Arg Tyr Asn Phe Leu Pro Glu Ala Leu
1410 1415 1420
Asp Phe Val Gly Val His Gln Glu Arg Thr Leu Gln Cys Leu Asn Ala
1425 1430 1435 1440
Val Arg Thr Val Gln Ser Leu Ala Tyr Leu Glu Glu Ala Asp His Thr
1445 1450 1455
Val Gly Phe Ile Leu Gln Leu Ser Asn Phe Met Lys Glu Trp His Phe
1460 1465 1470
His Leu Pro Gln Leu Met Arg Asp Ile Gln Val Asn Leu Gly Tyr Leu
1475 1480 1485
Cys Gln Ala Cys Thr Ser Leu Leu His Ser Arg Lys Met Leu Gln His
1490 1495 1500
Tyr Leu Gln Asn Lys Asn Gly Asp Gly Leu Pro Ser Ala Val Ala Gln
1505 1510 1515 1520
Arg Val Gln Arg Pro Pro Ser Ala Ala Ser Ala Ala Pro Ser Ser Ser
1525 1530 1535
Lys Gln Pro Ala Ala Asp Thr Glu Ala Ser Glu Gln Gln Ala Leu His
1540 1545 1550
Thr Val Gln Tyr Gly Leu Leu Lys Ile Leu Ser Lys Thr Leu Ala Ala
1555 1560 1565
Leu Arg His Phe Thr Pro Asp Val Cys Gln Ile Leu Leu Asp Gln Ser
1570 1575 1580
Leu Asp Leu Ala Glu Tyr Asn Phe Leu Phe Ala Leu Ser Phe Thr Thr
1585 1590 1595 1600
Pro Thr Phe Asp Ser Glu Val Ala Pro Ser Phe Gly Thr Leu Leu Ala
1605 1610 1615
Thr Val Asn Val Ala Leu Asn Met Leu Gly Glu Leu Asp Lys Lys Lys
1620 1625 1630
Glu Pro Leu Thr Gln Ala Val Gly Leu Ser Thr Gln Ala Glu Gly Thr
1635 1640 1645
Arg Thr Leu Lys Ser Leu Leu Met Phe Thr Mer Glu Asn Cys Phe Tyr
1650 1655 1660
Leu Leu Ile Ser Gln Ala Met Arg Tyr Leu Arg Asp Pro Ala Val His
1665 1670 1675 1680
Pro Arg Asp Lys Gln Arg Met Lys Gln Glu Leu Ser Ser Glu Leu Ser
1685 1690 1695
Thr Leu Leu Ser Ser Leu Ser Arg Tyr Phe Arg Arg Gly Ala Pro Ser
1700 1705 1710
Ser Pro Ala Thr Gly Val Leu Pro Ser Pro Gln Gly Lys Ser Thr Ser
1715 1720 1725
Leu Ser Lys Ala Ser Pro Glu Ser Gln Glu Pro Leu Ile Gln Leu Val
1730 1735 1740
Gln Ala Phe Val Arg His Met Gln Arg
1745 1750
<210>18
<211>1753
<212>PRT
<213>人
<400>18
Met Ile Arg Lys Ser Lys Ile Thr Ser Val Leu Ser Phe Cys Arg Ser
1 5 10 15
Ser Arg Glu Leu Trp Thr Ile Leu Leu Gly Arg Ser Ala Leu Arg Glu
20 25 30
Leu Ser Gln Ile Glu Ala Glu Leu Asn Lys His Trp Arg Arg Leu Leu
35 40 45
Glu Gly Leu Ser Tyr Tyr Lys Pro Pro Ser Pro Ser Ser Ala Glu Lys
50 55 60
Val Lys Ala Asn Lys Asp Val Ala Ser Pro Leu Lys Glu Leu Gly Leu
65 70 75 80
Arg Ile Ser Lys Phe Leu Gly Leu Asp Glu Glu Gln Ser Val Gln Leu
85 90 95
Leu Gln Cys Tyr Leu Gln Glu Asp Tyr Arg Gly Thr Arg Asp Ser Val
100 105 110
Lys Thr Val Leu Gln Asp Glu Arg Gln Ser Gln Ala Leu Ile Leu Lys
115 120 125
Ile Ala Asp Tyr Tyr Tyr Glu Glu Arg Thr Cys Ile Leu Arg Cys Val
130 135 140
Leu His Leu Leu Thr Tyr Phe Gln Asp Glu Arg His Pro Tyr Arg Val
145 150 155 160
Glu Tyr Ala Asp Cys Val Asp Lys Leu Glu Lys Glu Leu Val Ser Lys
165 170 175
Tyr Arg Gln Gln Phe Glu Glu Leu Tyr Lys Thr Glu Ala Pro Thr Trp
180 185 190
Glu Thr His Gly Asn Leu Met Thr Glu Arg Gln Val Ser Arg Trp Phe
195 200 205
Val Gln Cys Leu Arg Glu Gln Ser Met Leu Leu Glu Ile Ile Phe Leu
210 215 220
Tyr Tyr Ala Tyr Phe Glu Met Ala Pro Ser Asp Leu Leu Val Leu Thr
225 230 235 240
Lys Met Phe Lys Glu Gln Gly Phe Gly Ser Arg Gln Thr Asn Arg His
245 250 255
Leu Val Asp Glu Thr Met Asp Pro Phe Val Asp Arg Ile Gly Tyr Phe
260 265 270
Ser Ala Leu Ile Leu Val Glu Gly Met Asp Ile Glu Ser Leu His Lys
275 280 285
Cys Ala Leu Asp Asp Arg Arg Glu Leu His Gln Phe Ala Gln Asp Gly
290 295 300
Leu Ile Cys Gln Asp Met Asp Cys Leu Met Leu Thr Phe Gly Asp Ile
305 310 315 320
Pro His His Ala Pro Val Leu Leu Ala Trp Ala Leu Leu Arg His Thr
325 330 335
Leu Asn Pro Glu Glu Thr Ser Ser Val Val Arg Lys Ile Gly Gly Thr
340 345 350
Ala Ile Gln Leu Asn Val Phe Gln Tyr Leu Thr Arg Leu Leu Gln Ser
355 360 365
Leu Ala Ser Gly Gly Asn Asp Cys Thr Thr Ser Thr Ala Cys Met Cys
370 375 380
Val Tyr Gly Leu Leu Ser Phe Val Leu Thr Ser Leu Glu Leu His Thr
385 390 395 400
Leu Gly Asn Gln Gln Asp Ile Ile Asp Thr Ala Cys Glu Val Leu Ala
405 410 415
Asp Pro Ser Leu Pro Glu Leu Phe Trp Gly Thr Glu Pro Thr Ser Gly
420 425 430
Leu Gly Ile Ile Leu Asp Ser Val Cys Gly Met Phe Pro His Leu Leu
435 440 445
Ser Pro Leu Leu Gln Leu Leu Arg Ala Leu Val Ser Gly Lys Ser Thr
450 455 460
Ala Lys Lys Val Tyr Ser Phe Leu Asp Lys Met Ser Phe Tyr Asn Glu
465 470 475 480
Leu Tyr Lys His Lys Pro His Asp Val Ile Ser His Glu Asp Gly Thr
485 490 495
Leu Trp Arg Arg Gln Thr Pro Lys Leu Leu Tyr Pro Leu Gly Gly Gln
500 505 510
Thr Asn Leu Arg Ile Pro Gln Gly Thr Val Gly Gln Val Met Leu Asp
515 520 525
Asp Arg Ala Tyr Leu Val Arg Trp Glu Tyr Ser Tyr Ser Ser Trp Thr
530 535 540
Leu Phe Thr Cys Glu Ile Glu Met Leu Leu His Val Val Ser Thr Ala
545 550 555 560
Asp Val Ile Gln His Cys Gln Arg Val Lys Pro Ile Ile Asp Leu Val
565 570 575
His Lys Val Ile Ser Thr Asp Leu Ser Ile Ala Asp Cys Leu Leu Pro
580 585 590
Ile Thr Ser Arg Ile Tyr Met Leu Leu Gln Arg Leu Thr Thr Val Ile
595 600 605
Ser Pro Pro Val Asp Val Ile Ala Ser Cys Val Asn Cys Leu Thr Val
610 615 620
Leu Ala Ala Arg Asn Pro Ala Lys Val Trp Thr Asp Leu Arg His Thr
625 630 635 640
Gly Phe Leu Pro Phe Val Ala His Pro Val Ser Ser Leu Ser Gln Met
645 650 655
Ile Ser Ala Glu Gly Met Asn Ala Gly Gly Tyr Gly Asn Leu Leu Met
660 665 670
Asn Ser Glu Gln Pro Gln Gly Glu Tyr Gly Val Thr Ile Ala Phe Leu
675 680 685
Arg Leu Ile Thr Thr Leu Val Lys Gly Gln Leu Gly Ser Thr Gln Ser
690 695 700
Gln Gly Leu Val Pro Cys Val Met Phe Val Leu Lys Glu Met Leu Pro
705 710 715 720
Ser Tyr His Lys Trp Arg Tyr Asn Ser His Gly Val Arg Glu Gln Ile
725 730 735
Gly Cys Leu Ile Leu Glu Leu Ile His Ala Ile Leu Asn Leu Cys His
740 745 750
Glu Thr Asp Leu His Ser Ser His Thr Pro Ser Leu Gln Phe Leu Cys
755 760 765
Ile Cys Ser Leu Ala Tyr Thr Glu Ala Gly Gln Thr Val Ile Asn Ile
770 775 780
Met Gly Ile Gly Val Asp Thr Ile Asp Met Val Met Ala Ala Gln Pro
785 790 795 800
Arg Ser Asp Gly Ala Glu Gly Gln Gly Gln Gly Gln Leu Leu Ile Lys
805 810 815
Thr Val Lys Leu Ala Phe Ser Val Thr Asn Asn Val Ile Arg Leu Lys
820 825 830
Pro Pro Ser Asn Val Val Ser Pro Leu Glu Gln Ala Leu Ser Gln His
835 840 845
Gly Ala His Gly Asn Asn Leu Ile Ala Val Leu Ala Lys Tyr Ile Tyr
850 855 860
His Lys His Asp Pro Ala Leu Pro Arg Leu Ala Ile Gln Leu Leu Lys
865 870 875 880
Arg Leu Ala Thr Val Ala Pro Met Ser Val Tyr Ala Cys Leu Gly Asn
885 890 895
Asp Ala Ala Ala Ile Arg Asp Ala Phe Leu Thr Arg Leu Gln Ser Lys
900 905 910
Ile Glu Asp Met Arg Ile Lys Val Met Ile Leu Glu Phe Leu Thr Val
915 920 925
Ala Val Glu Thr Gln Pro Gly Leu Ile Glu Leu Phe Leu Asn Leu Glu
930 935 940
Val Lys Asp Gly Ser Asp Gly Ser Lys Glu Phe Ser Leu Gly Met Trp
945 950 955 960
Ser Cys Leu His Ala Val Leu Glu Leu Ile Asp Ser Gln Gln Gln Asp
965 970 975
Arg Tyr Trp Cys Pro Pro Leu Leu His Arg Ala Ala Ile Ala Phe Leu
980 985 990
His Ala Leu Trp Gln Asp Arg Arg Asp Ser Ala Met Leu Val Leu Arg
995 1000 1005
Thr Lys Pro Lys Phe Trp Glu Asn Leu Thr Ser Pro Leu Phe Gly Thr
1010 1015 1020
Leu Ser Pro Pro Ser Glu Thr Ser Glu Pro Ser Ile Leu Glu Thr Cys
1025 1030 1035 1040
Ala Leu Ile Met Lys Ile Ile Cys Leu Glu Ile Tyr Tyr Val Val Lys
1045 1050 1055
Gly Ser Leu Asp Gln Ser Leu Lys Asp Thr Leu Lys Lys Phe Ser Ile
1060 1065 1070
Glu Lys Arg Phe Ala Tyr Trp Ser Gly Tyr Val Lys Ser Leu Ala Val
1075 1080 1085
His Val Ala Glu Thr Glu Gly Ser Ser Cys Thr Ser Leu Leu Glu Tyr
1090 1095 1100
Gln Met Leu Val Ser Ala Trp Arg Met Leu Leu Ile Ile Ala Thr Thr
1105 1110 1115 1120
His Ala Asp Ile Met His Leu Thr Asp Ser Val Val Arg Arg Gln Leu
1125 1130 1135
Phe Leu Asp Val Leu Asp Gly Thr Lys Ala Leu Leu Leu Val Pro Ser
1140 1145 1150
Ser Val Asn Cys Leu Arg Leu Gly Ser Met Lys Cys Thr Leu Leu Leu
1155 1160 1165
Ile Leu Leu Arg Gln Trp Lys Arg Glu Leu Gly Ser Val Asp Glu Ile
1170 1175 1180
Leu Gly Pro Leu Thr Glu Ile Leu Glu Gly Val Leu Gln Ala Asp Gln
1185 1190 1195 1200
Gln Leu Met Glu Lys Thr Lys Ala Lys Val Phe Ser Ala Phe Ile Thr
1205 1210 1215
Val Leu Gln Met Lys Glu Met Lys Val Ser Asp Ile Pro Gln Tyr Ser
1220 1225 1230
Gln Leu Val Leu Asn Val Cys Glu Thr Leu Gln Glu Glu Val Ile Ala
1235 1240 1245
Leu Phe Asp Gln Thr Arg His Ser Leu Ala Leu Gly Ser Ala Thr Glu
1250 1255 1260
Asp Lys Asp Ser Met Glu Thr Asp Asp Cys Ser Arg Ser Arg His Arg
1265 1270 1275 1280
Asp Gln Arg Asp Gly Val Cys Val Leu Gly Leu His Leu Ala Lys Glu
1285 1290 1295
Leu Cys Glu Val Asp Glu Asp Gly Asp Ser Trp Leu Gln Val Thr Arg
1300 1305 1310
Arg Leu Pro Ile Leu Pro Thr Leu Leu Thr Thr Leu Glu Val Ser Leu
1315 1320 1325
Arg Met Lys Gln Asn Leu His Phe Thr Glu Ala Thr Leu His Leu Leu
1330 1335 1340
Leu Thr Leu Ala Arg Thr Gln Gln Gly Ala Thr Ala Val Ala Gly Ala
1345 1350 1355 1360
Gly Ile Thr Gln Ser Ile Cys Leu Pro Leu Leu Ser Val Tyr Gln Leu
1365 1370 1375
Ser Thr Asn Gly Thr Ala Gln Thr Pro Ser Ala Ser Arg Lys Ser Leu
1380 1385 1390
Asp Ala Pro Ser Trp Pro Gly Val Tyr Arg Leu Ser Met Ser Leu Met
1395 1400 1405
Glu Gln Leu Leu Lys Thr Leu Arg Tyr Asn Phe Leu Pro Glu Ala Leu
1410 1415 1420
Asp Phe Val Gly Val His Gln Glu Arg Thr Leu Gln Cys Leu Asn Ala
1425 1430 1435 1440
Val Arg Thr Val Gln Ser Leu Ala Cys Leu Glu Glu Ala Asp His Thr
1445 1450 1455
Val Gly Phe Ile Leu Gln Leu Ser Asn Phe Met Lys Glu Trp His Phe
1460 1465 1470
His Leu Pro Gln Leu Met Arg Asp Ile Gln Val Asn Leu Gly Tyr Leu
1475 1480 1485
Cys Gln Ala Cys Thr Ser Leu Leu His Ser Arg Lys Met Leu Gln His
1490 1495 1500
Tyr Leu Gln Asn Lys Asn Gly Asp Gly Leu Pro Ser Ala Val Ala Gln
1505 1510 1515 1520
Arg Val Gln Arg Pro Pro Ser Ala Ala Ser Ala Ala Pro Ser Ser Ser
1525 1530 1535
Lys Gln Pro Ala Ala Gln Thr Glu Ala Ser Glu Gln Gln Ala Leu His
1540 1545 1550
Thr Val Gln Tyr Gly Leu Leu Lys Ile Leu Ser Lys Thr Leu Ala Ala
1555 1560 1565
Leu Arg His Phe Thr Pro Asp Val Cys Gln Ile Leu Leu Asp Gln Ser
1570 1575 1580
Leu Asp Leu Ala Glu Tyr Asn Phe Leu Phe Ala Leu Ser Phe Thr Thr
1585 1590 1595 1600
Pro Thr Phe Asp Ser Glu Val Ala Pro Ser Phe Gly Thr Leu Leu Ala
1605 1610 1615
Thr Val Asn Val Ala Leu Asn Met Leu Gly Glu Leu Asp Lys Lys Lys
1620 1625 1630
Glu Pro Leu Thr Gln Ala ValGly Leu Ser Thr Gln Ala Glu Gly Thr
1635 1640 1645
Arg Thr Leu Lys Ser Leu Leu Met Phe Thr Met Glu Asn Cys Phe Tyr
1650 1655 1660
Leu Leu Ile Ser Gln Ala Met Arg Tyr Leu Arg Asp Pro Ala Val His
1665 1670 1675 1680
Pro Arg Asp Lys Gln Arg Met Lys Gln Glu Leu Ser Ser Glu Leu Ser
1685 1690 1695
Thr Leu Leu Ser Ser Leu Ser Arg Tyr Phe Arg Arg Gly Ala Pro Ser
1700 1705 1710
Ser Pro Ala Thr Gly Val Leu Pro Ser Pro Gln Gly Lys Ser Thr Ser
1715 1720 1725
Leu Ser Lys Ala Ser Pro Glu Ser Gln Glu Pro Leu Ile Gln Leu Val
1730 1735 1740
Gln Ala Phe Val Arg His Met Gln Arg
1745 1750
<210>19
<211>1753
<212>PRT
<213>人
<400>19
Met Ile Arg Lys Ser Lys Ile Thr Ser Val Leu Ser Phe Cys Arg Ser
1 5 10 15
Ser Arg Glu Leu Trp Thr Ile Leu Leu Gly Arg Ser Ala Leu Arg Glu
20 25 30
Leu Ser Gln Ile Glu Ala Glu Leu Asn Lys His Trp Arg Arg Leu Leu
35 40 45
Glu Gly Leu Ser Tyr Tyr Lys Pro Pro Ser Pro Ser Ser Ala Glu Lys
50 55 60
Val Lys Ala Asn Lys Asp Val Ala Ser Pro Leu Lys Glu Leu Gly Leu
65 70 75 80
Arg Ile Ser Lys Phe Leu Gly Leu Asp Glu Glu Gln Ser Val Gln Leu
85 90 95
Leu Gln Cys Tyr Leu Gln Glu Asp Tyr Arg Gly Thr Arg Asp Ser Val
100 105 110
Lys Thr Val Leu Gln Asp Glu Arg Gln Ser Gln Ala Leu Ile Leu Lys
115 120 125
Ile Ala Asp Tyr Tyr Tyr Glu Glu Arg Thr Cys Ile Leu Arg Cys Val
130 135 140
Leu His Leu Leu Thr Tyr Phe Gln Asp Glu Arg His Pro Tyr Arg Val
145 150 155 160
Glu Tyr Ala Asp Cys Val Asp Lys Leu Glu Lys Glu Leu Val Ser Lys
165 170 175
Tyr Arg Gln Gln Phe Glu Glu Leu Tyr Lys Thr Glu Ala Pro Thr Trp
180 185 190
Glu Thr His Gly Asn Leu Met Thr Glu Arg Gln Val Ser Arg Trp Phe
195 200 205
Val Gln Cys Leu Arg Glu Gln Ser Met Leu Leu Glu Ile Ile Phe Leu
210 215 220
Tyr Tyr Ala Tyr Phe Glu Met Ala Pro Ser Asp Leu Leu Val Leu Thr
225 230 235 240
Lys Met Phe Lys Glu Gln Gly Phe Gly Ser Arg Gln Thr Asn Arg His
245 250 255
Leu Val Asp Glu Thr Met Asp Pro Phe Val Asp Arg Ile Gly Tyr Phe
260 265 270
Ser Ala Leu Ile Leu Val Glu Gly Met Asp Ile Glu Ser Leu His Lys
275 280 285
Cys Ala Leu Asp Asp Arg Arg Glu Leu His Gln Phe Ala Gln Asp Gly
290 295 300
Leu Ile Cys Gln Asp Met Asp Cys Leu Met Leu Thr Phe Gly Asp Ile
305 310 315 320
Pro His His Ala Pro Val Leu Leu Ala Trp Ala Leu Leu Arg His Thr
325 330 335
Leu Asn Pro Glu Glu Thr Ser Ser Val Val Arg Lys Ile Gly Gly Thr
340 345 350
Ala Ile Gln Leu Asn Val Phe Gln Tyr Leu Thr Arg Leu Leu Gln Ser
355 360 365
Leu Ala Ser Gly Gly Asn Asp Cys Thr Thr Ser Thr Ala Cys Met Cys
370 375 380
Val Tyr Gly Leu Leu Ser Phe Val Leu Thr Ser Leu Glu Leu His Thr
385 390 395 400
Leu Gly Asn Gln Gln Asp Ile Ile Asp Thr Ala Cys Glu Val Leu Ala
405 410 415
Asp Pro Ser Leu Pro Glu Leu Phe Trp Gly Thr Glu Pro Thr Ser Gly
420 425 430
Leu Gly Ile Ile Leu Asp Ser Val Cys Gly Met Phe Pro His Leu Leu
435 440 445
Ser Pro Leu Leu Gln Leu Leu Arg Ala Leu Val Ser Gly Lys Ser Thr
450 455 460
Ala Lys Lys Val Tyr Ser Phe Leu Asp Lys Met Ser Phe Tyr Asn Glu
465 470 475 480
Leu Tyr Lys His Lys Pro His Asp Val Ile Ser His Glu Asp Gly Thr
485 490 495
Leu Trp Arg Arg Gln Thr Pro Lys Leu Leu Tyr Pro Leu Gly Gly Gln
500 505 510
Thr Asn Leu Arg Ile Pro Gln Gly Thr ValGly Gln Val Met Leu Asp
515 520 525
Asp Arg Ala Tyr Leu ValArg Trp Glu Tyr Ser Tyr Ser Ser Trp Thr
530 535 540
Leu Phe Thr Cys Glu Ile Glu Met Leu Leu His Val Val Ser Thr Ala
545 550 555 560
Asp Val Ile Gln His Cys Gln Arg Val Lys Pro Ile Ile Asp Leu Val
565 570 575
His Lys Val Ile Ser Thr Asp Leu Ser Ile Ala Asp Cys Leu Leu Pro
580 585 590
Ile Thr Ser Arg Ile Tyr Met Leu Leu Gln Arg Leu Thr Thr Val Ile
595 600 605
Ser Pro Pro Val Asp Val Ile Ala Ser Cys Val Asn Cys Leu Thr Val
610 615 620
Leu Ala Ala Arg Asn Pro Ala Lys Val Trp Thr Asp Leu Arg His Thr
625 630 635 640
Gly Phe Leu Pro Phe Val Ala His Pro Val Ser Ser Leu Ser Gln Met
645 650 655
Ile Ser Ala Glu Gly Met Asn Ala Gly Gly Tyr Gly Asn Leu Leu Met
660 665 670
Asn Ser Glu Gln Pro Gln Gly Glu Tyr Gly Val Thr Ile Ala Phe Leu
675 680 685
Arg Leu Ile Thr Thr Leu Val Lys Gly Gln Leu Gly Ser Thr Gln Ser
690 695 700
Gln Gly Leu Val Pro Cys Val Met Phe Val Leu Lys Glu Met Leu Pro
705 710 715 720
Ser Tyr His Lys Trp Arg Tyr Asn Ser His Gly Val Arg Glu Gln Ile
725 730 735
Gly Cys Leu Ile Leu Glu Leu Ile His Ala Ile Leu Asn Leu Cys His
740 745 750
Glu Thr Asp Leu His Ser Ser His Thr Pro Ser Leu Gln Phe Leu Cys
755 760 765
Ile Cys Ser Leu Ala Tyr Thr Glu Ala Gly Gln Thr Val Ile Asn Ile
770 775 780
Met Gly Ile Gly Val Asp Thr Ile Asp Met Val Met Ala Ala Gln Pro
785 790 795 800
Arg Ser Asp Gly Ala Glu Gly Gln Gly Gln Gly Gln Leu Leu Ile Lys
805 810 815
Thr Val Lys Leu Ala Phe Ser Val Thr Asn Asn Val Ile Arg Leu Lys
820 825 830
Pro Pro Ser Asn Val Val Ser Pro Leu Glu Gln Ala Leu Ser Gln His
835 840 845
Gly Ala His Gly Asn Asn Leu Ile Ala Val Leu Ala Lys Tyr Ile Tyr
850 855 860
His Lys His Asp Pro Ala Leu Pro Arg Leu Ala Ile Gln Leu Leu Lys
865 870 875 880
Arg Leu Ala Thr Val Ala Pro Met Ser Val Tyr Ala Cys Leu Gly Asn
885 890 895
Asp Ala Ala Ala Ile Arg Asp Ala Phe Leu Thr Arg Leu Gln Ser Lys
900 905 910
Ile Glu Asp Met Arg Ile Lys Val Met Ile Leu Glu Phe Leu Thr Val
915 920 925
Ala Val Glu Thr Gln Pro Gly Leu Ile Glu Leu Phe Leu Asn Leu Glu
930 935 940
Val Lys Asp Gly Ser Asp Gly Ser Lys Glu Phe Ser Leu Gly Met Trp
945 950 955 960
Ser Cys Leu His Ala Val Leu Glu Leu Ile Asp Ser Gln Gln Gln Asp
965 970 975
Arg Tyr Trp Cys Pro Pro Leu Leu His Arg Ala Ala Ile Ala Phe Leu
980 985 990
His Ala Leu Trp Gln Asp Arg Arg Asp Ser Ala Met Leu Val Leu Arg
995 1000 1005
Thr Lys Pro Lys Phe Trp Glu Asn Leu Thr Ser Pro Leu Phe Gly Thr
1010 1015 1020
Leu Ser Pro Pro Ser Glu Thr Ser Glu Pro Ser Ile Leu Glu Thr Cys
1025 1030 1035 1040
Ala Leu Ile Met Lys Ile Ile Cys Leu Glu Ile Tyr Tyr Val Val Lys
1045 1050 1055
Gly Ser Leu Asp Gln Ser Leu Lys Asp Thr Leu Lys Lys Phe Ser Ile
1060 1065 1070
Glu Lys Arg Phe Ala Tyr Trp Ser Gly Tyr Val Lys Ser Leu Ala Val
1075 1080 1085
His Val Ala Glu Thr Glu Gly Ser Ser Cys Thr Ser Leu Leu Glu Tyr
1090 1095 1100
Gln Met Leu Val Ser Ala Trp Arg Met Leu Leu Ile Ile Ala Thr Thr
1105 1110 1115 1120
His Ala Asp Ile Met His Leu Thr Asp Ser Val Val Arg Arg Gln Leu
1125 1130 1135
Phe Leu Asp Val Leu Asp Gly Thr Lys Ala Leu Leu Leu Val Pro Ser
1140 1145 1150
Ser Val Asn Cys Leu Arg Leu Gly Ser Met Lys Cys Thr Leu Leu Leu
1155 1160 1165
Ile Leu Leu Arg Gln Trp Lys Arg Glu Leu Gly Ser Val Asp Glu Ile
1170 1175 1180
Leu Gly Pro Leu Thr Glu Ile Leu Glu Gly Val Leu Gln Ala Asp Gln
1185 1190 1195 1200
Gln Leu Met Glu Lys Thr Lys Ala Lys Val Phe Ser Ala Phe Ile Thr
1205 1210 1215
Val Leu Gln Met Lys Glu Met Lys Val Ser Asp Ile Pro Gln Tyr Ser
1220 1225 1230
Gln Leu Val Leu Asn Val Cys Glu Thr Leu Gln Glu Glu Val Ile Ala
1235 1240 1245
Leu Phe Asp Gln Thr Arg His Ser Leu Ala Leu Gly Ser Ala Thr Glu
1250 1255 1260
Asp Lys Asp Ser Met Glu Thr Asp Asp Cys Ser Arg Ser Arg His Arg
1265 1270 1275 1280
Asp Gln Arg Asp Gly Val Cys Val Leu Gly Leu His Leu Ala Lys Glu
1285 1290 1295
Leu Cys Glu Val Asp Glu Asp Gly Asp Ser Trp Leu Gln Val Thr Arg
1300 1305 1310
Arg Leu Pro Ile Leu Pro Thr Leu Leu Thr Thr Leu Glu Val Ser Leu
1315 1320 1325
Arg Met Lys Gln Asn Leu His Phe Thr Glu Ala Thr Leu His Leu Leu
1330 1335 1340
Leu Thr Leu Ala Arg Thr Gln Gln Gly Ala Thr Ala Val Ala Gly Ala
1345 1350 1355 1360
Gly Ile Thr Gln Ser Ile Cys Leu Pro Leu Leu Ser Val Tyr Gln Leu
1365 1370 1375
Ser Thr Asn Gly Thr Ala Gln Thr Pro Ser Ala Ser Arg Lys Ser Leu
1380 1385 1390
Asp Ala Pro Ser Trp Pro Gly Val Tyr Arg Leu Ser Met Ser Leu Met
1395 1400 1405
Glu Gln Leu Leu Lys Thr Leu Arg Tyr Asn Phe Leu Pro Glu Ala Leu
1410 1415 1420
Asp Phe Val Gly Val His Gln Glu Arg Thr Leu Gln Cys Leu Asn Ala
1425 1430 1435 1440
Val Arg Thr Val Gln Ser Leu Ala Cys Leu Glu Glu Ala Asp His Thr
1445 1450 1455
ValGly Phe Ile Leu Gln Leu Ser Asn Phe Met Lys Glu Trp His Phe
1460 1465 1470
His Leu Pro Gln Leu Met Arg Asp Ile Gln Val Asn Leu Gly Tyr Leu
1475 1480 1485
Cys Gln Ala Cys Thr Ser Leu Leu His Ser Arg Lys Met Leu Gln His
1490 1495 1500
Tyr Leu Gln Asn Lys Asn Gly Asp Gly Leu Pro Ser Ala Val Ala Gln
1505 1510 1515 1520
Arg Val Gln Arg Pro Pro Ser Ala Ala Ser Ala Ala Pro Ser Ser Ser
1525 1530 1535
Lys Gln Pro Ala Ala Gln Thr Glu Ala Ser Glu Gln Gln Ala Leu His
1540 1545 1550
Thr Val Gln Tyr Gly Leu Leu Lys Ile Leu Ser Lys Thr Leu Ala Ala
1555 1560 1565
Leu Arg His Phe Thr Pro Asp Val Cys Gln Ile Leu Leu Asp Gln Ser
1570 1575 1580
Leu Asp Leu Ala Glu Tyr Asn Phe Leu Phe Ala Leu Ser Phe Thr Thr
1585 1590 1595 1600
Pro Thr Phe Asp Ser Glu Val Ala Pro Ser Phe Gly Thr Leu Leu Ala
1605 1610 1615
Thr Val Asn Val Ala Leu Asn Met Leu Gly Glu Leu Asp Lys Lys Lys
1620 1625 1630
Glu Pro Leu Thr Gln Ala ValGly Leu Ser Thr Gln Ala Glu Gly Thr
1635 1640 1645
Arg Thr Leu Lys Ser Leu Leu Met Phe Thr Met Glu Asn Cys Phe Tyr
1650 1655 1660
Leu Leu Ile Ser Gln Ala Met Arg Tyr Leu Arg Asp Pro Ala Val His
1665 1670 1675 1680
Pro Arg Asp Lys Gln Arg Met Lys Gln Glu Leu Ser Ser Glu Leu Ser
1685 1690 1695
Thr Leu Leu Ser Ser Leu Ser Arg Tyr His Arg Arg Gly Ala Pro Ser
1700 1705 1710
Ser Pro Ala Thr Gly Val Leu Pro Ser Pro Gln Gly Lys Ser Thr Ser
1715 1720 1725
Leu Ser Lys Ala Ser Pro Glu Ser Gln Glu Pro Leu Ile Gln Leu Val
1730 1735 1740
Gln Ala Phe Val Arg His Met Gln Arg
1745 1750
<210>20
<211>14
<212>PRT
<213>人
<400>20
Met Ile Arg Lys Ser Lys Ile Thr Ser Val Leu Ser Phe Cys
1 5 10
<210>21
<211>1745
<212>PRT
<213>人
<400>21
Ala Gly Gly Pro Cys Val Arg Ser Ser Arg Glu Leu Trp Thr Ile Leu
1 5 10 15
Leu Gly Arg Ser Ala Leu Arg Glu Leu Ser Gln Ile Glu Ala Glu Leu
20 25 30
Asn Lys His Trp Arg Arg Leu Leu Glu Gly Leu Ser Tyr Tyr Lys Pro
35 40 45
Pro Ser Pro Ser Ser Ala Glu Lys Val Lys Ala Asn Lys Asp Val Ala
50 55 60
Ser Pro Leu Lys Glu Leu Gly Leu Arg Ile Ser Lys Phe Leu Gly Leu
65 70 75 80
Asp Glu Glu Gln Ser Val Gln Leu Leu Gln Cys Tyr Leu Gln Glu Asp
85 90 95
Tyr Arg Gly Thr Arg Asp Ser Val Lys Thr Val Leu Gln Asp Glu Arg
100 105 110
Gln Ser Gln Ala Leu Ile Leu Lys Ile Ala Asp Tyr Tyr Tyr Glu Glu
115 120 125
Arg Thr Cys Ile Leu Arg Cys Val Leu His Leu Leu Thr Tyr Phe Gln
130 135 140
Asp Glu Arg His Pro Tyr Arg Val Glu Tyr Ala Asp Cys Val Asp Lys
145 150 155 160
Leu Glu Lys Glu Leu Val Ser Lys Tyr Arg Gln Gln Phe Glu Glu Leu
165 170 175
Tyr Lys Thr Glu Ala Pro Thr Trp Glu Thr His Gly Asn Leu Met Thr
180 185 190
Glu Arg Gln Val Ser Arg Trp Phe Val Gln Cys Leu Arg Glu Gln Ser
195 200 205
Met Leu Leu Glu Ile Ile Phe Leu Tyr Tyr Ala Tyr Phe Glu Met Ala
210 215 220
Pro Ser Asp Leu Leu Val Leu Thr Lys Met Phe Lys Glu Gln Gly Phe
225 230 235 240
Gly Ser Arg Gln Thr Asn Arg His Leu Val Asp Glu Thr Met Asp Pro
245 250 255
Phe Val Asp Arg Ile Gly Tyr Phe Ser Ala Leu Ile Leu Val Glu Gly
260 265 270
Met Asp Ile Glu Ser Leu His Lys Cys Ala Leu Asp Asp Arg Arg Glu
275 280 285
Leu His Gln Phe Ala Gln Asp Gly Leu Ile Cys Gln Asp Met Asp Cys
290 295 300
Leu Met Leu Thr Phe Gly Asp Ile Pro His His Ala Pro Val Leu Leu
305 310 315 320
Ala Trp Ala Leu Leu Arg His Thr Leu Asn Pro Glu Glu Thr Ser Ser
325 330 335
Val Val Arg Lys Ile Gly Gly Thr Ala Ile Gln Leu Asn Val Phe Gln
340 345 350
Tyr Leu Thr Arg Leu Leu Gln Ser Leu Ala Ser Gly Gly Asn Asp Cys
355 360 365
Thr Thr Ser Thr Ala Cys Met Cys Val Tyr Gly Leu Leu Ser Phe Val
370 375 380
Leu Thr Ser Leu Glu Leu His Thr Leu Gly Asn Gln Gln Asp Ile Ile
385 390 395 400
Asp Thr Ala Cys Glu Val Leu Ala Asp Pro Ser Leu Pro Glu Leu Phe
405 410 415
Trp Gly Thr Glu Pro Thr Ser Gly Leu Gly Ile Ile Leu Asp Ser Val
420 425 430
Cys Gly Met Phe Pro His Leu Leu Ser Pro Leu Leu Gln Leu Leu Arg
435 440 445
Ala Leu Val Ser Gly Lys Ser Thr Ala Lys Lys Val Tyr Ser Phe Leu
450 455 460
Asp Lys Met Ser Phe Tyr Asn Glu Leu Tyr Lys His Lys Pro His Asp
465 470 475 480
Val Ile Ser His Glu Asp Gly Thr Leu Trp Arg Arg Gln Thr Pro Lys
485 490 495
Leu Leu Tyr Pro Leu Gly Gly Gln Thr Asn Leu Arg Ile Pro Gln Gly
500 505 510
Thr Val Gly Gln Val Met Leu Asp Asp Arg Ala Tyr Leu Val Arg Trp
515 520 525
Glu Tyr Ser Tyr Ser Ser Trp Thr Leu Phe Thr Cys Glu Ile Glu Met
530 535 540
Leu Leu His Val Val Ser Thr Ala Asp Val Ile Gln His Cys Gln Arg
545 550 555 560
Val Lys Pro Ile Ile Asp Leu Val His Lys Val Ile Ser Thr Asp Leu
565 570 575
Ser Ile Ala Asp Cys Leu Leu Pro Ile Thr Ser Arg Ile Tyr Met Leu
580 585 590
Leu Gln Arg Leu Thr Thr Val Ile Ser Pro Pro Val Asp Val Ile Ala
595 600 605
Ser Cys Val Asn Cys Leu Thr Val Leu Ala Ala Arg Asn Pro Ala Lys
610 615 620
Val Trp Thr Asp Leu Arg His Thr Gly Phe Leu Pro Phe Val Ala His
625 630 635 640
Pro Val Ser Ser Leu Ser Gln Met Ile Ser Ala Glu Gly Met Asn Ala
645 650 655
Gly Gly Tyr Gly Asn Leu Leu Met Asn Ser Glu Gln Pro Gln Gly Glu
660 665 670
Tyr Gly Val Thr Ile Ala Phe Leu Arg Leu Ile Thr Thr Leu Val Lys
675 680 685
Gly Gln Leu Gly Ser Thr Gln Ser Gln Gly Leu Val Pro Cys Val Met
690 695 700
Phe Val Leu Lys Glu Met Leu Pro Ser Tyr His Lys Trp Arg Tyr Asn
705 710 715 720
Ser His Gly Val Arg Glu Gln Ile Gly Cys Leu Ile Leu Glu Leu Ile
725 730 735
His Ala Ile Leu Asn Leu Cys His Glu Thr Asp Leu His Ser Ser His
740 745 750
Thr Pro Ser Leu Gln Phe Leu Cys Ile Cys Ser Leu Ala Tyr Thr Glu
755 760 765
Ala Gly Gln Thr Val Ile Asn Ile Met Gly Ile Gly Val Asp Thr Ile
770 775 780
Asp Met Val Met Ala Ala Gln Pro Arg Ser Asp Gly Ala Glu Gly Gln
785 790 795 800
Gly Gln Gly Gln Leu Leu Ile Lys Thr Val Lys Leu Ala Phe Ser Val
805 810 815
Thr Asn Asn Val Ile Arg Leu Lys Pro Pro Ser Asn Val Val Ser Pro
820 825 830
Leu Glu Gln Ala Leu Ser Gln His Gly Ala His Gly Asn Asn Leu Ile
835 840 845
Ala Val Leu Ala Lys Tyr Ile Tyr His Lys His Asp Pro Ala Leu Pro
850 855 860
Arg Leu Ala Ile Gln Leu Leu Lys Arg Leu Ala Thr Val Ala Pro Met
865 870 875 880
Ser Val Tyr Ala Cys Leu Gly Asn Asp Ala Ala Ala Ile Arg Asp Ala
885 890 895
Phe Leu Thr Arg Leu Gln Ser Lys Ile Glu Asp Met Arg Ile Lys Val
900 905 910
Met Ile Leu Glu Phe Leu Thr Val Ala Val Glu Thr Gln Pro Gly Leu
915 920 925
Ile Glu Leu Phe Leu Asn Leu Glu Val Lys Asp Gly Ser Asp Gly Ser
930 935 940
Lys Glu Phe Ser Leu Gly Met Trp Ser Cys Leu His Ala Val Leu Glu
945 950 955 960
Leu Ile Asp Ser Gln Gln Gln Asp Arg Tyr Trp Cys Pro Pro Leu Leu
965 970 975
His Arg Ala Ala Ile Ala Phe Leu His Ala Leu Trp Gln Asp Arg Arg
980 985 990
Asp Ser Ala Met Leu Val Leu Arg Thr Lys Pro Lys Phe Trp Glu Asn
995 1000 1005
Leu Thr Ser Pro Leu Phe Gly Thr Leu Ser Pro Pro Ser Glu Thr Ser
1010 1015 1020
Glu Pro Ser Ile Leu Glu Thr Cys Ala Leu Ile Met Lys Ile Ile Cys
1025 1030 1035 1040
Leu Glu Ile Tyr Tyr Val Val Lys Gly Ser Leu Asp Gln Ser Leu Lys
1045 1050 1055
Asp Thr Leu Lys Lys Phe Ser Ile Glu Lys Arg Phe Ala Tyr Trp Ser
1060 1065 1070
Gly Tyr Val Lys Ser Leu Ala Val His Val Ala Glu Thr Glu Gly Ser
1075 1080 1085
Ser Cys Thr Ser Leu Leu Glu Tyr Gln Met Leu Val Ser Ala Trp Arg
1090 1095 1100
Met Leu Leu Ile Ile Ala Thr Thr His Ala Asp Ile Met His Leu Thr
1105 1110 1115 1120
Asp Ser Val Val Arg Arg Gln Leu Phe Leu Asp Val Leu Asp Gly Thr
1125 1130 1135
Lys Ala Leu Leu Leu Val Pro Ala Ser Val Asn Cys Leu Arg Leu Gly
1140 1145 1150
Ser Met Lys Cys Thr Leu Leu Leu Ile Leu Leu Arg Gln Trp Lys Arg
1155 1160 1165
Glu Leu Gly Ser Val Asp Glu Ile Leu Gly Pro Leu Thr Glu Ile Leu
1170 1175 1180
Glu Gly Val Leu Gln Ala Asp Gln Gln Leu Met Glu Lys Thr Lys Ala
1185 1190 1195 1200
Lys Val Phe Ser Ala Phe Ile Thr Val Leu Gln Met Lys Glu Met Lys
1205 1210 1215
Val Ser Asp Ile Pro Gln Tyr Ser Gln Leu Val Leu Asn Val Cys Glu
1220 1225 1230
Thr Leu Gln Glu Glu Val Ile Ala Leu Phe Asp Gln Thr Arg His Ser
1235 1240 1245
Leu Ala Leu Gly Ser Ala Thr Glu Asp Lys Asp Ser Met Glu Thr Asp
1250 1255 1260
Asp Cys Ser Arg Ser Arg His Arg Asp Gln Arg Asp Gly Val Cys Val
1265 1270 1275 1280
Leu Gly Leu His Leu Ala Lys Glu Leu Cys Glu Val Asp Glu Asp Gly
1285 1290 1295
Asp Ser Trp Leu Gln Val Thr Arg Arg Leu Pro Ile Leu Pro Thr Leu
1300 1305 1310
Leu Thr Thr Leu Glu Val Ser Leu Arg Met Lys Gln Asn Leu His Phe
1315 1320 1325
Thr Glu Ala Thr Leu His Leu Leu Leu Thr Leu Ala Arg Thr Gln Gln
1330 1335 1340
Gly Ala Thr Ala Val Ala Gly Ala Gly Ile Thr Gln Ser Ile Cys Leu
1345 1350 1355 1360
Pro Leu Leu Ser Val Tyr Gln Leu Ser Thr Asn Gly Thr Ala Gln Thr
1365 1370 1375
Pro Ser Ala Ser Arg Lys Ser Leu Asp Ala Pro Ser Trp Pro Gly Val
1380 1385 1390
Tyr Arg Leu Ser Met Ser Leu Met Glu Gln Leu Leu Lys Thr Leu Arg
1395 1400 1405
Tyr Asn Phe Leu Pro Glu Ala Leu Asp Phe Val Gly Val His Gln Glu
1410 1415 1420
Arg Thr Leu Gln Cys Leu Asn Ala Val Arg Thr Val Gln Ser Leu Ala
1425 1430 1435 1440
Cys Leu Glu Glu Ala Asp His Thr Val Gly Phe Ile Leu Gln Leu Ser
1445 1450 1455
Asn Phe Met Lys Glu Trp His Phe His Leu Pro Gln Leu Met Arg Asp
1460 1465 1470
Ile Gln Val Asn Leu Gly Tyr Leu Cys Gln Ala Cys Thr Ser Leu Leu
1475 1480 1485
His Ser Arg Lys Met Leu Gln His Tyr Leu Gln Asn Lys Asn Gly Asp
1490 1495 1500
Gly Leu Pro Ser Ala Val Ala Gln Arg Val Gln Arg Pro Pro Ser Ala
1505 1510 1515 1520
Ala Ser Ala Ala Pro Ser Ser Ser Lys Gln Pro Ala Ala Asp Thr Glu
1525 1530 1535
Ala Ser Glu Gln Gln Ala Leu His Thr Val Gln Tyr Gly Leu Leu Lys
1540 1545 1550
Ile Leu Ser Lys Thr Leu Ala Ala Leu Arg His Phe Thr Pro Asp Val
1555 1560 1565
Cys Gln Ile Leu Leu Asp Gln Ser Leu Asp Leu Ala Glu Tyr Asn Phe
1570 1575 1580
Leu Phe Ala Leu Ser Phe Thr Thr Pro Thr Phe Asp Ser Glu ValAla
1585 1590 1595 1600
Pro Ser Phe Gly Thr Leu Leu Ala Thr Val Asn Val Ala Leu Asn Met
1605 1610 1615
Leu Gly Glu Leu Asp Lys Lys Lys Glu Pro Leu Thr Gln Ala Val Gly
1620 1625 1630
Leu Ser Thr Gln Ala Glu Gly Thr Arg Thr Leu Lys Ser Leu Leu Met
1635 1640 1645
Phe Thr Met Glu Asn Cys Phe Tyr Leu Leu Ile Ser Gln Ala Met Arg
1650 1655 1660
Tyr Leu Arg Asp Pro Ala Val His Pro Arg Asp Lys Gln Arg Met Lys
1665 1670 1675 1680
Gln Glu Leu Ser Ser Glu Leu Ser Thr Leu Leu Ser Ser Leu Ser Arg
1685 1690 1695
Tyr Phe Arg Arg Gly Ala Pro Ser Ser Pro Ala Thr Gly Val Leu Pro
1700 1705 1710
Ser Pro Gln Gly Lys Ser Thr Ser Leu Ser Lys Ala Ser Pro Glu Ser
1715 1720 1725
Gln Glu Pro Leu Ile Gln Leu Val Gln Ala Phe Val Arg His Met Gln
1730 1735 1740
Arg
1745
<210>22
<211>3534
<212>PRT
<213>人
<400>22
Met Ala Ser Gly Gly Gly Val Arg Ala Ser Gly Arg Ala Lys Met Ala
1 5 10 15
Ala Ala Ala Gly Gly Pro Cys Val Arg Ser Ser Arg Glu Leu Trp Thr
20 25 30
Ile Leu Leu Gly Arg Ser Ala Leu Arg Glu Leu Ser Gln Ile Glu Ala
35 40 45
Glu Leu Asn Lys His Trp Arg Arg Leu Leu Glu Gly Leu Ser Tyr Tyr
50 55 60
Lys Pro Pro Ser Pro Ser Ser Ala Glu Lys Val Lys Ala Asn Lys Asp
65 70 75 80
Val Ala Ser Pro Leu Lys Glu Leu Gly Leu Arg Ile Ser Lys Phe Leu
85 90 95
Gly Leu Asp Glu Glu Gln Ser Val Gln Leu Leu Gln Cys Tyr Leu Gln
100 105 110
Glu Asp Tyr Arg Gly Thr Arg Asp Ser Val Lys Thr Val Leu Gln Asp
115 120 125
Glu Arg Gln Ser Gln Ala Leu Ile Leu Lys Ile Ala Asp Tyr Tyr Tyr
130 135 140
Glu Glu Arg Thr Cys Ile Leu Arg Cys Val Leu His Leu Leu Thr Tyr
145 150 155 160
Phe Gln Asp Glu Arg His Pro Tyr Arg Val Glu Tyr Ala Asp Cys Val
165 170 175
Asp Lys Leu Glu Lys Glu Leu Val Ser Lys Tyr Arg Gln Gln Phe Glu
180 185 190
Glu Leu Tyr Lys Thr Glu Ala Pro Thr Trp Glu Thr His Gly Asn Leu
195 200 205
Met Thr Glu Arg Gln Val Ser Arg Trp Phe Val Gln Cys Leu Arg Glu
210 215 220
Gln Ser Met Leu Leu Glu Ile Ile Phe Leu Tyr Tyr Ala Tyr Phe Glu
225 230 235 240
Met Ala Pro Ser Asp Leu Leu Val Leu Thr Lys Met Phe Lys Glu Gln
245 250 255
Gly Phe Gly Ser Arg Gln Thr Asn Arg His Leu Val Asp Glu Thr Met
260 265 270
Asp Pro Phe Val Asp Arg Ile Gly Tyr Phe Ser Ala Leu Ile Leu Val
275 280 285
Glu Gly Met Asp Ile Glu Ser Leu His Lys Cys Ala Leu Asp Asp Arg
290 295 300
Arg Glu Leu His Gln Phe Ala Gln Asp Gly Leu Ile Cys Gln Asp Met
305 310 315 320
Asp Cys Leu Met Leu Thr Phe Gly Asp Ile Pro His His Ala Pro Val
325 330 335
Leu Leu Ala Trp Ala Leu Leu Arg His Thr Leu Asn Pro Glu Glu Thr
340 345 350
Ser Ser Val Val Arg Lys Ile Gly Gly Thr Ala Ile Gln Leu Asn Val
355 360 365
Phe Gln Tyr Leu Thr Arg Leu Leu Gln Ser Leu Ala Ser Gly Gly Asn
370 375 380
Asp Cys Thr Thr Ser Thr Ala Cys Met Cys Val Tyr Gly Leu Leu Ser
385 390 395 400
Phe Val Leu Thr Ser Leu Glu Leu His Thr Leu Gly Asn Gln Gln Asp
405 410 415
Ile Ile Asp Thr Ala Cys Glu Val Leu Ala Asp Pro Ser Leu Pro Glu
420 425 430
Leu Phe Trp Gly Thr Glu Pro Thr Ser Gly Leu Gly Ile Ile Leu Asp
435 440 445
Ser Val Cys Gly Met Phe Pro His Leu Leu Ser Pro Leu Leu Gln Leu
450 455 460
Leu Arg Ala Leu Val Ser Gly Lys Ser Thr Ala Lys Lys Val Tyr Ser
465 470 475 480
Phe Leu Asp Lys Met Ser Phe Tyr Asn Glu Leu Tyr Lys His Lys Pro
485 490 495
His Asp Val Ile Ser His Glu Asp Gly Thr Leu Trp Arg Arg Gln Thr
500 505 510
Pro Lys Leu Leu Tyr Pro Leu Gly Gly Gln Thr Asn Leu Arg Ile Pro
515 520 525
Gln Gly Thr Val Gly Gln Val Met Leu Asp Asp Arg Ala Tyr Leu Val
530 535 540
Arg Trp Glu Tyr Ser Tyr Ser Ser Trp Thr Leu Phe Thr Cys Glu Ile
545 550 555 560
Glu Met Leu Leu His Val Val Ser Thr Ala Asp Val Ile Gln His Cys
565 570 575
Gln Arg Val Lys Pro Ile Ile Asp Leu Val His Lys Val Ile Ser Thr
580 585 590
Asp Leu Ser Ile Ala Asp Cys Leu Leu Pro Ile Thr Ser Arg Ile Tyr
595 600 605
Met Leu Leu Gln Arg Leu Thr Thr Val Ile Ser Pro Pro Val Asp Val
610 615 620
Ile Ala Ser Cys Val Asn Cys Leu Thr Val Leu Ala Ala Arg Asn Pro
625 630 635 640
Ala Lys Val Trp Thr Asp Leu Arg His Thr Gly Phe Leu Pro Phe Val
645 650 655
Ala His Pro Val Ser Ser Leu Ser Gln Met Ile Ser Ala Glu Gly Met
660 665 670
Asn Ala Gly Gly Tyr Gly Asn Leu Leu Met Asn Ser Glu Gln Pro Gln
675 680 685
Gly Glu Tyr Gly Val Thr Ile Ala Phe Leu Arg Leu Ile Thr Thr Leu
690 695 700
Val Lys Gly Gln Leu Gly Ser Thr Gln Ser Gln Gly Leu Val Pro Cys
705 710 715 720
Val Met Phe Val Leu Lys Glu Met Leu Pro Ser Tyr His Lys Trp Arg
725 730 735
Tyr Asn Ser His Gly Val Arg Glu Gln Ile Gly Cys Leu Ile Leu Glu
740 745 750
Leu Ile His Ala Ile Leu Asn Leu Cys His Glu Thr Asp Leu His Ser
755 760 765
Ser His Thr Pro Ser Leu Gln Phe Leu Cys Ile Cys Ser Leu Ala Tyr
770 775 780
Thr Glu Ala Gly Gln Thr Val Ile Asn Ile Met Gly Ile Gly Val Asp
785 790 795 800
Thr Ile Asp Met Val Met Ala Ala Gln Pro Arg Ser Asp Gly Ala Glu
805 810 815
Gly Gln Gly Gln Gly Gln Leu Leu Ile Lys Thr Val Lys Leu Ala Phe
820 825 830
Ser Val Thr Asn Asn Val Ile Arg Leu Lys Pro Pro Ser Asn Val Val
835 840 845
Ser Pro Leu Glu Gln Ala Leu Ser Gln His Gly Ala His Gly Asn Asn
850 855 860
Leu Ile Ala Val Leu Ala Lys Tyr Ile Tyr His Lys His Asp Pro Ala
865 870 875 880
Leu Pro Arg Leu Ala Ile Gln Leu Leu Lys Arg Leu Ala Thr Val Ala
885 890 895
Pro Met Ser Val Tyr Ala Cys Leu Gly Asn Asp Ala Ala Ala Ile Arg
900 905 910
Asp Ala Phe Leu Thr Arg Leu Gln Ser Lys Ile Glu Asp Met Arg Ile
915 920 925
Lys Val Met Ile Leu Glu Phe Leu Thr Val Ala Val Glu Thr Gln Pro
930 935 940
Gly Leu Ile Glu Leu Phe Leu Asn Leu Glu Val Lys Asp Gly Ser Asp
945 950 955 960
Gly Ser Lys Glu Phe Ser Leu Gly Met Trp Ser Cys Leu His Ala Val
965 970 975
Leu Glu Leu Ile Asp Ser Gln Gln Gln Asp Arg Tyr Trp Cys Pro Pro
980 985 990
Leu Leu His Arg Ala Ala Ile Ala Phe Leu His Ala Leu Trp Gln Asp
995 1000 1005
Arg Arg Asp Ser Ala Met Leu Val Leu Arg Thr Lys Pro Lys Phe Trp
1010 1015 1020
Glu Asn Leu Thr Ser Pro Leu Phe Gly Thr Leu Ser Pro Pro Ser Glu
1025 1030 1035 1040
Thr Ser Glu Pro Ser Ile Leu Glu Thr Cys Ala Leu Ile Met Lys Ile
1045 1050 1055
Ile Cys Leu Glu Ile Tyr Tyr Val Val Lys Gly Ser Leu Asp Gln Ser
1060 1065 1070
Leu Lys Asp Thr Leu Lys Lys Phe Ser Ile Glu Lys Arg Phe Ala Tyr
1075 1080 1085
Trp Ser Gly Tyr Val Lys Ser Leu Ala Val His Val Ala Glu Thr Glu
1090 1095 1100
Gly Ser Ser Cys Thr Ser Leu Leu Glu Tyr Gln Met Leu Val Ser Ala
1105 1110 1115 1120
Trp Arg Met Leu Leu Ile Ile Ala Thr Thr His Ala Asp Ile Met His
1125 1130 1135
Leu Thr Asp Ser Val Val Arg Arg Gln Leu Phe Leu Asp Val Leu Asp
1140 1145 1150
Gly Thr Lys Ala Leu Leu Leu Val Pro Ala Ser Val Asn Cys Leu Arg
1155 1160 1165
Leu Gly Ser Met Lys Cys Thr Leu Leu Leu Ile Leu Leu Arg Gln Trp
1170 1175 1180
Lys Ser Ile Leu Ser Arg Glu Leu Gly Ser Val Asp Glu Ile Leu Gly
1185 1190 1195 1200
Pro Leu Thr Glu Ile Leu Glu Gly Val Leu Gln Ala Asp Gln Gln Leu
1205 1210 1215
Met Glu Lys Thr Lys Ala Lys Val Phe Ser Ala Phe Ile Thr Val Leu
1220 1225 1230
Gln Met Lys Glu Met Lys Val Ser Asp Ile Pro Gln Tyr Ser Gln Leu
1235 1240 1245
Val Leu Asn Val Cys Glu Thr Leu Gln Glu Glu Val Ile Ala Leu Phe
1250 1255 1260
Asp Gln Thr Arg His Ser Leu Ala Leu Gly Ser Ala Thr Glu Asp Lys
1265 1270 1275 1280
Asp Ser Met Glu Thr Asp Asp Cys Ser Arg Ser Arg His Arg Asp Gln
1285 1290 1295
Arg Asp Gly Val Cys Val Leu Gly Leu His Leu Ala Lys Glu Leu Cys
1300 1305 1310
Glu Val Asp Glu Asp Gly Asp Ser Trp Leu Gln Val Thr Arg Arg Leu
1315 1320 1325
Pro Ile Leu Pro Thr Leu Leu Thr Thr Leu Glu Val Ser Leu Arg Met
1330 1335 1340
Lys Gln Asn Leu His Phe Thr Glu Ala Thr Leu His Leu Leu Leu Thr
1345 1350 1355 1360
Leu Ala Arg Thr Gln Gln Gly Ala Thr Ala Val Ala Gly Ala Gly Ile
1365 1370 1375
Thr Gln Ser Ile Cys Leu Pro Leu Leu Ser Val Tyr Gln Leu Ser Thr
1380 1385 1390
Asn Gly Thr Ala Gln Thr Pro Ser Ala Ser Arg Lys Ser Leu Asp Ala
1395 1400 1405
Pro Ser Trp Pro Gly Val Tyr Arg Leu Ser Met Ser Leu Met Glu Gln
1410 1415 1420
Leu Leu Lys Thr Leu Arg Tyr Asn Phe Leu Pro Glu Ala Leu Asp Phe
1425 1430 1435 1440
Val Gly Val His Gln Glu Arg Thr Leu Gln Cys Leu Asn Ala Val Arg
1445 1450 1455
Thr Val Gln Ser Leu Ala Cys Leu Glu Glu Ala Asp His Thr Val Gly
1460 1465 1470
Phe Ile Leu Gln Leu Ser Asn Phe Met Lys Glu Trp His Phe His Leu
1475 1480 1485
Pro Gln Leu Met Arg Asp Ile Gln Val Asn Leu Gly Tyr Leu Cys Gln
1490 1495 1500
Ala Cys Thr Ser Leu Leu His Ser Arg Lys Met Leu Gln His Tyr Leu
1505 1510 1515 1520
Gln Asn Lys Asn Gly Asp Gly Leu Pro Ser Ala Val Ala Gln Arg Val
1525 1530 1535
Gln Arg Pro Pro Ser Ala Ala Ser Ala Ala Pro Ser Ser Ser Lys Gln
1540 1545 1550
Pro Ala Ala Asp Thr Glu Ala Ser Glu Gln Gln Ala Leu His Thr Val
1555 1560 1565
Gln Tyr Gly Leu Leu Lys Ile Leu Ser Lys Thr Leu Ala Ala Leu Arg
1570 1575 1580
His Phe Thr Pro Asp Val Cys Gln Ile Leu Leu Asp Gln Ser Leu Asp
1585 1590 1595 1600
Leu Ala Glu Tyr Asn Phe Leu Phe Ala Leu Ser Phe Thr Thr Pro Thr
1605 1610 1615
Phe Asp Ser Glu Val Ala Pro Ser Phe Gly Thr Leu Leu Ala Thr Val
1620 1625 1630
Asn Val Ala Leu Asn Met Leu Gly Glu Leu Asp Lys Lys Lys Glu Pro
1635 1640 1645
Leu Thr Gln Ala Val Gly Leu Ser Thr Gln Ala Glu Gly Thr Arg Thr
1650 1655 1660
Leu Lys Ser Leu Leu Met Phe Thr Met Glu Asn Cys Phe Tyr Leu Leu
1665 1670 1675 1680
Ile Ser Gln Ala Met Arg Tyr Leu Arg Asp Pro Ala Val His Pro Arg
1685 1690 1695
Asp Lys Gln Arg Met Lys Gln Glu Leu Ser Ser Glu Leu Ser Thr Leu
1700 1705 1710
Leu Ser Ser Leu Ser Arg Tyr Phe Arg Arg Gly Ala Pro Ser Ser Pro
1715 1720 1725
Ala Thr Gly Val Leu Pro Ser Pro Gln Gly Lys Ser Thr Ser Leu Ser
1730 1735 1740
Lys Ala Ser Pro Glu Ser Gln Glu Pro Leu Ile Gln Leu Val Gln Ala
1745 1750 1755 1760
Phe Val Arg His Met Gln Arg Met Ala Ser Gly Gly Gly Val Arg Ala
1765 1770 1775
Ser Gly Arg Ala Lys Met Ala Ala Ala Ala Gly Gly Pro Cys Val Arg
1780 1785 1790
Ser Ser Arg Glu Leu Trp Thr Ile Leu Leu Gly Arg Ser Ala Leu Arg
1795 1800 1805
Glu Leu Ser Gln Ile Glu Ala Glu Leu Asn Lys His Trp Arg Arg Leu
1810 1815 1820
Leu Glu Gly Leu Ser Tyr Tyr Lys Pro Pro Ser Pro Ser Ser Ala Glu
1825 1830 1835 1840
Lys Val Lys Ala Asn Lys Asp Val Ala Ser Pro Leu Lys Glu Leu Gly
1845 1850 1855
Leu Arg Ile Ser Lys Phe Leu Gly Leu Asp Glu Glu Gln Ser Val Gln
1860 1865 1870
Leu Leu Gln Cys Tyr Leu Gln Glu Asp Tyr Arg Gly Thr Arg Asp Ser
1875 1880 1885
Val Lys Thr Val Leu Gln Asp Glu Arg Gln Ser Gln Ala Leu Ile Leu
1890 1895 1900
Lys Ile Ala Asp Tyr Tyr Tyr Glu Glu Arg Thr Cys Ile Leu Arg Cys
1905 1910 1915 1920
Val Leu His Leu Leu Thr Tyr Phe Gln Asp Glu Arg His Pro Tyr Arg
1925 1930 1935
Val Glu Tyr Ala Asp Cys Val Asp Lys Leu Glu Lys Glu Leu Val Ser
1940 1945 1950
Lys Tyr Arg Gln Gln Phe Glu Glu Leu Tyr Lys Thr Glu Ala Pro Thr
1955 1960 1965
Trp Glu Thr His Gly Asn Leu Met Thr Glu Arg Gln Val Ser Arg Trp
1970 1975 1980
Phe Val Gln Cys Leu Arg Glu Gln Ser Met Leu Leu Glu Ile Ile Phe
1985 1990 1995 2000
Leu Tyr Tyr Ala Tyr Phe Glu Met Ala Pro Ser Asp Leu Leu Val Leu
2005 2010 2015
Thr Lys Met Phe Lys Glu Gln Gly Phe Gly Ser Arg Gln Thr Asn Arg
2020 2025 2030
His Leu Val Asp Glu Thr Met Asp Pro Phe Val Asp Arg Ile Gly Tyr
2035 2040 2045
Phe Ser Ala Leu Ile Leu Val Glu Gly Met Asp Ile Glu Ser Leu His
2050 2055 2060
Lys Cys Ala Leu Asp Asp Arg Arg Glu Leu His Gln Phe Ala Gln Asp
2065 2070 2075 2080
Gly Leu Ile Cys Gln Asp Met Asp Cys Leu Met Leu Thr Phe Gly Asp
2085 2090 2095
Ile Pro His His Ala Pro Val Leu Leu Ala Trp Ala Leu Leu Arg His
2100 2105 2110
Thr Leu Asn Pro Glu Glu Thr Ser Ser Val Val Arg Lys Ile Gly Gly
2115 2120 2125
Thr Ala Ile Gln Leu Asn Val Phe Gln Tyr Leu Thr Arg Leu Leu Gln
2130 2135 2140
Ser Leu Ala Ser Gly Gly Asn Asp Cys Thr Thr Ser Thr Ala Cys Met
2145 2150 2155 2160
Cys ValTyr Gly Leu Leu Ser Phe Val Leu Thr Ser Leu Glu Leu His
2165 2170 2175
Thr Leu Gly Asn Gln Gln Asp Ile Ile Asp Thr Ala Cys Glu Val Leu
2180 2185 2190
Ala Asp Pro Ser Leu Pro Glu Leu Phe Trp Gly Thr Glu Pro Thr Ser
2195 2200 2205
Gly Leu Gly Ile Ile Leu Asp Ser Val Cys Gly Met Phe Pro His Leu
2210 2215 2220
Leu Ser Pro Leu Leu Gln Leu Leu Arg Ala Leu Val Ser Gly Lys Ser
2225 2230 2235 2240
Thr Ala Lys Lys Val Tyr Ser Phe Leu Asp Lys Met Ser Phe Tyr Asn
2245 2250 2255
Glu Leu Tyr Lys His Lys Pro His Asp Val Ile Ser His Glu Asp Gly
2260 2265 2270
Thr Leu Trp Arg Arg Gln Thr Pro Lys Leu Leu Tyr Pro Leu Gly Gly
2275 2280 2285
Gln Thr Asn Leu Arg Ile Pro Gln Gly Thr Val Gly Gln Val Met Leu
2290 2295 2300
Asp Asp Arg Ala Tyr Leu Val Arg Trp Glu Tyr Ser Tyr Ser Ser Trp
2305 2310 2315 2320
Thr Leu Phe Thr Cys Glu Ile Glu Met Leu Leu His Val Val Ser Thr
2325 2330 2335
Ala Asp Val Ile Gln His Cys Gln Arg Val Lys Pro Ile Ile Asp Leu
2340 2345 2350
Val His Lys Val Ile Ser Thr Asp Leu Ser Ile Ala Asp Cys Leu Leu
2355 2360 2365
Pro Ile Thr Ser Arg Ile Tyr Met Leu Leu Gln Arg Leu Thr Thr Val
2370 2375 2380
Ile Ser Pro Pro Val Asp Val Ile Ala Ser Cys Val Asn Cys Leu Thr
2385 2390 2395 2400
Val Leu Ala Ala Arg Asn Pro Ala Lys Val Trp Thr Asp Leu Arg His
2405 2410 2415
Thr Gly Phe Leu Pro Phe Val Ala His Pro Val Ser Ser Leu Ser Gln
2420 2425 2430
Met Ile Ser Ala Glu Gly Met Asn Ala Gly Gly Tyr Gly Asn Leu Leu
2435 2440 2445
Met Asn Ser Glu Gln Pro Gln Gly Glu Tyr Gly Val Thr Ile Ala Phe
2450 2455 2460
Leu Arg Leu Ile Thr Thr Leu Val Lys Gly Gln Leu Gly Ser Thr Gln
2465 2470 2475 2480
Ser Gln Gly Leu Val Pro Cys Val Met Phe Val Leu Lys Glu Met Leu
2485 2490 2495
Pro Ser Tyr His Lys Trp Arg Tyr Asn Ser His Gly Val Arg Glu Gln
2500 2505 2510
Ile Gly Cys Leu Ile Leu Glu Leu Ile His Ala Ile Leu Asn Leu Cys
2515 2520 2525
His Glu Thr Asp Leu His Ser Ser His Thr Pro Ser Leu Gln Phe Leu
2530 2535 2540
Cys Ile Cys Ser Leu Ala Tyr Thr Glu Ala Gly Gln Thr Val Ile Asn
2545 2550 2555 2560
Ile Met Gly Ile Gly Val Asp Thr Ile Asp Met Val Met Ala Ala Gln
2565 2570 2575
Pro Arg Ser Asp Gly Ala Glu Gly Gln Gly Gln Gly Gln Leu Leu Ile
2580 2585 2590
Lys Thr Val Lys Leu Ala Phe Ser Val Thr Asn Asn Val Ile Arg Leu
2595 2600 2605
Lys Pro Pro Ser Asn Val Val Ser Pro Leu Glu Gln Ala Leu Ser Gln
2610 2615 2620
His Gly Ala His Gly Asn Asn Leu Ile Ala Val Leu Ala Lys Tyr Ile
2625 2630 2635 2640
Tyr His Lys His Asp Pro Ala Leu Pro Arg Leu Ala Ile Gln Leu Leu
2645 2650 2655
Lys Arg Leu Ala Thr Val Ala Pro Met Ser Val Tyr Ala Cys Leu Gly
2660 2665 2670
Asn Asp Ala Ala Ala Ile Arg Asp Ala Phe Leu Thr Arg Leu Gln Ser
2675 2680 2685
Lys Ile Glu Asp Met Arg Ile Lys Val Met Ile Leu Glu Phe Leu Thr
2690 2695 2700
Val Ala Val Glu Thr Gln Pro Gly Leu Ile Glu Leu Phe Leu Asn Leu
2705 2710 2715 2720
Glu Val Lys Asp Gly Ser Asp Gly Ser Lys Glu Phe Ser Leu Gly Met
2725 2730 2735
Trp Ser Cys Leu His Ala Val Leu Glu Leu Ile Asp Ser Gln Gln Gln
2740 2745 2750
Asp Arg Tyr Trp Cys Pro Pro Leu Leu His Arg Ala Ala Ile Ala Phe
2755 2760 2765
Leu His Ala Leu Trp Gln Asp Arg Arg Asp Ser Ala Met Leu Val Leu
2770 2775 2780
Arg Thr Lys Pro Lys Phe Trp Glu Asn Leu Thr Ser Pro Leu Phe Gly
2785 2790 2795 2800
Thr Leu Ser Pro Pro Ser Glu Thr Ser Glu Pro Ser Ile Leu Glu Thr
2805 2810 2815
Cys Ala Leu Ile Met Lys Ile Ile Cys Leu Glu Ile Tyr Tyr Val Val
2820 2825 2830
Lys Gly Ser Leu Asp Gln Ser Leu Lys Asp Thr Leu Lys Lys Phe Ser
2835 2840 2845
Ile Glu Lys Arg Phe Ala Tyr Trp Ser Gly Tyr Val Lys Ser Leu Ala
2850 2855 2860
Val His Val Ala Glu Thr Glu Gly Ser Ser Cys Thr Ser Leu Leu Glu
2865 2870 2875 2880
Tyr Gln Met Leu Val Ser Ala Trp Arg Met Leu Leu Ile Ile Ala Thr
2885 2890 2895
Thr His Ala Asp Ile Met His Leu Thr Asp Ser Val Val Arg Arg Gln
2900 2905 2910
Leu Phe Leu Asp Val Leu Asp Gly Thr Lys Ala Leu Leu Leu Val Pro
2915 2920 2925
Ala Ser ValAsn Cys Leu Arg Leu Gly Ser Met Lys Cys Thr Leu Leu
2930 2935 2940
Leu Ile Leu Leu Arg Gln Trp Lys Ser Ile Leu Ser Arg Glu Leu Gly
2945 2950 2955 2960
Ser Val Asp Glu Ile Leu Gly Pro Leu Thr Glu Ile Leu Glu Gly Val
2965 2970 2975
Leu Gln Ala Asp Gln Gln Leu Met Glu Lys Thr Lys Ala Lys Val Phe
2980 2985 2990
Ser Ala Phe Ile Thr Val Leu Gln Met Lys Glu Met Lys Val Ser Asp
2995 3000 3005
Ile Pro Gln Tyr Ser Gln Leu Val Leu Asn Val Cys Glu Thr Leu Gln
3010 3015 3020
Glu Glu Val Ile Ala Leu Phe Asp Gln Thr Arg His Ser Leu Ala Leu
3025 3030 3035 3040
Gly Ser Ala Thr Glu Asp Lys Asp Ser Met Glu Thr Asp Asp Cys Ser
3045 3050 3055
Arg Ser Arg His Arg Asp Gln Arg Asp Gly Val Cys Val Leu Gly Leu
3060 3065 3070
His Leu Ala Lys Glu Leu Cys Glu Val Asp Glu Asp Gly Asp Ser Trp
3075 3080 3085
Leu Gln ValThr Arg Arg Leu Pro Ile Leu Pro Thr Leu Leu Thr Thr
3090 3095 3100
Leu Glu Val Ser Leu Arg Met Lys Gln Asn Leu His Phe Thr Glu Ala
3105 3110 3115 3120
Thr Leu His Leu Leu Leu Thr Leu Ala Arg Thr Gln Gln Gly Ala Thr
3125 3130 3135
Ala Val Ala Gly Ala Gly Ile Thr Gln Ser Ile Cys Leu Pro Leu Leu
3140 3145 3150
Ser Val Tyr Gln Leu Ser Thr Asn Gly Thr Ala Gln Thr Pro Ser Ala
3155 3160 3165
Ser Arg Lys Ser Leu Asp Ala Pro Ser Trp Pro Gly Val Tyr Arg Leu
3170 3175 3180
Ser Met Ser Leu Met Glu Gln Leu Leu Lys Thr Leu Arg Tyr Asn Phe
3185 3190 3195 3200
Leu Pro Glu Ala Leu Asp Phe Val Gly Val His Gln Glu Arg Thr Leu
3205 3210 3215
Gln Cys Leu Asn Ala Val Arg Thr Val Gln Ser Leu Ala Cys Leu Glu
3220 3225 3230
Glu Ala Asp His Thr Val Gly Phe Ile Leu Gln Leu Ser Asn Phe Met
3235 3240 3245
Lys Glu Trp His Phe His Leu Pro Gln Leu Met Arg Asp Ile Gln Val
3250 3255 3260
Asn Leu Gly Tyr Leu Cys Gln Ala Cys Thr Ser Leu Leu His Ser Arg
3265 3270 3275 3280
Lys Met Leu Gln His Tyr Leu Gln Asn Lys Asn Gly Asp Gly Leu Pro
3285 3290 3295
Ser Ala Val Ala Gln Arg Val Gln Arg Pro Pro Ser Ala Ala Ser Ala
3300 3305 3310
Ala Pro Ser Ser Ser Lys Gln Pro Ala Ala Asp Thr Glu Ala Ser Glu
3315 3320 3325
Gln Gln Ala Leu His Thr Val Gln Tyr Gly Leu Leu Lys Ile Leu Ser
3330 3335 3340
Lys Thr Leu Ala Ala Leu Arg His Phe Thr Pro Asp Val Cys Gln Ile
3345 3350 3355 3360
Leu Leu Asp Gln Ser Leu Asp Leu Ala Glu Tyr Asn Phe Leu Phe Ala
3365 3370 3375
Leu Ser Phe Thr Thr Pro Thr Phe Asp Ser Glu Val Ala Pro Ser Phe
3380 3385 3390
Gly Thr Leu Leu Ala Thr Val Asn Val Ala Leu Asn Met Leu Gly Glu
3395 3400 3405
Leu Asp Lys Lys Lys Glu Pro Leu Thr Gln Ala Val Gly Leu Ser Thr
3410 3415 3420
Gln Ala Glu Gly Thr Arg Thr Leu Lys Ser Leu Leu Met Phe Thr Met
3425 3430 3435 3440
Glu Asn Cys Phe Tyr Leu Leu Ile Ser Gln Ala Met Arg Tyr Leu Arg
3445 3450 3455
Asp Pro Ala Val His Pro Arg Asp Lys Gln Arg Met Lys Gln Glu Leu
3460 3465 3470
Ser Ser Glu Leu Ser Thr Leu Leu Ser Ser Leu Ser Arg Tyr Phe Arg
3475 3480 3485
Arg Gly Ala Pro Ser Ser Pro Ala Thr Gly Val Leu Pro Ser Pro Gln
3490 3495 3500
Gly Lys Ser Thr Ser Leu Ser Lys Ala Ser Pro Glu Ser Gln Glu Pro
3505 3510 3515 3520
Leu Ile Gln Leu Val Gln Ala Phe Val Arg His Met Gln Arg
3525 3530
<210>23
<211>1111
<212>PRT
<213>人
<400>23
Met Thr Gln Met Ile Ser Ala Glu Gly Met Asn Ala Gly Gly Tyr Gly
1 5 10 15
Ser Leu Leu Met Asn Ser Glu Gln Pro Gln Gly Glu Tyr Gly Val Thr
20 25 30
Ile Ala Phe Leu Arg Leu Val Thr Thr Leu Val Lys Gly Gln Leu Gly
35 40 45
Ser Thr Gln Ser Gln Gly Leu Val Pro Cys Val Met Phe Val Leu Lys
50 55 60
Glu Met Leu Pro Ser Tyr His Lys Trp Arg Tyr Asn Ser His Gly Val
65 70 75 80
Arg Glu Leu Ile Gly Cys Leu Ile Leu Glu Leu Ile His Ala Ile Leu
85 90 95
Asn Leu Cys Gln Glu Thr Glu Leu His Ser Ser His Thr Pro Ser Leu
100 105 110
Pro Ser Leu Cys Ile Cys Ser Leu Ala Tyr Thr Glu Ala Gly Gln Thr
115 120 125
Val Ile Ser Ile Met Gly Ile Gly Val Asp Thr Ile Asp Met Val Met
130 135 140
Ala Ala Gln Pro Arg Ser Asp Gly Pro Glu Gly Gln Gly Gln Gly Gln
145 150 155 160
Leu Leu Ile Lys Thr Val Lys Leu Ala Phe Ser Val Thr Asn Asn Val
165 170 175
Ile Arg Leu Lys Pro Pro Ser Asn Val Val Ser Pro Leu Glu Gln Ala
180 185 190
Leu Thr Gln His Gly Ala His Gly Asn Asn Leu Ile Ala Val Leu Ala
195 200 205
Lys Tyr Ile Tyr His Arg His Asp Pro Ala Leu Pro Arg Leu Ala Ile
210 215 220
Gln Leu Leu Lys Arg Leu Ala Thr Val Ala Pro Met Ser Val Tyr Ala
225 230 235 240
Cys Leu Gly Ser Asp Ala Ala Ala Ile Arg Asp Ala Phe Leu Thr Arg
245 250 255
Leu Gln Ser Lys Ile Glu Asp Met Arg Ile Lys Val Met Ile Leu Glu
260 265 270
Phe Leu Thr Val Ala Val Glu Thr Gln Pro Gly Leu Ile Glu Leu Phe
275 280 285
Leu Asn Leu Glu Val Lys Asp Gly Ser Asn Gly Ser Lys Glu Phe Ser
290 295 300
Leu Gly Val Trp Ser Cys Leu His Val Val Leu Glu Leu Ile Asp Ser
305 310 315 320
Gln Gln Gln Asp Arg Tyr Trp Cys Pro Pro Leu Leu His Arg Ala Ala
325 330 335
Ile Ala Phe Leu His Ala Leu Trp Gln Asp Arg Arg Asp Ser Ala Met
340 345 350
Leu Val Leu Arg Thr Lys Pro Lys Phe Trp Glu Asn Leu Thr Ser Pro
355 360 365
Leu Phe Gly Thr Leu Ser Pro Pro Ser Glu Thr Ser Glu Pro Ser Val
370 375 380
Leu Glu Thr Cys Ala Leu Ile Met Lys Ile Ile Cys Leu Glu Ile Tyr
385 390 395 400
Tyr Val Val Lys Gly Ser Leu Asp Gln Ser Leu Lys Asp Thr Leu Lys
405 410 415
Lys Phe Ser Ser Glu Lys Arg Phe Ala Tyr Trp Ser Gly Tyr Val Lys
420 425 430
Ser Leu Ala Val Tyr Met Ala Asp Thr Glu Gly Ser Ser Cys Thr Ser
435 440 445
Leu Leu Glu Tyr Gln Met Leu Val Ser Ala Trp Arg Ile Leu Leu Ile
450 455 460
Ile Ala Ala Ser His Ala Asp Val Met His Leu Thr Asp Met Ala Val
465 470 475 480
Arg Arg Gln Leu Phe Leu Asp Val Leu Asp Gly Thr Lys Ala Leu Leu
485 490 495
Leu Val Ala Ala Ser Val Asn Cys Leu Arg Leu Gly Ser Met Met Cys
500 505 510
Thr Leu Leu Leu Ile Leu Leu Arg Gln Trp Lys Arg Glu Leu Gly Ala
515 520 525
Val Glu Lys Ile Leu Gly Pro Leu Thr Glu Ile Leu Glu Gly Val Leu
530 535 540
Gln Ala Asp Gln Gln Leu Met Glu Lys Thr Lys Ala Lys Val Phe Ser
545 550 555 560
Ala Phe Ile Thr Val Leu Gln Met Lys Glu Leu Arg Val Gly Asp Ile
565 570 575
Pro Gln Tyr Ser Gln Leu Val Leu Asn ValCys Glu Thr Leu Gln Glu
580 585 590
Glu Val Ile Ala Leu Phe Asp Gln Thr Arg His Ser Leu Ala Ser Asp
595 600 605
Ser Ala Ala Glu Asp Lys Asp Ser Met Glu Thr Asp Asp Cys Pro Arg
610 615 620
Pro Arg His Lys Asp Gln Arg Asp Gly Val Cys Val Leu Gly Leu His
625 630 635 640
Leu Ala Lys Glu Leu Cys Glu Val Asp Glu Asp Gly Asp Ser Trp Leu
645 650 655
Gln Val Thr Arg Arg Leu Pro Ile Leu Pro Thr Leu Leu Thr Thr Leu
660 665 670
Glu Val Ser Leu Arg Met Lys Gln Asn Leu His Phe Thr Glu Ala Ala
675 680 685
Leu His Leu Leu Leu Thr Leu Ala Arg Thr Gln Gln Gly Ala Thr Ala
690 695 700
Val Ala Gly Ala Gly Ile Thr Gln Ser Ile Cys Leu Pro Leu Leu Ser
705 710 715 720
Val Tyr Gln Leu Ser Ser Asn Gly Thr Gly Gln Thr Pro Ser Thr Ser
725 730 735
Arg Lys Ser Leu Asp Ala Pro Ser Trp Pro Gly Val Tyr Arg Leu Ser
740 745 750
Met Ser Leu Met Glu Arg Leu Leu Lys Thr Leu Arg Tyr Asn Phe Leu
755 760 765
Thr Glu Ala Leu Asp Phe Val Gly Val His Gln Glu Arg Thr Leu Gln
770 775 780
Cys Leu Asn Ala Val Lys Thr Val Gln Ser Leu Ala Cys Leu Glu Glu
785 790 795 800
Ala Asp His Thr Val Gly Phe Ile Leu Gln Leu Ser His Phe Arg Lys
805 810 815
Glu Trp His Phe His Leu Pro Gln Leu Met Arg Asp Val Gln Val Asn
820 825 830
Leu Gly Tyr Leu Cys Gln Ala Cys Thr Ser Leu Leu His Ser Arg Lys
835 840 845
Met Leu Gln His Tyr Leu Gln Asn Lys Asn Gly Asp Gly Leu Pro Ser
850 855 860
Ala Val Thr Pro Arg Ala Gln Arg Pro Ser Thr Thr Thr Thr Thr Thr
865 870 875 880
Thr Thr Thr Thr Ala Leu Ala Thr Pro Ala Gly Cys Ser Ser Lys Gln
885 890 895
Pro Thr Ala Asp Thr Glu Ala Ser Glu Gln Arg Ala Leu His Thr Val
900 905 910
Gln Tyr Gly Leu Leu Lys Ile Leu Ser Arg Thr Leu Ala Ala Leu Arg
915 920 925
His Phe Thr Pro Asp Val Cys Gln Ile Leu Leu Asp Gln Ser Leu Asp
930 935 940
Leu Ala Glu Tyr Asn Phe Leu Phe Ala Leu Ser Phe Thr Thr Pro Thr
945 950 955 960
Phe Asp Ser Glu Val Ala Pro Ser Phe Gly Thr Leu Leu Ala Thr Val
965 970 975
Asn Val Ala Leu Asn Met Leu Gly Glu Leu Asp Lys Lys Lys Glu Ser
980 985 990
Leu Thr Gln Ala Val Gly Leu Ser Thr Gln Ala Glu Gly Thr Arg Thr
995 1000 1005
Leu Lys Ser Leu Leu Met Phe Thr Met Glu Asn Cys Phe Tyr Leu Leu
1010 1015 1020
Ile Ser Gln Ala Val Arg Tyr Leu Arg Asp Pro Ala Val His Pro Arg
1025 1030 1035 1040
Asp Lys Gln Arg Met Lys Gln Glu Leu Ser Ser Glu Leu Ser Thr Leu
1045 1050 1055
Leu Ser Ser Leu Ser Arg Tyr Phe Arg Arg Gly Ala Pro Ser Ser Pro
1060 1065 1070
Ala Ala Gly Val Leu Pro Ser Pro Gln Gly Lys Ala Thr Ser Leu Ser
1075 1080 1085
Lys Ala Ser Pro Glu Ser Gln Glu Pro Leu Ile Gln Leu Val Gln Ala
1090 1095 1100
Phe Val Arg His Val Gln Arg
1105 1110
<210>24
<211>853
<212>PRT
<213>人
<400>24
Val Thr Ile Ala Phe Leu Arg Leu Ile Thr Thr Leu Val Lys Gly Gln
1 5 10 15
Leu Gly Ser Thr Gln Ser Gln Gly Leu Val Pro Cys Val Met Phe Val
20 25 30
Leu Lys Glu Met Leu Pro Ser Tyr His Lys Trp Arg Tyr Asn Ser His
35 40 45
Gly Val Arg Glu Gln Ile Gly Cys Leu Ile Leu Glu Leu Ile His Ala
50 55 60
Ile Leu Asn Leu Cys His Glu Thr Asp Leu His Ser Ser His Thr Pro
65 70 75 80
Ser Leu Gln Phe Leu Cys Ile Cys Ser Leu Ala Tyr Thr Glu Ala Gly
85 90 95
Gln Thr Val Ile Asn Ile Met Gly Ile Gly Val Asp Thr Ile Asp Met
100 105 110
Val Met Ala Ala Gln Pro Arg Ser Asp Gly Ala Glu Gly Gln Gly Gln
115 120 125
Gly Gln Leu Leu Ile Lys Thr Val Lys Leu Ala Phe Ser Val Thr Asn
130 135 140
Asn Val Ile Arg Leu Lys Pro Pro Ser Asn Val Val Ser Pro Leu Glu
145 150 155 160
Gln Ala Leu Ser Gln His Gly Ala His Gly Asn Asn Leu Ile Ala Val
165 170 175
Leu Ala Lys Tyr Ile Tyr His Lys His Asp Pro Ala Leu Pro Arg Leu
180 185 190
Ala Ile Gln Leu Leu Lys Arg Leu Ala Thr Val Ala Pro Met Ser Val
195 200 205
Tyr Ala Cys Leu Gly Asn Asp Ala Ala Ala Ile Arg Asp Ala Phe Leu
210 215 220
Thr Arg Leu Gln Ser Lys Ile Glu Asp Met Arg Ile Lys Val Met Ile
225 230 235 240
Leu Glu Phe Leu Thr Val Ala Val Glu Thr Gln Pro Gly Leu Ile Glu
245 250 255
Leu Phe Leu Asn Leu Glu Val Lys Asp Gly Ser Asp Gly Ser Lys Glu
260 265 270
Phe Ser Leu Gly Met Trp Ser Cys Leu His Ala Val Leu Glu Leu Ile
275 280 285
Asp Ser Gln Gln Gln Asp Arg Tyr Trp Cys Pro Pro Leu Leu His Arg
290 295 300
Ala Ala Ile Ala Phe Leu His Ala Leu Trp Gln Asp Arg Arg Asp Ser
305 310 315 320
Ala Met Leu Val Leu Arg Thr Lys Pro Lys Phe Trp Glu Asn Leu Thr
325 330 335
Ser Pro Leu Phe Gly Thr Leu Ser Pro Pro Ser Glu Thr Ser Glu Pro
340 345 350
Ser Ile Leu Glu Thr Cys Ala Leu Ile Met Lys Ile Ile Cys Leu Glu
355 360 365
Ile Tyr Tyr Val Val Lys Gly Ser Leu Asp Gln Ser Leu Lys Asp Thr
370 375 380
Leu Lys Lys Phe Ser Ile Glu Lys Arg Phe Ala Tyr Trp Ser Gly Tyr
385 390 395 400
Val Lys Ser Leu Ala Val His Val Ala Glu Thr Glu Gly Ser Ser Cys
405 410 415
Thr Ser Leu Leu Glu Tyr Gln Met Leu Val Ser Ala Trp Arg Met Leu
420 425 430
Leu Ile Ile Ala Thr Thr His Ala Asp Ile Met His Leu Thr Asp Ser
435 440 445
Val Val Arg Arg Gln Leu Phe Leu Asp Val Leu Asp Gly Thr Lys Ala
450 455 460
Leu Leu Leu Val Pro Ala Ser Val Asn Cys Leu Arg Leu Gly Ser Met
465 470 475 480
Lys Cys Thr Leu Leu Leu Ile Leu Leu Arg Gln Trp Lys Arg Glu Leu
485 490 495
Gly Ser Val Asp Glu Ile Leu Gly Pro Leu Thr Glu Ile Leu Glu Gly
500 505 510
Val Leu Gln Ala Asp Gln Gln Leu Met Glu Lys Thr Lys Ala Lys Val
515 520 525
Phe Ser Ala Phe Ile Thr Val Leu Gln Met Lys Glu Met Lys Val Ser
530 535 540
Asp Ile Pro Gln Tyr Ser Gln Leu Val Leu Asn Val Cys Glu Thr Leu
545 550 555 560
Gln Glu Glu Val Ile Ala Leu Phe Asp Gln Thr Arg His Ser Leu Ala
565 570 575
Leu Gly Ser Ala Thr Glu Asp Lys Asp Ser Met Glu Thr Asp Asp Cys
580 585 590
Ser Arg Ser Arg His Arg Asp Gln Arg Asp Gly Val Cys Val Leu Gly
595 600 605
Leu His Leu Ala Lys Glu Leu Cys Glu Val Asp Glu Asp Gly Asp Ser
610 615 620
Trp Leu Gln Val Thr Arg Arg Leu Pro Ile Leu Pro Thr Leu Leu Thr
625 630 635 640
Thr Leu Glu Val Ser Leu Arg Met Lys Gln Asn Leu His Phe Thr Glu
645 650 655
Ala Thr Leu His Leu Leu Leu Thr Leu Ala Arg Thr Gln Gln Gly Ala
660 665 670
Thr Ala Val Ala Gly Ala Gly Ile Thr Gln Ser Ile Cys Leu Pro Leu
675 680 685
Leu Ser Val Tyr Gln Leu Ser Thr Asn Gly Thr Ala Gln Thr Pro Ser
690 695 700
Ala Ser Arg Lys Ser Leu Asp Ala Pro Ser Trp Pro Gly Val Tyr Arg
705 710 715 720
Leu Ser Met Ser Leu Met Glu Gln Leu Leu Lys Thr Leu Arg Tyr Asn
725 730 735
Phe Leu Pro Glu Ala Leu Asp Phe Val Gly Val His Gln Glu Arg Thr
740 745 750
Leu Gln Cys Leu Asn Ala Val Arg Thr Val Gln Ser Leu Ala Cys Leu
755 760 765
Glu Glu Ala Asp His Thr Val Gly Phe Ile Leu Gln Leu Ser Asn Phe
770 775 780
Met Lys Glu Trp His Phe His Leu Pro Gln Leu Met Arg Asp Ile Gln
785 790 795 800
Val Gly Ala Gln Asp Gly Val Leu Glu Ser Gly Val Met Leu Gly Asp
805 810 815
Arg Glu Ala Val Arg Ser His Trp Gly Thr Pro Ser Glu Leu Gln Asp
820 825 830
Val Pro Glu Arg Gly Leu Phe Pro Trp Gly Ala Gln Gly Leu Leu Ser
835 840 845
Cys Ala Tyr Ser Gly
850
<210>25
<211>525
<212>PRT
<213>鼠肌
<400>25
Thr Arg Pro Leu Gln Glu Glu Val Ile Ala Leu Phe Asp Gln Thr Arg
1 5 10 15
His Ser Leu Ala Ser Asp Ser Ala Ala Glu Asp Lys Asp Ser Met Glu
20 25 30
Thr Asp Asp Cys Pro Arg Pro Arg His Lys Asp Gln Arg Asp Gly Val
35 40 45
Cys Val Leu Gly Leu His Leu Ala Lys Glu Leu Cys Glu Val Asp Glu
50 55 60
Asp Gly Asp Ser Trp Leu Gln Val Thr Arg Arg Leu Pro Ile Leu Pro
65 70 75 80
Thr Leu Leu Thr Thr Leu Glu Val Ser Leu Arg Met Lys Gln Asn Leu
85 90 95
His Phe Thr Glu Ala Ala Leu His Leu Leu Leu Thr Leu Ala Arg Thr
100 105 110
Gln Gln Gly Ala Thr Ala Val Ala Gly Ala Gly Ile Thr Gln Ser Ile
115 120 125
Cys Leu Pro Leu Leu Ser Val Tyr Gln Leu Ser Ser Asn Gly Thr Gly
130 135 140
Gln Thr Pro Ser Thr Ser Arg Lys Ser Leu Asp Ala Pro Ser Trp Pro
145 150 155 160
Gly Val Tyr Arg Leu Ser Met Ser Leu Met Glu Arg Leu Leu Lys Thr
165 170 175
Leu Arg Tyr Asn Phe Leu Thr Glu Ala Leu Asp Phe Val Gly Val His
180 185 190
Gln Glu Arg Thr Leu Gln Cys Leu Asn Ala Val Lys Thr Val Gln Ser
195 200 205
Leu Ala Cys Leu Glu Glu Ala Asp His Thr Val Gly Phe Ile Leu Gln
210 215 220
Leu Ser His Phe Arg Lys Glu Trp His Phe His Leu Pro Gln Leu Met
225 230 235 240
Arg Asp Val Gln Val Asn Leu Gly Tyr Leu Cys Gln Ala Cys Thr Ser
245 250 255
Leu Leu His Ser Arg Lys Met Leu Gln His Tyr Leu Gln Asn Lys Asn
260 265 270
Gly Asp Gly Leu Pro Ser Ala Val Thr Pro Arg Ala Gln Arg Pro Ser
275 280 285
Thr Thr Thr Thr Thr Thr Thr Thr Thr Thr Ala Leu Ala Thr Pro Ala
290 295 300
Gly Cys Ser Ser Lys Gln Pro Thr Ala Asp Thr Glu Ala Ser Glu Gln
305 310 315 320
Arg Ala Leu His Thr Val Gln Tyr Gly Leu Leu Lys Ile Leu Ser Arg
325 330 335
Thr Leu Ala Ala Leu Arg His Phe Thr Pro Asp Val Cys Gln Ile Leu
340 345 350
Leu Asp Gln Ser Leu Asp Leu Ala Glu Tyr Asn Phe Leu Phe Ala Leu
355 360 365
Ser Phe Thr Thr Pro Thr Phe Asp Ser Glu Val Ala Pro Ser Phe Gly
370 375 380
Thr Leu Leu Ala Thr Val Asn Val Ala Leu Asn Met Leu Gly Glu Leu
385 390 395 400
Asp Lys Lys Lys Glu Ser Leu Thr Gln Ala Val Gly Leu Ser Thr Gln
405 410 415
Ala Glu Gly Thr Arg Thr Leu Lys Ser Leu Leu Met Phe Thr Met Glu
420 425 430
Asn Cys Phe Tyr Leu Leu Ile Ser Gln Ala Val Arg Tyr Leu Arg Asp
435 440 445
Pro Ala Val His Pro Arg Asp Lys Gln Arg Met Lys Gln Glu Leu Ser
450 455 460
Ser Glu Leu Ser Thr Leu Leu Ser Ser Leu Ser Arg Tyr Phe Arg Arg
465 470 475 480
Gly Ala Pro Ser Ser Pro Ala Ala Gly Val Leu Pro Ser Pro Gln Gly
485 490 495
Lys Ala Thr Ser Leu Ser Lys Ala Ser Pro Glu Ser Gln Glu Pro Leu
500 505 510
Ile Gln Leu Val Gln Ala Phe Val Arg His Val Gln Arg
515 520 525
<210>26
<211>6
<212>PRT
<213>人
<400>26
Ala Gly Gly Pro Cys Val
1 5
Claims (53)
1.一种编码多肽的分离核酸分子,所述多肽包括与SEQ ID NO:2的氨基酸序列至少95%同一的氨基酸序列。
2.权利要求1的分离核酸分子,其中所述的核酸分子编码结合雷帕霉素的多肽。
3.权利要求1的分离核酸分子,其中所述的核酸分子编码与SEQ IDNO:2的氨基酸序列至少98%同一的多肽。
4.权利要求1的核酸分子,其中所述的分子在严谨条件下与互补于包括SEQ ID NO:1的第1-1811位核苷酸的核酸分子的核酸序列杂交。
5.权利要求1的分离核酸分子,其中所述的核酸分子编码包括SEQID NO:2的氨基酸序列的多肽。
6.权利要求1的分离核酸分子,其中所述的核酸分子包括SEQ IDNO:1的第1-1811位核苷酸。
7.包括权利要求1的核酸分子的载体。
8.包括权利要求7的载体的细胞。
9.一种基本上纯化的多肽,其包括与SEQ ID NO:2的氨基酸序列至少95%同一的氨基酸序列。
10.权利要求9的多肽,其中所述的多肽结合雷帕霉素。
11.权利要求9的多肽,其中所述多肽的氨基酸序列与SEQ ID NO:2的氨基酸序列至少98%同一。
12.权利要求9的多肽,其中所述多肽的氨基酸序列与SEQ ID NO:2的氨基酸序列至少99%同一。
13.权利要求9的多肽,其中所述多肽的氨基酸序列包括SEQ IDNO:2的氨基酸序列。
14.权利要求9的多肽,其中所述多肽的氨基酸序列由SEQ ID NO:2的氨基酸序列组成。
15.一种融合多肽,其包括与非BFLP0169多肽可操作连接的权利要求9的多肽。
16.权利要求9的融合多肽,其中所述的非BFLP0169多肽包括选自免疫球蛋白分子的Fc区域或FLAG表位、HIS标记,和MYC标记的至少一个成员。
17.一种多肽,其包括SEQ ID NO:2的氨基酸序列的雷帕霉素结合结构域。
18.一种长度为至少1740个氨基酸的多肽,其包括SEQ ID NO:2的至少5个连续的氨基酸,只要所述的多肽包括除了SEQ ID NO:26外的氨基酸序列。
19.权利要求18的多肽,其中所述的多肽包括雷帕霉素结合结构域。
20.一种多肽,其包括SEQ ID NO:20的至少5个连续的氨基酸。
21.权利要求20的多肽,其中所述的多肽包括雷帕霉素结合结构域。
22.权利要求20的多肽,其中所述多肽的长度为至少50个氨基酸。
23.权利要求20的多肽,其中所述多肽的长度为至少100个氨基酸。
24.权利要求20的多肽,其中所述多肽的长度为至少220个氨基酸。
25.一种药物组合物,其包括权利要求17的多肽和药物学上可接受的载体。
26.一种融合多肽,其包括与非BFLP0169多肽可操作连接的BFLP0169多肽的雷帕霉素结合结构域。
27.权利要求26的融合多肽,其中所述的非BFLP01626多肽包括选自免疫球蛋白分子的Fc区域或FLAG表位、HIS标记,和MYC标记的至少一个成员。
28.一种药物组合物,其包括权利要求26的融合多肽和药物学上可接受的载体。
29.选择性地结合权利要求9的多肽的抗体。
30.权利要求29的抗体,其中所述的抗体抑制BFLP0169多肽与雷帕霉素的结合。
31.权利要求29的抗体,其中所述的抗体是多克隆抗体。
32.权利要求29的抗体,其中所述的抗体是单克隆抗体。
33.权利要求32的单克隆抗体,其中所述的单克隆抗体选自鼠单克隆抗体和人源化的单克隆抗体。
34.一种生产BFLP0169多肽的方法,所述的方法包括在容许所述核酸分子编码的BFLP0169多肽表达的条件下培养包括权利要求1的核酸分子的细胞。
35.一种检测在生物样品中存在BFLP0169核酸分子的方法,该方法包括:
将样品与特异结合BFLP0169核酸的核酸探针接触;以及
鉴定结合的探针,如果存在,
由此检测在所述的样品中BFLP0169核酸分子的存在。
36.一种检测在样品中存在BFLP0169多肽的方法,该方法包括:
将样品与选择性地结合所述多肽的化合物在容许在所述多肽与所述化合物之间形成复合物的条件下接触;以及
检测所述的复合物,如果存在,由此鉴定在所述的样品中所述的多肽的存在。
37.权利要求36的方法,其中所述的化合物是雷帕霉素。
38.权利要求36的方法,其中所述的化合物是抗-BFLP0169的抗体。
39.一种用于确定在受试个体中存在狼疮肾炎或是易患狼疮肾炎的体质的方法,该方法包括:
a)测量来自所述受试个体的样品中BFLP0169核酸分子的数量;以及
b)将上述步骤中所述核酸的数量与存在于来自没有狼疮肾炎的受试个体的对照样品中的核酸数量进行比较,
其中步骤(a)中所述BFLP0169的核酸水平与对照样品中的核酸水平相比有增加,就表明在所述的受试个体中存在狼疮肾炎或是易患狼疮肾炎的体质。
40.权利要求39的方法,其中所述的受试个体是人。
41.一种用于确定在受试个体中存在狼疮肾炎或是易患狼疮肾炎的体质的方法,该方法包括:
a)测量来自所述受试个体的样品中BFLP0169多肽的数量;以及
b)将所述多肽的数量与来自存在于没有狼疮肾炎的受试个体对照样品中的核酸数量进行比较,
其中所述BFLP0169的多肽水平与对照样品中的多肽水平相比有增加,就表明在所述的受试个体中存在狼疮肾炎或是易患狼疮肾炎的体质。
42.权利要求41的方法,其中所述的受试个体是人。
43.一种筛选用于治疗自身免疫病症的治疗剂的方法,该方法包括:
将测试化合物与BFLP0169多肽接触;以及
确定所述的测试化合物是否结合所述的BFLP0169多肽,
其中所述测试化合物与所述多肽的结合表明该测试化合物是用于自身免疫病症的治疗剂。
44.权利要求43的方法,其中所述的免疫病症是自身免疫病症。
45.权利要求44的方法,其中所述的自身免疫病症是狼疮。
46.权利要求44的方法,其中所述的自身免疫病症是狼疮肾炎。
47.权利要求43的方法,其中所述的BFLP0169是在无细胞抽提物中提供的。
48.权利要求43的方法,其中所述的BFLP1069是在细胞中提供的。
49.一种在受试个体中治疗狼疮肾炎的方法,该方法包括对所述的受试个体施用在所述的受试个体中抑制BFLP0169多肽活性的治疗有效量的试剂。
50.权利要求49的方法,其中所述的受试个体是人。
51.权利要求49的方法,其中所述的试剂是抗-BFLP0169的抗体。
52.一种药物组合物,其包括在受试个体中抑制BFLP0169多肽活性的试剂和药物学上可接受的载体。
53.权利要求52的药物组合物,其中所述的试剂是抗-BFLP0169的抗体。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42809402P | 2002-11-21 | 2002-11-21 | |
US60/428,094 | 2002-11-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1741741A true CN1741741A (zh) | 2006-03-01 |
Family
ID=32393347
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2003801090876A Pending CN1741741A (zh) | 2002-11-21 | 2003-11-21 | 用于治疗狼疮肾炎的组合物和方法 |
Country Status (9)
Country | Link |
---|---|
US (3) | US7060797B2 (zh) |
EP (1) | EP1578197A4 (zh) |
JP (1) | JP2006516388A (zh) |
CN (1) | CN1741741A (zh) |
AU (1) | AU2003294438A1 (zh) |
BR (1) | BR0316476A (zh) |
CA (1) | CA2506633A1 (zh) |
MX (1) | MXPA05005385A (zh) |
WO (1) | WO2004048521A2 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106170700A (zh) * | 2014-01-20 | 2016-11-30 | 玛丽亚·阿黛尔·西尔维亚·丹尼杰奥派德4有限公司 | 用于狼疮肾炎的治疗性随访中的预测、诊断和监测的体外方法 |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE427948T1 (de) * | 2001-04-24 | 2009-04-15 | Purdue Research Foundation | Folat-mimetika und deren folatrezeptorbindende konjugate |
ES2324708T3 (es) * | 2002-05-15 | 2009-08-13 | Endocyte, Inc. | Conjugados de vitamina-mitomicina. |
US7601332B2 (en) | 2003-01-27 | 2009-10-13 | Endocyte, Inc. | Vitamin receptor binding drug delivery conjugates |
EP1789391B1 (en) | 2004-07-23 | 2017-06-28 | Endocyte, Inc. | Bivalent linkers and conjugates thereof |
US7838657B2 (en) * | 2004-12-03 | 2010-11-23 | University Of Massachusetts | Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences |
EP1863816B1 (en) * | 2005-03-16 | 2014-06-25 | Endocyte, Inc. | Synthesis and purification of pteroic acid and conjugates thereof |
EP1948241B1 (en) * | 2005-08-19 | 2014-03-05 | Endocyte, Inc. | Multi-drug ligand conjugates |
WO2007022493A2 (en) * | 2005-08-19 | 2007-02-22 | Endocyte, Inc. | Ligand conjugates of vinca alkaloids, analogs, and derivatives |
US20100104626A1 (en) * | 2007-02-16 | 2010-04-29 | Endocyte, Inc. | Methods and compositions for treating and diagnosing kidney disease |
AU2008224988A1 (en) * | 2007-03-14 | 2008-09-18 | Endocyte, Inc. | Binding ligand linked drug delivery conjugates of tubulysins |
US9877965B2 (en) | 2007-06-25 | 2018-01-30 | Endocyte, Inc. | Vitamin receptor drug delivery conjugates for treating inflammation |
US9138484B2 (en) | 2007-06-25 | 2015-09-22 | Endocyte, Inc. | Conjugates containing hydrophilic spacer linkers |
CA2703491C (en) | 2007-10-25 | 2017-06-13 | Endocyte, Inc. | Tubulysins and processes for preparing |
WO2013126797A1 (en) | 2012-02-24 | 2013-08-29 | Purdue Research Foundation | Cholecystokinin b receptor targeting for imaging and therapy |
US20140080175A1 (en) | 2012-03-29 | 2014-03-20 | Endocyte, Inc. | Processes for preparing tubulysin derivatives and conjugates thereof |
RU2670743C9 (ru) * | 2012-05-11 | 2018-12-19 | Файв Прайм Терапьютикс, Инк. | Способы лечения состояний антителами, которые связывают рецептор колониестимулирующего фактора 1 (csf1r) |
SG11201502896XA (en) | 2012-10-16 | 2015-05-28 | Endocyte Inc | Drug delivery conjugates containing unnatural amino acids and methods for using |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2004A (en) * | 1841-03-12 | Improvement in the manner of constructing and propelling steam-vessels | ||
US2002A (en) * | 1841-03-12 | Tor and planter for plowing | ||
US2003A (en) * | 1841-03-12 | Improvement in horizontal windivhlls | ||
IL112873A (en) * | 1994-03-08 | 2005-03-20 | Wyeth Corp | Rapamycin-fkbp12 binding proteins, their isolation and their use |
US20030049804A1 (en) * | 1999-06-25 | 2003-03-13 | Markus Pompejus | Corynebacterium glutamicum genes encoding metabolic pathway proteins |
WO2001053312A1 (en) * | 1999-12-23 | 2001-07-26 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
US20020197679A1 (en) * | 2000-06-20 | 2002-12-26 | Tang Y. Tom | Novel nucleic acids and polypeptides |
JP2005535290A (ja) * | 2002-02-22 | 2005-11-24 | ジェネンテック・インコーポレーテッド | 免疫関連疾患の治療のための組成物と方法 |
-
2003
- 2003-11-21 CA CA002506633A patent/CA2506633A1/en not_active Abandoned
- 2003-11-21 JP JP2004555572A patent/JP2006516388A/ja active Pending
- 2003-11-21 CN CNA2003801090876A patent/CN1741741A/zh active Pending
- 2003-11-21 EP EP03789922A patent/EP1578197A4/en not_active Withdrawn
- 2003-11-21 BR BR0316476-4A patent/BR0316476A/pt not_active IP Right Cessation
- 2003-11-21 AU AU2003294438A patent/AU2003294438A1/en not_active Abandoned
- 2003-11-21 US US10/719,385 patent/US7060797B2/en not_active Expired - Fee Related
- 2003-11-21 MX MXPA05005385A patent/MXPA05005385A/es unknown
- 2003-11-21 WO PCT/US2003/037339 patent/WO2004048521A2/en active Application Filing
-
2006
- 2006-02-15 US US11/355,297 patent/US7491513B2/en not_active Expired - Fee Related
-
2008
- 2008-09-23 US US12/235,674 patent/US20090098132A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106170700A (zh) * | 2014-01-20 | 2016-11-30 | 玛丽亚·阿黛尔·西尔维亚·丹尼杰奥派德4有限公司 | 用于狼疮肾炎的治疗性随访中的预测、诊断和监测的体外方法 |
Also Published As
Publication number | Publication date |
---|---|
CA2506633A1 (en) | 2004-06-10 |
JP2006516388A (ja) | 2006-07-06 |
US7060797B2 (en) | 2006-06-13 |
EP1578197A2 (en) | 2005-09-28 |
AU2003294438A1 (en) | 2004-06-18 |
US7491513B2 (en) | 2009-02-17 |
US20090098132A1 (en) | 2009-04-16 |
MXPA05005385A (es) | 2005-08-03 |
US20060228356A1 (en) | 2006-10-12 |
BR0316476A (pt) | 2005-10-11 |
US20040209284A1 (en) | 2004-10-21 |
WO2004048521A3 (en) | 2005-06-02 |
WO2004048521A2 (en) | 2004-06-10 |
EP1578197A4 (en) | 2006-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1741741A (zh) | 用于治疗狼疮肾炎的组合物和方法 | |
CN100340292C (zh) | Baff,其封闭剂以及它们在b细胞应答的调节中的应用 | |
CN101065501A (zh) | 确定基因毒性的方法 | |
CN1390232A (zh) | 人β分泌酶、抑制剂、其组合物和用途 | |
CN1128049A (zh) | 多肿瘤抑制因子基因种系突变及检测该基因癌肿倾向性的方法 | |
CN1491280A (zh) | 滑膜细胞蛋白质 | |
CN1809370A (zh) | B7-h3作为免疫调节剂的应用 | |
CN1680441A (zh) | 新型化合物 | |
CN1894409A (zh) | 人LXRα变体 | |
CN1906211A (zh) | 新的肌肉生长调节物 | |
CN1592793A (zh) | 肝细胞癌-相关基因和多肽,以及检测肝细胞癌的方法 | |
CN1684977A (zh) | 多肽与编码这些多肽的核酸和它们用于预防、诊断或治疗肝脏失调和上皮癌的用途 | |
CN101039956A (zh) | 细胞表面糖蛋白 | |
CN1630708A (zh) | 破骨细胞相关受体 | |
CN1241940C (zh) | 新型胶原蛋白样蛋白clac、其前体和它们的编码基因 | |
CN1249087C (zh) | 新的人g蛋白偶联受体 | |
CN1390256A (zh) | 新型蛋白质及其dna | |
CN1630664A (zh) | 胱冬酶-8结合蛋白及其制备和使用 | |
CN1708589A (zh) | Cns中crh应答基因 | |
CN1932016A (zh) | 影响sre活性的多核苷酸及其编码多肽和用途 | |
CN1200735C (zh) | 肾小球膜细胞增生性肾炎动物模型 | |
CN1738896A (zh) | 用于治疗狼疮性肾炎的组合物和方法 | |
CN1708511A (zh) | 对促肾上腺皮质激素释放激素刺激的应答而表达增加的基因 | |
CN1177864C (zh) | 在肝癌组织中具有表达差异的新的人蛋白及其编码序列 | |
CN1246457C (zh) | 人tsc403基因和人ing1l基因 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20060301 |
|
C20 | Patent right or utility model deemed to be abandoned or is abandoned |